<?xml version="1.0" encoding="UTF-8"?>
<drugbank>
<drug type="biotech" created="2005-06-13" updated="2020-11-02">
  <drugbank-id primary="true">DB00001</drugbank-id>
  <drugbank-id>BTD00024</drugbank-id>
  <drugbank-id>BIOD00024</drugbank-id>
  <name>Lepirudin</name>
  <description>Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.</description>
  <cas-number>138068-37-8</cas-number>
  <unii>Y43GF64R34</unii>
  <state>liquid</state>
  <indication>For the treatment of heparin-induced thrombocytopenia</indication>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB06605</drugbank-id>
      <name>Apixaban</name>
      <description>Apixaban may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06695</drugbank-id>
      <name>Dabigatran etexilate</name>
      <description>Dabigatran etexilate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01609</drugbank-id>
      <name>Deferasirox</name>
      <description>The risk or severity of gastrointestinal bleeding can be increased when Lepirudin is combined with Deferasirox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01586</drugbank-id>
      <name>Ursodeoxycholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Ursodeoxycholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02123</drugbank-id>
      <name>Glycochenodeoxycholic Acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycochenodeoxycholic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02659</drugbank-id>
      <name>Cholic Acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Cholic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02691</drugbank-id>
      <name>Glycocholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Glycocholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03619</drugbank-id>
      <name>Deoxycholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Deoxycholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04348</drugbank-id>
      <name>Taurocholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurocholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05990</drugbank-id>
      <name>Obeticholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Obeticholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06777</drugbank-id>
      <name>Chenodeoxycholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Chenodeoxycholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08833</drugbank-id>
      <name>Taurochenodeoxycholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08834</drugbank-id>
      <name>Tauroursodeoxycholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Tauroursodeoxycholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08857</drugbank-id>
      <name>Bamet-UD2</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Bamet-UD2.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11622</drugbank-id>
      <name>Dehydrocholic acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Dehydrocholic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11789</drugbank-id>
      <name>Hyodeoxycholic Acid</name>
      <description>The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Hyodeoxycholic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09075</drugbank-id>
      <name>Edoxaban</name>
      <description>The risk or severity of bleeding can be increased when Edoxaban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09053</drugbank-id>
      <name>Ibrutinib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08935</drugbank-id>
      <name>Obinutuzumab</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Obinutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06228</drugbank-id>
      <name>Rivaroxaban</name>
      <description>Lepirudin may increase the anticoagulant activities of Rivaroxaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06206</drugbank-id>
      <name>Sugammadex</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Sugammadex.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09070</drugbank-id>
      <name>Tibolone</name>
      <description>Tibolone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00932</drugbank-id>
      <name>Tipranavir</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00013</drugbank-id>
      <name>Urokinase</name>
      <description>Urokinase may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00163</drugbank-id>
      <name>Vitamin E</name>
      <description>Vitamin E may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09030</drugbank-id>
      <name>Vorapaxar</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01381</drugbank-id>
      <name>Ginkgo biloba</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Ginkgo biloba.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01181</drugbank-id>
      <name>Ifosfamide</name>
      <description>The risk or severity of bleeding can be increased when Ifosfamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00468</drugbank-id>
      <name>Quinine</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00908</drugbank-id>
      <name>Quinidine</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00675</drugbank-id>
      <name>Tamoxifen</name>
      <description>The risk or severity of bleeding can be increased when Tamoxifen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00539</drugbank-id>
      <name>Toremifene</name>
      <description>The risk or severity of bleeding can be increased when Toremifene is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00806</drugbank-id>
      <name>Pentoxifylline</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Pentoxifylline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00686</drugbank-id>
      <name>Pentosan polysulfate</name>
      <description>Pentosan polysulfate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00583</drugbank-id>
      <name>Levocarnitine</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Levocarnitine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00255</drugbank-id>
      <name>Diethylstilbestrol</name>
      <description>Diethylstilbestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00269</drugbank-id>
      <name>Chlorotrianisene</name>
      <description>Chlorotrianisene may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00286</drugbank-id>
      <name>Conjugated estrogens</name>
      <description>Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00783</drugbank-id>
      <name>Estradiol</name>
      <description>Estradiol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00977</drugbank-id>
      <name>Ethinylestradiol</name>
      <description>Ethinylestradiol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01357</drugbank-id>
      <name>Mestranol</name>
      <description>Mestranol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04574</drugbank-id>
      <name>Estrone sulfate</name>
      <description>Estrone sulfate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04575</drugbank-id>
      <name>Quinestrol</name>
      <description>Quinestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07931</drugbank-id>
      <name>Hexestrol</name>
      <description>Hexestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09317</drugbank-id>
      <name>Synthetic Conjugated Estrogens, A</name>
      <description>Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09318</drugbank-id>
      <name>Synthetic Conjugated Estrogens, B</name>
      <description>Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09369</drugbank-id>
      <name>Polyestradiol phosphate</name>
      <description>Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09381</drugbank-id>
      <name>Esterified estrogens</name>
      <description>Esterified estrogens may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11478</drugbank-id>
      <name>Zeranol</name>
      <description>Zeranol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11674</drugbank-id>
      <name>Equol</name>
      <description>Equol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13143</drugbank-id>
      <name>Methallenestril</name>
      <description>Methallenestril may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13386</drugbank-id>
      <name>Epimestrol</name>
      <description>Epimestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13418</drugbank-id>
      <name>Moxestrol</name>
      <description>Moxestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13952</drugbank-id>
      <name>Estradiol acetate</name>
      <description>Estradiol acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13953</drugbank-id>
      <name>Estradiol benzoate</name>
      <description>Estradiol benzoate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13954</drugbank-id>
      <name>Estradiol cypionate</name>
      <description>Estradiol cypionate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13956</drugbank-id>
      <name>Estradiol valerate</name>
      <description>Estradiol valerate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15334</drugbank-id>
      <name>Biochanin A</name>
      <description>Biochanin A may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15335</drugbank-id>
      <name>Formononetin</name>
      <description>Formononetin may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00655</drugbank-id>
      <name>Estrone</name>
      <description>Estrone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04573</drugbank-id>
      <name>Estriol</name>
      <description>Estriol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09211</drugbank-id>
      <name>Limaprost</name>
      <description>The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00159</drugbank-id>
      <name>Icosapent</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00244</drugbank-id>
      <name>Mesalazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00328</drugbank-id>
      <name>Indomethacin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00461</drugbank-id>
      <name>Nabumetone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00465</drugbank-id>
      <name>Ketorolac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00469</drugbank-id>
      <name>Tenoxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00482</drugbank-id>
      <name>Celecoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00500</drugbank-id>
      <name>Tolmetin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00533</drugbank-id>
      <name>Rofecoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00554</drugbank-id>
      <name>Piroxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00573</drugbank-id>
      <name>Fenoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00580</drugbank-id>
      <name>Valdecoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00586</drugbank-id>
      <name>Diclofenac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00605</drugbank-id>
      <name>Sulindac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00712</drugbank-id>
      <name>Flurbiprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00749</drugbank-id>
      <name>Etodolac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00784</drugbank-id>
      <name>Mefenamic acid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00788</drugbank-id>
      <name>Naproxen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00795</drugbank-id>
      <name>Sulfasalazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00812</drugbank-id>
      <name>Phenylbutazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00814</drugbank-id>
      <name>Meloxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00821</drugbank-id>
      <name>Carprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00861</drugbank-id>
      <name>Diflunisal</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00936</drugbank-id>
      <name>Salicylic acid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00939</drugbank-id>
      <name>Meclofenamic acid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00991</drugbank-id>
      <name>Oxaprozin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01009</drugbank-id>
      <name>Ketoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01014</drugbank-id>
      <name>Balsalazide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01250</drugbank-id>
      <name>Olsalazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01283</drugbank-id>
      <name>Lumiracoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01397</drugbank-id>
      <name>Magnesium salicylate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01399</drugbank-id>
      <name>Salsalate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01401</drugbank-id>
      <name>Choline magnesium trisalicylate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01419</drugbank-id>
      <name>Antrafenine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01424</drugbank-id>
      <name>Aminophenazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01435</drugbank-id>
      <name>Antipyrine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01600</drugbank-id>
      <name>Tiaprofenic acid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01628</drugbank-id>
      <name>Etoricoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02224</drugbank-id>
      <name>Taxifolin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03585</drugbank-id>
      <name>Oxyphenbutazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04725</drugbank-id>
      <name>Licofelone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04812</drugbank-id>
      <name>Benoxaprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04817</drugbank-id>
      <name>Metamizole</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04828</drugbank-id>
      <name>Zomepirac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05095</drugbank-id>
      <name>Cimicoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06725</drugbank-id>
      <name>Lornoxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06736</drugbank-id>
      <name>Aceclofenac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06737</drugbank-id>
      <name>Zaltoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07402</drugbank-id>
      <name>Azapropazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08439</drugbank-id>
      <name>Parecoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08797</drugbank-id>
      <name>Salicylamide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08940</drugbank-id>
      <name>Kebuzone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08942</drugbank-id>
      <name>Isoxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08951</drugbank-id>
      <name>Indoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08955</drugbank-id>
      <name>Ibuproxam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08976</drugbank-id>
      <name>Floctafenine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08981</drugbank-id>
      <name>Fenbufen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08984</drugbank-id>
      <name>Etofenamate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08991</drugbank-id>
      <name>Epirizole</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09084</drugbank-id>
      <name>Benzydamine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09214</drugbank-id>
      <name>Dexketoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09215</drugbank-id>
      <name>Droxicam</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09216</drugbank-id>
      <name>Tolfenamic acid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09217</drugbank-id>
      <name>Firocoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09218</drugbank-id>
      <name>Clonixin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09285</drugbank-id>
      <name>Morniflumate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09288</drugbank-id>
      <name>Propacetamol</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09295</drugbank-id>
      <name>Talniflumate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11455</drugbank-id>
      <name>Robenacoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11466</drugbank-id>
      <name>Tepoxalin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11518</drugbank-id>
      <name>Flunixin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12399</drugbank-id>
      <name>Polmacoxib</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12610</drugbank-id>
      <name>Ebselen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13001</drugbank-id>
      <name>Tinoridine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13167</drugbank-id>
      <name>Alclofenac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13217</drugbank-id>
      <name>Fentiazac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13232</drugbank-id>
      <name>Suxibuzone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13286</drugbank-id>
      <name>Bumadizone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13314</drugbank-id>
      <name>Alminoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13371</drugbank-id>
      <name>Difenpiramide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13407</drugbank-id>
      <name>Nifenazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13432</drugbank-id>
      <name>Lonazolac</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13481</drugbank-id>
      <name>Tenidap</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13524</drugbank-id>
      <name>Propyphenazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13527</drugbank-id>
      <name>Proglumetacin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13538</drugbank-id>
      <name>Guacetisal</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13544</drugbank-id>
      <name>Ethenzamide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13612</drugbank-id>
      <name>Carbaspirin calcium</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13629</drugbank-id>
      <name>Mofebutazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13649</drugbank-id>
      <name>Proquazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13657</drugbank-id>
      <name>Benorilate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13722</drugbank-id>
      <name>Pirprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13860</drugbank-id>
      <name>Imidazole salicylate</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14059</drugbank-id>
      <name>SC-236</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14060</drugbank-id>
      <name>NS-398</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14938</drugbank-id>
      <name>Flurbiprofen axetil</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09212</drugbank-id>
      <name>Loxoprofen</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04865</drugbank-id>
      <name>Omacetaxine mepesuccinate</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11133</drugbank-id>
      <name>Omega-3 fatty acids</name>
      <description>Omega-3 fatty acids may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00081</drugbank-id>
      <name>Tositumomab</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Lepirudin is combined with Tositumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00048</drugbank-id>
      <name>Collagenase clostridium histolyticum</name>
      <description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00389</drugbank-id>
      <name>Carbimazole</name>
      <description>Carbimazole may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00550</drugbank-id>
      <name>Propylthiouracil</name>
      <description>Propylthiouracil may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00763</drugbank-id>
      <name>Methimazole</name>
      <description>Methimazole may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03374</drugbank-id>
      <name>3,5-Diiodotyrosine</name>
      <description>3,5-Diiodotyrosine may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06715</drugbank-id>
      <name>Potassium Iodide</name>
      <description>Potassium Iodide may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07637</drugbank-id>
      <name>Dibromotyrosine</name>
      <description>Dibromotyrosine may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09418</drugbank-id>
      <name>Potassium perchlorate</name>
      <description>Potassium perchlorate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13644</drugbank-id>
      <name>Methylthiouracil</name>
      <description>Methylthiouracil may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13804</drugbank-id>
      <name>Benzylthiouracil</name>
      <description>Benzylthiouracil may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00834</drugbank-id>
      <name>Mifepristone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mifepristone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04066</drugbank-id>
      <name>p-Coumaric acid</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with p-Coumaric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04682</drugbank-id>
      <name>Octylphenoxy polyethoxyethanol</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05830</drugbank-id>
      <name>Trestolone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trestolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06266</drugbank-id>
      <name>Lonidamine</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Lonidamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08867</drugbank-id>
      <name>Ulipristal</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ulipristal.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09401</drugbank-id>
      <name>Isosorbide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Isosorbide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11507</drugbank-id>
      <name>Cloprostenol</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cloprostenol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12025</drugbank-id>
      <name>Triptolide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triptolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13044</drugbank-id>
      <name>Gossypol</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gossypol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13310</drugbank-id>
      <name>Ormeloxifene</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ormeloxifene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00294</drugbank-id>
      <name>Etonogestrel</name>
      <description>Etonogestrel may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00304</drugbank-id>
      <name>Desogestrel</name>
      <description>Desogestrel may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00351</drugbank-id>
      <name>Megestrol acetate</name>
      <description>Megestrol acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00367</drugbank-id>
      <name>Levonorgestrel</name>
      <description>Levonorgestrel may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00378</drugbank-id>
      <name>Dydrogesterone</name>
      <description>Dydrogesterone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00396</drugbank-id>
      <name>Progesterone</name>
      <description>Progesterone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00603</drugbank-id>
      <name>Medroxyprogesterone acetate</name>
      <description>Medroxyprogesterone acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00717</drugbank-id>
      <name>Norethisterone</name>
      <description>Norethisterone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00823</drugbank-id>
      <name>Ethynodiol diacetate</name>
      <description>Ethynodiol diacetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00957</drugbank-id>
      <name>Norgestimate</name>
      <description>Norgestimate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01395</drugbank-id>
      <name>Drospirenone</name>
      <description>Drospirenone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01431</drugbank-id>
      <name>Allylestrenol</name>
      <description>Allylestrenol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04839</drugbank-id>
      <name>Cyproterone acetate</name>
      <description>Cyproterone acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06713</drugbank-id>
      <name>Norelgestromin</name>
      <description>Norelgestromin may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06730</drugbank-id>
      <name>Gestodene</name>
      <description>Gestodene may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06789</drugbank-id>
      <name>Hydroxyprogesterone caproate</name>
      <description>Hydroxyprogesterone caproate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09123</drugbank-id>
      <name>Dienogest</name>
      <description>Dienogest may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09124</drugbank-id>
      <name>Medrogestone</name>
      <description>Medrogestone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09371</drugbank-id>
      <name>Norethynodrel</name>
      <description>Norethynodrel may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09389</drugbank-id>
      <name>Norgestrel</name>
      <description>Norgestrel may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11372</drugbank-id>
      <name>Altrenogest</name>
      <description>Altrenogest may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11619</drugbank-id>
      <name>Gestrinone</name>
      <description>Gestrinone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11636</drugbank-id>
      <name>Nomegestrol</name>
      <description>Nomegestrol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12474</drugbank-id>
      <name>Lynestrenol</name>
      <description>Lynestrenol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13230</drugbank-id>
      <name>Gestonorone</name>
      <description>Gestonorone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13528</drugbank-id>
      <name>Chlormadinone</name>
      <description>Chlormadinone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13533</drugbank-id>
      <name>Methylestrenolone</name>
      <description>Methylestrenolone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13563</drugbank-id>
      <name>Norgestrienone</name>
      <description>Norgestrienone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13602</drugbank-id>
      <name>Promegestone</name>
      <description>Promegestone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13685</drugbank-id>
      <name>Quingestanol</name>
      <description>Quingestanol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13857</drugbank-id>
      <name>Demegestone</name>
      <description>Demegestone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13866</drugbank-id>
      <name>Etynodiol</name>
      <description>Etynodiol may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13981</drugbank-id>
      <name>Nomegestrol acetate</name>
      <description>Nomegestrol acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14570</drugbank-id>
      <name>Hydroxyprogesterone</name>
      <description>Hydroxyprogesterone may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14678</drugbank-id>
      <name>Norethindrone enanthate</name>
      <description>Norethindrone enanthate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14679</drugbank-id>
      <name>Quingestanol acetate</name>
      <description>Quingestanol acetate may decrease the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00233</drugbank-id>
      <name>Aminosalicylic acid</name>
      <description>The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01294</drugbank-id>
      <name>Bismuth subsalicylate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06251</drugbank-id>
      <name>Dersalazine</name>
      <description>The risk or severity of bleeding can be increased when Dersalazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06807</drugbank-id>
      <name>Phenyl aminosalicylate</name>
      <description>The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09543</drugbank-id>
      <name>Methyl salicylate</name>
      <description>The risk or severity of bleeding can be increased when Methyl salicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11079</drugbank-id>
      <name>Trolamine salicylate</name>
      <description>The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13509</drugbank-id>
      <name>Aloxiprin</name>
      <description>The risk or severity of bleeding can be increased when Aloxiprin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14006</drugbank-id>
      <name>Choline salicylate</name>
      <description>The risk or severity of bleeding can be increased when Choline salicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14026</drugbank-id>
      <name>Thiosalicylic acid</name>
      <description>The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00054</drugbank-id>
      <name>Abciximab</name>
      <description>The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00063</drugbank-id>
      <name>Eptifibatide</name>
      <description>The risk or severity of bleeding can be increased when Eptifibatide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00208</drugbank-id>
      <name>Ticlopidine</name>
      <description>The risk or severity of bleeding can be increased when Ticlopidine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>The risk or severity of bleeding can be increased when Anagrelide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00758</drugbank-id>
      <name>Clopidogrel</name>
      <description>The risk or severity of bleeding can be increased when Clopidogrel is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00775</drugbank-id>
      <name>Tirofiban</name>
      <description>The risk or severity of bleeding can be increased when Tirofiban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00975</drugbank-id>
      <name>Dipyridamole</name>
      <description>The risk or severity of bleeding can be increased when Dipyridamole is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01088</drugbank-id>
      <name>Iloprost</name>
      <description>The risk or severity of bleeding can be increased when Iloprost is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01138</drugbank-id>
      <name>Sulfinpyrazone</name>
      <description>The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01166</drugbank-id>
      <name>Cilostazol</name>
      <description>The risk or severity of bleeding can be increased when Cilostazol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01207</drugbank-id>
      <name>Ridogrel</name>
      <description>The risk or severity of bleeding can be increased when Ridogrel is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01236</drugbank-id>
      <name>Sevoflurane</name>
      <description>The risk or severity of bleeding can be increased when Sevoflurane is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01240</drugbank-id>
      <name>Epoprostenol</name>
      <description>The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02709</drugbank-id>
      <name>Resveratrol</name>
      <description>The risk or severity of bleeding can be increased when Resveratrol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04743</drugbank-id>
      <name>Nimesulide</name>
      <description>The risk or severity of bleeding can be increased when Nimesulide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04905</drugbank-id>
      <name>Tesmilifene</name>
      <description>The risk or severity of bleeding can be increased when Tesmilifene is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04932</drugbank-id>
      <name>Defibrotide</name>
      <description>The risk or severity of bleeding can be increased when Defibrotide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05229</drugbank-id>
      <name>Beraprost</name>
      <description>The risk or severity of bleeding can be increased when Beraprost is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05266</drugbank-id>
      <name>Ibudilast</name>
      <description>The risk or severity of bleeding can be increased when Ibudilast is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05767</drugbank-id>
      <name>Andrographolide</name>
      <description>The risk or severity of bleeding can be increased when Andrographolide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06081</drugbank-id>
      <name>Caplacizumab</name>
      <description>The risk or severity of bleeding can be increased when Caplacizumab is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06209</drugbank-id>
      <name>Prasugrel</name>
      <description>The risk or severity of bleeding can be increased when Prasugrel is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06441</drugbank-id>
      <name>Cangrelor</name>
      <description>The risk or severity of bleeding can be increased when Cangrelor is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07615</drugbank-id>
      <name>Tranilast</name>
      <description>The risk or severity of bleeding can be increased when Tranilast is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08814</drugbank-id>
      <name>Triflusal</name>
      <description>The risk or severity of bleeding can be increased when Triflusal is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08816</drugbank-id>
      <name>Ticagrelor</name>
      <description>The risk or severity of bleeding can be increased when Ticagrelor is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08887</drugbank-id>
      <name>Icosapent ethyl</name>
      <description>The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09283</drugbank-id>
      <name>Trapidil</name>
      <description>The risk or severity of bleeding can be increased when Trapidil is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12092</drugbank-id>
      <name>Naftopidil</name>
      <description>The risk or severity of bleeding can be increased when Naftopidil is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12163</drugbank-id>
      <name>Sarpogrelate</name>
      <description>The risk or severity of bleeding can be increased when Sarpogrelate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12321</drugbank-id>
      <name>Ifetroban</name>
      <description>The risk or severity of bleeding can be increased when Ifetroban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12445</drugbank-id>
      <name>Nitroaspirin</name>
      <description>The risk or severity of bleeding can be increased when Nitroaspirin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12465</drugbank-id>
      <name>Ketanserin</name>
      <description>The risk or severity of bleeding can be increased when Ketanserin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12545</drugbank-id>
      <name>Indobufen</name>
      <description>The risk or severity of bleeding can be increased when Indobufen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12749</drugbank-id>
      <name>Butylphthalide</name>
      <description>The risk or severity of bleeding can be increased when Butylphthalide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12771</drugbank-id>
      <name>Hydroxytyrosol</name>
      <description>The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13036</drugbank-id>
      <name>Ramatroban</name>
      <description>The risk or severity of bleeding can be increased when Ramatroban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13327</drugbank-id>
      <name>Picotamide</name>
      <description>The risk or severity of bleeding can be increased when Picotamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13367</drugbank-id>
      <name>Cloricromen</name>
      <description>The risk or severity of bleeding can be increased when Cloricromen is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13400</drugbank-id>
      <name>Linsidomine</name>
      <description>The risk or severity of bleeding can be increased when Linsidomine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13510</drugbank-id>
      <name>Buflomedil</name>
      <description>The risk or severity of bleeding can be increased when Buflomedil is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13929</drugbank-id>
      <name>Relcovaptan</name>
      <description>The risk or severity of bleeding can be increased when Relcovaptan is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00374</drugbank-id>
      <name>Treprostinil</name>
      <description>The risk or severity of bleeding can be increased when Treprostinil is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03404</drugbank-id>
      <name>Hemin</name>
      <description>Hemin may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13783</drugbank-id>
      <name>Acemetacin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00624</drugbank-id>
      <name>Testosterone</name>
      <description>Testosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01420</drugbank-id>
      <name>Testosterone propionate</name>
      <description>Testosterone propionate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01481</drugbank-id>
      <name>1-Testosterone</name>
      <description>1-Testosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01485</drugbank-id>
      <name>4-Hydroxytestosterone</name>
      <description>4-Hydroxytestosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01510</drugbank-id>
      <name>Dehydrochloromethyltestosterone</name>
      <description>Dehydrochloromethyltestosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01541</drugbank-id>
      <name>Boldenone</name>
      <description>Boldenone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01543</drugbank-id>
      <name>18-methyl-19-nortestosterone</name>
      <description>18-methyl-19-nortestosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01564</drugbank-id>
      <name>Calusterone</name>
      <description>Calusterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01569</drugbank-id>
      <name>Formebolone</name>
      <description>Formebolone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01572</drugbank-id>
      <name>Methyl-1-testosterone</name>
      <description>Methyl-1-testosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07447</drugbank-id>
      <name>5beta-dihydrotestosterone</name>
      <description>5beta-dihydrotestosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08619</drugbank-id>
      <name>Testosterone succinate</name>
      <description>Testosterone succinate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11429</drugbank-id>
      <name>Mibolerone</name>
      <description>Mibolerone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13943</drugbank-id>
      <name>Testosterone cypionate</name>
      <description>Testosterone cypionate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13944</drugbank-id>
      <name>Testosterone enanthate</name>
      <description>Testosterone enanthate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13946</drugbank-id>
      <name>Testosterone undecanoate</name>
      <description>Testosterone undecanoate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13947</drugbank-id>
      <name>Testosterone enantate benzilic acid hydrazone</name>
      <description>Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13951</drugbank-id>
      <name>Stanolone acetate</name>
      <description>Stanolone acetate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13958</drugbank-id>
      <name>Trestolone acetate</name>
      <description>Trestolone acetate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14093</drugbank-id>
      <name>(1,2,6,7-3H)Testosterone</name>
      <description>(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14655</drugbank-id>
      <name>Drostanolone propionate</name>
      <description>Drostanolone propionate may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11051</drugbank-id>
      <name>Azficel-T</name>
      <description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Azficel-T.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09568</drugbank-id>
      <name>Omega-3-carboxylic acids</name>
      <description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Omega-3-carboxylic acids.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00025</drugbank-id>
      <name>Antihemophilic factor, human recombinant</name>
      <description>The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00036</drugbank-id>
      <name>Coagulation factor VIIa Recombinant Human</name>
      <description>The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00100</drugbank-id>
      <name>Coagulation Factor IX (Recombinant)</name>
      <description>The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00258</drugbank-id>
      <name>Calcium acetate</name>
      <description>The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01164</drugbank-id>
      <name>Calcium chloride</name>
      <description>The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01373</drugbank-id>
      <name>Calcium</name>
      <description>The therapeutic efficacy of Calcium can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01783</drugbank-id>
      <name>Pantothenic acid</name>
      <description>The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01942</drugbank-id>
      <name>Formic acid</name>
      <description>The therapeutic efficacy of Formic acid can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02261</drugbank-id>
      <name>Platelet Activating Factor</name>
      <description>The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06724</drugbank-id>
      <name>Calcium carbonate</name>
      <description>The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09109</drugbank-id>
      <name>Turoctocog alfa</name>
      <description>The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09222</drugbank-id>
      <name>Fibrinogen human</name>
      <description>The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09310</drugbank-id>
      <name>Catridecacog</name>
      <description>The therapeutic efficacy of Catridecacog can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09329</drugbank-id>
      <name>Antihemophilic Factor (Recombinant), PEGylated</name>
      <description>The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11093</drugbank-id>
      <name>Calcium citrate</name>
      <description>The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11126</drugbank-id>
      <name>Calcium gluconate</name>
      <description>The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11168</drugbank-id>
      <name>Calcium threonate</name>
      <description>The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11311</drugbank-id>
      <name>Prothrombin</name>
      <description>The therapeutic efficacy of Prothrombin can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11330</drugbank-id>
      <name>Factor IX Complex (Human)</name>
      <description>The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11348</drugbank-id>
      <name>Calcium Phosphate</name>
      <description>The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11606</drugbank-id>
      <name>Susoctocog alfa</name>
      <description>The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11608</drugbank-id>
      <name>Eftrenonacog alfa</name>
      <description>The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11668</drugbank-id>
      <name>Rusalatide acetate</name>
      <description>The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12409</drugbank-id>
      <name>Vatreptacog alfa</name>
      <description>The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12909</drugbank-id>
      <name>Factor XIII (human)</name>
      <description>The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13133</drugbank-id>
      <name>Von Willebrand Factor Human</name>
      <description>The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13148</drugbank-id>
      <name>Coagulation factor X human</name>
      <description>The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13150</drugbank-id>
      <name>Coagulation factor VII human</name>
      <description>The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13151</drugbank-id>
      <name>Anti-inhibitor coagulant complex</name>
      <description>The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13152</drugbank-id>
      <name>Coagulation Factor IX Human</name>
      <description>The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13192</drugbank-id>
      <name>Antihemophilic factor human</name>
      <description>The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13197</drugbank-id>
      <name>Kallidinogenase</name>
      <description>The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13201</drugbank-id>
      <name>Trenonacog alfa</name>
      <description>The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13884</drugbank-id>
      <name>Albutrepenonacog alfa</name>
      <description>The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13923</drugbank-id>
      <name>Emicizumab</name>
      <description>The therapeutic efficacy of Emicizumab can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13933</drugbank-id>
      <name>Nonacog beta pegol</name>
      <description>The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13999</drugbank-id>
      <name>Moroctocog alfa</name>
      <description>The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14473</drugbank-id>
      <name>Beroctocog alfa</name>
      <description>The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14562</drugbank-id>
      <name>Andexanet alfa</name>
      <description>The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14577</drugbank-id>
      <name>Calcium cation</name>
      <description>The therapeutic efficacy of Calcium cation can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14700</drugbank-id>
      <name>Damoctocog alfa pegol</name>
      <description>The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14738</drugbank-id>
      <name>Turoctocog alfa pegol</name>
      <description>The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00176</drugbank-id>
      <name>Fluvoxamine</name>
      <description>The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00215</drugbank-id>
      <name>Citalopram</name>
      <description>The risk or severity of hemorrhage can be increased when Citalopram is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00472</drugbank-id>
      <name>Fluoxetine</name>
      <description>The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00715</drugbank-id>
      <name>Paroxetine</name>
      <description>The risk or severity of hemorrhage can be increased when Paroxetine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01149</drugbank-id>
      <name>Nefazodone</name>
      <description>The risk or severity of hemorrhage can be increased when Nefazodone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04832</drugbank-id>
      <name>Zimelidine</name>
      <description>The risk or severity of hemorrhage can be increased when Zimelidine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04884</drugbank-id>
      <name>Dapoxetine</name>
      <description>The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06731</drugbank-id>
      <name>Seproxetine</name>
      <description>The risk or severity of hemorrhage can be increased when Seproxetine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08953</drugbank-id>
      <name>Indalpine</name>
      <description>The risk or severity of hemorrhage can be increased when Indalpine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12693</drugbank-id>
      <name>Ritanserin</name>
      <description>The risk or severity of hemorrhage can be increased when Ritanserin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13233</drugbank-id>
      <name>Alaproclate</name>
      <description>The risk or severity of hemorrhage can be increased when Alaproclate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00476</drugbank-id>
      <name>Duloxetine</name>
      <description>The risk or severity of hemorrhage can be increased when Duloxetine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01105</drugbank-id>
      <name>Sibutramine</name>
      <description>The risk or severity of hemorrhage can be increased when Sibutramine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04896</drugbank-id>
      <name>Milnacipran</name>
      <description>The risk or severity of hemorrhage can be increased when Milnacipran is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06700</drugbank-id>
      <name>Desvenlafaxine</name>
      <description>The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08918</drugbank-id>
      <name>Levomilnacipran</name>
      <description>The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00285</drugbank-id>
      <name>Venlafaxine</name>
      <description>Venlafaxine may increase the antiplatelet activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00182</drugbank-id>
      <name>Amphetamine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00601</drugbank-id>
      <name>Linezolid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00614</drugbank-id>
      <name>Furazolidone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00721</drugbank-id>
      <name>Procaine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00752</drugbank-id>
      <name>Tranylcypromine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00780</drugbank-id>
      <name>Phenelzine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00805</drugbank-id>
      <name>Minaprine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01037</drugbank-id>
      <name>Selegiline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01168</drugbank-id>
      <name>Procarbazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01171</drugbank-id>
      <name>Moclobemide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01247</drugbank-id>
      <name>Isocarboxazid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01367</drugbank-id>
      <name>Rasagiline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01626</drugbank-id>
      <name>Pargyline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04017</drugbank-id>
      <name>Clorgiline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04818</drugbank-id>
      <name>Iproniazid</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04820</drugbank-id>
      <name>Nialamide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06654</drugbank-id>
      <name>Safinamide</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08550</drugbank-id>
      <name>7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09241</drugbank-id>
      <name>Methylene blue</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09243</drugbank-id>
      <name>Hydracarbazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09244</drugbank-id>
      <name>Pirlindole</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09245</drugbank-id>
      <name>Toloxatone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09246</drugbank-id>
      <name>Benmoxin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09248</drugbank-id>
      <name>Mebanazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09249</drugbank-id>
      <name>Octamoxin</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09250</drugbank-id>
      <name>Pheniprazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09251</drugbank-id>
      <name>Phenoxypropazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09252</drugbank-id>
      <name>Pivhydrazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09253</drugbank-id>
      <name>Safrazine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09254</drugbank-id>
      <name>Caroxazone</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13875</drugbank-id>
      <name>Harmaline</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13876</drugbank-id>
      <name>Brofaromine</name>
      <description>The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00006</drugbank-id>
      <name>Bivalirudin</name>
      <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00266</drugbank-id>
      <name>Dicoumarol</name>
      <description>The risk or severity of bleeding can be increased when Dicoumarol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00278</drugbank-id>
      <name>Argatroban</name>
      <description>The risk or severity of bleeding can be increased when Argatroban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00407</drugbank-id>
      <name>Ardeparin</name>
      <description>The risk or severity of bleeding can be increased when Ardeparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00498</drugbank-id>
      <name>Phenindione</name>
      <description>The risk or severity of bleeding can be increased when Phenindione is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00569</drugbank-id>
      <name>Fondaparinux</name>
      <description>The risk or severity of bleeding can be increased when Fondaparinux is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00682</drugbank-id>
      <name>Warfarin</name>
      <description>The risk or severity of bleeding can be increased when Warfarin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00946</drugbank-id>
      <name>Phenprocoumon</name>
      <description>The risk or severity of bleeding can be increased when Phenprocoumon is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00974</drugbank-id>
      <name>Edetic acid</name>
      <description>The risk or severity of bleeding can be increased when Edetic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01109</drugbank-id>
      <name>Heparin</name>
      <description>The risk or severity of bleeding can be increased when Heparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01225</drugbank-id>
      <name>Enoxaparin</name>
      <description>The risk or severity of bleeding can be increased when Enoxaparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01418</drugbank-id>
      <name>Acenocoumarol</name>
      <description>The risk or severity of bleeding can be increased when Acenocoumarol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04898</drugbank-id>
      <name>Ximelagatran</name>
      <description>The risk or severity of bleeding can be increased when Ximelagatran is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05099</drugbank-id>
      <name>Ancrod</name>
      <description>The risk or severity of bleeding can be increased when Ancrod is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06271</drugbank-id>
      <name>Sulodexide</name>
      <description>The risk or severity of bleeding can be increased when Sulodexide is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06406</drugbank-id>
      <name>Idraparinux</name>
      <description>The risk or severity of bleeding can be increased when Idraparinux is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06635</drugbank-id>
      <name>Otamixaban</name>
      <description>The risk or severity of bleeding can be increased when Otamixaban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06754</drugbank-id>
      <name>Danaparoid</name>
      <description>The risk or severity of bleeding can be increased when Danaparoid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06779</drugbank-id>
      <name>Dalteparin</name>
      <description>The risk or severity of bleeding can be increased when Dalteparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07767</drugbank-id>
      <name>Ferulic acid</name>
      <description>The risk or severity of bleeding can be increased when Ferulic acid is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08794</drugbank-id>
      <name>Ethyl biscoumacetate</name>
      <description>The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08813</drugbank-id>
      <name>Nadroparin</name>
      <description>The risk or severity of bleeding can be increased when Nadroparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09255</drugbank-id>
      <name>Dextran</name>
      <description>The risk or severity of bleeding can be increased when Dextran is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11095</drugbank-id>
      <name>Desirudin</name>
      <description>The risk or severity of bleeding can be increased when Desirudin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11268</drugbank-id>
      <name>Protocatechualdehyde</name>
      <description>The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11312</drugbank-id>
      <name>Protein C</name>
      <description>The risk or severity of bleeding can be increased when Protein C is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11598</drugbank-id>
      <name>Antithrombin III human</name>
      <description>The risk or severity of bleeding can be increased when Antithrombin III human is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11984</drugbank-id>
      <name>Letaxaban</name>
      <description>The risk or severity of bleeding can be increased when Letaxaban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12289</drugbank-id>
      <name>Darexaban</name>
      <description>The risk or severity of bleeding can be increased when Darexaban is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12598</drugbank-id>
      <name>Nafamostat</name>
      <description>The risk or severity of bleeding can be increased when Nafamostat is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12831</drugbank-id>
      <name>Gabexate</name>
      <description>The risk or severity of bleeding can be increased when Gabexate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13124</drugbank-id>
      <name>Troxerutin</name>
      <description>The risk or severity of bleeding can be increased when Troxerutin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13136</drugbank-id>
      <name>Fluindione</name>
      <description>The risk or severity of bleeding can be increased when Fluindione is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13149</drugbank-id>
      <name>Protein S human</name>
      <description>The risk or severity of bleeding can be increased when Protein S human is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13616</drugbank-id>
      <name>Melagatran</name>
      <description>The risk or severity of bleeding can be increased when Melagatran is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09125</drugbank-id>
      <name>Potassium citrate</name>
      <description>The risk or severity of bleeding can be increased when Potassium citrate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09154</drugbank-id>
      <name>Sodium citrate</name>
      <description>The risk or severity of bleeding can be increased when Sodium citrate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00031</drugbank-id>
      <name>Tenecteplase</name>
      <description>The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00055</drugbank-id>
      <name>Drotrecogin alfa</name>
      <description>The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06822</drugbank-id>
      <name>Tinzaparin</name>
      <description>The risk or severity of bleeding can be increased when Tinzaparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13199</drugbank-id>
      <name>Brinase</name>
      <description>The risk or severity of bleeding can be increased when Brinase is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13646</drugbank-id>
      <name>Saruplase</name>
      <description>The risk or severity of bleeding can be increased when Saruplase is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00086</drugbank-id>
      <name>Streptokinase</name>
      <description>The risk or severity of bleeding can be increased when Streptokinase is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04925</drugbank-id>
      <name>Desmoteplase</name>
      <description>The risk or severity of bleeding can be increased when Desmoteplase is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05254</drugbank-id>
      <name>Fibrinolysin</name>
      <description>The risk or severity of bleeding can be increased when Fibrinolysin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06543</drugbank-id>
      <name>Astaxanthin</name>
      <description>The risk or severity of bleeding can be increased when Astaxanthin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08994</drugbank-id>
      <name>Ditazole</name>
      <description>The risk or severity of bleeding can be increased when Ditazole is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09258</drugbank-id>
      <name>Bemiparin</name>
      <description>The risk or severity of bleeding can be increased when Bemiparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09260</drugbank-id>
      <name>Parnaparin</name>
      <description>The risk or severity of bleeding can be increased when Parnaparin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13275</drugbank-id>
      <name>Clorindione</name>
      <description>The risk or severity of bleeding can be increased when Clorindione is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13347</drugbank-id>
      <name>Diphenadione</name>
      <description>The risk or severity of bleeding can be increased when Diphenadione is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13451</drugbank-id>
      <name>Tioclomarol</name>
      <description>The risk or severity of bleeding can be increased when Tioclomarol is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00009</drugbank-id>
      <name>Alteplase</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00015</drugbank-id>
      <name>Reteplase</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00029</drugbank-id>
      <name>Anistreplase</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14094</drugbank-id>
      <name>Tocopherylquinone</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Tocopherylquinone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06679</drugbank-id>
      <name>Amediplase</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Amediplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03410</drugbank-id>
      <name>4-hydroxycoumarin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with 4-hydroxycoumarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08496</drugbank-id>
      <name>(R)-warfarin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with (R)-warfarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14055</drugbank-id>
      <name>(S)-Warfarin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with (S)-Warfarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12364</drugbank-id>
      <name>Betrixaban</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Betrixaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14598</drugbank-id>
      <name>Edetate calcium disodium anhydrous</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Edetate calcium disodium anhydrous.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11154</drugbank-id>
      <name>Zinc citrate</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Zinc citrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11166</drugbank-id>
      <name>Antithrombin Alfa</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Antithrombin Alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04665</drugbank-id>
      <name>Coumarin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Coumarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14726</drugbank-id>
      <name>Dabigatran</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Dabigatran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06294</drugbank-id>
      <name>Semuloparin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Semuloparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12726</drugbank-id>
      <name>Monteplase</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Monteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09259</drugbank-id>
      <name>Reviparin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Reviparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00203</drugbank-id>
      <name>Sildenafil</name>
      <description>The risk or severity of hemorrhage can be increased when Lepirudin is combined with Sildenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00008</drugbank-id>
      <name>Peginterferon alfa-2a</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00011</drugbank-id>
      <name>Interferon alfa-n1</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00018</drugbank-id>
      <name>Interferon alfa-n3</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00022</drugbank-id>
      <name>Peginterferon alfa-2b</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00033</drugbank-id>
      <name>Interferon gamma-1b</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00034</drugbank-id>
      <name>Interferon alfa-2a, Recombinant</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00041</drugbank-id>
      <name>Aldesleukin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00056</drugbank-id>
      <name>Gemtuzumab ozogamicin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Gemtuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00068</drugbank-id>
      <name>Interferon beta-1b</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon beta-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00069</drugbank-id>
      <name>Interferon alfacon-1</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfacon-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00073</drugbank-id>
      <name>Rituximab</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Rituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00078</drugbank-id>
      <name>Ibritumomab tiuxetan</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Ibritumomab tiuxetan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00087</drugbank-id>
      <name>Alemtuzumab</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Alemtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00105</drugbank-id>
      <name>Interferon alfa-2b</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00120</drugbank-id>
      <name>Phenylalanine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Phenylalanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00188</drugbank-id>
      <name>Bortezomib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Bortezomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00242</drugbank-id>
      <name>Cladribine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cladribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00262</drugbank-id>
      <name>Carmustine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Carmustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00276</drugbank-id>
      <name>Amsacrine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Amsacrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00291</drugbank-id>
      <name>Chlorambucil</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Chlorambucil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00293</drugbank-id>
      <name>Raltitrexed</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Raltitrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00305</drugbank-id>
      <name>Mitomycin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Mitomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00307</drugbank-id>
      <name>Bexarotene</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Bexarotene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00309</drugbank-id>
      <name>Vindesine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Vindesine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00322</drugbank-id>
      <name>Floxuridine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Floxuridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00352</drugbank-id>
      <name>Tioguanine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Tioguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Vinorelbine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00380</drugbank-id>
      <name>Dexrazoxane</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Dexrazoxane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00398</drugbank-id>
      <name>Sorafenib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Sorafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00428</drugbank-id>
      <name>Streptozocin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Streptozocin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00441</drugbank-id>
      <name>Gemcitabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Gemcitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Teniposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00445</drugbank-id>
      <name>Epirubicin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Epirubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00446</drugbank-id>
      <name>Chloramphenicol</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00480</drugbank-id>
      <name>Lenalidomide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Lenalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00488</drugbank-id>
      <name>Altretamine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Altretamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00495</drugbank-id>
      <name>Zidovudine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00515</drugbank-id>
      <name>Cisplatin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cisplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00526</drugbank-id>
      <name>Oxaliplatin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Oxaliplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00531</drugbank-id>
      <name>Cyclophosphamide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cyclophosphamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00544</drugbank-id>
      <name>Fluorouracil</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Fluorouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00552</drugbank-id>
      <name>Pentostatin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Pentostatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Methotrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00570</drugbank-id>
      <name>Vinblastine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Vinblastine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Imatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00631</drugbank-id>
      <name>Clofarabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00642</drugbank-id>
      <name>Pemetrexed</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Pemetrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00694</drugbank-id>
      <name>Daunorubicin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Daunorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00762</drugbank-id>
      <name>Irinotecan</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Irinotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00773</drugbank-id>
      <name>Etoposide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Etoposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00851</drugbank-id>
      <name>Dacarbazine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Dacarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00853</drugbank-id>
      <name>Temozolomide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Temozolomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00859</drugbank-id>
      <name>Penicillamine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Penicillamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00864</drugbank-id>
      <name>Tacrolimus</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Tacrolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00877</drugbank-id>
      <name>Sirolimus</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Sirolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00888</drugbank-id>
      <name>Mechlorethamine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Mechlorethamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00928</drugbank-id>
      <name>Azacitidine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Azacitidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00958</drugbank-id>
      <name>Carboplatin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Carboplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00970</drugbank-id>
      <name>Dactinomycin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Dactinomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00987</drugbank-id>
      <name>Cytarabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cytarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00997</drugbank-id>
      <name>Doxorubicin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Doxorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01005</drugbank-id>
      <name>Hydroxyurea</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Hydroxyurea.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01008</drugbank-id>
      <name>Busulfan</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Busulfan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01030</drugbank-id>
      <name>Topotecan</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Topotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01033</drugbank-id>
      <name>Mercaptopurine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Mercaptopurine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01041</drugbank-id>
      <name>Thalidomide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Thalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01042</drugbank-id>
      <name>Melphalan</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Melphalan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01073</drugbank-id>
      <name>Fludarabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Fludarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01099</drugbank-id>
      <name>Flucytosine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Flucytosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01101</drugbank-id>
      <name>Capecitabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Capecitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01169</drugbank-id>
      <name>Arsenic trioxide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Arsenic trioxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01177</drugbank-id>
      <name>Idarubicin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Idarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01204</drugbank-id>
      <name>Mitoxantrone</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01206</drugbank-id>
      <name>Lomustine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Lomustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Paclitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01248</drugbank-id>
      <name>Docetaxel</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Docetaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01262</drugbank-id>
      <name>Decitabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Decitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01280</drugbank-id>
      <name>Nelarabine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Nelarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01590</drugbank-id>
      <name>Everolimus</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Everolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02546</drugbank-id>
      <name>Vorinostat</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Vorinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04572</drugbank-id>
      <name>Thiotepa</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Thiotepa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04845</drugbank-id>
      <name>Ixabepilone</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Ixabepilone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Nilotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05015</drugbank-id>
      <name>Belinostat</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Belinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05109</drugbank-id>
      <name>Trabectedin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Trabectedin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05258</drugbank-id>
      <name>Interferon alfa</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05472</drugbank-id>
      <name>Human interferon omega-1</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Human interferon omega-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Trastuzumab emtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06287</drugbank-id>
      <name>Temsirolimus</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Temsirolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06616</drugbank-id>
      <name>Bosutinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Bosutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06769</drugbank-id>
      <name>Bendamustine</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Bendamustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06772</drugbank-id>
      <name>Cabazitaxel</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cabazitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08871</drugbank-id>
      <name>Eribulin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Eribulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08877</drugbank-id>
      <name>Ruxolitinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Ruxolitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08889</drugbank-id>
      <name>Carfilzomib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Carfilzomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08895</drugbank-id>
      <name>Tofacitinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Tofacitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08901</drugbank-id>
      <name>Ponatinib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Ponatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08910</drugbank-id>
      <name>Pomalidomide</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Pomalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09042</drugbank-id>
      <name>Tedizolid phosphate</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Tedizolid phosphate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09052</drugbank-id>
      <name>Blinatumomab</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Blinatumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Palbociclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Olaparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09077</drugbank-id>
      <name>Dinutuximab</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Dinutuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09122</drugbank-id>
      <name>Peginterferon beta-1a</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon beta-1a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12814</drugbank-id>
      <name>Cepeginterferon alfa-2B</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Cepeginterferon alfa-2B.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00229</drugbank-id>
      <name>Cefotiam</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotiam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00267</drugbank-id>
      <name>Cefmenoxime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmenoxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00274</drugbank-id>
      <name>Cefmetazole</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefmetazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00430</drugbank-id>
      <name>Cefpiramide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpiramide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00438</drugbank-id>
      <name>Ceftazidime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftazidime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00447</drugbank-id>
      <name>Loracarbef</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Loracarbef.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00456</drugbank-id>
      <name>Cefalotin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefalotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00493</drugbank-id>
      <name>Cefotaxime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotaxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00535</drugbank-id>
      <name>Cefdinir</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefdinir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00567</drugbank-id>
      <name>Cephalexin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00671</drugbank-id>
      <name>Cefixime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00689</drugbank-id>
      <name>Cephaloglycin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephaloglycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00833</drugbank-id>
      <name>Cefaclor</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaclor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00923</drugbank-id>
      <name>Ceforanide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceforanide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01066</drugbank-id>
      <name>Cefditoren</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefditoren.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01112</drugbank-id>
      <name>Cefuroxime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefuroxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01139</drugbank-id>
      <name>Cefapirin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefapirin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01140</drugbank-id>
      <name>Cefadroxil</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefadroxil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01150</drugbank-id>
      <name>Cefprozil</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefprozil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01212</drugbank-id>
      <name>Ceftriaxone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftriaxone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01326</drugbank-id>
      <name>Cefamandole</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01327</drugbank-id>
      <name>Cefazolin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazolin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01328</drugbank-id>
      <name>Cefonicid</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefonicid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01329</drugbank-id>
      <name>Cefoperazone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoperazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01330</drugbank-id>
      <name>Cefotetan</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01331</drugbank-id>
      <name>Cefoxitin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefoxitin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01332</drugbank-id>
      <name>Ceftizoxime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftizoxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01333</drugbank-id>
      <name>Cefradine</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefradine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01413</drugbank-id>
      <name>Cefepime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefepime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01414</drugbank-id>
      <name>Cefacetrile</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefacetrile.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01415</drugbank-id>
      <name>Ceftibuten</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftibuten.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01416</drugbank-id>
      <name>Cefpodoxime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpodoxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04570</drugbank-id>
      <name>Latamoxef</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Latamoxef.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04918</drugbank-id>
      <name>Ceftobiprole</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftobiprole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06590</drugbank-id>
      <name>Ceftaroline fosamil</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftaroline fosamil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09008</drugbank-id>
      <name>Cefaloridine</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefaloridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09050</drugbank-id>
      <name>Ceftolozane</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftolozane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09062</drugbank-id>
      <name>Cefminox</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefminox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11367</drugbank-id>
      <name>Cefroxadine</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefroxadine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11935</drugbank-id>
      <name>Flomoxef</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Flomoxef.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13266</drugbank-id>
      <name>Cefatrizine</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefatrizine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13461</drugbank-id>
      <name>Cefcapene</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefcapene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13470</drugbank-id>
      <name>Cefodizime</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefodizime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13499</drugbank-id>
      <name>Cefsulodin</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefsulodin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13504</drugbank-id>
      <name>Cefetamet</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefetamet.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13638</drugbank-id>
      <name>Cefbuperazone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefbuperazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13667</drugbank-id>
      <name>Cefozopran</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefozopran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13682</drugbank-id>
      <name>Cefpirome</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefpirome.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13778</drugbank-id>
      <name>Cefazedone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefazedone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13821</drugbank-id>
      <name>Ceftezole</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Ceftezole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14725</drugbank-id>
      <name>Cefamandole nafate</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefamandole nafate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00254</drugbank-id>
      <name>Doxycycline</name>
      <description>The risk or severity of bleeding can be increased when Doxycycline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00207</drugbank-id>
      <name>Azithromycin</name>
      <description>The risk or severity of adverse effects can be increased when Azithromycin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09539</drugbank-id>
      <name>Omega-3-acid ethyl esters</name>
      <description>The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00945</drugbank-id>
      <name>Acetylsalicylic acid</name>
      <description>Acetylsalicylic acid may increase the anticoagulant activities of Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01606</drugbank-id>
      <name>Tazobactam</name>
      <description>The risk or severity of bleeding can be increased when Tazobactam is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00199</drugbank-id>
      <name>Erythromycin</name>
      <description>The risk or severity of bleeding can be increased when Erythromycin is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00656</drugbank-id>
      <name>Trazodone</name>
      <description>The risk or severity of bleeding can be increased when Trazodone is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00620</drugbank-id>
      <name>Triamcinolone</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Triamcinolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09079</drugbank-id>
      <name>Nintedanib</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Nintedanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01175</drugbank-id>
      <name>Escitalopram</name>
      <description>The risk or severity of bleeding can be increased when Escitalopram is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01104</drugbank-id>
      <name>Sertraline</name>
      <description>The risk or severity of bleeding can be increased when Sertraline is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00232</drugbank-id>
      <name>Methyclothiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methyclothiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00436</drugbank-id>
      <name>Bendroflumethiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Bendroflumethiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00562</drugbank-id>
      <name>Benzthiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Benzthiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00606</drugbank-id>
      <name>Cyclothiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclothiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00774</drugbank-id>
      <name>Hydroflumethiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroflumethiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00880</drugbank-id>
      <name>Chlorothiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Chlorothiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00999</drugbank-id>
      <name>Hydrochlorothiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydrochlorothiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01021</drugbank-id>
      <name>Trichlormethiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Trichlormethiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01324</drugbank-id>
      <name>Polythiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Polythiazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13430</drugbank-id>
      <name>Mebutizide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Mebutizide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13532</drugbank-id>
      <name>Cyclopenthiazide</name>
      <description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cyclopenthiazide.</description>
    </drug-interaction>
  </drug-interactions>
</drug>
<drug type="biotech" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00002</drugbank-id>
  <drugbank-id>BTD00071</drugbank-id>
  <drugbank-id>BIOD00071</drugbank-id>
  <name>Cetuximab</name>
  <description>Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Cetuximab is marketed under the brand Erbitux by Eli Lilly and Company. In the United States, a regimen of cetuximab costs approximately $30,790 for an eight-week course.</description>
  <cas-number>205923-56-4</cas-number>
  <unii>PQX0D8J21J</unii>
  <state>liquid</state><indication>Cetuximab, used in combination with irinotecan, is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma in patients who are refractory to irinotecan-based chemotherapy. Cetuximab administered as a single agent is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma in patients who are intolerant to irinotecan-based chemotherapy.</indication>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00012</drugbank-id>
      <name>Darbepoetin alfa</name>
      <description>The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00016</drugbank-id>
      <name>Erythropoietin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08894</drugbank-id>
      <name>Peginesatide</name>
      <description>The risk or severity of Thrombosis can be increased when Peginesatide is combined with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09107</drugbank-id>
      <name>Methoxy polyethylene glycol-epoetin beta</name>
      <description>The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00255</drugbank-id>
      <name>Diethylstilbestrol</name>
      <description>Diethylstilbestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00269</drugbank-id>
      <name>Chlorotrianisene</name>
      <description>Chlorotrianisene may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00286</drugbank-id>
      <name>Conjugated estrogens</name>
      <description>Conjugated estrogens may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00655</drugbank-id>
      <name>Estrone</name>
      <description>Estrone may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00783</drugbank-id>
      <name>Estradiol</name>
      <description>Estradiol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00890</drugbank-id>
      <name>Dienestrol</name>
      <description>Dienestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00977</drugbank-id>
      <name>Ethinylestradiol</name>
      <description>Ethinylestradiol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01357</drugbank-id>
      <name>Mestranol</name>
      <description>Mestranol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04573</drugbank-id>
      <name>Estriol</name>
      <description>Estriol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04574</drugbank-id>
      <name>Estrone sulfate</name>
      <description>Estrone sulfate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04575</drugbank-id>
      <name>Quinestrol</name>
      <description>Quinestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07931</drugbank-id>
      <name>Hexestrol</name>
      <description>Hexestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09070</drugbank-id>
      <name>Tibolone</name>
      <description>Tibolone may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09317</drugbank-id>
      <name>Synthetic Conjugated Estrogens, A</name>
      <description>Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09318</drugbank-id>
      <name>Synthetic Conjugated Estrogens, B</name>
      <description>Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09369</drugbank-id>
      <name>Polyestradiol phosphate</name>
      <description>Polyestradiol phosphate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09381</drugbank-id>
      <name>Esterified estrogens</name>
      <description>Esterified estrogens may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11478</drugbank-id>
      <name>Zeranol</name>
      <description>Zeranol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11674</drugbank-id>
      <name>Equol</name>
      <description>Equol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12487</drugbank-id>
      <name>Promestriene</name>
      <description>Promestriene may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13143</drugbank-id>
      <name>Methallenestril</name>
      <description>Methallenestril may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13386</drugbank-id>
      <name>Epimestrol</name>
      <description>Epimestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13418</drugbank-id>
      <name>Moxestrol</name>
      <description>Moxestrol may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13952</drugbank-id>
      <name>Estradiol acetate</name>
      <description>Estradiol acetate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13953</drugbank-id>
      <name>Estradiol benzoate</name>
      <description>Estradiol benzoate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13954</drugbank-id>
      <name>Estradiol cypionate</name>
      <description>Estradiol cypionate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13956</drugbank-id>
      <name>Estradiol valerate</name>
      <description>Estradiol valerate may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15334</drugbank-id>
      <name>Biochanin A</name>
      <description>Biochanin A may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15335</drugbank-id>
      <name>Formononetin</name>
      <description>Formononetin may increase the thrombogenic activities of Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00028</drugbank-id>
      <name>Human immunoglobulin G</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00043</drugbank-id>
      <name>Omalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00051</drugbank-id>
      <name>Adalimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00054</drugbank-id>
      <name>Abciximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00056</drugbank-id>
      <name>Gemtuzumab ozogamicin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gemtuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00057</drugbank-id>
      <name>Indium In-111 satumomab pendetide</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Indium In-111 satumomab pendetide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00065</drugbank-id>
      <name>Infliximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Infliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00072</drugbank-id>
      <name>Trastuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00073</drugbank-id>
      <name>Rituximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00074</drugbank-id>
      <name>Basiliximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Basiliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00075</drugbank-id>
      <name>Muromonab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Muromonab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00076</drugbank-id>
      <name>Digoxin Immune Fab (Ovine)</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Digoxin Immune Fab (Ovine).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00078</drugbank-id>
      <name>Ibritumomab tiuxetan</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibritumomab tiuxetan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00081</drugbank-id>
      <name>Tositumomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tositumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00087</drugbank-id>
      <name>Alemtuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Alemtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00089</drugbank-id>
      <name>Capromab pendetide</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Capromab pendetide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00095</drugbank-id>
      <name>Efalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Efalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00098</drugbank-id>
      <name>Antithymocyte immunoglobulin (rabbit)</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Antithymocyte immunoglobulin (rabbit).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00108</drugbank-id>
      <name>Natalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Natalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00110</drugbank-id>
      <name>Palivizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Palivizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00111</drugbank-id>
      <name>Daclizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Daclizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00112</drugbank-id>
      <name>Bevacizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00113</drugbank-id>
      <name>Technetium Tc-99m arcitumomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Technetium Tc-99m arcitumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01257</drugbank-id>
      <name>Eculizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Eculizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01269</drugbank-id>
      <name>Panitumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Panitumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01270</drugbank-id>
      <name>Ranibizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ranibizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04901</drugbank-id>
      <name>Galiximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Galiximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04949</drugbank-id>
      <name>Pexelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pexelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04956</drugbank-id>
      <name>Afelimomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Afelimomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04958</drugbank-id>
      <name>Epratuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Epratuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04962</drugbank-id>
      <name>Bectumomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bectumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04964</drugbank-id>
      <name>Oregovomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Oregovomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04988</drugbank-id>
      <name>IGN311</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with IGN311.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05006</drugbank-id>
      <name>Adecatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Adecatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05097</drugbank-id>
      <name>Labetuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05101</drugbank-id>
      <name>Matuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Matuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05111</drugbank-id>
      <name>Fontolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fontolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05136</drugbank-id>
      <name>Bavituximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bavituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05139</drugbank-id>
      <name>CR002</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with CR002.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05209</drugbank-id>
      <name>Rozrolimupab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozrolimupab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05304</drugbank-id>
      <name>Girentuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Girentuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05336</drugbank-id>
      <name>Obiltoxaximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Obiltoxaximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05405</drugbank-id>
      <name>XTL-001</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with XTL-001.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05437</drugbank-id>
      <name>NAV 1800</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with NAV 1800.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05459</drugbank-id>
      <name>Briakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Briakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05496</drugbank-id>
      <name>Otelixizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Otelixizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05545</drugbank-id>
      <name>AMG 108</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with AMG 108.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05550</drugbank-id>
      <name>Iratumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Iratumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05555</drugbank-id>
      <name>Enokizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Enokizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05578</drugbank-id>
      <name>Ramucirumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ramucirumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05595</drugbank-id>
      <name>Farletuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Farletuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05656</drugbank-id>
      <name>Veltuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Veltuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05679</drugbank-id>
      <name>Ustekinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ustekinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab emtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05793</drugbank-id>
      <name>PRO-542</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with PRO-542.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05797</drugbank-id>
      <name>TNX-901</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with TNX-901.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05889</drugbank-id>
      <name>Inotuzumab ozogamicin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Inotuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05892</drugbank-id>
      <name>RI 624</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with RI 624.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05915</drugbank-id>
      <name>MYO-029</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with MYO-029.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05916</drugbank-id>
      <name>CT-011</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with CT-011.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05941</drugbank-id>
      <name>Leronlimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Leronlimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05996</drugbank-id>
      <name>Glembatumumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Glembatumumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06043</drugbank-id>
      <name>Olaratumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Olaratumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06049</drugbank-id>
      <name>IPH 2101</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with IPH 2101.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06050</drugbank-id>
      <name>TB-402</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with TB-402.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06081</drugbank-id>
      <name>Caplacizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Caplacizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06101</drugbank-id>
      <name>IMC-1C11</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with IMC-1C11.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06116</drugbank-id>
      <name>Eldelumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Eldelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06162</drugbank-id>
      <name>Lumiliximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumiliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06168</drugbank-id>
      <name>Canakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Canakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06186</drugbank-id>
      <name>Ipilimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipilimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06192</drugbank-id>
      <name>Nimotuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Nimotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06241</drugbank-id>
      <name>Clenoliximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Clenoliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06273</drugbank-id>
      <name>Tocilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tocilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06304</drugbank-id>
      <name>BIIB015</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with BIIB015.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06305</drugbank-id>
      <name>Sonepcizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sonepcizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06310</drugbank-id>
      <name>Motavizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Motavizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06317</drugbank-id>
      <name>Elotuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Elotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06318</drugbank-id>
      <name>AVE9633</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with AVE9633.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06322</drugbank-id>
      <name>Carotuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Carotuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06324</drugbank-id>
      <name>XmAb 2513</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with XmAb 2513.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06342</drugbank-id>
      <name>Coltuximab ravtansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Coltuximab ravtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06343</drugbank-id>
      <name>Teprotumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Teprotumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06360</drugbank-id>
      <name>Lucatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lucatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06366</drugbank-id>
      <name>Pertuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pertuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06371</drugbank-id>
      <name>Siplizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Siplizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06467</drugbank-id>
      <name>Apolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Apolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06474</drugbank-id>
      <name>Sibrotuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sibrotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06550</drugbank-id>
      <name>Bivatuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bivatuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06557</drugbank-id>
      <name>Lerdelimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lerdelimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06599</drugbank-id>
      <name>Lexatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lexatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06602</drugbank-id>
      <name>Reslizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Reslizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06606</drugbank-id>
      <name>Teplizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Teplizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06607</drugbank-id>
      <name>Catumaxomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Catumaxomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06612</drugbank-id>
      <name>Mepolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Mepolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06643</drugbank-id>
      <name>Denosumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Denosumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06647</drugbank-id>
      <name>Volociximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Volociximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06650</drugbank-id>
      <name>Ofatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ofatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06674</drugbank-id>
      <name>Golimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Golimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08870</drugbank-id>
      <name>Brentuximab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Brentuximab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08879</drugbank-id>
      <name>Belimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Belimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08902</drugbank-id>
      <name>Raxibacumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Raxibacumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08904</drugbank-id>
      <name>Certolizumab pegol</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Certolizumab pegol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08935</drugbank-id>
      <name>Obinutuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Obinutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09029</drugbank-id>
      <name>Secukinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Secukinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09033</drugbank-id>
      <name>Vedolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Vedolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09035</drugbank-id>
      <name>Nivolumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Nivolumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09036</drugbank-id>
      <name>Siltuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Siltuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09037</drugbank-id>
      <name>Pembrolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pembrolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09045</drugbank-id>
      <name>Dulaglutide</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dulaglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09052</drugbank-id>
      <name>Blinatumomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Blinatumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09057</drugbank-id>
      <name>Anthrax immune globulin human</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Anthrax immune globulin human.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09077</drugbank-id>
      <name>Dinutuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dinutuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09105</drugbank-id>
      <name>Asfotase alfa</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Asfotase alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09264</drugbank-id>
      <name>Idarucizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Idarucizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09302</drugbank-id>
      <name>Alirocumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Alirocumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09303</drugbank-id>
      <name>Evolocumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Evolocumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09312</drugbank-id>
      <name>Antilymphocyte immunoglobulin (horse)</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Antilymphocyte immunoglobulin (horse).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09331</drugbank-id>
      <name>Daratumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Daratumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09559</drugbank-id>
      <name>Necitumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Necitumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11569</drugbank-id>
      <name>Ixekizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ixekizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11580</drugbank-id>
      <name>Ravulizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ravulizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11595</drugbank-id>
      <name>Atezolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Atezolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11604</drugbank-id>
      <name>Tetanus Immune Globulin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tetanus Immune Globulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11608</drugbank-id>
      <name>Eftrenonacog alfa</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Eftrenonacog alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11621</drugbank-id>
      <name>Human Varicella-Zoster Immune Globulin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Human Varicella-Zoster Immune Globulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11646</drugbank-id>
      <name>Conatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Conatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11657</drugbank-id>
      <name>Tabalumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tabalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11680</drugbank-id>
      <name>Ficlatuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ficlatuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11685</drugbank-id>
      <name>Figitumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Figitumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11714</drugbank-id>
      <name>Durvalumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Durvalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11715</drugbank-id>
      <name>Bapineuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bapineuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11731</drugbank-id>
      <name>Depatuxizumab mafodotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab mafodotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11746</drugbank-id>
      <name>Onartuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Onartuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11756</drugbank-id>
      <name>Solanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Solanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11767</drugbank-id>
      <name>Sarilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sarilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11771</drugbank-id>
      <name>Tremelimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tremelimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11776</drugbank-id>
      <name>Brodalumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Brodalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11803</drugbank-id>
      <name>Sirukumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sirukumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11826</drugbank-id>
      <name>Lampalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lampalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11834</drugbank-id>
      <name>Guselkumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Guselkumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11840</drugbank-id>
      <name>Dalotuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11849</drugbank-id>
      <name>Emibetuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Emibetuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11850</drugbank-id>
      <name>Ublituximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ublituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11856</drugbank-id>
      <name>Ligelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ligelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11857</drugbank-id>
      <name>Seribantumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Seribantumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11862</drugbank-id>
      <name>Landogrozumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Landogrozumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11866</drugbank-id>
      <name>Romosozumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Romosozumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11884</drugbank-id>
      <name>Vadastuximab Talirine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Vadastuximab Talirine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11914</drugbank-id>
      <name>Lebrikizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lebrikizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11930</drugbank-id>
      <name>Varlilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Varlilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11945</drugbank-id>
      <name>Avelumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Avelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11959</drugbank-id>
      <name>Crenezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Crenezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11972</drugbank-id>
      <name>Rilotumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rilotumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11976</drugbank-id>
      <name>Anifrolumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Anifrolumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11988</drugbank-id>
      <name>Ocrelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ocrelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12023</drugbank-id>
      <name>Benralizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Benralizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12034</drugbank-id>
      <name>Gantenerumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gantenerumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12053</drugbank-id>
      <name>Visilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Visilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12077</drugbank-id>
      <name>Urelumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Urelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12089</drugbank-id>
      <name>Lorvotuzumab mertansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorvotuzumab mertansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12090</drugbank-id>
      <name>Patritumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Patritumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12102</drugbank-id>
      <name>Fulranumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fulranumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12104</drugbank-id>
      <name>Tarextumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tarextumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12118</drugbank-id>
      <name>Sotatercept</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sotatercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12119</drugbank-id>
      <name>Gevokizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gevokizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12142</drugbank-id>
      <name>Duligotuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Duligotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12152</drugbank-id>
      <name>Simtuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Simtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12157</drugbank-id>
      <name>Fasinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fasinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12159</drugbank-id>
      <name>Dupilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dupilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12169</drugbank-id>
      <name>Tralokinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tralokinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12189</drugbank-id>
      <name>Etrolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Etrolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12202</drugbank-id>
      <name>Zalutumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Zalutumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12205</drugbank-id>
      <name>Ganitumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ganitumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12213</drugbank-id>
      <name>Etaracizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Etaracizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12240</drugbank-id>
      <name>Polatuzumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Polatuzumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12246</drugbank-id>
      <name>Inclacumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Inclacumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12250</drugbank-id>
      <name>Cixutumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Cixutumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12261</drugbank-id>
      <name>Ascrinvacumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ascrinvacumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12274</drugbank-id>
      <name>Aducanumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Aducanumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12281</drugbank-id>
      <name>Luspatercept</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Luspatercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12296</drugbank-id>
      <name>GS-5745</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with GS-5745.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12317</drugbank-id>
      <name>Vanucizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Vanucizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12331</drugbank-id>
      <name>Labetuzumab govitecan</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Labetuzumab govitecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12335</drugbank-id>
      <name>Tanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12342</drugbank-id>
      <name>Ensituximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ensituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12344</drugbank-id>
      <name>Fezakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fezakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12363</drugbank-id>
      <name>Dusigitumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dusigitumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12396</drugbank-id>
      <name>Fresolimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fresolimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12413</drugbank-id>
      <name>Indusatumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Indusatumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12456</drugbank-id>
      <name>Bococizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bococizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12489</drugbank-id>
      <name>Mirvetuximab Soravtansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Mirvetuximab Soravtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12498</drugbank-id>
      <name>Mogamulizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Mogamulizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12520</drugbank-id>
      <name>Plozalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Plozalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12530</drugbank-id>
      <name>Inebilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Inebilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12534</drugbank-id>
      <name>Mavrilimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Mavrilimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12560</drugbank-id>
      <name>Blosozumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Blosozumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12584</drugbank-id>
      <name>Bimagrumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimagrumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12589</drugbank-id>
      <name>Dacetuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dacetuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12609</drugbank-id>
      <name>Tovetumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tovetumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12683</drugbank-id>
      <name>Lumretuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lumretuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12698</drugbank-id>
      <name>Ibalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ibalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12701</drugbank-id>
      <name>Intetumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Intetumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12718</drugbank-id>
      <name>Carlumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Carlumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12734</drugbank-id>
      <name>Demcizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Demcizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12773</drugbank-id>
      <name>Sifalimumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sifalimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12775</drugbank-id>
      <name>Abituzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Abituzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12797</drugbank-id>
      <name>Ecromeximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ecromeximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12807</drugbank-id>
      <name>Naptumomab Estafenatox</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Naptumomab Estafenatox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12815</drugbank-id>
      <name>Crotedumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Crotedumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12820</drugbank-id>
      <name>Concizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Concizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12826</drugbank-id>
      <name>Depatuxizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Depatuxizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12844</drugbank-id>
      <name>Rontalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rontalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12845</drugbank-id>
      <name>Amatuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Amatuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12849</drugbank-id>
      <name>Clazakizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Clazakizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12891</drugbank-id>
      <name>Ozanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ozanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12893</drugbank-id>
      <name>Sacituzumab govitecan</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sacituzumab govitecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12917</drugbank-id>
      <name>Bimekizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bimekizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12943</drugbank-id>
      <name>Milatuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Milatuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12976</drugbank-id>
      <name>Robatumumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Robatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13017</drugbank-id>
      <name>Rovalpituzumab Tesirine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rovalpituzumab Tesirine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13037</drugbank-id>
      <name>Namilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Namilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13045</drugbank-id>
      <name>Racotumomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Racotumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13073</drugbank-id>
      <name>Tregalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tregalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13127</drugbank-id>
      <name>Olokizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Olokizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13140</drugbank-id>
      <name>Bezlotoxumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bezlotoxumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13375</drugbank-id>
      <name>Edrecolomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Edrecolomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13535</drugbank-id>
      <name>Nebacumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Nebacumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13886</drugbank-id>
      <name>Human cytomegalovirus immune globulin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Human cytomegalovirus immune globulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13923</drugbank-id>
      <name>Emicizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Emicizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13976</drugbank-id>
      <name>Sulesomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sulesomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13979</drugbank-id>
      <name>Besilesomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Besilesomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14004</drugbank-id>
      <name>Tildrakizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tildrakizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14012</drugbank-id>
      <name>Burosumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Burosumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14039</drugbank-id>
      <name>Erenumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Erenumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14040</drugbank-id>
      <name>Eptinezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Eptinezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14041</drugbank-id>
      <name>Fremanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fremanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14042</drugbank-id>
      <name>Galcanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Galcanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14211</drugbank-id>
      <name>Fanolesomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Fanolesomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14580</drugbank-id>
      <name>Lecanemab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lecanemab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14597</drugbank-id>
      <name>Lanadelumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lanadelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14707</drugbank-id>
      <name>Cemiplimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Cemiplimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14724</drugbank-id>
      <name>Emapalumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Emapalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14762</drugbank-id>
      <name>Risankizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Risankizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14776</drugbank-id>
      <name>Camrelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Camrelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14778</drugbank-id>
      <name>Setrusumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Setrusumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14784</drugbank-id>
      <name>Gancotamab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gancotamab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14809</drugbank-id>
      <name>Anetumab ravtansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Anetumab ravtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14811</drugbank-id>
      <name>Isatuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Isatuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14824</drugbank-id>
      <name>Icrucumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Icrucumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14843</drugbank-id>
      <name>Codrituzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Codrituzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14864</drugbank-id>
      <name>Brolucizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Brolucizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14871</drugbank-id>
      <name>Xentuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Xentuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14877</drugbank-id>
      <name>Lintuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lintuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14891</drugbank-id>
      <name>Vobarilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Vobarilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14897</drugbank-id>
      <name>Parsatuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Parsatuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14905</drugbank-id>
      <name>Emactuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Emactuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14907</drugbank-id>
      <name>Bevacizumab zirconium Zr-89</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bevacizumab zirconium Zr-89.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14908</drugbank-id>
      <name>Refanezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Refanezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14919</drugbank-id>
      <name>Rozanolixizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Rozanolixizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14947</drugbank-id>
      <name>Bermekimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bermekimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14952</drugbank-id>
      <name>Pamrevlumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pamrevlumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14959</drugbank-id>
      <name>Opicinumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Opicinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14962</drugbank-id>
      <name>Trastuzumab deruxtecan</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab deruxtecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14967</drugbank-id>
      <name>Margetuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Margetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14988</drugbank-id>
      <name>Dalantercept</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Dalantercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14997</drugbank-id>
      <name>Pateclizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pateclizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15014</drugbank-id>
      <name>Gremubamab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gremubamab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15022</drugbank-id>
      <name>Apomab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Apomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15044</drugbank-id>
      <name>Tafasitamab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tafasitamab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15045</drugbank-id>
      <name>Ipafricept</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ipafricept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15076</drugbank-id>
      <name>Abrilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Abrilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15089</drugbank-id>
      <name>Frovocimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Frovocimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15090</drugbank-id>
      <name>Tezepelumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tezepelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15101</drugbank-id>
      <name>Tigatuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tigatuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15104</drugbank-id>
      <name>Telisotuzumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Telisotuzumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15113</drugbank-id>
      <name>Utomilumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Utomilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15118</drugbank-id>
      <name>Zolbetuximab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Zolbetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15135</drugbank-id>
      <name>Ponezumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ponezumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15160</drugbank-id>
      <name>Asunercept</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Asunercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15172</drugbank-id>
      <name>Suvratoxumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Suvratoxumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15225</drugbank-id>
      <name>Mitazalimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Mitazalimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15252</drugbank-id>
      <name>Nemolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Nemolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15253</drugbank-id>
      <name>Bleselumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Bleselumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15277</drugbank-id>
      <name>Gedivumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Gedivumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15336</drugbank-id>
      <name>Valanafusp alfa</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Valanafusp alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15349</drugbank-id>
      <name>Sofituzumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Sofituzumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15354</drugbank-id>
      <name>Evinacumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Evinacumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15363</drugbank-id>
      <name>Istiratumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Istiratumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15383</drugbank-id>
      <name>Pidilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pidilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15397</drugbank-id>
      <name>GMA-161</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with GMA-161.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15409</drugbank-id>
      <name>Ladiratuzumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Ladiratuzumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15415</drugbank-id>
      <name>Tomaralimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Tomaralimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15428</drugbank-id>
      <name>Vesencumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Vesencumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15432</drugbank-id>
      <name>Pinatuzumab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Pinatuzumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15441</drugbank-id>
      <name>Lulizumab pegol</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lulizumab pegol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15443</drugbank-id>
      <name>Lorukafusp alfa</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Lorukafusp alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15453</drugbank-id>
      <name>Naratuximab emtansine</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Naratuximab emtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15559</drugbank-id>
      <name>Zenocutuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Zenocutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15898</drugbank-id>
      <name>Atoltivimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Atoltivimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15899</drugbank-id>
      <name>Maftivimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Maftivimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15900</drugbank-id>
      <name>Odesivimab</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Odesivimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15719</drugbank-id>
      <name>Belantamab mafodotin</name>
      <description>The risk or severity of adverse effects can be increased when Cetuximab is combined with Belantamab mafodotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15595</drugbank-id>
      <name>Ebola Zaire vaccine (live, attenuated)</name>
      <description>The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15258</drugbank-id>
      <name>Imlifidase</name>
      <description>The therapeutic efficacy of Cetuximab can be decreased when used in combination with Imlifidase.</description>
    </drug-interaction>
  </drug-interactions>
</drug>
<drug type="biotech" created="2005-06-13" updated="2021-01-01"  >

  <drugbank-id primary="true">DB00003</drugbank-id>
  <drugbank-id>BTD00001</drugbank-id>
  <drugbank-id>BIOD00001</drugbank-id>
  <name>Dornase alfa</name>
  <description>Dornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. The 260-amino acid sequence of dornase alfa is identical to the endogenous human enzyme. Dornase alfa cleaves extracellular DNA to 5-phosphodinucleotide and 5-phosphooligonucleotide end products without affecting intracellular DNA. In individuals with cystic fibrosis, extracellular DNA, which is an extremely viscous anion, is released by degenerating leukocytes that accumulate during inflammatory responses to infections. Enzymatic breakdown of this extracellular DNA appears to reduce sputum viscosity and viscoelasticity.</description>
  <cas-number>143831-71-4</cas-number>
  <unii>953A26OA1Y</unii>
  <state>liquid</state>
  <indication>Used as adjunct therapy in the treatment of cystic fibrosis. </indication>
  <drug-interaction></drug-interaction>
</drug>
<drug type="biotech" created="2005-06-13" updated="2020-09-03">
  <drugbank-id primary="true">DB00004</drugbank-id>
  <drugbank-id>BTD00084</drugbank-id>
  <drugbank-id>BIOD00084</drugbank-id>
  <name>Denileukin diftitox</name>
  <description>A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.</description>
  <cas-number>173146-27-5</cas-number>
  <unii>25E79B5CTM</unii>
  <state>liquid</state>
  <indication>For treatment of cutaneous T-cell lymphoma</indication>
</drug>
<drug type="biotech" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00005</drugbank-id>
  <drugbank-id>BTD00052</drugbank-id>
  <drugbank-id>BIOD00052</drugbank-id>
  <name>Etanercept</name>
  <description>Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.[L14862,A216522] The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids. It is used to treat or manage a variety of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis (AS), and juvenile idiopathic poly-articular arthritis (JIA).</description>
  <indication>Etanercept is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults and in chronic moderate to severe plaque psoriasis in patients 4 years of age and older.[L14862] It is also used to manage signs and symptoms of polyarticular idiopathic arthritis in those aged 2 years and older. Etanercept is also used to manage the symptoms of psoriatic arthritis and ankylosing spondylitis. </indication>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB01281</drugbank-id>
      <name>Abatacept</name>
      <description>The risk or severity of infection can be increased when Etanercept is combined with Abatacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00026</drugbank-id>
      <name>Anakinra</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08879</drugbank-id>
      <name>Belimumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Belimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06168</drugbank-id>
      <name>Canakinumab</name>
      <description>The risk or severity of infection and neutropenia can be increased when Etanercept is combined with Canakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08904</drugbank-id>
      <name>Certolizumab pegol</name>
      <description>The risk or severity of infection can be increased when Etanercept is combined with Certolizumab pegol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00531</drugbank-id>
      <name>Cyclophosphamide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cyclophosphamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06643</drugbank-id>
      <name>Denosumab</name>
      <description>The risk or severity of adverse effects can be increased when Denosumab is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00065</drugbank-id>
      <name>Infliximab</name>
      <description>Etanercept may increase the immunosuppressive activities of Infliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00008</drugbank-id>
      <name>Peginterferon alfa-2a</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00011</drugbank-id>
      <name>Interferon alfa-n1</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00018</drugbank-id>
      <name>Interferon alfa-n3</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00022</drugbank-id>
      <name>Peginterferon alfa-2b</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00033</drugbank-id>
      <name>Interferon gamma-1b</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00034</drugbank-id>
      <name>Interferon alfa-2a, Recombinant</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00041</drugbank-id>
      <name>Aldesleukin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00051</drugbank-id>
      <name>Adalimumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00056</drugbank-id>
      <name>Gemtuzumab ozogamicin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Gemtuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00059</drugbank-id>
      <name>Pegaspargase</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Pegaspargase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00068</drugbank-id>
      <name>Interferon beta-1b</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon beta-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00069</drugbank-id>
      <name>Interferon alfacon-1</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfacon-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00073</drugbank-id>
      <name>Rituximab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Rituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00074</drugbank-id>
      <name>Basiliximab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Basiliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00075</drugbank-id>
      <name>Muromonab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Muromonab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00078</drugbank-id>
      <name>Ibritumomab tiuxetan</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Ibritumomab tiuxetan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00081</drugbank-id>
      <name>Tositumomab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tositumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00087</drugbank-id>
      <name>Alemtuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Alemtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00092</drugbank-id>
      <name>Alefacept</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Alefacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00095</drugbank-id>
      <name>Efalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Efalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00098</drugbank-id>
      <name>Antithymocyte immunoglobulin (rabbit)</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Antithymocyte immunoglobulin (rabbit).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00105</drugbank-id>
      <name>Interferon alfa-2b</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00111</drugbank-id>
      <name>Daclizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Daclizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00112</drugbank-id>
      <name>Bevacizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Bevacizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00120</drugbank-id>
      <name>Phenylalanine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Phenylalanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00242</drugbank-id>
      <name>Cladribine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cladribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00276</drugbank-id>
      <name>Amsacrine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Amsacrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00290</drugbank-id>
      <name>Bleomycin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Bleomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00291</drugbank-id>
      <name>Chlorambucil</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Chlorambucil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00293</drugbank-id>
      <name>Raltitrexed</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Raltitrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00305</drugbank-id>
      <name>Mitomycin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mitomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00322</drugbank-id>
      <name>Floxuridine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Floxuridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00352</drugbank-id>
      <name>Tioguanine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tioguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00380</drugbank-id>
      <name>Dexrazoxane</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Dexrazoxane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00428</drugbank-id>
      <name>Streptozocin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Streptozocin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00432</drugbank-id>
      <name>Trifluridine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Trifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00441</drugbank-id>
      <name>Gemcitabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Gemcitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00445</drugbank-id>
      <name>Epirubicin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Epirubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00446</drugbank-id>
      <name>Chloramphenicol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Chloramphenicol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00480</drugbank-id>
      <name>Lenalidomide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Lenalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00488</drugbank-id>
      <name>Altretamine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Altretamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00515</drugbank-id>
      <name>Cisplatin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cisplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00526</drugbank-id>
      <name>Oxaliplatin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Oxaliplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00550</drugbank-id>
      <name>Propylthiouracil</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Propylthiouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00552</drugbank-id>
      <name>Pentostatin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Pentostatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00601</drugbank-id>
      <name>Linezolid</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Linezolid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00631</drugbank-id>
      <name>Clofarabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Clofarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00763</drugbank-id>
      <name>Methimazole</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Methimazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00853</drugbank-id>
      <name>Temozolomide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Temozolomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00859</drugbank-id>
      <name>Penicillamine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Penicillamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00888</drugbank-id>
      <name>Mechlorethamine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mechlorethamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00928</drugbank-id>
      <name>Azacitidine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Azacitidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00958</drugbank-id>
      <name>Carboplatin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Carboplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00970</drugbank-id>
      <name>Dactinomycin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Dactinomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01005</drugbank-id>
      <name>Hydroxyurea</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Hydroxyurea.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01024</drugbank-id>
      <name>Mycophenolic acid</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mycophenolic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01030</drugbank-id>
      <name>Topotecan</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Topotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01033</drugbank-id>
      <name>Mercaptopurine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mercaptopurine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01042</drugbank-id>
      <name>Melphalan</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Melphalan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01073</drugbank-id>
      <name>Fludarabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fludarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01099</drugbank-id>
      <name>Flucytosine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Flucytosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01168</drugbank-id>
      <name>Procarbazine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Procarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01169</drugbank-id>
      <name>Arsenic trioxide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Arsenic trioxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01204</drugbank-id>
      <name>Mitoxantrone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mitoxantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01206</drugbank-id>
      <name>Lomustine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Lomustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01257</drugbank-id>
      <name>Eculizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Eculizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01262</drugbank-id>
      <name>Decitabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Decitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01280</drugbank-id>
      <name>Nelarabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Nelarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01423</drugbank-id>
      <name>Stepronin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Stepronin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01816</drugbank-id>
      <name>Castanospermine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Castanospermine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02546</drugbank-id>
      <name>Vorinostat</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Vorinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02806</drugbank-id>
      <name>2-Methoxyethanol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with 2-Methoxyethanol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03523</drugbank-id>
      <name>Brequinar</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Brequinar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04956</drugbank-id>
      <name>Afelimomab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Afelimomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05258</drugbank-id>
      <name>Interferon alfa</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05259</drugbank-id>
      <name>Glatiramer</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Glatiramer.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05260</drugbank-id>
      <name>Gallium nitrate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Gallium nitrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05459</drugbank-id>
      <name>Briakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Briakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05472</drugbank-id>
      <name>Human interferon omega-1</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Human interferon omega-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06612</drugbank-id>
      <name>Mepolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mepolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06662</drugbank-id>
      <name>Abetimus</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Abetimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06674</drugbank-id>
      <name>Golimumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Golimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06681</drugbank-id>
      <name>Belatacept</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Belatacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Pralatrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08059</drugbank-id>
      <name>Wortmannin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Wortmannin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08871</drugbank-id>
      <name>Eribulin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Eribulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08880</drugbank-id>
      <name>Teriflunomide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Teriflunomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08889</drugbank-id>
      <name>Carfilzomib</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Carfilzomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08908</drugbank-id>
      <name>Dimethyl fumarate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Dimethyl fumarate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08935</drugbank-id>
      <name>Obinutuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Obinutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09029</drugbank-id>
      <name>Secukinumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Secukinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09036</drugbank-id>
      <name>Siltuximab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Siltuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09052</drugbank-id>
      <name>Blinatumomab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Blinatumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09077</drugbank-id>
      <name>Dinutuximab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Dinutuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09091</drugbank-id>
      <name>Tixocortol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tixocortol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09122</drugbank-id>
      <name>Peginterferon beta-1a</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon beta-1a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09312</drugbank-id>
      <name>Antilymphocyte immunoglobulin (horse)</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Antilymphocyte immunoglobulin (horse).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11466</drugbank-id>
      <name>Tepoxalin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tepoxalin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11569</drugbank-id>
      <name>Ixekizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Ixekizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11580</drugbank-id>
      <name>Ravulizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Ravulizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11616</drugbank-id>
      <name>Pirarubicin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Pirarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11693</drugbank-id>
      <name>Voclosporin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Voclosporin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11708</drugbank-id>
      <name>Peficitinib</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Peficitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11767</drugbank-id>
      <name>Sarilumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Sarilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11776</drugbank-id>
      <name>Brodalumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Brodalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11803</drugbank-id>
      <name>Sirukumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Sirukumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11834</drugbank-id>
      <name>Guselkumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Guselkumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11988</drugbank-id>
      <name>Ocrelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Ocrelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12025</drugbank-id>
      <name>Triptolide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Triptolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12612</drugbank-id>
      <name>Ozanimod</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Ozanimod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12617</drugbank-id>
      <name>Mizoribine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mizoribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12692</drugbank-id>
      <name>Gusperimus</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Gusperimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12814</drugbank-id>
      <name>Cepeginterferon alfa-2B</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cepeginterferon alfa-2B.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12902</drugbank-id>
      <name>Trofosfamide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Trofosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12947</drugbank-id>
      <name>Doxifluridine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Doxifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12991</drugbank-id>
      <name>Deoxyspergualin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Deoxyspergualin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12996</drugbank-id>
      <name>Acteoside</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Acteoside.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13003</drugbank-id>
      <name>Cortivazol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cortivazol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13014</drugbank-id>
      <name>Hypericin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Hypericin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13068</drugbank-id>
      <name>9-(N-methyl-L-isoleucine)-cyclosporin A</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13223</drugbank-id>
      <name>Fluocortin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13241</drugbank-id>
      <name>Begelomab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Begelomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13491</drugbank-id>
      <name>Fluperolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluperolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13843</drugbank-id>
      <name>Cloprednol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cloprednol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13856</drugbank-id>
      <name>Fluclorolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluclorolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14219</drugbank-id>
      <name>Monomethyl fumarate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Monomethyl fumarate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14724</drugbank-id>
      <name>Emapalumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Emapalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14762</drugbank-id>
      <name>Risankizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Risankizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14919</drugbank-id>
      <name>Rozanolixizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Rozanolixizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15253</drugbank-id>
      <name>Bleselumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Bleselumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00180</drugbank-id>
      <name>Flunisolide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Flunisolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00394</drugbank-id>
      <name>Beclomethasone dipropionate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Beclomethasone dipropionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00443</drugbank-id>
      <name>Betamethasone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Betamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00591</drugbank-id>
      <name>Fluocinolone acetonide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinolone acetonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00687</drugbank-id>
      <name>Fludrocortisone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fludrocortisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Prednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Methylprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01196</drugbank-id>
      <name>Estramustine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Estramustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01285</drugbank-id>
      <name>Corticotropin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Corticotropin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01380</drugbank-id>
      <name>Cortisone acetate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cortisone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01384</drugbank-id>
      <name>Paramethasone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Paramethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04630</drugbank-id>
      <name>Aldosterone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Aldosterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08970</drugbank-id>
      <name>Fluprednidene</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednidene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09082</drugbank-id>
      <name>Vilanterol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Vilanterol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09378</drugbank-id>
      <name>Fluprednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09383</drugbank-id>
      <name>Meprednisone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Meprednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11487</drugbank-id>
      <name>Dexamethasone isonicotinate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Dexamethasone isonicotinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11529</drugbank-id>
      <name>Melengestrol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Melengestrol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11921</drugbank-id>
      <name>Deflazacort</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Deflazacort.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13208</drugbank-id>
      <name>Prednylidene</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Prednylidene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14066</drugbank-id>
      <name>Tetrandrine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tetrandrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14512</drugbank-id>
      <name>Mometasone furoate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone furoate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14545</drugbank-id>
      <name>Hydrocortisone succinate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Hydrocortisone succinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01222</drugbank-id>
      <name>Budesonide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Budesonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01394</drugbank-id>
      <name>Colchicine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Colchicine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00694</drugbank-id>
      <name>Daunorubicin</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Daunorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00987</drugbank-id>
      <name>Cytarabine</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Cytarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01108</drugbank-id>
      <name>Trilostane</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Trilostane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05015</drugbank-id>
      <name>Belinostat</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Belinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01013</drugbank-id>
      <name>Clobetasol propionate</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol propionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01047</drugbank-id>
      <name>Fluocinonide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00547</drugbank-id>
      <name>Desoximetasone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Desoximetasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00764</drugbank-id>
      <name>Mometasone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Mometasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08971</drugbank-id>
      <name>Fluocortolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11750</drugbank-id>
      <name>Clobetasol</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Clobetasol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00324</drugbank-id>
      <name>Fluorometholone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Fluorometholone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09095</drugbank-id>
      <name>Difluocortolone</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Difluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00108</drugbank-id>
      <name>Natalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Natalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00337</drugbank-id>
      <name>Pimecrolimus</name>
      <description>The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06372</drugbank-id>
      <name>Rilonacept</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Rilonacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01656</drugbank-id>
      <name>Roflumilast</name>
      <description>Etanercept may increase the immunosuppressive activities of Roflumilast.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06688</drugbank-id>
      <name>Sipuleucel-T</name>
      <description>The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06273</drugbank-id>
      <name>Tocilizumab</name>
      <description>Tocilizumab may increase the immunosuppressive activities of Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08895</drugbank-id>
      <name>Tofacitinib</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Tofacitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09033</drugbank-id>
      <name>Vedolizumab</name>
      <description>The risk or severity of infection can be increased when Etanercept is combined with Vedolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01015</drugbank-id>
      <name>Sulfamethoxazole</name>
      <description>The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01097</drugbank-id>
      <name>Leflunomide</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Leflunomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00072</drugbank-id>
      <name>Trastuzumab</name>
      <description>Trastuzumab may increase the neutropenic activities of Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08868</drugbank-id>
      <name>Fingolimod</name>
      <description>Etanercept may increase the immunosuppressive activities of Fingolimod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00864</drugbank-id>
      <name>Tacrolimus</name>
      <description>Tacrolimus may increase the immunosuppressive activities of Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04914</drugbank-id>
      <name>G17DT</name>
      <description>The therapeutic efficacy of G17DT can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05144</drugbank-id>
      <name>PEV3A</name>
      <description>The therapeutic efficacy of PEV3A can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05325</drugbank-id>
      <name>INGN 225</name>
      <description>The therapeutic efficacy of INGN 225 can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05374</drugbank-id>
      <name>Rindopepimut</name>
      <description>The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05440</drugbank-id>
      <name>SRP 299</name>
      <description>The therapeutic efficacy of SRP 299 can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05942</drugbank-id>
      <name>GI-5005</name>
      <description>The therapeutic efficacy of GI-5005 can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06400</drugbank-id>
      <name>Vitespen</name>
      <description>The therapeutic efficacy of Vitespen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06584</drugbank-id>
      <name>TG4010</name>
      <description>The therapeutic efficacy of TG4010 can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09057</drugbank-id>
      <name>Anthrax immune globulin human</name>
      <description>The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10062</drugbank-id>
      <name>Rabies virus inactivated antigen, B</name>
      <description>The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10076</drugbank-id>
      <name>Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10276</drugbank-id>
      <name>Rotavirus vaccine</name>
      <description>The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10283</drugbank-id>
      <name>Rabies virus inactivated antigen, A</name>
      <description>The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10342</drugbank-id>
      <name>Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10583</drugbank-id>
      <name>Clostridium tetani toxoid antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10584</drugbank-id>
      <name>Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10600</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10769</drugbank-id>
      <name>Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10794</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10803</drugbank-id>
      <name>Typhoid Vi polysaccharide vaccine</name>
      <description>The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10989</drugbank-id>
      <name>Hepatitis A Vaccine</name>
      <description>The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10990</drugbank-id>
      <name>Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11038</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11040</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11041</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11044</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11603</drugbank-id>
      <name>Human rabies virus immune globulin</name>
      <description>The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11627</drugbank-id>
      <name>Hepatitis B Vaccine (Recombinant)</name>
      <description>The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12568</drugbank-id>
      <name>Tecemotide</name>
      <description>The therapeutic efficacy of Tecemotide can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14022</drugbank-id>
      <name>Typhoid vaccine</name>
      <description>The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14384</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14385</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14394</drugbank-id>
      <name>Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14445</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14449</drugbank-id>
      <name>Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen</name>
      <description>The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14619</drugbank-id>
      <name>Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14620</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14711</drugbank-id>
      <name>Smallpox (Vaccinia) Vaccine, Live</name>
      <description>The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15274</drugbank-id>
      <name>Pertussis vaccine</name>
      <description>The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15461</drugbank-id>
      <name>Yersinia pestis 195/p antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13924</drugbank-id>
      <name>Varicella Zoster Vaccine (Recombinant)</name>
      <description>The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15483</drugbank-id>
      <name>Modified vaccinia ankara</name>
      <description>The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15595</drugbank-id>
      <name>Ebola Zaire vaccine (live, attenuated)</name>
      <description>The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15654</drugbank-id>
      <name>Moderna COVID-19 Vaccine</name>
      <description>The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10317</drugbank-id>
      <name>Rubella virus vaccine</name>
      <description>The risk or severity of infection can be increased when Rubella virus vaccine is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10318</drugbank-id>
      <name>Varicella Zoster Vaccine (Live/attenuated)</name>
      <description>The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10343</drugbank-id>
      <name>Bacillus calmette-guerin substrain tice live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10804</drugbank-id>
      <name>Bacillus calmette-guerin substrain connaught live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10805</drugbank-id>
      <name>Yellow Fever Vaccine</name>
      <description>The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11003</drugbank-id>
      <name>Anthrax vaccine</name>
      <description>The risk or severity of infection can be increased when Anthrax vaccine is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11050</drugbank-id>
      <name>Typhoid Vaccine Live</name>
      <description>The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12386</drugbank-id>
      <name>Bacillus calmette-guerin substrain danish 1331 live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12768</drugbank-id>
      <name>BCG vaccine</name>
      <description>The risk or severity of infection can be increased when BCG vaccine is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14409</drugbank-id>
      <name>Human adenovirus e serotype 4 strain cl-68578 antigen</name>
      <description>The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14443</drugbank-id>
      <name>Vibrio cholerae CVD 103-HgR strain live antigen</name>
      <description>The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14685</drugbank-id>
      <name>Adenovirus type 7 vaccine live</name>
      <description>The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00795</drugbank-id>
      <name>Sulfasalazine</name>
      <description>The risk or severity of neutropenia can be increased when Etanercept is combined with Sulfasalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00201</drugbank-id>
      <name>Caffeine</name>
      <description>The metabolism of Caffeine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00176</drugbank-id>
      <name>Fluvoxamine</name>
      <description>The metabolism of Fluvoxamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00195</drugbank-id>
      <name>Betaxolol</name>
      <description>The metabolism of Betaxolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00262</drugbank-id>
      <name>Carmustine</name>
      <description>The metabolism of Carmustine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00268</drugbank-id>
      <name>Ropinirole</name>
      <description>The metabolism of Ropinirole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00280</drugbank-id>
      <name>Disopyramide</name>
      <description>The metabolism of Disopyramide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00286</drugbank-id>
      <name>Conjugated estrogens</name>
      <description>The metabolism of Conjugated estrogens can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00296</drugbank-id>
      <name>Ropivacaine</name>
      <description>The metabolism of Ropivacaine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00315</drugbank-id>
      <name>Zolmitriptan</name>
      <description>The metabolism of Zolmitriptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00316</drugbank-id>
      <name>Acetaminophen</name>
      <description>The metabolism of Acetaminophen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00334</drugbank-id>
      <name>Olanzapine</name>
      <description>The metabolism of Olanzapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00356</drugbank-id>
      <name>Chlorzoxazone</name>
      <description>The metabolism of Chlorzoxazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00365</drugbank-id>
      <name>Grepafloxacin</name>
      <description>The metabolism of Grepafloxacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00370</drugbank-id>
      <name>Mirtazapine</name>
      <description>The metabolism of Mirtazapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00379</drugbank-id>
      <name>Mexiletine</name>
      <description>The metabolism of Mexiletine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00382</drugbank-id>
      <name>Tacrine</name>
      <description>The metabolism of Tacrine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00384</drugbank-id>
      <name>Triamterene</name>
      <description>The metabolism of Triamterene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00442</drugbank-id>
      <name>Entecavir</name>
      <description>The metabolism of Entecavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00477</drugbank-id>
      <name>Chlorpromazine</name>
      <description>The metabolism of Chlorpromazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00518</drugbank-id>
      <name>Albendazole</name>
      <description>The metabolism of Albendazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00629</drugbank-id>
      <name>Guanabenz</name>
      <description>The metabolism of Guanabenz can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00642</drugbank-id>
      <name>Pemetrexed</name>
      <description>The metabolism of Pemetrexed can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00730</drugbank-id>
      <name>Thiabendazole</name>
      <description>The metabolism of Thiabendazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00740</drugbank-id>
      <name>Riluzole</name>
      <description>The metabolism of Riluzole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00787</drugbank-id>
      <name>Acyclovir</name>
      <description>The metabolism of Acyclovir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00806</drugbank-id>
      <name>Pentoxifylline</name>
      <description>The metabolism of Pentoxifylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00831</drugbank-id>
      <name>Trifluoperazine</name>
      <description>The metabolism of Trifluoperazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00863</drugbank-id>
      <name>Ranitidine</name>
      <description>The metabolism of Ranitidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00898</drugbank-id>
      <name>Ethanol</name>
      <description>The metabolism of Ethanol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00934</drugbank-id>
      <name>Maprotiline</name>
      <description>The metabolism of Maprotiline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00978</drugbank-id>
      <name>Lomefloxacin</name>
      <description>The metabolism of Lomefloxacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00993</drugbank-id>
      <name>Azathioprine</name>
      <description>The metabolism of Azathioprine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00998</drugbank-id>
      <name>Frovatriptan</name>
      <description>The metabolism of Frovatriptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01002</drugbank-id>
      <name>Levobupivacaine</name>
      <description>The metabolism of Levobupivacaine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01012</drugbank-id>
      <name>Cinacalcet</name>
      <description>The metabolism of Cinacalcet can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01056</drugbank-id>
      <name>Tocainide</name>
      <description>The metabolism of Tocainide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01087</drugbank-id>
      <name>Primaquine</name>
      <description>The metabolism of Primaquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01094</drugbank-id>
      <name>Hesperetin</name>
      <description>The metabolism of Hesperetin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01182</drugbank-id>
      <name>Propafenone</name>
      <description>The metabolism of Propafenone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01191</drugbank-id>
      <name>Dexfenfluramine</name>
      <description>The metabolism of Dexfenfluramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01303</drugbank-id>
      <name>Oxtriphylline</name>
      <description>The metabolism of Oxtriphylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01367</drugbank-id>
      <name>Rasagiline</name>
      <description>The metabolism of Rasagiline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01405</drugbank-id>
      <name>Temafloxacin</name>
      <description>The metabolism of Temafloxacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01412</drugbank-id>
      <name>Theobromine</name>
      <description>The metabolism of Theobromine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01482</drugbank-id>
      <name>Fenethylline</name>
      <description>The metabolism of Fenethylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01558</drugbank-id>
      <name>Bromazepam</name>
      <description>The metabolism of Bromazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01623</drugbank-id>
      <name>Thiothixene</name>
      <description>The metabolism of Thiothixene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01645</drugbank-id>
      <name>Genistein</name>
      <description>The metabolism of Genistein can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01667</drugbank-id>
      <name>8-azaguanine</name>
      <description>The metabolism of 8-azaguanine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02134</drugbank-id>
      <name>Xanthine</name>
      <description>The metabolism of Xanthine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02489</drugbank-id>
      <name>9-Methylguanine</name>
      <description>The metabolism of 9-Methylguanine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02568</drugbank-id>
      <name>Peldesine</name>
      <description>The metabolism of Peldesine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02709</drugbank-id>
      <name>Resveratrol</name>
      <description>The metabolism of Resveratrol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04076</drugbank-id>
      <name>Hypoxanthine</name>
      <description>The metabolism of Hypoxanthine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04356</drugbank-id>
      <name>9-Deazaguanine</name>
      <description>The metabolism of 9-Deazaguanine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04871</drugbank-id>
      <name>Lorcaserin</name>
      <description>The metabolism of Lorcaserin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04948</drugbank-id>
      <name>Lofexidine</name>
      <description>The metabolism of Lofexidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04951</drugbank-id>
      <name>Pirfenidone</name>
      <description>The metabolism of Pirfenidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06148</drugbank-id>
      <name>Mianserin</name>
      <description>The metabolism of Mianserin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06210</drugbank-id>
      <name>Eltrombopag</name>
      <description>The metabolism of Eltrombopag can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06216</drugbank-id>
      <name>Asenapine</name>
      <description>The metabolism of Asenapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06235</drugbank-id>
      <name>Vadimezan</name>
      <description>The metabolism of Vadimezan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06479</drugbank-id>
      <name>Propentofylline</name>
      <description>The metabolism of Propentofylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06594</drugbank-id>
      <name>Agomelatine</name>
      <description>The metabolism of Agomelatine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06770</drugbank-id>
      <name>Benzyl alcohol</name>
      <description>The metabolism of Benzyl alcohol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06774</drugbank-id>
      <name>Capsaicin</name>
      <description>The metabolism of Capsaicin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08496</drugbank-id>
      <name>(R)-warfarin</name>
      <description>The metabolism of (R)-warfarin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09071</drugbank-id>
      <name>Tasimelteon</name>
      <description>The metabolism of Tasimelteon can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09118</drugbank-id>
      <name>Stiripentol</name>
      <description>The metabolism of Stiripentol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09225</drugbank-id>
      <name>Zotepine</name>
      <description>The metabolism of Zotepine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09273</drugbank-id>
      <name>Doxofylline</name>
      <description>The metabolism of Doxofylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09290</drugbank-id>
      <name>Ramosetron</name>
      <description>The metabolism of Ramosetron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11919</drugbank-id>
      <name>6-O-benzylguanine</name>
      <description>The metabolism of 6-O-benzylguanine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11967</drugbank-id>
      <name>Binimetinib</name>
      <description>The metabolism of Binimetinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12026</drugbank-id>
      <name>Voxilaprevir</name>
      <description>The metabolism of Voxilaprevir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12245</drugbank-id>
      <name>Triclabendazole</name>
      <description>The metabolism of Triclabendazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12332</drugbank-id>
      <name>Rucaparib</name>
      <description>The metabolism of Rucaparib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12406</drugbank-id>
      <name>Lisofylline</name>
      <description>The metabolism of Lisofylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12531</drugbank-id>
      <name>Lobucavir</name>
      <description>The metabolism of Lobucavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12926</drugbank-id>
      <name>Cafedrine</name>
      <description>The metabolism of Cafedrine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12927</drugbank-id>
      <name>Theodrenaline</name>
      <description>The metabolism of Theodrenaline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12945</drugbank-id>
      <name>Dihydralazine</name>
      <description>The metabolism of Dihydralazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13203</drugbank-id>
      <name>Bamifylline</name>
      <description>The metabolism of Bamifylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13449</drugbank-id>
      <name>Proxyphylline</name>
      <description>The metabolism of Proxyphylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13573</drugbank-id>
      <name>Acefylline</name>
      <description>The metabolism of Acefylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13592</drugbank-id>
      <name>Etamiphylline</name>
      <description>The metabolism of Etamiphylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13634</drugbank-id>
      <name>Pentifylline</name>
      <description>The metabolism of Pentifylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13812</drugbank-id>
      <name>Bufylline</name>
      <description>The metabolism of Bufylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14018</drugbank-id>
      <name>Bromotheophylline</name>
      <description>The metabolism of Bromotheophylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14132</drugbank-id>
      <name>8-chlorotheophylline</name>
      <description>The metabolism of 8-chlorotheophylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11757</drugbank-id>
      <name>Istradefylline</name>
      <description>The metabolism of Istradefylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04889</drugbank-id>
      <name>Bicifadine</name>
      <description>The metabolism of Bicifadine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05708</drugbank-id>
      <name>GTS-21</name>
      <description>The metabolism of GTS-21 can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00977</drugbank-id>
      <name>Ethinylestradiol</name>
      <description>The metabolism of Ethinylestradiol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00425</drugbank-id>
      <name>Zolpidem</name>
      <description>The metabolism of Zolpidem can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00532</drugbank-id>
      <name>Mephenytoin</name>
      <description>The metabolism of Mephenytoin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00924</drugbank-id>
      <name>Cyclobenzaprine</name>
      <description>The metabolism of Cyclobenzaprine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11689</drugbank-id>
      <name>Selumetinib</name>
      <description>The metabolism of Selumetinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00655</drugbank-id>
      <name>Estrone</name>
      <description>The metabolism of Estrone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00363</drugbank-id>
      <name>Clozapine</name>
      <description>The metabolism of Clozapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00299</drugbank-id>
      <name>Penciclovir</name>
      <description>The metabolism of Penciclovir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00277</drugbank-id>
      <name>Theophylline</name>
      <description>The metabolism of Theophylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00682</drugbank-id>
      <name>Warfarin</name>
      <description>The metabolism of Warfarin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00697</drugbank-id>
      <name>Tizanidine</name>
      <description>The metabolism of Tizanidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01100</drugbank-id>
      <name>Pimozide</name>
      <description>The metabolism of Pimozide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01223</drugbank-id>
      <name>Aminophylline</name>
      <description>The metabolism of Aminophylline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01418</drugbank-id>
      <name>Acenocoumarol</name>
      <description>The metabolism of Acenocoumarol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09256</drugbank-id>
      <name>Tegafur</name>
      <description>The metabolism of Tegafur can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>The metabolism of Anagrelide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00544</drugbank-id>
      <name>Fluorouracil</name>
      <description>The metabolism of Fluorouracil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00851</drugbank-id>
      <name>Dacarbazine</name>
      <description>The metabolism of Dacarbazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06769</drugbank-id>
      <name>Bendamustine</name>
      <description>The metabolism of Bendamustine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08910</drugbank-id>
      <name>Pomalidomide</name>
      <description>The metabolism of Pomalidomide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00458</drugbank-id>
      <name>Imipramine</name>
      <description>The metabolism of Imipramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00575</drugbank-id>
      <name>Clonidine</name>
      <description>The metabolism of Clonidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01242</drugbank-id>
      <name>Clomipramine</name>
      <description>The metabolism of Clomipramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00238</drugbank-id>
      <name>Nevirapine</name>
      <description>The metabolism of Nevirapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00471</drugbank-id>
      <name>Montelukast</name>
      <description>The metabolism of Montelukast can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00690</drugbank-id>
      <name>Flurazepam</name>
      <description>The metabolism of Flurazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00916</drugbank-id>
      <name>Metronidazole</name>
      <description>The metabolism of Metronidazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00983</drugbank-id>
      <name>Formoterol</name>
      <description>The metabolism of Formoterol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01006</drugbank-id>
      <name>Letrozole</name>
      <description>The metabolism of Letrozole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01028</drugbank-id>
      <name>Methoxyflurane</name>
      <description>The metabolism of Methoxyflurane can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01159</drugbank-id>
      <name>Halothane</name>
      <description>The metabolism of Halothane can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01236</drugbank-id>
      <name>Sevoflurane</name>
      <description>The metabolism of Sevoflurane can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01274</drugbank-id>
      <name>Arformoterol</name>
      <description>The metabolism of Arformoterol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01544</drugbank-id>
      <name>Flunitrazepam</name>
      <description>The metabolism of Flunitrazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06292</drugbank-id>
      <name>Dapagliflozin</name>
      <description>The metabolism of Dapagliflozin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06470</drugbank-id>
      <name>Clomethiazole</name>
      <description>The metabolism of Clomethiazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09068</drugbank-id>
      <name>Vortioxetine</name>
      <description>The metabolism of Vortioxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09327</drugbank-id>
      <name>Tegafur-uracil</name>
      <description>The metabolism of Tegafur-uracil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11586</drugbank-id>
      <name>Asunaprevir</name>
      <description>The metabolism of Asunaprevir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04977</drugbank-id>
      <name>Plitidepsin</name>
      <description>The metabolism of Plitidepsin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06119</drugbank-id>
      <name>Cenobamate</name>
      <description>The metabolism of Cenobamate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00313</drugbank-id>
      <name>Valproic acid</name>
      <description>The metabolism of Valproic acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00604</drugbank-id>
      <name>Cisapride</name>
      <description>The metabolism of Cisapride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00193</drugbank-id>
      <name>Tramadol</name>
      <description>The metabolism of Tramadol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00333</drugbank-id>
      <name>Methadone</name>
      <description>The metabolism of Methadone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00349</drugbank-id>
      <name>Clobazam</name>
      <description>The metabolism of Clobazam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00625</drugbank-id>
      <name>Efavirenz</name>
      <description>The metabolism of Efavirenz can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00753</drugbank-id>
      <name>Isoflurane</name>
      <description>The metabolism of Isoflurane can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00818</drugbank-id>
      <name>Propofol</name>
      <description>The metabolism of Propofol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00835</drugbank-id>
      <name>Brompheniramine</name>
      <description>The metabolism of Brompheniramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00836</drugbank-id>
      <name>Loperamide</name>
      <description>The metabolism of Loperamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00849</drugbank-id>
      <name>Methylphenobarbital</name>
      <description>The metabolism of Methylphenobarbital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00865</drugbank-id>
      <name>Benzphetamine</name>
      <description>The metabolism of Benzphetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01069</drugbank-id>
      <name>Promethazine</name>
      <description>The metabolism of Promethazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01074</drugbank-id>
      <name>Perhexiline</name>
      <description>The metabolism of Perhexiline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01221</drugbank-id>
      <name>Ketamine</name>
      <description>The metabolism of Ketamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01466</drugbank-id>
      <name>Ethylmorphine</name>
      <description>The metabolism of Ethylmorphine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01559</drugbank-id>
      <name>Clotiazepam</name>
      <description>The metabolism of Clotiazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04938</drugbank-id>
      <name>Ospemifene</name>
      <description>The metabolism of Ospemifene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04975</drugbank-id>
      <name>Banoxantrone</name>
      <description>The metabolism of Banoxantrone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05541</drugbank-id>
      <name>Brivaracetam</name>
      <description>The metabolism of Brivaracetam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06209</drugbank-id>
      <name>Prasugrel</name>
      <description>The metabolism of Prasugrel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06697</drugbank-id>
      <name>Artemether</name>
      <description>The metabolism of Artemether can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06710</drugbank-id>
      <name>Methyltestosterone</name>
      <description>The metabolism of Methyltestosterone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06738</drugbank-id>
      <name>Ketobemidone</name>
      <description>The metabolism of Ketobemidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06739</drugbank-id>
      <name>Seratrodast</name>
      <description>The metabolism of Seratrodast can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11613</drugbank-id>
      <name>Velpatasvir</name>
      <description>The metabolism of Velpatasvir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13132</drugbank-id>
      <name>Artemisinin</name>
      <description>The metabolism of Artemisinin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13943</drugbank-id>
      <name>Testosterone cypionate</name>
      <description>The metabolism of Testosterone cypionate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13944</drugbank-id>
      <name>Testosterone enanthate</name>
      <description>The metabolism of Testosterone enanthate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13946</drugbank-id>
      <name>Testosterone undecanoate</name>
      <description>The metabolism of Testosterone undecanoate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01156</drugbank-id>
      <name>Bupropion</name>
      <description>The metabolism of Bupropion can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00956</drugbank-id>
      <name>Hydrocodone</name>
      <description>The metabolism of Hydrocodone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14975</drugbank-id>
      <name>Voxelotor</name>
      <description>The metabolism of Voxelotor can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11837</drugbank-id>
      <name>Osilodrostat</name>
      <description>The metabolism of Osilodrostat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13384</drugbank-id>
      <name>Melitracen</name>
      <description>The metabolism of Melitracen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13411</drugbank-id>
      <name>Lofepramine</name>
      <description>The metabolism of Lofepramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00714</drugbank-id>
      <name>Apomorphine</name>
      <description>The metabolism of Apomorphine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00751</drugbank-id>
      <name>Epinastine</name>
      <description>The metabolism of Epinastine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00957</drugbank-id>
      <name>Norgestimate</name>
      <description>The metabolism of Norgestimate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04930</drugbank-id>
      <name>Permethrin</name>
      <description>The metabolism of Permethrin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09167</drugbank-id>
      <name>Dosulepin</name>
      <description>The metabolism of Dosulepin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00213</drugbank-id>
      <name>Pantoprazole</name>
      <description>The metabolism of Pantoprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00215</drugbank-id>
      <name>Citalopram</name>
      <description>The metabolism of Citalopram can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00312</drugbank-id>
      <name>Pentobarbital</name>
      <description>The metabolism of Pentobarbital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00338</drugbank-id>
      <name>Omeprazole</name>
      <description>The metabolism of Omeprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00347</drugbank-id>
      <name>Trimethadione</name>
      <description>The metabolism of Trimethadione can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00395</drugbank-id>
      <name>Carisoprodol</name>
      <description>The metabolism of Carisoprodol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00448</drugbank-id>
      <name>Lansoprazole</name>
      <description>The metabolism of Lansoprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00474</drugbank-id>
      <name>Methohexital</name>
      <description>The metabolism of Methohexital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00582</drugbank-id>
      <name>Voriconazole</name>
      <description>The metabolism of Voriconazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00679</drugbank-id>
      <name>Thioridazine</name>
      <description>The metabolism of Thioridazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00736</drugbank-id>
      <name>Esomeprazole</name>
      <description>The metabolism of Esomeprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00794</drugbank-id>
      <name>Primidone</name>
      <description>The metabolism of Primidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00909</drugbank-id>
      <name>Zonisamide</name>
      <description>The metabolism of Zonisamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01129</drugbank-id>
      <name>Rabeprazole</name>
      <description>The metabolism of Rabeprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01131</drugbank-id>
      <name>Proguanil</name>
      <description>The metabolism of Proguanil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01175</drugbank-id>
      <name>Escitalopram</name>
      <description>The metabolism of Escitalopram can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01259</drugbank-id>
      <name>Lapatinib</name>
      <description>The metabolism of Lapatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01323</drugbank-id>
      <name>St. John's Wort</name>
      <description>The metabolism of St. John's Wort can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01355</drugbank-id>
      <name>Hexobarbital</name>
      <description>The metabolism of Hexobarbital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01483</drugbank-id>
      <name>Barbital</name>
      <description>The metabolism of Barbital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05246</drugbank-id>
      <name>Methsuximide</name>
      <description>The metabolism of Methsuximide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05351</drugbank-id>
      <name>Dexlansoprazole</name>
      <description>The metabolism of Dexlansoprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06218</drugbank-id>
      <name>Lacosamide</name>
      <description>The metabolism of Lacosamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06414</drugbank-id>
      <name>Etravirine</name>
      <description>The metabolism of Etravirine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06605</drugbank-id>
      <name>Apixaban</name>
      <description>The metabolism of Apixaban can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09166</drugbank-id>
      <name>Etizolam</name>
      <description>The metabolism of Etizolam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12130</drugbank-id>
      <name>Lorlatinib</name>
      <description>The metabolism of Lorlatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12474</drugbank-id>
      <name>Lynestrenol</name>
      <description>The metabolism of Lynestrenol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13762</drugbank-id>
      <name>Dexrabeprazole</name>
      <description>The metabolism of Dexrabeprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14055</drugbank-id>
      <name>(S)-Warfarin</name>
      <description>The metabolism of (S)-Warfarin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00715</drugbank-id>
      <name>Paroxetine</name>
      <description>The metabolism of Paroxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12500</drugbank-id>
      <name>Fedratinib</name>
      <description>The metabolism of Fedratinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04861</drugbank-id>
      <name>Nebivolol</name>
      <description>The metabolism of Nebivolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06684</drugbank-id>
      <name>Vilazodone</name>
      <description>The metabolism of Vilazodone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01104</drugbank-id>
      <name>Sertraline</name>
      <description>The metabolism of Sertraline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11823</drugbank-id>
      <name>Esketamine</name>
      <description>The metabolism of Esketamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>The metabolism of Phenytoin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00599</drugbank-id>
      <name>Thiopental</name>
      <description>The metabolism of Thiopental can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>The metabolism of Phenobarbital can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01320</drugbank-id>
      <name>Fosphenytoin</name>
      <description>The metabolism of Fosphenytoin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00726</drugbank-id>
      <name>Trimipramine</name>
      <description>The metabolism of Trimipramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00613</drugbank-id>
      <name>Amodiaquine</name>
      <description>The metabolism of Amodiaquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00799</drugbank-id>
      <name>Tazarotene</name>
      <description>The metabolism of Tazarotene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05229</drugbank-id>
      <name>Beraprost</name>
      <description>The metabolism of Beraprost can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06510</drugbank-id>
      <name>Muraglitazar</name>
      <description>The metabolism of Muraglitazar can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09296</drugbank-id>
      <name>Ombitasvir</name>
      <description>The metabolism of Ombitasvir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01217</drugbank-id>
      <name>Anastrozole</name>
      <description>The metabolism of Anastrozole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00255</drugbank-id>
      <name>Diethylstilbestrol</name>
      <description>The metabolism of Diethylstilbestrol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00295</drugbank-id>
      <name>Morphine</name>
      <description>The metabolism of Morphine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00359</drugbank-id>
      <name>Sulfadiazine</name>
      <description>The metabolism of Sulfadiazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00402</drugbank-id>
      <name>Eszopiclone</name>
      <description>The metabolism of Eszopiclone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00622</drugbank-id>
      <name>Nicardipine</name>
      <description>The metabolism of Nicardipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00912</drugbank-id>
      <name>Repaglinide</name>
      <description>The metabolism of Repaglinide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01261</drugbank-id>
      <name>Sitagliptin</name>
      <description>The metabolism of Sitagliptin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06670</drugbank-id>
      <name>Odanacatib</name>
      <description>The metabolism of Odanacatib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08502</drugbank-id>
      <name>Capravirine</name>
      <description>The metabolism of Capravirine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08931</drugbank-id>
      <name>Riociguat</name>
      <description>The metabolism of Riociguat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09198</drugbank-id>
      <name>Lobeglitazone</name>
      <description>The metabolism of Lobeglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09199</drugbank-id>
      <name>Netoglitazone</name>
      <description>The metabolism of Netoglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09200</drugbank-id>
      <name>Rivoglitazone</name>
      <description>The metabolism of Rivoglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09201</drugbank-id>
      <name>Ciglitazone</name>
      <description>The metabolism of Ciglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11362</drugbank-id>
      <name>Selexipag</name>
      <description>The metabolism of Selexipag can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11901</drugbank-id>
      <name>Apalutamide</name>
      <description>The metabolism of Apalutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11978</drugbank-id>
      <name>Glasdegib</name>
      <description>The metabolism of Glasdegib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12781</drugbank-id>
      <name>Balaglitazone</name>
      <description>The metabolism of Balaglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01132</drugbank-id>
      <name>Pioglitazone</name>
      <description>The metabolism of Pioglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11652</drugbank-id>
      <name>Tucatinib</name>
      <description>The metabolism of Tucatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00946</drugbank-id>
      <name>Phenprocoumon</name>
      <description>The metabolism of Phenprocoumon can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>The metabolism of Paclitaxel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06772</drugbank-id>
      <name>Cabazitaxel</name>
      <description>The metabolism of Cabazitaxel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00177</drugbank-id>
      <name>Valsartan</name>
      <description>The metabolism of Valsartan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00184</drugbank-id>
      <name>Nicotine</name>
      <description>The metabolism of Nicotine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00197</drugbank-id>
      <name>Troglitazone</name>
      <description>The metabolism of Troglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00214</drugbank-id>
      <name>Torasemide</name>
      <description>The metabolism of Torasemide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00222</drugbank-id>
      <name>Glimepiride</name>
      <description>The metabolism of Glimepiride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00285</drugbank-id>
      <name>Venlafaxine</name>
      <description>The metabolism of Venlafaxine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00304</drugbank-id>
      <name>Desogestrel</name>
      <description>The metabolism of Desogestrel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00307</drugbank-id>
      <name>Bexarotene</name>
      <description>The metabolism of Bexarotene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00327</drugbank-id>
      <name>Hydromorphone</name>
      <description>The metabolism of Hydromorphone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00328</drugbank-id>
      <name>Indomethacin</name>
      <description>The metabolism of Indomethacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00343</drugbank-id>
      <name>Diltiazem</name>
      <description>The metabolism of Diltiazem can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00374</drugbank-id>
      <name>Treprostinil</name>
      <description>The metabolism of Treprostinil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00412</drugbank-id>
      <name>Rosiglitazone</name>
      <description>The metabolism of Rosiglitazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00414</drugbank-id>
      <name>Acetohexamide</name>
      <description>The metabolism of Acetohexamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00420</drugbank-id>
      <name>Promazine</name>
      <description>The metabolism of Promazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00440</drugbank-id>
      <name>Trimethoprim</name>
      <description>The metabolism of Trimethoprim can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00461</drugbank-id>
      <name>Nabumetone</name>
      <description>The metabolism of Nabumetone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00468</drugbank-id>
      <name>Quinine</name>
      <description>The metabolism of Quinine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00469</drugbank-id>
      <name>Tenoxicam</name>
      <description>The metabolism of Tenoxicam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00472</drugbank-id>
      <name>Fluoxetine</name>
      <description>The metabolism of Fluoxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00476</drugbank-id>
      <name>Duloxetine</name>
      <description>The metabolism of Duloxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00482</drugbank-id>
      <name>Celecoxib</name>
      <description>The metabolism of Celecoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00495</drugbank-id>
      <name>Zidovudine</name>
      <description>The metabolism of Zidovudine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00502</drugbank-id>
      <name>Haloperidol</name>
      <description>The metabolism of Haloperidol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00533</drugbank-id>
      <name>Rofecoxib</name>
      <description>The metabolism of Rofecoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00549</drugbank-id>
      <name>Zafirlukast</name>
      <description>The metabolism of Zafirlukast can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00554</drugbank-id>
      <name>Piroxicam</name>
      <description>The metabolism of Piroxicam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00559</drugbank-id>
      <name>Bosentan</name>
      <description>The metabolism of Bosentan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00568</drugbank-id>
      <name>Cinnarizine</name>
      <description>The metabolism of Cinnarizine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00580</drugbank-id>
      <name>Valdecoxib</name>
      <description>The metabolism of Valdecoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00586</drugbank-id>
      <name>Diclofenac</name>
      <description>The metabolism of Diclofenac can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00617</drugbank-id>
      <name>Paramethadione</name>
      <description>The metabolism of Paramethadione can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00661</drugbank-id>
      <name>Verapamil</name>
      <description>The metabolism of Verapamil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00672</drugbank-id>
      <name>Chlorpropamide</name>
      <description>The metabolism of Chlorpropamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00678</drugbank-id>
      <name>Losartan</name>
      <description>The metabolism of Losartan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00701</drugbank-id>
      <name>Amprenavir</name>
      <description>The metabolism of Amprenavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00712</drugbank-id>
      <name>Flurbiprofen</name>
      <description>The metabolism of Flurbiprofen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00731</drugbank-id>
      <name>Nateglinide</name>
      <description>The metabolism of Nateglinide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00744</drugbank-id>
      <name>Zileuton</name>
      <description>The metabolism of Zileuton can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00749</drugbank-id>
      <name>Etodolac</name>
      <description>The metabolism of Etodolac can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00755</drugbank-id>
      <name>Tretinoin</name>
      <description>The metabolism of Tretinoin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00758</drugbank-id>
      <name>Clopidogrel</name>
      <description>The metabolism of Clopidogrel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00783</drugbank-id>
      <name>Estradiol</name>
      <description>The metabolism of Estradiol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00784</drugbank-id>
      <name>Mefenamic acid</name>
      <description>The metabolism of Mefenamic acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00788</drugbank-id>
      <name>Naproxen</name>
      <description>The metabolism of Naproxen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00796</drugbank-id>
      <name>Candesartan cilexetil</name>
      <description>The metabolism of Candesartan cilexetil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00812</drugbank-id>
      <name>Phenylbutazone</name>
      <description>The metabolism of Phenylbutazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00814</drugbank-id>
      <name>Meloxicam</name>
      <description>The metabolism of Meloxicam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00839</drugbank-id>
      <name>Tolazamide</name>
      <description>The metabolism of Tolazamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00843</drugbank-id>
      <name>Donepezil</name>
      <description>The metabolism of Donepezil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00857</drugbank-id>
      <name>Terbinafine</name>
      <description>The metabolism of Terbinafine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00904</drugbank-id>
      <name>Ondansetron</name>
      <description>The metabolism of Ondansetron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00921</drugbank-id>
      <name>Buprenorphine</name>
      <description>The metabolism of Buprenorphine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00936</drugbank-id>
      <name>Salicylic acid</name>
      <description>The metabolism of Salicylic acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00945</drugbank-id>
      <name>Acetylsalicylic acid</name>
      <description>The metabolism of Acetylsalicylic acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00969</drugbank-id>
      <name>Alosetron</name>
      <description>The metabolism of Alosetron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00972</drugbank-id>
      <name>Azelastine</name>
      <description>The metabolism of Azelastine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00980</drugbank-id>
      <name>Ramelteon</name>
      <description>The metabolism of Ramelteon can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01016</drugbank-id>
      <name>Glyburide</name>
      <description>The metabolism of Glyburide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01029</drugbank-id>
      <name>Irbesartan</name>
      <description>The metabolism of Irbesartan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01036</drugbank-id>
      <name>Tolterodine</name>
      <description>The metabolism of Tolterodine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01037</drugbank-id>
      <name>Selegiline</name>
      <description>The metabolism of Selegiline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01041</drugbank-id>
      <name>Thalidomide</name>
      <description>The metabolism of Thalidomide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01050</drugbank-id>
      <name>Ibuprofen</name>
      <description>The metabolism of Ibuprofen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01065</drugbank-id>
      <name>Melatonin</name>
      <description>The metabolism of Melatonin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01067</drugbank-id>
      <name>Glipizide</name>
      <description>The metabolism of Glipizide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01072</drugbank-id>
      <name>Atazanavir</name>
      <description>The metabolism of Atazanavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01075</drugbank-id>
      <name>Diphenhydramine</name>
      <description>The metabolism of Diphenhydramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01095</drugbank-id>
      <name>Fluvastatin</name>
      <description>The metabolism of Fluvastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01098</drugbank-id>
      <name>Rosuvastatin</name>
      <description>The metabolism of Rosuvastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01120</drugbank-id>
      <name>Gliclazide</name>
      <description>The metabolism of Gliclazide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01124</drugbank-id>
      <name>Tolbutamide</name>
      <description>The metabolism of Tolbutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01136</drugbank-id>
      <name>Carvedilol</name>
      <description>The metabolism of Carvedilol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01154</drugbank-id>
      <name>Thiamylal</name>
      <description>The metabolism of Thiamylal can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01171</drugbank-id>
      <name>Moclobemide</name>
      <description>The metabolism of Moclobemide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01177</drugbank-id>
      <name>Idarubicin</name>
      <description>The metabolism of Idarubicin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01198</drugbank-id>
      <name>Zopiclone</name>
      <description>The metabolism of Zopiclone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01251</drugbank-id>
      <name>Gliquidone</name>
      <description>The metabolism of Gliquidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01283</drugbank-id>
      <name>Lumiracoxib</name>
      <description>The metabolism of Lumiracoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01289</drugbank-id>
      <name>Glisoxepide</name>
      <description>The metabolism of Glisoxepide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01357</drugbank-id>
      <name>Mestranol</name>
      <description>The metabolism of Mestranol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01424</drugbank-id>
      <name>Aminophenazone</name>
      <description>The metabolism of Aminophenazone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01435</drugbank-id>
      <name>Antipyrine</name>
      <description>The metabolism of Antipyrine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01589</drugbank-id>
      <name>Quazepam</name>
      <description>The metabolism of Quazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01628</drugbank-id>
      <name>Etoricoxib</name>
      <description>The metabolism of Etoricoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03756</drugbank-id>
      <name>Doconexent</name>
      <description>The metabolism of Doconexent can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03783</drugbank-id>
      <name>Phenacetin</name>
      <description>The metabolism of Phenacetin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04557</drugbank-id>
      <name>Arachidonic Acid</name>
      <description>The metabolism of Arachidonic Acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04574</drugbank-id>
      <name>Estrone sulfate</name>
      <description>The metabolism of Estrone sulfate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04665</drugbank-id>
      <name>Coumarin</name>
      <description>The metabolism of Coumarin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04725</drugbank-id>
      <name>Licofelone</name>
      <description>The metabolism of Licofelone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04841</drugbank-id>
      <name>Flunarizine</name>
      <description>The metabolism of Flunarizine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04898</drugbank-id>
      <name>Ximelagatran</name>
      <description>The metabolism of Ximelagatran can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06204</drugbank-id>
      <name>Tapentadol</name>
      <description>The metabolism of Tapentadol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06268</drugbank-id>
      <name>Sitaxentan</name>
      <description>The metabolism of Sitaxentan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06370</drugbank-id>
      <name>Indisulam</name>
      <description>The metabolism of Indisulam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06652</drugbank-id>
      <name>Vicriviroc</name>
      <description>The metabolism of Vicriviroc can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06725</drugbank-id>
      <name>Lornoxicam</name>
      <description>The metabolism of Lornoxicam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06737</drugbank-id>
      <name>Zaltoprofen</name>
      <description>The metabolism of Zaltoprofen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06803</drugbank-id>
      <name>Niclosamide</name>
      <description>The metabolism of Niclosamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07615</drugbank-id>
      <name>Tranilast</name>
      <description>The metabolism of Tranilast can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08439</drugbank-id>
      <name>Parecoxib</name>
      <description>The metabolism of Parecoxib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08828</drugbank-id>
      <name>Vismodegib</name>
      <description>The metabolism of Vismodegib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08860</drugbank-id>
      <name>Pitavastatin</name>
      <description>The metabolism of Pitavastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08899</drugbank-id>
      <name>Enzalutamide</name>
      <description>The metabolism of Enzalutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08962</drugbank-id>
      <name>Glibornuride</name>
      <description>The metabolism of Glibornuride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09048</drugbank-id>
      <name>Netupitant</name>
      <description>The metabolism of Netupitant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09061</drugbank-id>
      <name>Cannabidiol</name>
      <description>The metabolism of Cannabidiol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09080</drugbank-id>
      <name>Olodaterol</name>
      <description>The metabolism of Olodaterol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09288</drugbank-id>
      <name>Propacetamol</name>
      <description>The metabolism of Propacetamol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11560</drugbank-id>
      <name>Lesinurad</name>
      <description>The metabolism of Lesinurad can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11614</drugbank-id>
      <name>Rupatadine</name>
      <description>The metabolism of Rupatadine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13406</drugbank-id>
      <name>Carbutamide</name>
      <description>The metabolism of Carbutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13675</drugbank-id>
      <name>Metahexamide</name>
      <description>The metabolism of Metahexamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13919</drugbank-id>
      <name>Candesartan</name>
      <description>The metabolism of Candesartan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13941</drugbank-id>
      <name>Piperaquine</name>
      <description>The metabolism of Piperaquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13952</drugbank-id>
      <name>Estradiol acetate</name>
      <description>The metabolism of Estradiol acetate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13953</drugbank-id>
      <name>Estradiol benzoate</name>
      <description>The metabolism of Estradiol benzoate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13954</drugbank-id>
      <name>Estradiol cypionate</name>
      <description>The metabolism of Estradiol cypionate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13955</drugbank-id>
      <name>Estradiol dienanthate</name>
      <description>The metabolism of Estradiol dienanthate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13956</drugbank-id>
      <name>Estradiol valerate</name>
      <description>The metabolism of Estradiol valerate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14009</drugbank-id>
      <name>Medical Cannabis</name>
      <description>The metabolism of Medical Cannabis can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14011</drugbank-id>
      <name>Nabiximols</name>
      <description>The metabolism of Nabiximols can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00829</drugbank-id>
      <name>Diazepam</name>
      <description>The metabolism of Diazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00514</drugbank-id>
      <name>Dextromethorphan</name>
      <description>The metabolism of Dextromethorphan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00470</drugbank-id>
      <name>Dronabinol</name>
      <description>The metabolism of Dronabinol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09213</drugbank-id>
      <name>Dexibuprofen</name>
      <description>The metabolism of Dexibuprofen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00465</drugbank-id>
      <name>Ketorolac</name>
      <description>The metabolism of Ketorolac can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15233</drugbank-id>
      <name>Avapritinib</name>
      <description>The metabolism of Avapritinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01142</drugbank-id>
      <name>Doxepin</name>
      <description>The metabolism of Doxepin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00216</drugbank-id>
      <name>Eletriptan</name>
      <description>The metabolism of Eletriptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The metabolism of Imatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06448</drugbank-id>
      <name>Lonafarnib</name>
      <description>The metabolism of Lonafarnib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01101</drugbank-id>
      <name>Capecitabine</name>
      <description>The metabolism of Capecitabine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00266</drugbank-id>
      <name>Dicoumarol</name>
      <description>The metabolism of Dicoumarol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13136</drugbank-id>
      <name>Fluindione</name>
      <description>The metabolism of Fluindione can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08875</drugbank-id>
      <name>Cabozantinib</name>
      <description>The metabolism of Cabozantinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12371</drugbank-id>
      <name>Siponimod</name>
      <description>The metabolism of Siponimod can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01224</drugbank-id>
      <name>Quetiapine</name>
      <description>The metabolism of Quetiapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00182</drugbank-id>
      <name>Amphetamine</name>
      <description>The metabolism of Amphetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00187</drugbank-id>
      <name>Esmolol</name>
      <description>The metabolism of Esmolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00245</drugbank-id>
      <name>Benzatropine</name>
      <description>The metabolism of Benzatropine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00289</drugbank-id>
      <name>Atomoxetine</name>
      <description>The metabolism of Atomoxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00335</drugbank-id>
      <name>Atenolol</name>
      <description>The metabolism of Atenolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00373</drugbank-id>
      <name>Timolol</name>
      <description>The metabolism of Timolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00409</drugbank-id>
      <name>Remoxipride</name>
      <description>The metabolism of Remoxipride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00592</drugbank-id>
      <name>Piperazine</name>
      <description>The metabolism of Piperazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00699</drugbank-id>
      <name>Nicergoline</name>
      <description>The metabolism of Nicergoline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00737</drugbank-id>
      <name>Meclizine</name>
      <description>The metabolism of Meclizine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00805</drugbank-id>
      <name>Minaprine</name>
      <description>The metabolism of Minaprine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00866</drugbank-id>
      <name>Alprenolol</name>
      <description>The metabolism of Alprenolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00914</drugbank-id>
      <name>Phenformin</name>
      <description>The metabolism of Phenformin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00933</drugbank-id>
      <name>Mesoridazine</name>
      <description>The metabolism of Mesoridazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00960</drugbank-id>
      <name>Pindolol</name>
      <description>The metabolism of Pindolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01071</drugbank-id>
      <name>Mequitazine</name>
      <description>The metabolism of Mequitazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01079</drugbank-id>
      <name>Tegaserod</name>
      <description>The metabolism of Tegaserod can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01193</drugbank-id>
      <name>Acebutolol</name>
      <description>The metabolism of Acebutolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01203</drugbank-id>
      <name>Nadolol</name>
      <description>The metabolism of Nadolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01228</drugbank-id>
      <name>Encainide</name>
      <description>The metabolism of Encainide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01233</drugbank-id>
      <name>Metoclopramide</name>
      <description>The metabolism of Metoclopramide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01255</drugbank-id>
      <name>Lisdexamfetamine</name>
      <description>The metabolism of Lisdexamfetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01295</drugbank-id>
      <name>Bevantolol</name>
      <description>The metabolism of Bevantolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01297</drugbank-id>
      <name>Practolol</name>
      <description>The metabolism of Practolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01359</drugbank-id>
      <name>Penbutolol</name>
      <description>The metabolism of Penbutolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01403</drugbank-id>
      <name>Methotrimeprazine</name>
      <description>The metabolism of Methotrimeprazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01429</drugbank-id>
      <name>Aprindine</name>
      <description>The metabolism of Aprindine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01454</drugbank-id>
      <name>Midomafetamine</name>
      <description>The metabolism of Midomafetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01472</drugbank-id>
      <name>4-Methoxyamphetamine</name>
      <description>The metabolism of 4-Methoxyamphetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01576</drugbank-id>
      <name>Dextroamphetamine</name>
      <description>The metabolism of Dextroamphetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01577</drugbank-id>
      <name>Metamfetamine</name>
      <description>The metabolism of Metamfetamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01580</drugbank-id>
      <name>Oxprenolol</name>
      <description>The metabolism of Oxprenolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04840</drugbank-id>
      <name>Debrisoquine</name>
      <description>The metabolism of Debrisoquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04844</drugbank-id>
      <name>Tetrabenazine</name>
      <description>The metabolism of Tetrabenazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04846</drugbank-id>
      <name>Celiprolol</name>
      <description>The metabolism of Celiprolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06217</drugbank-id>
      <name>Vernakalant</name>
      <description>The metabolism of Vernakalant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06506</drugbank-id>
      <name>Repinotan</name>
      <description>The metabolism of Repinotan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06608</drugbank-id>
      <name>Tafenoquine</name>
      <description>The metabolism of Tafenoquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06678</drugbank-id>
      <name>Esmirtazapine</name>
      <description>The metabolism of Esmirtazapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06726</drugbank-id>
      <name>Bufuralol</name>
      <description>The metabolism of Bufuralol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06727</drugbank-id>
      <name>Sparteine</name>
      <description>The metabolism of Sparteine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06735</drugbank-id>
      <name>Enclomiphene</name>
      <description>The metabolism of Enclomiphene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08807</drugbank-id>
      <name>Bopindolol</name>
      <description>The metabolism of Bopindolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08808</drugbank-id>
      <name>Bupranolol</name>
      <description>The metabolism of Bupranolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08952</drugbank-id>
      <name>Indenolol</name>
      <description>The metabolism of Indenolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09076</drugbank-id>
      <name>Umeclidinium</name>
      <description>The metabolism of Umeclidinium can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09204</drugbank-id>
      <name>Arotinolol</name>
      <description>The metabolism of Arotinolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09351</drugbank-id>
      <name>Levobetaxolol</name>
      <description>The metabolism of Levobetaxolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11770</drugbank-id>
      <name>Talinolol</name>
      <description>The metabolism of Talinolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11785</drugbank-id>
      <name>Anisodamine</name>
      <description>The metabolism of Anisodamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11855</drugbank-id>
      <name>Revefenacin</name>
      <description>The metabolism of Revefenacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11979</drugbank-id>
      <name>Elagolix</name>
      <description>The metabolism of Elagolix can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12070</drugbank-id>
      <name>Letermovir</name>
      <description>The metabolism of Letermovir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12212</drugbank-id>
      <name>Landiolol</name>
      <description>The metabolism of Landiolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12752</drugbank-id>
      <name>Bucindolol</name>
      <description>The metabolism of Bucindolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13443</drugbank-id>
      <name>Esatenolol</name>
      <description>The metabolism of Esatenolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13508</drugbank-id>
      <name>Cloranolol</name>
      <description>The metabolism of Cloranolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13530</drugbank-id>
      <name>Mepindolol</name>
      <description>The metabolism of Mepindolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13679</drugbank-id>
      <name>Dexchlorpheniramine</name>
      <description>The metabolism of Dexchlorpheniramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13757</drugbank-id>
      <name>Epanolol</name>
      <description>The metabolism of Epanolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13775</drugbank-id>
      <name>Tertatolol</name>
      <description>The metabolism of Tertatolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00850</drugbank-id>
      <name>Perphenazine</name>
      <description>The metabolism of Perphenazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09173</drugbank-id>
      <name>Butyrfentanyl</name>
      <description>The metabolism of Butyrfentanyl can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00281</drugbank-id>
      <name>Lidocaine</name>
      <description>The metabolism of Lidocaine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00598</drugbank-id>
      <name>Labetalol</name>
      <description>The metabolism of Labetalol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14010</drugbank-id>
      <name>5-methoxy-N,N-dimethyltryptamine</name>
      <description>The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01410</drugbank-id>
      <name>Ciclesonide</name>
      <description>The metabolism of Ciclesonide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01611</drugbank-id>
      <name>Hydroxychloroquine</name>
      <description>The metabolism of Hydroxychloroquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00918</drugbank-id>
      <name>Almotriptan</name>
      <description>The metabolism of Almotriptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08918</drugbank-id>
      <name>Levomilnacipran</name>
      <description>The metabolism of Levomilnacipran can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08922</drugbank-id>
      <name>Perospirone</name>
      <description>The metabolism of Perospirone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09183</drugbank-id>
      <name>Dasabuvir</name>
      <description>The metabolism of Dasabuvir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00185</drugbank-id>
      <name>Cevimeline</name>
      <description>The metabolism of Cevimeline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00243</drugbank-id>
      <name>Ranolazine</name>
      <description>The metabolism of Ranolazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00297</drugbank-id>
      <name>Bupivacaine</name>
      <description>The metabolism of Bupivacaine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00318</drugbank-id>
      <name>Codeine</name>
      <description>The metabolism of Codeine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00377</drugbank-id>
      <name>Palonosetron</name>
      <description>The metabolism of Palonosetron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00589</drugbank-id>
      <name>Lisuride</name>
      <description>The metabolism of Lisuride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00647</drugbank-id>
      <name>Dextropropoxyphene</name>
      <description>The metabolism of Dextropropoxyphene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00674</drugbank-id>
      <name>Galantamine</name>
      <description>The metabolism of Galantamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00705</drugbank-id>
      <name>Delavirdine</name>
      <description>The metabolism of Delavirdine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00706</drugbank-id>
      <name>Tamsulosin</name>
      <description>The metabolism of Tamsulosin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00757</drugbank-id>
      <name>Dolasetron</name>
      <description>The metabolism of Dolasetron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01149</drugbank-id>
      <name>Nefazodone</name>
      <description>The metabolism of Nefazodone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01192</drugbank-id>
      <name>Oxymorphone</name>
      <description>The metabolism of Oxymorphone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01244</drugbank-id>
      <name>Bepridil</name>
      <description>The metabolism of Bepridil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01392</drugbank-id>
      <name>Yohimbine</name>
      <description>The metabolism of Yohimbine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01409</drugbank-id>
      <name>Tiotropium</name>
      <description>The metabolism of Tiotropium can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01551</drugbank-id>
      <name>Dihydrocodeine</name>
      <description>The metabolism of Dihydrocodeine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01591</drugbank-id>
      <name>Solifenacin</name>
      <description>The metabolism of Solifenacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01621</drugbank-id>
      <name>Pipotiazine</name>
      <description>The metabolism of Pipotiazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02703</drugbank-id>
      <name>Fusidic acid</name>
      <description>The metabolism of Fusidic acid can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04829</drugbank-id>
      <name>Lysergic acid diethylamide</name>
      <description>The metabolism of Lysergic acid diethylamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04884</drugbank-id>
      <name>Dapoxetine</name>
      <description>The metabolism of Dapoxetine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04905</drugbank-id>
      <name>Tesmilifene</name>
      <description>The metabolism of Tesmilifene can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04920</drugbank-id>
      <name>Clevidipine</name>
      <description>The metabolism of Clevidipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05271</drugbank-id>
      <name>Rotigotine</name>
      <description>The metabolism of Rotigotine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06016</drugbank-id>
      <name>Cariprazine</name>
      <description>The metabolism of Cariprazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06144</drugbank-id>
      <name>Sertindole</name>
      <description>The metabolism of Sertindole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06203</drugbank-id>
      <name>Alogliptin</name>
      <description>The metabolism of Alogliptin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06702</drugbank-id>
      <name>Fesoterodine</name>
      <description>The metabolism of Fesoterodine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08893</drugbank-id>
      <name>Mirabegron</name>
      <description>The metabolism of Mirabegron can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09128</drugbank-id>
      <name>Brexpiprazole</name>
      <description>The metabolism of Brexpiprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09195</drugbank-id>
      <name>Lorpiprazole</name>
      <description>The metabolism of Lorpiprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09555</drugbank-id>
      <name>Dexchlorpheniramine maleate</name>
      <description>The metabolism of Dexchlorpheniramine maleate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11130</drugbank-id>
      <name>Opium</name>
      <description>The metabolism of Opium can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11642</drugbank-id>
      <name>Pitolisant</name>
      <description>The metabolism of Pitolisant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13293</drugbank-id>
      <name>Ipecac</name>
      <description>The metabolism of Ipecac can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00344</drugbank-id>
      <name>Protriptyline</name>
      <description>The metabolism of Protriptyline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00496</drugbank-id>
      <name>Darifenacin</name>
      <description>The metabolism of Darifenacin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00932</drugbank-id>
      <name>Tipranavir</name>
      <description>The metabolism of Tipranavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09039</drugbank-id>
      <name>Eliglustat</name>
      <description>The metabolism of Eliglustat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12930</drugbank-id>
      <name>Opipramol</name>
      <description>The metabolism of Opipramol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14881</drugbank-id>
      <name>Oliceridine</name>
      <description>The metabolism of Oliceridine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09053</drugbank-id>
      <name>Ibrutinib</name>
      <description>The metabolism of Ibrutinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11718</drugbank-id>
      <name>Encorafenib</name>
      <description>The metabolism of Encorafenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00342</drugbank-id>
      <name>Terfenadine</name>
      <description>The metabolism of Terfenadine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00489</drugbank-id>
      <name>Sotalol</name>
      <description>The metabolism of Sotalol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01035</drugbank-id>
      <name>Procainamide</name>
      <description>The metabolism of Procainamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01195</drugbank-id>
      <name>Flecainide</name>
      <description>The metabolism of Flecainide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00321</drugbank-id>
      <name>Amitriptyline</name>
      <description>The metabolism of Amitriptyline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00637</drugbank-id>
      <name>Astemizole</name>
      <description>The metabolism of Astemizole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00543</drugbank-id>
      <name>Amoxapine</name>
      <description>The metabolism of Amoxapine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00540</drugbank-id>
      <name>Nortriptyline</name>
      <description>The metabolism of Nortriptyline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01151</drugbank-id>
      <name>Desipramine</name>
      <description>The metabolism of Desipramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00228</drugbank-id>
      <name>Enflurane</name>
      <description>The metabolism of Enflurane can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06712</drugbank-id>
      <name>Nilvadipine</name>
      <description>The metabolism of Nilvadipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06728</drugbank-id>
      <name>Aniline</name>
      <description>The metabolism of Aniline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00949</drugbank-id>
      <name>Felbamate</name>
      <description>The metabolism of Felbamate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00593</drugbank-id>
      <name>Ethosuximide</name>
      <description>The metabolism of Ethosuximide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00186</drugbank-id>
      <name>Lorazepam</name>
      <description>The metabolism of Lorazepam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00191</drugbank-id>
      <name>Phentermine</name>
      <description>The metabolism of Phentermine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00207</drugbank-id>
      <name>Azithromycin</name>
      <description>The metabolism of Azithromycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00208</drugbank-id>
      <name>Ticlopidine</name>
      <description>The metabolism of Ticlopidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00264</drugbank-id>
      <name>Metoprolol</name>
      <description>The metabolism of Metoprolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00426</drugbank-id>
      <name>Famciclovir</name>
      <description>The metabolism of Famciclovir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00433</drugbank-id>
      <name>Prochlorperazine</name>
      <description>The metabolism of Prochlorperazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00567</drugbank-id>
      <name>Cephalexin</name>
      <description>The metabolism of Cephalexin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00590</drugbank-id>
      <name>Doxazosin</name>
      <description>The metabolism of Doxazosin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01039</drugbank-id>
      <name>Fenofibrate</name>
      <description>The metabolism of Fenofibrate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01395</drugbank-id>
      <name>Drospirenone</name>
      <description>The metabolism of Drospirenone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01411</drugbank-id>
      <name>Pranlukast</name>
      <description>The metabolism of Pranlukast can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01431</drugbank-id>
      <name>Allylestrenol</name>
      <description>The metabolism of Allylestrenol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01624</drugbank-id>
      <name>Zuclopenthixol</name>
      <description>The metabolism of Zuclopenthixol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06201</drugbank-id>
      <name>Rufinamide</name>
      <description>The metabolism of Rufinamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06480</drugbank-id>
      <name>Prucalopride</name>
      <description>The metabolism of Prucalopride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08882</drugbank-id>
      <name>Linagliptin</name>
      <description>The metabolism of Linagliptin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09030</drugbank-id>
      <name>Vorapaxar</name>
      <description>The metabolism of Vorapaxar can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09034</drugbank-id>
      <name>Suvorexant</name>
      <description>The metabolism of Suvorexant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09079</drugbank-id>
      <name>Nintedanib</name>
      <description>The metabolism of Nintedanib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09299</drugbank-id>
      <name>Tenofovir alafenamide</name>
      <description>The metabolism of Tenofovir alafenamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11094</drugbank-id>
      <name>Vitamin D</name>
      <description>The metabolism of Vitamin D can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11273</drugbank-id>
      <name>Dihydroergocornine</name>
      <description>The metabolism of Dihydroergocornine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11730</drugbank-id>
      <name>Ribociclib</name>
      <description>The metabolism of Ribociclib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11952</drugbank-id>
      <name>Duvelisib</name>
      <description>The metabolism of Duvelisib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12141</drugbank-id>
      <name>Gilteritinib</name>
      <description>The metabolism of Gilteritinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12515</drugbank-id>
      <name>9-aminocamptothecin</name>
      <description>The metabolism of 9-aminocamptothecin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12952</drugbank-id>
      <name>Methylprednisone</name>
      <description>The metabolism of Methylprednisone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13345</drugbank-id>
      <name>Dihydroergocristine</name>
      <description>The metabolism of Dihydroergocristine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13385</drugbank-id>
      <name>Dihydroergocryptine</name>
      <description>The metabolism of Dihydroergocryptine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14126</drugbank-id>
      <name>Tenofovir</name>
      <description>The metabolism of Tenofovir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15444</drugbank-id>
      <name>Elexacaftor</name>
      <description>The metabolism of Elexacaftor can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06717</drugbank-id>
      <name>Fosaprepitant</name>
      <description>The metabolism of Fosaprepitant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12825</drugbank-id>
      <name>Lefamulin</name>
      <description>The metabolism of Lefamulin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12887</drugbank-id>
      <name>Tazemetostat</name>
      <description>The metabolism of Tazemetostat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00454</drugbank-id>
      <name>Meperidine</name>
      <description>The metabolism of Meperidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00247</drugbank-id>
      <name>Methysergide</name>
      <description>The metabolism of Methysergide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11742</drugbank-id>
      <name>Ebastine</name>
      <description>The metabolism of Ebastine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11633</drugbank-id>
      <name>Isavuconazole</name>
      <description>The metabolism of Isavuconazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01118</drugbank-id>
      <name>Amiodarone</name>
      <description>The metabolism of Amiodarone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00675</drugbank-id>
      <name>Tamoxifen</name>
      <description>The metabolism of Tamoxifen can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06176</drugbank-id>
      <name>Romidepsin</name>
      <description>The metabolism of Romidepsin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00204</drugbank-id>
      <name>Dofetilide</name>
      <description>The metabolism of Dofetilide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00877</drugbank-id>
      <name>Sirolimus</name>
      <description>The metabolism of Sirolimus can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01008</drugbank-id>
      <name>Busulfan</name>
      <description>The metabolism of Busulfan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The metabolism of Dasatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>The metabolism of Digitoxin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01590</drugbank-id>
      <name>Everolimus</name>
      <description>The metabolism of Everolimus can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04855</drugbank-id>
      <name>Dronedarone</name>
      <description>The metabolism of Dronedarone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06287</drugbank-id>
      <name>Temsirolimus</name>
      <description>The metabolism of Temsirolimus can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09289</drugbank-id>
      <name>Tianeptine</name>
      <description>The metabolism of Tianeptine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00398</drugbank-id>
      <name>Sorafenib</name>
      <description>The metabolism of Sorafenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>The metabolism of Teniposide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00530</drugbank-id>
      <name>Erlotinib</name>
      <description>The metabolism of Erlotinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00541</drugbank-id>
      <name>Vincristine</name>
      <description>The metabolism of Vincristine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00762</drugbank-id>
      <name>Irinotecan</name>
      <description>The metabolism of Irinotecan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00773</drugbank-id>
      <name>Etoposide</name>
      <description>The metabolism of Etoposide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01248</drugbank-id>
      <name>Docetaxel</name>
      <description>The metabolism of Docetaxel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01268</drugbank-id>
      <name>Sunitinib</name>
      <description>The metabolism of Sunitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The metabolism of Trastuzumab emtansine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06626</drugbank-id>
      <name>Axitinib</name>
      <description>The metabolism of Axitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08865</drugbank-id>
      <name>Crizotinib</name>
      <description>The metabolism of Crizotinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08901</drugbank-id>
      <name>Ponatinib</name>
      <description>The metabolism of Ponatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The metabolism of Olaparib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12483</drugbank-id>
      <name>Copanlisib</name>
      <description>The metabolism of Copanlisib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00188</drugbank-id>
      <name>Bortezomib</name>
      <description>The metabolism of Bortezomib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01181</drugbank-id>
      <name>Ifosfamide</name>
      <description>The metabolism of Ifosfamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05109</drugbank-id>
      <name>Trabectedin</name>
      <description>The metabolism of Trabectedin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12147</drugbank-id>
      <name>Erdafitinib</name>
      <description>The metabolism of Erdafitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13874</drugbank-id>
      <name>Enasidenib</name>
      <description>The metabolism of Enasidenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06589</drugbank-id>
      <name>Pazopanib</name>
      <description>The metabolism of Pazopanib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05239</drugbank-id>
      <name>Cobimetinib</name>
      <description>The metabolism of Cobimetinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09063</drugbank-id>
      <name>Ceritinib</name>
      <description>The metabolism of Ceritinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09330</drugbank-id>
      <name>Osimertinib</name>
      <description>The metabolism of Osimertinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11963</drugbank-id>
      <name>Dacomitinib</name>
      <description>The metabolism of Dacomitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12015</drugbank-id>
      <name>Alpelisib</name>
      <description>The metabolism of Alpelisib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00309</drugbank-id>
      <name>Vindesine</name>
      <description>The metabolism of Vindesine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>The metabolism of Vinorelbine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00570</drugbank-id>
      <name>Vinblastine</name>
      <description>The metabolism of Vinblastine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00997</drugbank-id>
      <name>Doxorubicin</name>
      <description>The metabolism of Doxorubicin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04572</drugbank-id>
      <name>Thiotepa</name>
      <description>The metabolism of Thiotepa can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04845</drugbank-id>
      <name>Ixabepilone</name>
      <description>The metabolism of Ixabepilone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The metabolism of Nilotinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06603</drugbank-id>
      <name>Panobinostat</name>
      <description>The metabolism of Panobinostat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06616</drugbank-id>
      <name>Bosutinib</name>
      <description>The metabolism of Bosutinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08870</drugbank-id>
      <name>Brentuximab vedotin</name>
      <description>The metabolism of Brentuximab vedotin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08877</drugbank-id>
      <name>Ruxolitinib</name>
      <description>The metabolism of Ruxolitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The metabolism of Palbociclib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11817</drugbank-id>
      <name>Baricitinib</name>
      <description>The metabolism of Baricitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08912</drugbank-id>
      <name>Dabrafenib</name>
      <description>The metabolism of Dabrafenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12267</drugbank-id>
      <name>Brigatinib</name>
      <description>The metabolism of Brigatinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The metabolism of Methotrexate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08827</drugbank-id>
      <name>Lomitapide</name>
      <description>The metabolism of Lomitapide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05294</drugbank-id>
      <name>Vandetanib</name>
      <description>The metabolism of Vandetanib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08881</drugbank-id>
      <name>Vemurafenib</name>
      <description>The metabolism of Vemurafenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11363</drugbank-id>
      <name>Alectinib</name>
      <description>The metabolism of Alectinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11581</drugbank-id>
      <name>Venetoclax</name>
      <description>The metabolism of Venetoclax can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11641</drugbank-id>
      <name>Vinflunine</name>
      <description>The metabolism of Vinflunine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11703</drugbank-id>
      <name>Acalabrutinib</name>
      <description>The metabolism of Acalabrutinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15035</drugbank-id>
      <name>Zanubrutinib</name>
      <description>The metabolism of Zanubrutinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00248</drugbank-id>
      <name>Cabergoline</name>
      <description>The metabolism of Cabergoline can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06595</drugbank-id>
      <name>Midostaurin</name>
      <description>The metabolism of Midostaurin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09143</drugbank-id>
      <name>Sonidegib</name>
      <description>The metabolism of Sonidegib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11828</drugbank-id>
      <name>Neratinib</name>
      <description>The metabolism of Neratinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11986</drugbank-id>
      <name>Entrectinib</name>
      <description>The metabolism of Entrectinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12978</drugbank-id>
      <name>Pexidartinib</name>
      <description>The metabolism of Pexidartinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14568</drugbank-id>
      <name>Ivosidenib</name>
      <description>The metabolism of Ivosidenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09054</drugbank-id>
      <name>Idelalisib</name>
      <description>The metabolism of Idelalisib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09570</drugbank-id>
      <name>Ixazomib</name>
      <description>The metabolism of Ixazomib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06212</drugbank-id>
      <name>Tolvaptan</name>
      <description>The metabolism of Tolvaptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08896</drugbank-id>
      <name>Regorafenib</name>
      <description>The metabolism of Regorafenib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12001</drugbank-id>
      <name>Abemaciclib</name>
      <description>The metabolism of Abemaciclib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00320</drugbank-id>
      <name>Dihydroergotamine</name>
      <description>The metabolism of Dihydroergotamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The metabolism of Carbamazepine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00696</drugbank-id>
      <name>Ergotamine</name>
      <description>The metabolism of Ergotamine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00872</drugbank-id>
      <name>Conivaptan</name>
      <description>The metabolism of Conivaptan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00908</drugbank-id>
      <name>Quinidine</name>
      <description>The metabolism of Quinidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01128</drugbank-id>
      <name>Bicalutamide</name>
      <description>The metabolism of Bicalutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01227</drugbank-id>
      <name>Levacetylmethadol</name>
      <description>The metabolism of Levacetylmethadol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00199</drugbank-id>
      <name>Erythromycin</name>
      <description>The metabolism of Erythromycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00246</drugbank-id>
      <name>Ziprasidone</name>
      <description>The metabolism of Ziprasidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00439</drugbank-id>
      <name>Cerivastatin</name>
      <description>The metabolism of Cerivastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00499</drugbank-id>
      <name>Flutamide</name>
      <description>The metabolism of Flutamide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00528</drugbank-id>
      <name>Lercanidipine</name>
      <description>The metabolism of Lercanidipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00571</drugbank-id>
      <name>Propranolol</name>
      <description>The metabolism of Propranolol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00588</drugbank-id>
      <name>Fluticasone propionate</name>
      <description>The metabolism of Fluticasone propionate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00608</drugbank-id>
      <name>Chloroquine</name>
      <description>The metabolism of Chloroquine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00688</drugbank-id>
      <name>Mycophenolate mofetil</name>
      <description>The metabolism of Mycophenolate mofetil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00717</drugbank-id>
      <name>Norethisterone</name>
      <description>The metabolism of Norethisterone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00738</drugbank-id>
      <name>Pentamidine</name>
      <description>The metabolism of Pentamidine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00741</drugbank-id>
      <name>Hydrocortisone</name>
      <description>The metabolism of Hydrocortisone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00822</drugbank-id>
      <name>Disulfiram</name>
      <description>The metabolism of Disulfiram can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00834</drugbank-id>
      <name>Mifepristone</name>
      <description>The metabolism of Mifepristone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00938</drugbank-id>
      <name>Salmeterol</name>
      <description>The metabolism of Salmeterol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00962</drugbank-id>
      <name>Zaleplon</name>
      <description>The metabolism of Zaleplon can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00976</drugbank-id>
      <name>Telithromycin</name>
      <description>The metabolism of Telithromycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01054</drugbank-id>
      <name>Nitrendipine</name>
      <description>The metabolism of Nitrendipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01058</drugbank-id>
      <name>Praziquantel</name>
      <description>The metabolism of Praziquantel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01062</drugbank-id>
      <name>Oxybutynin</name>
      <description>The metabolism of Oxybutynin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01076</drugbank-id>
      <name>Atorvastatin</name>
      <description>The metabolism of Atorvastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01103</drugbank-id>
      <name>Quinacrine</name>
      <description>The metabolism of Quinacrine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01115</drugbank-id>
      <name>Nifedipine</name>
      <description>The metabolism of Nifedipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01126</drugbank-id>
      <name>Dutasteride</name>
      <description>The metabolism of Dutasteride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01166</drugbank-id>
      <name>Cilostazol</name>
      <description>The metabolism of Cilostazol can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01184</drugbank-id>
      <name>Domperidone</name>
      <description>The metabolism of Domperidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01211</drugbank-id>
      <name>Clarithromycin</name>
      <description>The metabolism of Clarithromycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01216</drugbank-id>
      <name>Finasteride</name>
      <description>The metabolism of Finasteride can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01218</drugbank-id>
      <name>Halofantrine</name>
      <description>The metabolism of Halofantrine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05521</drugbank-id>
      <name>Telaprevir</name>
      <description>The metabolism of Telaprevir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06267</drugbank-id>
      <name>Udenafil</name>
      <description>The metabolism of Udenafil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06335</drugbank-id>
      <name>Saxagliptin</name>
      <description>The metabolism of Saxagliptin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06403</drugbank-id>
      <name>Ambrisentan</name>
      <description>The metabolism of Ambrisentan can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06419</drugbank-id>
      <name>Cethromycin</name>
      <description>The metabolism of Cethromycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06789</drugbank-id>
      <name>Hydroxyprogesterone caproate</name>
      <description>The metabolism of Hydroxyprogesterone caproate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08820</drugbank-id>
      <name>Ivacaftor</name>
      <description>The metabolism of Ivacaftor can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08873</drugbank-id>
      <name>Boceprevir</name>
      <description>The metabolism of Boceprevir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08883</drugbank-id>
      <name>Perampanel</name>
      <description>The metabolism of Perampanel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08906</drugbank-id>
      <name>Fluticasone furoate</name>
      <description>The metabolism of Fluticasone furoate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09065</drugbank-id>
      <name>Cobicistat</name>
      <description>The metabolism of Cobicistat can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09102</drugbank-id>
      <name>Daclatasvir</name>
      <description>The metabolism of Daclatasvir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09231</drugbank-id>
      <name>Benidipine</name>
      <description>The metabolism of Benidipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09297</drugbank-id>
      <name>Paritaprevir</name>
      <description>The metabolism of Paritaprevir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11574</drugbank-id>
      <name>Elbasvir</name>
      <description>The metabolism of Elbasvir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11712</drugbank-id>
      <name>Tezacaftor</name>
      <description>The metabolism of Tezacaftor can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11737</drugbank-id>
      <name>Icotinib</name>
      <description>The metabolism of Icotinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12301</drugbank-id>
      <name>Doravirine</name>
      <description>The metabolism of Doravirine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13867</drugbank-id>
      <name>Fluticasone</name>
      <description>The metabolism of Fluticasone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14539</drugbank-id>
      <name>Hydrocortisone acetate</name>
      <description>The metabolism of Hydrocortisone acetate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14541</drugbank-id>
      <name>Hydrocortisone cypionate</name>
      <description>The metabolism of Hydrocortisone cypionate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00396</drugbank-id>
      <name>Progesterone</name>
      <description>The metabolism of Progesterone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04856</drugbank-id>
      <name>Dexloxiglumide</name>
      <description>The metabolism of Dexloxiglumide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04957</drugbank-id>
      <name>Azimilide</name>
      <description>The metabolism of Azimilide can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00250</drugbank-id>
      <name>Dapsone</name>
      <description>The metabolism of Dapsone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00317</drugbank-id>
      <name>Gefitinib</name>
      <description>The metabolism of Gefitinib can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00367</drugbank-id>
      <name>Levonorgestrel</name>
      <description>The metabolism of Levonorgestrel can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00497</drugbank-id>
      <name>Oxycodone</name>
      <description>The metabolism of Oxycodone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00620</drugbank-id>
      <name>Triamcinolone</name>
      <description>The metabolism of Triamcinolone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00624</drugbank-id>
      <name>Testosterone</name>
      <description>The metabolism of Testosterone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00656</drugbank-id>
      <name>Trazodone</name>
      <description>The metabolism of Trazodone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00734</drugbank-id>
      <name>Risperidone</name>
      <description>The metabolism of Risperidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01114</drugbank-id>
      <name>Chlorpheniramine</name>
      <description>The metabolism of Chlorpheniramine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01238</drugbank-id>
      <name>Aripiprazole</name>
      <description>The metabolism of Aripiprazole can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01267</drugbank-id>
      <name>Paliperidone</name>
      <description>The metabolism of Paliperidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04946</drugbank-id>
      <name>Iloperidone</name>
      <description>The metabolism of Iloperidone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11915</drugbank-id>
      <name>Valbenazine</name>
      <description>The metabolism of Valbenazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12161</drugbank-id>
      <name>Deutetrabenazine</name>
      <description>The metabolism of Deutetrabenazine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14185</drugbank-id>
      <name>Aripiprazole lauroxil</name>
      <description>The metabolism of Aripiprazole lauroxil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The metabolism of Dexamethasone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09237</drugbank-id>
      <name>Levamlodipine</name>
      <description>The metabolism of Levamlodipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11951</drugbank-id>
      <name>Lemborexant</name>
      <description>The metabolism of Lemborexant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00557</drugbank-id>
      <name>Hydroxyzine</name>
      <description>The metabolism of Hydroxyzine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00203</drugbank-id>
      <name>Sildenafil</name>
      <description>The metabolism of Sildenafil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00227</drugbank-id>
      <name>Lovastatin</name>
      <description>The metabolism of Lovastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00490</drugbank-id>
      <name>Buspirone</name>
      <description>The metabolism of Buspirone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00641</drugbank-id>
      <name>Simvastatin</name>
      <description>The metabolism of Simvastatin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00673</drugbank-id>
      <name>Aprepitant</name>
      <description>The metabolism of Aprepitant can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00820</drugbank-id>
      <name>Tadalafil</name>
      <description>The metabolism of Tadalafil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00862</drugbank-id>
      <name>Vardenafil</name>
      <description>The metabolism of Vardenafil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01190</drugbank-id>
      <name>Clindamycin</name>
      <description>The metabolism of Clindamycin can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00503</drugbank-id>
      <name>Ritonavir</name>
      <description>The metabolism of Ritonavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00224</drugbank-id>
      <name>Indinavir</name>
      <description>The metabolism of Indinavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00401</drugbank-id>
      <name>Nisoldipine</name>
      <description>The metabolism of Nisoldipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00683</drugbank-id>
      <name>Midazolam</name>
      <description>The metabolism of Midazolam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00700</drugbank-id>
      <name>Eplerenone</name>
      <description>The metabolism of Eplerenone can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00802</drugbank-id>
      <name>Alfentanil</name>
      <description>The metabolism of Alfentanil can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00813</drugbank-id>
      <name>Fentanyl</name>
      <description>The metabolism of Fentanyl can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00897</drugbank-id>
      <name>Triazolam</name>
      <description>The metabolism of Triazolam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01023</drugbank-id>
      <name>Felodipine</name>
      <description>The metabolism of Felodipine can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01232</drugbank-id>
      <name>Saquinavir</name>
      <description>The metabolism of Saquinavir can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06228</drugbank-id>
      <name>Rivaroxaban</name>
      <description>The metabolism of Rivaroxaban can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00404</drugbank-id>
      <name>Alprazolam</name>
      <description>The metabolism of Alprazolam can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14540</drugbank-id>
      <name>Hydrocortisone butyrate</name>
      <description>The metabolism of Hydrocortisone butyrate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14542</drugbank-id>
      <name>Hydrocortisone phosphate</name>
      <description>The metabolism of Hydrocortisone phosphate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05804</drugbank-id>
      <name>Prasterone sulfate</name>
      <description>The metabolism of Prasterone sulfate can be increased when combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00091</drugbank-id>
      <name>Cyclosporine</name>
      <description>Etanercept may increase the immunosuppressive activities of Cyclosporine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05676</drugbank-id>
      <name>Apremilast</name>
      <description>The therapeutic efficacy of Apremilast can be decreased when used in combination with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14513</drugbank-id>
      <name>Magnesium</name>
      <description>The serum concentration of Magnesium can be decreased when it is combined with Etanercept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01601</drugbank-id>
      <name>Lopinavir</name>
      <description>The serum concentration of Etanercept can be increased when it is combined with Lopinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12530</drugbank-id>
      <name>Inebilizumab</name>
      <description>The risk or severity of infection can be increased when Etanercept is combined with Inebilizumab.</description>
    </drug-interaction>
  </drug-interactions>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00006</drugbank-id>
  <drugbank-id>BTD00076</drugbank-id>
  <drugbank-id>EXPT03302</drugbank-id>
  <drugbank-id>BIOD00076</drugbank-id>
  <drugbank-id>DB02351</drugbank-id>
  <name>Bivalirudin</name>
  <description>Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is administered intravenously. Because it can cause blood stagnation, it is important to monitor changes in hematocrit, activated partial thromboplastin time, international normalized ratio and blood pressure.</description>
  <cas-number>128270-60-0</cas-number>
  <unii>TN9BEX005G</unii>
  <average-mass>2180.2853</average-mass>
  <monoisotopic-mass>2178.985813062</monoisotopic-mass>
  <state>solid</state>
  <indication>For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.</indication>
<drug-interactions>
  <drug-interaction>
    <drugbank-id>DB01250</drugbank-id>
    <name>Olsalazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01283</drugbank-id>
    <name>Lumiracoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01397</drugbank-id>
    <name>Magnesium salicylate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01399</drugbank-id>
    <name>Salsalate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01401</drugbank-id>
    <name>Choline magnesium trisalicylate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01419</drugbank-id>
    <name>Antrafenine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01424</drugbank-id>
    <name>Aminophenazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01435</drugbank-id>
    <name>Antipyrine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01600</drugbank-id>
    <name>Tiaprofenic acid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01628</drugbank-id>
    <name>Etoricoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02224</drugbank-id>
    <name>Taxifolin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03585</drugbank-id>
    <name>Oxyphenbutazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04725</drugbank-id>
    <name>Licofelone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04812</drugbank-id>
    <name>Benoxaprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04817</drugbank-id>
    <name>Metamizole</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04828</drugbank-id>
    <name>Zomepirac</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05095</drugbank-id>
    <name>Cimicoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06725</drugbank-id>
    <name>Lornoxicam</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06736</drugbank-id>
    <name>Aceclofenac</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06737</drugbank-id>
    <name>Zaltoprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07402</drugbank-id>
    <name>Azapropazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08439</drugbank-id>
    <name>Parecoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08797</drugbank-id>
    <name>Salicylamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08940</drugbank-id>
    <name>Kebuzone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08942</drugbank-id>
    <name>Isoxicam</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08951</drugbank-id>
    <name>Indoprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08955</drugbank-id>
    <name>Ibuproxam</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08976</drugbank-id>
    <name>Floctafenine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08981</drugbank-id>
    <name>Fenbufen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08984</drugbank-id>
    <name>Etofenamate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08991</drugbank-id>
    <name>Epirizole</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09084</drugbank-id>
    <name>Benzydamine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09214</drugbank-id>
    <name>Dexketoprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09215</drugbank-id>
    <name>Droxicam</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09216</drugbank-id>
    <name>Tolfenamic acid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09217</drugbank-id>
    <name>Firocoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09218</drugbank-id>
    <name>Clonixin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09285</drugbank-id>
    <name>Morniflumate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09288</drugbank-id>
    <name>Propacetamol</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09295</drugbank-id>
    <name>Talniflumate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11455</drugbank-id>
    <name>Robenacoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11466</drugbank-id>
    <name>Tepoxalin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11518</drugbank-id>
    <name>Flunixin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12399</drugbank-id>
    <name>Polmacoxib</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12610</drugbank-id>
    <name>Ebselen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13001</drugbank-id>
    <name>Tinoridine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13167</drugbank-id>
    <name>Alclofenac</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13217</drugbank-id>
    <name>Fentiazac</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13232</drugbank-id>
    <name>Suxibuzone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13286</drugbank-id>
    <name>Bumadizone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13314</drugbank-id>
    <name>Alminoprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13371</drugbank-id>
    <name>Difenpiramide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13407</drugbank-id>
    <name>Nifenazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13432</drugbank-id>
    <name>Lonazolac</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13481</drugbank-id>
    <name>Tenidap</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13524</drugbank-id>
    <name>Propyphenazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13527</drugbank-id>
    <name>Proglumetacin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13538</drugbank-id>
    <name>Guacetisal</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13544</drugbank-id>
    <name>Ethenzamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13612</drugbank-id>
    <name>Carbaspirin calcium</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13629</drugbank-id>
    <name>Mofebutazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13649</drugbank-id>
    <name>Proquazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13657</drugbank-id>
    <name>Benorilate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13722</drugbank-id>
    <name>Pirprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13860</drugbank-id>
    <name>Imidazole salicylate</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14059</drugbank-id>
    <name>SC-236</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14060</drugbank-id>
    <name>NS-398</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14938</drugbank-id>
    <name>Flurbiprofen axetil</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09212</drugbank-id>
    <name>Loxoprofen</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04865</drugbank-id>
    <name>Omacetaxine mepesuccinate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Omacetaxine mepesuccinate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11133</drugbank-id>
    <name>Omega-3 fatty acids</name>
    <description>Omega-3 fatty acids may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00081</drugbank-id>
    <name>Tositumomab</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Tositumomab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00048</drugbank-id>
    <name>Collagenase clostridium histolyticum</name>
    <description>The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00389</drugbank-id>
    <name>Carbimazole</name>
    <description>Carbimazole may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00550</drugbank-id>
    <name>Propylthiouracil</name>
    <description>Propylthiouracil may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00763</drugbank-id>
    <name>Methimazole</name>
    <description>Methimazole may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03374</drugbank-id>
    <name>3,5-Diiodotyrosine</name>
    <description>3,5-Diiodotyrosine may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06715</drugbank-id>
    <name>Potassium Iodide</name>
    <description>Potassium Iodide may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07637</drugbank-id>
    <name>Dibromotyrosine</name>
    <description>Dibromotyrosine may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09418</drugbank-id>
    <name>Potassium perchlorate</name>
    <description>Potassium perchlorate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13644</drugbank-id>
    <name>Methylthiouracil</name>
    <description>Methylthiouracil may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13804</drugbank-id>
    <name>Benzylthiouracil</name>
    <description>Benzylthiouracil may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00834</drugbank-id>
    <name>Mifepristone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mifepristone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04066</drugbank-id>
    <name>p-Coumaric acid</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with p-Coumaric acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04682</drugbank-id>
    <name>Octylphenoxy polyethoxyethanol</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05830</drugbank-id>
    <name>Trestolone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trestolone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06266</drugbank-id>
    <name>Lonidamine</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Lonidamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08867</drugbank-id>
    <name>Ulipristal</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ulipristal.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09401</drugbank-id>
    <name>Isosorbide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Isosorbide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11507</drugbank-id>
    <name>Cloprostenol</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cloprostenol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12025</drugbank-id>
    <name>Triptolide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triptolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13044</drugbank-id>
    <name>Gossypol</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Gossypol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13310</drugbank-id>
    <name>Ormeloxifene</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ormeloxifene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00294</drugbank-id>
    <name>Etonogestrel</name>
    <description>Etonogestrel may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00304</drugbank-id>
    <name>Desogestrel</name>
    <description>Desogestrel may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00351</drugbank-id>
    <name>Megestrol acetate</name>
    <description>Megestrol acetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00367</drugbank-id>
    <name>Levonorgestrel</name>
    <description>Levonorgestrel may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00378</drugbank-id>
    <name>Dydrogesterone</name>
    <description>Dydrogesterone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00396</drugbank-id>
    <name>Progesterone</name>
    <description>Progesterone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00603</drugbank-id>
    <name>Medroxyprogesterone acetate</name>
    <description>Medroxyprogesterone acetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00717</drugbank-id>
    <name>Norethisterone</name>
    <description>Norethisterone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00823</drugbank-id>
    <name>Ethynodiol diacetate</name>
    <description>Ethynodiol diacetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00957</drugbank-id>
    <name>Norgestimate</name>
    <description>Norgestimate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01395</drugbank-id>
    <name>Drospirenone</name>
    <description>Drospirenone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01431</drugbank-id>
    <name>Allylestrenol</name>
    <description>Allylestrenol may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04839</drugbank-id>
    <name>Cyproterone acetate</name>
    <description>Cyproterone acetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06713</drugbank-id>
    <name>Norelgestromin</name>
    <description>Norelgestromin may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06730</drugbank-id>
    <name>Gestodene</name>
    <description>Gestodene may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06789</drugbank-id>
    <name>Hydroxyprogesterone caproate</name>
    <description>Hydroxyprogesterone caproate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09123</drugbank-id>
    <name>Dienogest</name>
    <description>Dienogest may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09124</drugbank-id>
    <name>Medrogestone</name>
    <description>Medrogestone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09371</drugbank-id>
    <name>Norethynodrel</name>
    <description>Norethynodrel may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09389</drugbank-id>
    <name>Norgestrel</name>
    <description>Norgestrel may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11372</drugbank-id>
    <name>Altrenogest</name>
    <description>Altrenogest may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11619</drugbank-id>
    <name>Gestrinone</name>
    <description>Gestrinone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11636</drugbank-id>
    <name>Nomegestrol</name>
    <description>Nomegestrol may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12474</drugbank-id>
    <name>Lynestrenol</name>
    <description>Lynestrenol may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13230</drugbank-id>
    <name>Gestonorone</name>
    <description>Gestonorone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13528</drugbank-id>
    <name>Chlormadinone</name>
    <description>Chlormadinone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13533</drugbank-id>
    <name>Methylestrenolone</name>
    <description>Methylestrenolone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13563</drugbank-id>
    <name>Norgestrienone</name>
    <description>Norgestrienone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13602</drugbank-id>
    <name>Promegestone</name>
    <description>Promegestone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13685</drugbank-id>
    <name>Quingestanol</name>
    <description>Quingestanol may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13857</drugbank-id>
    <name>Demegestone</name>
    <description>Demegestone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13866</drugbank-id>
    <name>Etynodiol</name>
    <description>Etynodiol may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13981</drugbank-id>
    <name>Nomegestrol acetate</name>
    <description>Nomegestrol acetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14570</drugbank-id>
    <name>Hydroxyprogesterone</name>
    <description>Hydroxyprogesterone may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14678</drugbank-id>
    <name>Norethindrone enanthate</name>
    <description>Norethindrone enanthate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14679</drugbank-id>
    <name>Quingestanol acetate</name>
    <description>Quingestanol acetate may decrease the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00233</drugbank-id>
    <name>Aminosalicylic acid</name>
    <description>The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01294</drugbank-id>
    <name>Bismuth subsalicylate</name>
    <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06251</drugbank-id>
    <name>Dersalazine</name>
    <description>The risk or severity of bleeding can be increased when Dersalazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06807</drugbank-id>
    <name>Phenyl aminosalicylate</name>
    <description>The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09543</drugbank-id>
    <name>Methyl salicylate</name>
    <description>The risk or severity of bleeding can be increased when Methyl salicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11079</drugbank-id>
    <name>Trolamine salicylate</name>
    <description>The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13509</drugbank-id>
    <name>Aloxiprin</name>
    <description>The risk or severity of bleeding can be increased when Aloxiprin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14006</drugbank-id>
    <name>Choline salicylate</name>
    <description>The risk or severity of bleeding can be increased when Choline salicylate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14026</drugbank-id>
    <name>Thiosalicylic acid</name>
    <description>The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00054</drugbank-id>
    <name>Abciximab</name>
    <description>The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00063</drugbank-id>
    <name>Eptifibatide</name>
    <description>The risk or severity of bleeding can be increased when Eptifibatide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00208</drugbank-id>
    <name>Ticlopidine</name>
    <description>The risk or severity of bleeding can be increased when Ticlopidine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00261</drugbank-id>
    <name>Anagrelide</name>
    <description>The risk or severity of bleeding can be increased when Anagrelide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00758</drugbank-id>
    <name>Clopidogrel</name>
    <description>The risk or severity of bleeding can be increased when Clopidogrel is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00775</drugbank-id>
    <name>Tirofiban</name>
    <description>The risk or severity of bleeding can be increased when Tirofiban is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00975</drugbank-id>
    <name>Dipyridamole</name>
    <description>The risk or severity of bleeding can be increased when Dipyridamole is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01088</drugbank-id>
    <name>Iloprost</name>
    <description>The risk or severity of bleeding can be increased when Iloprost is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01138</drugbank-id>
    <name>Sulfinpyrazone</name>
    <description>The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01166</drugbank-id>
    <name>Cilostazol</name>
    <description>The risk or severity of bleeding can be increased when Cilostazol is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01207</drugbank-id>
    <name>Ridogrel</name>
    <description>The risk or severity of bleeding can be increased when Ridogrel is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01236</drugbank-id>
    <name>Sevoflurane</name>
    <description>The risk or severity of bleeding can be increased when Sevoflurane is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01240</drugbank-id>
    <name>Epoprostenol</name>
    <description>The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02709</drugbank-id>
    <name>Resveratrol</name>
    <description>The risk or severity of bleeding can be increased when Resveratrol is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04743</drugbank-id>
    <name>Nimesulide</name>
    <description>The risk or severity of bleeding can be increased when Nimesulide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04905</drugbank-id>
    <name>Tesmilifene</name>
    <description>The risk or severity of bleeding can be increased when Tesmilifene is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04932</drugbank-id>
    <name>Defibrotide</name>
    <description>The risk or severity of bleeding can be increased when Defibrotide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05229</drugbank-id>
    <name>Beraprost</name>
    <description>The risk or severity of bleeding can be increased when Beraprost is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05266</drugbank-id>
    <name>Ibudilast</name>
    <description>The risk or severity of bleeding can be increased when Ibudilast is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05767</drugbank-id>
    <name>Andrographolide</name>
    <description>The risk or severity of bleeding can be increased when Andrographolide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06081</drugbank-id>
    <name>Caplacizumab</name>
    <description>The risk or severity of bleeding can be increased when Caplacizumab is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06209</drugbank-id>
    <name>Prasugrel</name>
    <description>The risk or severity of bleeding can be increased when Prasugrel is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06441</drugbank-id>
    <name>Cangrelor</name>
    <description>The risk or severity of bleeding can be increased when Cangrelor is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07615</drugbank-id>
    <name>Tranilast</name>
    <description>The risk or severity of bleeding can be increased when Tranilast is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08814</drugbank-id>
    <name>Triflusal</name>
    <description>The risk or severity of bleeding can be increased when Triflusal is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08816</drugbank-id>
    <name>Ticagrelor</name>
    <description>The risk or severity of bleeding can be increased when Ticagrelor is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08887</drugbank-id>
    <name>Icosapent ethyl</name>
    <description>The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09283</drugbank-id>
    <name>Trapidil</name>
    <description>The risk or severity of bleeding can be increased when Trapidil is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12092</drugbank-id>
    <name>Naftopidil</name>
    <description>The risk or severity of bleeding can be increased when Naftopidil is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12163</drugbank-id>
    <name>Sarpogrelate</name>
    <description>The risk or severity of bleeding can be increased when Sarpogrelate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12321</drugbank-id>
    <name>Ifetroban</name>
    <description>The risk or severity of bleeding can be increased when Ifetroban is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12445</drugbank-id>
    <name>Nitroaspirin</name>
    <description>The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12465</drugbank-id>
    <name>Ketanserin</name>
    <description>The risk or severity of bleeding can be increased when Ketanserin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12545</drugbank-id>
    <name>Indobufen</name>
    <description>The risk or severity of bleeding can be increased when Indobufen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12749</drugbank-id>
    <name>Butylphthalide</name>
    <description>The risk or severity of bleeding can be increased when Butylphthalide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12771</drugbank-id>
    <name>Hydroxytyrosol</name>
    <description>The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13036</drugbank-id>
    <name>Ramatroban</name>
    <description>The risk or severity of bleeding can be increased when Ramatroban is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13327</drugbank-id>
    <name>Picotamide</name>
    <description>The risk or severity of bleeding can be increased when Picotamide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13367</drugbank-id>
    <name>Cloricromen</name>
    <description>The risk or severity of bleeding can be increased when Cloricromen is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13400</drugbank-id>
    <name>Linsidomine</name>
    <description>The risk or severity of bleeding can be increased when Linsidomine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13510</drugbank-id>
    <name>Buflomedil</name>
    <description>The risk or severity of bleeding can be increased when Buflomedil is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13929</drugbank-id>
    <name>Relcovaptan</name>
    <description>The risk or severity of bleeding can be increased when Relcovaptan is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00374</drugbank-id>
    <name>Treprostinil</name>
    <description>The risk or severity of bleeding can be increased when Treprostinil is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03404</drugbank-id>
    <name>Hemin</name>
    <description>Hemin may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13783</drugbank-id>
    <name>Acemetacin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00624</drugbank-id>
    <name>Testosterone</name>
    <description>Testosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01420</drugbank-id>
    <name>Testosterone propionate</name>
    <description>Testosterone propionate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01481</drugbank-id>
    <name>1-Testosterone</name>
    <description>1-Testosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01485</drugbank-id>
    <name>4-Hydroxytestosterone</name>
    <description>4-Hydroxytestosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01510</drugbank-id>
    <name>Dehydrochloromethyltestosterone</name>
    <description>Dehydrochloromethyltestosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01541</drugbank-id>
    <name>Boldenone</name>
    <description>Boldenone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01543</drugbank-id>
    <name>18-methyl-19-nortestosterone</name>
    <description>18-methyl-19-nortestosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01564</drugbank-id>
    <name>Calusterone</name>
    <description>Calusterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01569</drugbank-id>
    <name>Formebolone</name>
    <description>Formebolone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01572</drugbank-id>
    <name>Methyl-1-testosterone</name>
    <description>Methyl-1-testosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07447</drugbank-id>
    <name>5beta-dihydrotestosterone</name>
    <description>5beta-dihydrotestosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08619</drugbank-id>
    <name>Testosterone succinate</name>
    <description>Testosterone succinate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11429</drugbank-id>
    <name>Mibolerone</name>
    <description>Mibolerone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13943</drugbank-id>
    <name>Testosterone cypionate</name>
    <description>Testosterone cypionate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13944</drugbank-id>
    <name>Testosterone enanthate</name>
    <description>Testosterone enanthate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13946</drugbank-id>
    <name>Testosterone undecanoate</name>
    <description>Testosterone undecanoate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13947</drugbank-id>
    <name>Testosterone enantate benzilic acid hydrazone</name>
    <description>Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13951</drugbank-id>
    <name>Stanolone acetate</name>
    <description>Stanolone acetate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13958</drugbank-id>
    <name>Trestolone acetate</name>
    <description>Trestolone acetate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14093</drugbank-id>
    <name>(1,2,6,7-3H)Testosterone</name>
    <description>(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14655</drugbank-id>
    <name>Drostanolone propionate</name>
    <description>Drostanolone propionate may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11051</drugbank-id>
    <name>Azficel-T</name>
    <description>The risk or severity of adverse effects can be increased when Bivalirudin is combined with Azficel-T.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09568</drugbank-id>
    <name>Omega-3-carboxylic acids</name>
    <description>The therapeutic efficacy of Bivalirudin can be increased when used in combination with Omega-3-carboxylic acids.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00025</drugbank-id>
    <name>Antihemophilic factor, human recombinant</name>
    <description>The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00036</drugbank-id>
    <name>Coagulation factor VIIa Recombinant Human</name>
    <description>The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00100</drugbank-id>
    <name>Coagulation Factor IX (Recombinant)</name>
    <description>The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00258</drugbank-id>
    <name>Calcium acetate</name>
    <description>The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01164</drugbank-id>
    <name>Calcium chloride</name>
    <description>The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01373</drugbank-id>
    <name>Calcium</name>
    <description>The therapeutic efficacy of Calcium can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01783</drugbank-id>
    <name>Pantothenic acid</name>
    <description>The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01942</drugbank-id>
    <name>Formic acid</name>
    <description>The therapeutic efficacy of Formic acid can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02261</drugbank-id>
    <name>Platelet Activating Factor</name>
    <description>The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06724</drugbank-id>
    <name>Calcium carbonate</name>
    <description>The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09109</drugbank-id>
    <name>Turoctocog alfa</name>
    <description>The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09222</drugbank-id>
    <name>Fibrinogen human</name>
    <description>The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09310</drugbank-id>
    <name>Catridecacog</name>
    <description>The therapeutic efficacy of Catridecacog can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09329</drugbank-id>
    <name>Antihemophilic Factor (Recombinant), PEGylated</name>
    <description>The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11093</drugbank-id>
    <name>Calcium citrate</name>
    <description>The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11126</drugbank-id>
    <name>Calcium gluconate</name>
    <description>The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11168</drugbank-id>
    <name>Calcium threonate</name>
    <description>The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11311</drugbank-id>
    <name>Prothrombin</name>
    <description>The therapeutic efficacy of Prothrombin can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11330</drugbank-id>
    <name>Factor IX Complex (Human)</name>
    <description>The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11348</drugbank-id>
    <name>Calcium Phosphate</name>
    <description>The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11606</drugbank-id>
    <name>Susoctocog alfa</name>
    <description>The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11608</drugbank-id>
    <name>Eftrenonacog alfa</name>
    <description>The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11668</drugbank-id>
    <name>Rusalatide acetate</name>
    <description>The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12409</drugbank-id>
    <name>Vatreptacog alfa</name>
    <description>The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12909</drugbank-id>
    <name>Factor XIII (human)</name>
    <description>The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13133</drugbank-id>
    <name>Von Willebrand Factor Human</name>
    <description>The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13148</drugbank-id>
    <name>Coagulation factor X human</name>
    <description>The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13150</drugbank-id>
    <name>Coagulation factor VII human</name>
    <description>The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13151</drugbank-id>
    <name>Anti-inhibitor coagulant complex</name>
    <description>The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13152</drugbank-id>
    <name>Coagulation Factor IX Human</name>
    <description>The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13192</drugbank-id>
    <name>Antihemophilic factor human</name>
    <description>The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13197</drugbank-id>
    <name>Kallidinogenase</name>
    <description>The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13201</drugbank-id>
    <name>Trenonacog alfa</name>
    <description>The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13884</drugbank-id>
    <name>Albutrepenonacog alfa</name>
    <description>The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13923</drugbank-id>
    <name>Emicizumab</name>
    <description>The therapeutic efficacy of Emicizumab can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13933</drugbank-id>
    <name>Nonacog beta pegol</name>
    <description>The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13999</drugbank-id>
    <name>Moroctocog alfa</name>
    <description>The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14473</drugbank-id>
    <name>Beroctocog alfa</name>
    <description>The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14562</drugbank-id>
    <name>Andexanet alfa</name>
    <description>The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14577</drugbank-id>
    <name>Calcium cation</name>
    <description>The therapeutic efficacy of Calcium cation can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14700</drugbank-id>
    <name>Damoctocog alfa pegol</name>
    <description>The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14738</drugbank-id>
    <name>Turoctocog alfa pegol</name>
    <description>The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00176</drugbank-id>
    <name>Fluvoxamine</name>
    <description>The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00215</drugbank-id>
    <name>Citalopram</name>
    <description>The risk or severity of hemorrhage can be increased when Citalopram is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00472</drugbank-id>
    <name>Fluoxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00715</drugbank-id>
    <name>Paroxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Paroxetine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01149</drugbank-id>
    <name>Nefazodone</name>
    <description>The risk or severity of hemorrhage can be increased when Nefazodone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04832</drugbank-id>
    <name>Zimelidine</name>
    <description>The risk or severity of hemorrhage can be increased when Zimelidine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04884</drugbank-id>
    <name>Dapoxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06731</drugbank-id>
    <name>Seproxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Seproxetine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08953</drugbank-id>
    <name>Indalpine</name>
    <description>The risk or severity of hemorrhage can be increased when Indalpine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12693</drugbank-id>
    <name>Ritanserin</name>
    <description>The risk or severity of hemorrhage can be increased when Ritanserin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13233</drugbank-id>
    <name>Alaproclate</name>
    <description>The risk or severity of hemorrhage can be increased when Alaproclate is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00476</drugbank-id>
    <name>Duloxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Duloxetine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01105</drugbank-id>
    <name>Sibutramine</name>
    <description>The risk or severity of hemorrhage can be increased when Sibutramine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04896</drugbank-id>
    <name>Milnacipran</name>
    <description>The risk or severity of hemorrhage can be increased when Milnacipran is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06700</drugbank-id>
    <name>Desvenlafaxine</name>
    <description>The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08918</drugbank-id>
    <name>Levomilnacipran</name>
    <description>The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00285</drugbank-id>
    <name>Venlafaxine</name>
    <description>Venlafaxine may increase the antiplatelet activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00182</drugbank-id>
    <name>Amphetamine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00601</drugbank-id>
    <name>Linezolid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00614</drugbank-id>
    <name>Furazolidone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00721</drugbank-id>
    <name>Procaine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00752</drugbank-id>
    <name>Tranylcypromine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00780</drugbank-id>
    <name>Phenelzine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00805</drugbank-id>
    <name>Minaprine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01037</drugbank-id>
    <name>Selegiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01168</drugbank-id>
    <name>Procarbazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01171</drugbank-id>
    <name>Moclobemide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01247</drugbank-id>
    <name>Isocarboxazid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01367</drugbank-id>
    <name>Rasagiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01626</drugbank-id>
    <name>Pargyline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04017</drugbank-id>
    <name>Clorgiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04818</drugbank-id>
    <name>Iproniazid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04820</drugbank-id>
    <name>Nialamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06654</drugbank-id>
    <name>Safinamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08550</drugbank-id>
    <name>7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09241</drugbank-id>
    <name>Methylene blue</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09243</drugbank-id>
    <name>Hydracarbazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09244</drugbank-id>
    <name>Pirlindole</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09245</drugbank-id>
    <name>Toloxatone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09246</drugbank-id>
    <name>Benmoxin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09248</drugbank-id>
    <name>Mebanazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09249</drugbank-id>
    <name>Octamoxin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09250</drugbank-id>
    <name>Pheniprazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09251</drugbank-id>
    <name>Phenoxypropazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09252</drugbank-id>
    <name>Pivhydrazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09253</drugbank-id>
    <name>Safrazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09254</drugbank-id>
    <name>Caroxazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13875</drugbank-id>
    <name>Harmaline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13876</drugbank-id>
    <name>Brofaromine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00266</drugbank-id>
    <name>Dicoumarol</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dicoumarol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00278</drugbank-id>
    <name>Argatroban</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Argatroban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00407</drugbank-id>
    <name>Ardeparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ardeparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00498</drugbank-id>
    <name>Phenindione</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenindione.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00569</drugbank-id>
    <name>Fondaparinux</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Fondaparinux.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00682</drugbank-id>
    <name>Warfarin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Warfarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00946</drugbank-id>
    <name>Phenprocoumon</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenprocoumon.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00974</drugbank-id>
    <name>Edetic acid</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01109</drugbank-id>
    <name>Heparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Heparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01225</drugbank-id>
    <name>Enoxaparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Enoxaparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01418</drugbank-id>
    <name>Acenocoumarol</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Acenocoumarol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04898</drugbank-id>
    <name>Ximelagatran</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ximelagatran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05099</drugbank-id>
    <name>Ancrod</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ancrod.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06271</drugbank-id>
    <name>Sulodexide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Sulodexide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06406</drugbank-id>
    <name>Idraparinux</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Idraparinux.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06635</drugbank-id>
    <name>Otamixaban</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Otamixaban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06754</drugbank-id>
    <name>Danaparoid</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Danaparoid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06779</drugbank-id>
    <name>Dalteparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dalteparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07767</drugbank-id>
    <name>Ferulic acid</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ferulic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08794</drugbank-id>
    <name>Ethyl biscoumacetate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ethyl biscoumacetate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08813</drugbank-id>
    <name>Nadroparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Nadroparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09255</drugbank-id>
    <name>Dextran</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dextran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11095</drugbank-id>
    <name>Desirudin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Desirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11268</drugbank-id>
    <name>Protocatechualdehyde</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Protocatechualdehyde.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11312</drugbank-id>
    <name>Protein C</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein C.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11598</drugbank-id>
    <name>Antithrombin III human</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin III human.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11984</drugbank-id>
    <name>Letaxaban</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Letaxaban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12289</drugbank-id>
    <name>Darexaban</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Darexaban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12598</drugbank-id>
    <name>Nafamostat</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Nafamostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12831</drugbank-id>
    <name>Gabexate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Gabexate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13124</drugbank-id>
    <name>Troxerutin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Troxerutin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13136</drugbank-id>
    <name>Fluindione</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluindione.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13149</drugbank-id>
    <name>Protein S human</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Protein S human.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13616</drugbank-id>
    <name>Melagatran</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Melagatran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09125</drugbank-id>
    <name>Potassium citrate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Potassium citrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09154</drugbank-id>
    <name>Sodium citrate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Sodium citrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00031</drugbank-id>
    <name>Tenecteplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00055</drugbank-id>
    <name>Drotrecogin alfa</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Drotrecogin alfa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06822</drugbank-id>
    <name>Tinzaparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tinzaparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13199</drugbank-id>
    <name>Brinase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Brinase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13646</drugbank-id>
    <name>Saruplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Saruplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00086</drugbank-id>
    <name>Streptokinase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptokinase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04925</drugbank-id>
    <name>Desmoteplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Desmoteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05254</drugbank-id>
    <name>Fibrinolysin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Fibrinolysin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06543</drugbank-id>
    <name>Astaxanthin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Astaxanthin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08994</drugbank-id>
    <name>Ditazole</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ditazole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09258</drugbank-id>
    <name>Bemiparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Bemiparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09260</drugbank-id>
    <name>Parnaparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Parnaparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13275</drugbank-id>
    <name>Clorindione</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Clorindione.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13347</drugbank-id>
    <name>Diphenadione</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Diphenadione.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13451</drugbank-id>
    <name>Tioclomarol</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioclomarol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00001</drugbank-id>
    <name>Lepirudin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Lepirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00009</drugbank-id>
    <name>Alteplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00015</drugbank-id>
    <name>Reteplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00029</drugbank-id>
    <name>Anistreplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14094</drugbank-id>
    <name>Tocopherylquinone</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tocopherylquinone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06679</drugbank-id>
    <name>Amediplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Amediplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03410</drugbank-id>
    <name>4-hydroxycoumarin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with 4-hydroxycoumarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08496</drugbank-id>
    <name>(R)-warfarin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with (R)-warfarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14055</drugbank-id>
    <name>(S)-Warfarin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with (S)-Warfarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12364</drugbank-id>
    <name>Betrixaban</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Betrixaban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14598</drugbank-id>
    <name>Edetate calcium disodium anhydrous</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Edetate calcium disodium anhydrous.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11154</drugbank-id>
    <name>Zinc citrate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Zinc citrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11166</drugbank-id>
    <name>Antithrombin Alfa</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Antithrombin Alfa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04665</drugbank-id>
    <name>Coumarin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Coumarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14726</drugbank-id>
    <name>Dabigatran</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dabigatran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06294</drugbank-id>
    <name>Semuloparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Semuloparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12726</drugbank-id>
    <name>Monteplase</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Monteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09259</drugbank-id>
    <name>Reviparin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Reviparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00203</drugbank-id>
    <name>Sildenafil</name>
    <description>The risk or severity of hemorrhage can be increased when Bivalirudin is combined with Sildenafil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00008</drugbank-id>
    <name>Peginterferon alfa-2a</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00011</drugbank-id>
    <name>Interferon alfa-n1</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00018</drugbank-id>
    <name>Interferon alfa-n3</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00022</drugbank-id>
    <name>Peginterferon alfa-2b</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00033</drugbank-id>
    <name>Interferon gamma-1b</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00034</drugbank-id>
    <name>Interferon alfa-2a, Recombinant</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00041</drugbank-id>
    <name>Aldesleukin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00056</drugbank-id>
    <name>Gemtuzumab ozogamicin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemtuzumab ozogamicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00068</drugbank-id>
    <name>Interferon beta-1b</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon beta-1b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00069</drugbank-id>
    <name>Interferon alfacon-1</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfacon-1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00073</drugbank-id>
    <name>Rituximab</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Rituximab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00078</drugbank-id>
    <name>Ibritumomab tiuxetan</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ibritumomab tiuxetan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00087</drugbank-id>
    <name>Alemtuzumab</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Alemtuzumab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00105</drugbank-id>
    <name>Interferon alfa-2b</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00120</drugbank-id>
    <name>Phenylalanine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenylalanine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00188</drugbank-id>
    <name>Bortezomib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Bortezomib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00242</drugbank-id>
    <name>Cladribine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cladribine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00262</drugbank-id>
    <name>Carmustine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Carmustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00276</drugbank-id>
    <name>Amsacrine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Amsacrine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00291</drugbank-id>
    <name>Chlorambucil</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Chlorambucil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00293</drugbank-id>
    <name>Raltitrexed</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Raltitrexed.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00305</drugbank-id>
    <name>Mitomycin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitomycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00307</drugbank-id>
    <name>Bexarotene</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Bexarotene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00309</drugbank-id>
    <name>Vindesine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Vindesine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00322</drugbank-id>
    <name>Floxuridine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Floxuridine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00352</drugbank-id>
    <name>Tioguanine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tioguanine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00361</drugbank-id>
    <name>Vinorelbine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinorelbine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00380</drugbank-id>
    <name>Dexrazoxane</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dexrazoxane.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00398</drugbank-id>
    <name>Sorafenib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Sorafenib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00428</drugbank-id>
    <name>Streptozocin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Streptozocin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00441</drugbank-id>
    <name>Gemcitabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemcitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00444</drugbank-id>
    <name>Teniposide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Teniposide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00445</drugbank-id>
    <name>Epirubicin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Epirubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00446</drugbank-id>
    <name>Chloramphenicol</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Chloramphenicol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00480</drugbank-id>
    <name>Lenalidomide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Lenalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00488</drugbank-id>
    <name>Altretamine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Altretamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00495</drugbank-id>
    <name>Zidovudine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00515</drugbank-id>
    <name>Cisplatin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cisplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00526</drugbank-id>
    <name>Oxaliplatin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Oxaliplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00531</drugbank-id>
    <name>Cyclophosphamide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cyclophosphamide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00544</drugbank-id>
    <name>Fluorouracil</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Fluorouracil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00552</drugbank-id>
    <name>Pentostatin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Pentostatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00563</drugbank-id>
    <name>Methotrexate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Methotrexate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00564</drugbank-id>
    <name>Carbamazepine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Carbamazepine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00570</drugbank-id>
    <name>Vinblastine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinblastine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00619</drugbank-id>
    <name>Imatinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Imatinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00631</drugbank-id>
    <name>Clofarabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Clofarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00642</drugbank-id>
    <name>Pemetrexed</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Pemetrexed.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00694</drugbank-id>
    <name>Daunorubicin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Daunorubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00762</drugbank-id>
    <name>Irinotecan</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Irinotecan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00773</drugbank-id>
    <name>Etoposide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Etoposide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00851</drugbank-id>
    <name>Dacarbazine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dacarbazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00853</drugbank-id>
    <name>Temozolomide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Temozolomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00859</drugbank-id>
    <name>Penicillamine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Penicillamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00864</drugbank-id>
    <name>Tacrolimus</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tacrolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00877</drugbank-id>
    <name>Sirolimus</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Sirolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00888</drugbank-id>
    <name>Mechlorethamine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Mechlorethamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00928</drugbank-id>
    <name>Azacitidine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Azacitidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00958</drugbank-id>
    <name>Carboplatin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Carboplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00970</drugbank-id>
    <name>Dactinomycin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dactinomycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00987</drugbank-id>
    <name>Cytarabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cytarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00997</drugbank-id>
    <name>Doxorubicin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Doxorubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01005</drugbank-id>
    <name>Hydroxyurea</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Hydroxyurea.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01008</drugbank-id>
    <name>Busulfan</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Busulfan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01030</drugbank-id>
    <name>Topotecan</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Topotecan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01033</drugbank-id>
    <name>Mercaptopurine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Mercaptopurine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01041</drugbank-id>
    <name>Thalidomide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Thalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01042</drugbank-id>
    <name>Melphalan</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Melphalan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01073</drugbank-id>
    <name>Fludarabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Fludarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01099</drugbank-id>
    <name>Flucytosine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Flucytosine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01101</drugbank-id>
    <name>Capecitabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Capecitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01169</drugbank-id>
    <name>Arsenic trioxide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Arsenic trioxide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01177</drugbank-id>
    <name>Idarubicin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Idarubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01204</drugbank-id>
    <name>Mitoxantrone</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitoxantrone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01206</drugbank-id>
    <name>Lomustine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Lomustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01229</drugbank-id>
    <name>Paclitaxel</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Paclitaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01248</drugbank-id>
    <name>Docetaxel</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Docetaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01262</drugbank-id>
    <name>Decitabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Decitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01280</drugbank-id>
    <name>Nelarabine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Nelarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01590</drugbank-id>
    <name>Everolimus</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Everolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02546</drugbank-id>
    <name>Vorinostat</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Vorinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04572</drugbank-id>
    <name>Thiotepa</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Thiotepa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04845</drugbank-id>
    <name>Ixabepilone</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ixabepilone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04868</drugbank-id>
    <name>Nilotinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Nilotinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05015</drugbank-id>
    <name>Belinostat</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Belinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05109</drugbank-id>
    <name>Trabectedin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Trabectedin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05258</drugbank-id>
    <name>Interferon alfa</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05472</drugbank-id>
    <name>Human interferon omega-1</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Human interferon omega-1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05773</drugbank-id>
    <name>Trastuzumab emtansine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Trastuzumab emtansine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06287</drugbank-id>
    <name>Temsirolimus</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Temsirolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06616</drugbank-id>
    <name>Bosutinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Bosutinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06769</drugbank-id>
    <name>Bendamustine</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Bendamustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06772</drugbank-id>
    <name>Cabazitaxel</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cabazitaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08871</drugbank-id>
    <name>Eribulin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Eribulin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08877</drugbank-id>
    <name>Ruxolitinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ruxolitinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08889</drugbank-id>
    <name>Carfilzomib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Carfilzomib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08895</drugbank-id>
    <name>Tofacitinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tofacitinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08901</drugbank-id>
    <name>Ponatinib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Ponatinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08910</drugbank-id>
    <name>Pomalidomide</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Pomalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09042</drugbank-id>
    <name>Tedizolid phosphate</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Tedizolid phosphate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09052</drugbank-id>
    <name>Blinatumomab</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Blinatumomab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09073</drugbank-id>
    <name>Palbociclib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Palbociclib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09074</drugbank-id>
    <name>Olaparib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Olaparib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09077</drugbank-id>
    <name>Dinutuximab</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Dinutuximab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09122</drugbank-id>
    <name>Peginterferon beta-1a</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon beta-1a.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12814</drugbank-id>
    <name>Cepeginterferon alfa-2B</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Cepeginterferon alfa-2B.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00229</drugbank-id>
    <name>Cefotiam</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotiam.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00267</drugbank-id>
    <name>Cefmenoxime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmenoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00274</drugbank-id>
    <name>Cefmetazole</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefmetazole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00430</drugbank-id>
    <name>Cefpiramide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpiramide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00438</drugbank-id>
    <name>Ceftazidime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftazidime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00447</drugbank-id>
    <name>Loracarbef</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Loracarbef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00456</drugbank-id>
    <name>Cefalotin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefalotin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00493</drugbank-id>
    <name>Cefotaxime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotaxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00535</drugbank-id>
    <name>Cefdinir</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefdinir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00567</drugbank-id>
    <name>Cephalexin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephalexin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00671</drugbank-id>
    <name>Cefixime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefixime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00689</drugbank-id>
    <name>Cephaloglycin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephaloglycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00833</drugbank-id>
    <name>Cefaclor</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaclor.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00923</drugbank-id>
    <name>Ceforanide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceforanide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01066</drugbank-id>
    <name>Cefditoren</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefditoren.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01112</drugbank-id>
    <name>Cefuroxime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefuroxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01139</drugbank-id>
    <name>Cefapirin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefapirin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01140</drugbank-id>
    <name>Cefadroxil</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefadroxil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01150</drugbank-id>
    <name>Cefprozil</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefprozil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01212</drugbank-id>
    <name>Ceftriaxone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftriaxone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01326</drugbank-id>
    <name>Cefamandole</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01327</drugbank-id>
    <name>Cefazolin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazolin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01328</drugbank-id>
    <name>Cefonicid</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefonicid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01329</drugbank-id>
    <name>Cefoperazone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoperazone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01330</drugbank-id>
    <name>Cefotetan</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotetan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01331</drugbank-id>
    <name>Cefoxitin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefoxitin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01332</drugbank-id>
    <name>Ceftizoxime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftizoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01333</drugbank-id>
    <name>Cefradine</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefradine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01413</drugbank-id>
    <name>Cefepime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefepime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01414</drugbank-id>
    <name>Cefacetrile</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefacetrile.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01415</drugbank-id>
    <name>Ceftibuten</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftibuten.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01416</drugbank-id>
    <name>Cefpodoxime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpodoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04570</drugbank-id>
    <name>Latamoxef</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Latamoxef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04918</drugbank-id>
    <name>Ceftobiprole</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftobiprole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06590</drugbank-id>
    <name>Ceftaroline fosamil</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftaroline fosamil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09008</drugbank-id>
    <name>Cefaloridine</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefaloridine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09050</drugbank-id>
    <name>Ceftolozane</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftolozane.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09062</drugbank-id>
    <name>Cefminox</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefminox.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11367</drugbank-id>
    <name>Cefroxadine</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefroxadine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11935</drugbank-id>
    <name>Flomoxef</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Flomoxef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13266</drugbank-id>
    <name>Cefatrizine</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefatrizine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13461</drugbank-id>
    <name>Cefcapene</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefcapene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13470</drugbank-id>
    <name>Cefodizime</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefodizime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13499</drugbank-id>
    <name>Cefsulodin</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefsulodin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13504</drugbank-id>
    <name>Cefetamet</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefetamet.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13638</drugbank-id>
    <name>Cefbuperazone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefbuperazone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13667</drugbank-id>
    <name>Cefozopran</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefozopran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13682</drugbank-id>
    <name>Cefpirome</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefpirome.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13778</drugbank-id>
    <name>Cefazedone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefazedone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13821</drugbank-id>
    <name>Ceftezole</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ceftezole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14725</drugbank-id>
    <name>Cefamandole nafate</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefamandole nafate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00254</drugbank-id>
    <name>Doxycycline</name>
    <description>The risk or severity of bleeding can be increased when Doxycycline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00207</drugbank-id>
    <name>Azithromycin</name>
    <description>The risk or severity of adverse effects can be increased when Azithromycin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09539</drugbank-id>
    <name>Omega-3-acid ethyl esters</name>
    <description>The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00945</drugbank-id>
    <name>Acetylsalicylic acid</name>
    <description>Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01606</drugbank-id>
    <name>Tazobactam</name>
    <description>The risk or severity of bleeding can be increased when Tazobactam is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00199</drugbank-id>
    <name>Erythromycin</name>
    <description>The risk or severity of bleeding can be increased when Erythromycin is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00656</drugbank-id>
    <name>Trazodone</name>
    <description>The risk or severity of bleeding can be increased when Trazodone is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00620</drugbank-id>
    <name>Triamcinolone</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Triamcinolone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09079</drugbank-id>
    <name>Nintedanib</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Nintedanib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01175</drugbank-id>
    <name>Escitalopram</name>
    <description>The risk or severity of bleeding can be increased when Escitalopram is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01104</drugbank-id>
    <name>Sertraline</name>
    <description>The risk or severity of bleeding can be increased when Sertraline is combined with Bivalirudin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00232</drugbank-id>
    <name>Methyclothiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Methyclothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00436</drugbank-id>
    <name>Bendroflumethiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Bendroflumethiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00562</drugbank-id>
    <name>Benzthiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Benzthiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00606</drugbank-id>
    <name>Cyclothiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00774</drugbank-id>
    <name>Hydroflumethiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydroflumethiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00880</drugbank-id>
    <name>Chlorothiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Chlorothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00999</drugbank-id>
    <name>Hydrochlorothiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydrochlorothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01021</drugbank-id>
    <name>Trichlormethiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trichlormethiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01324</drugbank-id>
    <name>Polythiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Polythiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13430</drugbank-id>
    <name>Mebutizide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Mebutizide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13532</drugbank-id>
    <name>Cyclopenthiazide</name>
    <description>The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cyclopenthiazide.</description>
  </drug-interaction>
  </drug-interactions>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2021-01-01"></drug>
  <drugbank-id primary="true">DB00007</drugbank-id>
  <drugbank-id>BTD00009</drugbank-id>
  <drugbank-id>BIOD00009</drugbank-id>
  <name>Leuprolide</name>
  <description>Leuprolide is a synthetic 9-residue peptide analogue of gonadotropin-releasing hormone (GnRH). Unlike the endogenous decapeptide GnRH, leuprolide contains a single D-amino acid (D-leucyl) residue, which helps to increase its circulating half-life from three to four minutes to approximately three hours.[A203222] As a GnRH mimic, leuprolide is capable of binding to the GnRH receptor (GnRHR) and inducing downstream modulation of both gonadotropin hormone and sex steroid levels. Prolonged activation of GnRHR results in significant downregulation of sex steroid levels, which is primarily responsible for the clinical efficacy of leuprolide in diverse conditions, including advanced prostate cancer, endometriosis, and central precocious puberty.[A203126, A203132]&#13;
    &#13;
    Leuprolide was first approved in 1985 as a daily subcutaneous injection under the tradename Lupron by Abbvie Endocrine Inc.[L13850] Since this initial approval, various long-acting intramuscular and subcutaneous products have been developed such that patients can be dosed once every six months.[L13781, L13790] Leuprolide remains frontline therapy in all conditions for which it is indicated for use.</description>
  <indication>Leuprolide is indicated for the palliative treatment of advanced prostate cancer[L13781, L13790] as well as for the treatment of pediatric patients with central precocious puberty (CPP).[L13784, L13787] In combination with oral [norethisterone] (also known as norethindrone), leuprolide is also indicated for the initial treatment of the symptoms of endometriosis.[L10310] Finally, in combination with iron supplementation, leuprolide is indicated for the preoperative hematological improvement of anemic patients with uterine leiomyomata (uterine fibroids).[L13814]</indication>
  <drug-interactions>
    <drug-interaction>
    <drugbank-id>DB00450</drugbank-id>
    <name>Droperidol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Droperidol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00477</drugbank-id>
    <name>Chlorpromazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpromazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00526</drugbank-id>
    <name>Oxaliplatin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxaliplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00537</drugbank-id>
    <name>Ciprofloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ciprofloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00544</drugbank-id>
    <name>Fluorouracil</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluorouracil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00556</drugbank-id>
    <name>Perflutren</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Perflutren.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00568</drugbank-id>
    <name>Cinnarizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinnarizine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00571</drugbank-id>
    <name>Propranolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propranolol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00572</drugbank-id>
    <name>Atropine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Atropine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00608</drugbank-id>
    <name>Chloroquine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chloroquine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00640</drugbank-id>
    <name>Adenosine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Adenosine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00738</drugbank-id>
    <name>Pentamidine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pentamidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00743</drugbank-id>
    <name>Gadobenic acid</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gadobenic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00748</drugbank-id>
    <name>Carbinoxamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Carbinoxamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00757</drugbank-id>
    <name>Dolasetron</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dolasetron.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00778</drugbank-id>
    <name>Roxithromycin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Roxithromycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00779</drugbank-id>
    <name>Nalidixic acid</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nalidixic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00827</drugbank-id>
    <name>Cinoxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cinoxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00889</drugbank-id>
    <name>Granisetron</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Granisetron.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00904</drugbank-id>
    <name>Ondansetron</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ondansetron.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00922</drugbank-id>
    <name>Levosimendan</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levosimendan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00933</drugbank-id>
    <name>Mesoridazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mesoridazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00967</drugbank-id>
    <name>Desloratadine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Desloratadine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00978</drugbank-id>
    <name>Lomefloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lomefloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00985</drugbank-id>
    <name>Dimenhydrinate</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dimenhydrinate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01087</drugbank-id>
    <name>Primaquine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Primaquine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01113</drugbank-id>
    <name>Papaverine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Papaverine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01114</drugbank-id>
    <name>Chlorpheniramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chlorpheniramine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01115</drugbank-id>
    <name>Nifedipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nifedipine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01137</drugbank-id>
    <name>Levofloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levofloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01155</drugbank-id>
    <name>Gemifloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gemifloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01165</drugbank-id>
    <name>Ofloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ofloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01182</drugbank-id>
    <name>Propafenone</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propafenone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01193</drugbank-id>
    <name>Acebutolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Acebutolol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01195</drugbank-id>
    <name>Flecainide</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Flecainide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01580</drugbank-id>
    <name>Oxprenolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxprenolol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01599</drugbank-id>
    <name>Probucol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Probucol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01615</drugbank-id>
    <name>Aceprometazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Aceprometazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02638</drugbank-id>
    <name>Terlipressin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Terlipressin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04825</drugbank-id>
    <name>Prenylamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Prenylamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04842</drugbank-id>
    <name>Fluspirilene</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluspirilene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04948</drugbank-id>
    <name>Lofexidine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lofexidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04957</drugbank-id>
    <name>Azimilide</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Azimilide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05223</drugbank-id>
    <name>Pracinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pracinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05488</drugbank-id>
    <name>Technetium Tc-99m ciprofloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Technetium Tc-99m ciprofloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06160</drugbank-id>
    <name>Garenoxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Garenoxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06200</drugbank-id>
    <name>Tedisamil</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tedisamil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06334</drugbank-id>
    <name>Tucidinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Tucidinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06402</drugbank-id>
    <name>Telavancin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telavancin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06589</drugbank-id>
    <name>Pazopanib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Pazopanib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06600</drugbank-id>
    <name>Nemonoxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nemonoxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06603</drugbank-id>
    <name>Panobinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Panobinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06712</drugbank-id>
    <name>Nilvadipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nilvadipine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08799</drugbank-id>
    <name>Antazoline</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Antazoline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08865</drugbank-id>
    <name>Crizotinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Crizotinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08903</drugbank-id>
    <name>Bedaquiline</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bedaquiline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08980</drugbank-id>
    <name>Fendiline</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fendiline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08992</drugbank-id>
    <name>Eperisone</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Eperisone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09016</drugbank-id>
    <name>Butriptyline</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Butriptyline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09063</drugbank-id>
    <name>Ceritinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ceritinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09078</drugbank-id>
    <name>Lenvatinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lenvatinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09224</drugbank-id>
    <name>Melperone</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Melperone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09231</drugbank-id>
    <name>Benidipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Benidipine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09555</drugbank-id>
    <name>Dexchlorpheniramine maleate</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine maleate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11640</drugbank-id>
    <name>Amifampridine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amifampridine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11830</drugbank-id>
    <name>Mocetinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mocetinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11841</drugbank-id>
    <name>Entinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12141</drugbank-id>
    <name>Gilteritinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Gilteritinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12174</drugbank-id>
    <name>CUDC-101</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with CUDC-101.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12286</drugbank-id>
    <name>Simendan</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Simendan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12376</drugbank-id>
    <name>Ricolinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ricolinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12523</drugbank-id>
    <name>Mizolastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mizolastine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12565</drugbank-id>
    <name>Abexinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Abexinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12877</drugbank-id>
    <name>Oxatomide</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Oxatomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13261</drugbank-id>
    <name>Sitafloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sitafloxacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13273</drugbank-id>
    <name>Sultopride</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Sultopride.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13500</drugbank-id>
    <name>Otilonium</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Otilonium.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13546</drugbank-id>
    <name>Nizofenone</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nizofenone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13652</drugbank-id>
    <name>Bunaftine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Bunaftine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13653</drugbank-id>
    <name>Lorcainide</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lorcainide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13679</drugbank-id>
    <name>Dexchlorpheniramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13791</drugbank-id>
    <name>Penfluridol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Penfluridol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14063</drugbank-id>
    <name>Dexverapamil</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexverapamil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14568</drugbank-id>
    <name>Ivosidenib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ivosidenib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00625</drugbank-id>
    <name>Efavirenz</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Efavirenz.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00836</drugbank-id>
    <name>Loperamide</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Loperamide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00976</drugbank-id>
    <name>Telithromycin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telithromycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01211</drugbank-id>
    <name>Clarithromycin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clarithromycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01224</drugbank-id>
    <name>Quetiapine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quetiapine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01227</drugbank-id>
    <name>Levacetylmethadol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Levacetylmethadol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01232</drugbank-id>
    <name>Saquinavir</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Saquinavir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01388</drugbank-id>
    <name>Mibefradil</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mibefradil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00321</drugbank-id>
    <name>Amitriptyline</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amitriptyline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00458</drugbank-id>
    <name>Imipramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imipramine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01242</drugbank-id>
    <name>Clomipramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clomipramine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11718</drugbank-id>
    <name>Encorafenib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Encorafenib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01084</drugbank-id>
    <name>Emedastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Emedastine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB15982</drugbank-id>
    <name>Berotralstat</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Berotralstat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00104</drugbank-id>
    <name>Octreotide</name>
    <description>The risk or severity of QTc prolongation can be increased when Octreotide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00107</drugbank-id>
    <name>Oxytocin</name>
    <description>The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00187</drugbank-id>
    <name>Esmolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Esmolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00188</drugbank-id>
    <name>Bortezomib</name>
    <description>The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00196</drugbank-id>
    <name>Fluconazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00230</drugbank-id>
    <name>Pregabalin</name>
    <description>The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00245</drugbank-id>
    <name>Benzatropine</name>
    <description>The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00270</drugbank-id>
    <name>Isradipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Isradipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00285</drugbank-id>
    <name>Venlafaxine</name>
    <description>The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00289</drugbank-id>
    <name>Atomoxetine</name>
    <description>The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00334</drugbank-id>
    <name>Olanzapine</name>
    <description>The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00341</drugbank-id>
    <name>Cetirizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00344</drugbank-id>
    <name>Protriptyline</name>
    <description>The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00346</drugbank-id>
    <name>Alfuzosin</name>
    <description>The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00347</drugbank-id>
    <name>Trimethadione</name>
    <description>The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00354</drugbank-id>
    <name>Buclizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Buclizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00358</drugbank-id>
    <name>Mefloquine</name>
    <description>The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00366</drugbank-id>
    <name>Doxylamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00370</drugbank-id>
    <name>Mirtazapine</name>
    <description>The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00373</drugbank-id>
    <name>Timolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Timolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00374</drugbank-id>
    <name>Treprostinil</name>
    <description>The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00398</drugbank-id>
    <name>Sorafenib</name>
    <description>The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00405</drugbank-id>
    <name>Dexbrompheniramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00424</drugbank-id>
    <name>Hyoscyamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00427</drugbank-id>
    <name>Triprolidine</name>
    <description>The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00434</drugbank-id>
    <name>Cyproheptadine</name>
    <description>The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00467</drugbank-id>
    <name>Enoxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00487</drugbank-id>
    <name>Pefloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00529</drugbank-id>
    <name>Foscarnet</name>
    <description>The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00543</drugbank-id>
    <name>Amoxapine</name>
    <description>The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00555</drugbank-id>
    <name>Lamotrigine</name>
    <description>The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00613</drugbank-id>
    <name>Amodiaquine</name>
    <description>The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00622</drugbank-id>
    <name>Nicardipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00674</drugbank-id>
    <name>Galantamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Galantamine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00675</drugbank-id>
    <name>Tamoxifen</name>
    <description>The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00678</drugbank-id>
    <name>Losartan</name>
    <description>The risk or severity of QTc prolongation can be increased when Losartan is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00680</drugbank-id>
    <name>Moricizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Moricizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00691</drugbank-id>
    <name>Moexipril</name>
    <description>The risk or severity of QTc prolongation can be increased when Moexipril is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00697</drugbank-id>
    <name>Tizanidine</name>
    <description>The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00710</drugbank-id>
    <name>Ibandronate</name>
    <description>The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00714</drugbank-id>
    <name>Apomorphine</name>
    <description>The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00719</drugbank-id>
    <name>Azatadine</name>
    <description>The risk or severity of QTc prolongation can be increased when Azatadine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00734</drugbank-id>
    <name>Risperidone</name>
    <description>The risk or severity of QTc prolongation can be increased when Risperidone is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00753</drugbank-id>
    <name>Isoflurane</name>
    <description>The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00808</drugbank-id>
    <name>Indapamide</name>
    <description>The risk or severity of QTc prolongation can be increased when Indapamide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00817</drugbank-id>
    <name>Rosoxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00818</drugbank-id>
    <name>Propofol</name>
    <description>The risk or severity of QTc prolongation can be increased when Propofol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00822</drugbank-id>
    <name>Disulfiram</name>
    <description>The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00825</drugbank-id>
    <name>Levomenthol</name>
    <description>The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00835</drugbank-id>
    <name>Brompheniramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00871</drugbank-id>
    <name>Terbutaline</name>
    <description>The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00909</drugbank-id>
    <name>Zonisamide</name>
    <description>The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00915</drugbank-id>
    <name>Amantadine</name>
    <description>The risk or severity of QTc prolongation can be increased when Amantadine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00916</drugbank-id>
    <name>Metronidazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00920</drugbank-id>
    <name>Ketotifen</name>
    <description>The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00927</drugbank-id>
    <name>Famotidine</name>
    <description>The risk or severity of QTc prolongation can be increased when Famotidine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00934</drugbank-id>
    <name>Maprotiline</name>
    <description>The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00938</drugbank-id>
    <name>Salmeterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00949</drugbank-id>
    <name>Felbamate</name>
    <description>The risk or severity of QTc prolongation can be increased when Felbamate is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00983</drugbank-id>
    <name>Formoterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Formoterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00999</drugbank-id>
    <name>Hydrochlorothiazide</name>
    <description>The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01001</drugbank-id>
    <name>Salbutamol</name>
    <description>The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01015</drugbank-id>
    <name>Sulfamethoxazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01036</drugbank-id>
    <name>Tolterodine</name>
    <description>The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01044</drugbank-id>
    <name>Gatifloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01054</drugbank-id>
    <name>Nitrendipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01059</drugbank-id>
    <name>Norfloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01069</drugbank-id>
    <name>Promethazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Promethazine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01071</drugbank-id>
    <name>Mequitazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01074</drugbank-id>
    <name>Perhexiline</name>
    <description>The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01075</drugbank-id>
    <name>Diphenhydramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01106</drugbank-id>
    <name>Levocabastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01158</drugbank-id>
    <name>Bretylium</name>
    <description>The risk or severity of QTc prolongation can be increased when Bretylium is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01166</drugbank-id>
    <name>Cilostazol</name>
    <description>The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01173</drugbank-id>
    <name>Orphenadrine</name>
    <description>The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01176</drugbank-id>
    <name>Cyclizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01189</drugbank-id>
    <name>Desflurane</name>
    <description>The risk or severity of QTc prolongation can be increased when Desflurane is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01228</drugbank-id>
    <name>Encainide</name>
    <description>The risk or severity of QTc prolongation can be increased when Encainide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01233</drugbank-id>
    <name>Metoclopramide</name>
    <description>The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01236</drugbank-id>
    <name>Sevoflurane</name>
    <description>The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01238</drugbank-id>
    <name>Aripiprazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01239</drugbank-id>
    <name>Chlorprothixene</name>
    <description>The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01246</drugbank-id>
    <name>Alimemazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01259</drugbank-id>
    <name>Lapatinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01268</drugbank-id>
    <name>Sunitinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01274</drugbank-id>
    <name>Arformoterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01403</drugbank-id>
    <name>Methotrimeprazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01426</drugbank-id>
    <name>Ajmaline</name>
    <description>The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01591</drugbank-id>
    <name>Solifenacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01611</drugbank-id>
    <name>Hydroxychloroquine</name>
    <description>The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01620</drugbank-id>
    <name>Pheniramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01623</drugbank-id>
    <name>Thiothixene</name>
    <description>The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02546</drugbank-id>
    <name>Vorinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04576</drugbank-id>
    <name>Fleroxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04695</drugbank-id>
    <name>Farnesyl thiopyrophosphate</name>
    <description>The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04846</drugbank-id>
    <name>Celiprolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04953</drugbank-id>
    <name>Ezogabine</name>
    <description>The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05039</drugbank-id>
    <name>Indacaterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05246</drugbank-id>
    <name>Methsuximide</name>
    <description>The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05465</drugbank-id>
    <name>Tandutinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06217</drugbank-id>
    <name>Vernakalant</name>
    <description>The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06282</drugbank-id>
    <name>Levocetirizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06288</drugbank-id>
    <name>Amisulpride</name>
    <description>The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06468</drugbank-id>
    <name>Cariporide</name>
    <description>The risk or severity of QTc prolongation can be increased when Cariporide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06663</drugbank-id>
    <name>Pasireotide</name>
    <description>The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06691</drugbank-id>
    <name>Mepyramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06699</drugbank-id>
    <name>Degarelix</name>
    <description>The risk or severity of QTc prolongation can be increased when Degarelix is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06719</drugbank-id>
    <name>Buserelin</name>
    <description>The risk or severity of QTc prolongation can be increased when Buserelin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06788</drugbank-id>
    <name>Histrelin</name>
    <description>The risk or severity of QTc prolongation can be increased when Histrelin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06825</drugbank-id>
    <name>Triptorelin</name>
    <description>The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07780</drugbank-id>
    <name>Farnesyl diphosphate</name>
    <description>The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07841</drugbank-id>
    <name>Geranylgeranyl diphosphate</name>
    <description>The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08808</drugbank-id>
    <name>Bupranolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08871</drugbank-id>
    <name>Eribulin</name>
    <description>The risk or severity of QTc prolongation can be increased when Eribulin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08893</drugbank-id>
    <name>Mirabegron</name>
    <description>The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08912</drugbank-id>
    <name>Dabrafenib</name>
    <description>The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08936</drugbank-id>
    <name>Chlorcyclizine</name>
    <description>The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08952</drugbank-id>
    <name>Indenolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Indenolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08972</drugbank-id>
    <name>Flumequine</name>
    <description>The risk or severity of QTc prolongation can be increased when Flumequine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09080</drugbank-id>
    <name>Olodaterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09082</drugbank-id>
    <name>Vilanterol</name>
    <description>The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09089</drugbank-id>
    <name>Trimebutine</name>
    <description>The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09090</drugbank-id>
    <name>Pinaverium</name>
    <description>The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09167</drugbank-id>
    <name>Dosulepin</name>
    <description>The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09229</drugbank-id>
    <name>Aranidipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09235</drugbank-id>
    <name>Efonidipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09236</drugbank-id>
    <name>Lacidipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09239</drugbank-id>
    <name>Niguldipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09488</drugbank-id>
    <name>Acrivastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11390</drugbank-id>
    <name>Coumaphos</name>
    <description>The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11397</drugbank-id>
    <name>Dichlorvos</name>
    <description>The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11408</drugbank-id>
    <name>Famphur</name>
    <description>The risk or severity of QTc prolongation can be increased when Famphur is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11412</drugbank-id>
    <name>Fenthion</name>
    <description>The risk or severity of QTc prolongation can be increased when Fenthion is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11443</drugbank-id>
    <name>Orbifloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11448</drugbank-id>
    <name>Phosmet</name>
    <description>The risk or severity of QTc prolongation can be increased when Phosmet is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11491</drugbank-id>
    <name>Sarafloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11511</drugbank-id>
    <name>Difloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11591</drugbank-id>
    <name>Bilastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Bilastine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11614</drugbank-id>
    <name>Rupatadine</name>
    <description>The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11770</drugbank-id>
    <name>Talinolol</name>
    <description>The risk or severity of QTc prolongation can be increased when Talinolol is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11774</drugbank-id>
    <name>Pazufloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11785</drugbank-id>
    <name>Anisodamine</name>
    <description>The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11891</drugbank-id>
    <name>CUDC-907</name>
    <description>The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11892</drugbank-id>
    <name>Prulifloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11943</drugbank-id>
    <name>Delafloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12093</drugbank-id>
    <name>Tetrahydropalmatine</name>
    <description>The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12231</drugbank-id>
    <name>Temefos</name>
    <description>The risk or severity of QTc prolongation can be increased when Temefos is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12245</drugbank-id>
    <name>Triclabendazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12645</drugbank-id>
    <name>Givinostat</name>
    <description>The risk or severity of QTc prolongation can be increased when Givinostat is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12712</drugbank-id>
    <name>Pilsicainide</name>
    <description>The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12766</drugbank-id>
    <name>Cicletanine</name>
    <description>The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12923</drugbank-id>
    <name>Gallopamil</name>
    <description>The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13358</drugbank-id>
    <name>Cibenzoline</name>
    <description>The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13488</drugbank-id>
    <name>Bencyclane</name>
    <description>The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13555</drugbank-id>
    <name>Prajmaline</name>
    <description>The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13627</drugbank-id>
    <name>Oxolinic acid</name>
    <description>The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13651</drugbank-id>
    <name>Lorajmine</name>
    <description>The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13691</drugbank-id>
    <name>Acetyldigoxin</name>
    <description>The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13744</drugbank-id>
    <name>Piromidic acid</name>
    <description>The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13766</drugbank-id>
    <name>Lidoflazine</name>
    <description>The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13772</drugbank-id>
    <name>Rufloxacin</name>
    <description>The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13823</drugbank-id>
    <name>Pipemidic acid</name>
    <description>The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14185</drugbank-id>
    <name>Aripiprazole lauroxil</name>
    <description>The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14713</drugbank-id>
    <name>Inotersen</name>
    <description>The risk or severity of QTc prolongation can be increased when Inotersen is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00220</drugbank-id>
    <name>Nelfinavir</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Nelfinavir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00726</drugbank-id>
    <name>Trimipramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00540</drugbank-id>
    <name>Nortriptyline</name>
    <description>The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00582</drugbank-id>
    <name>Voriconazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00593</drugbank-id>
    <name>Ethosuximide</name>
    <description>The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00862</drugbank-id>
    <name>Vardenafil</name>
    <description>The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00864</drugbank-id>
    <name>Tacrolimus</name>
    <description>The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01023</drugbank-id>
    <name>Felodipine</name>
    <description>The risk or severity of QTc prolongation can be increased when Felodipine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01026</drugbank-id>
    <name>Ketoconazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01072</drugbank-id>
    <name>Atazanavir</name>
    <description>The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01167</drugbank-id>
    <name>Itraconazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01254</drugbank-id>
    <name>Dasatinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01263</drugbank-id>
    <name>Posaconazole</name>
    <description>The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01396</drugbank-id>
    <name>Digitoxin</name>
    <description>The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08815</drugbank-id>
    <name>Lurasidone</name>
    <description>The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08864</drugbank-id>
    <name>Rilpivirine</name>
    <description>The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11742</drugbank-id>
    <name>Ebastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Ebastine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01142</drugbank-id>
    <name>Doxepin</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Doxepin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01151</drugbank-id>
    <name>Desipramine</name>
    <description>The risk or severity of QTc prolongation can be increased when Desipramine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00503</drugbank-id>
    <name>Ritonavir</name>
    <description>The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00845</drugbank-id>
    <name>Clofazimine</name>
    <description>The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11796</drugbank-id>
    <name>Fostemsavir</name>
    <description>The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00751</drugbank-id>
    <name>Epinastine</name>
    <description>The risk or severity of QTc prolongation can be increased when Epinastine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11853</drugbank-id>
    <name>Relugolix</name>
    <description>The risk or severity of QTc prolongation can be increased when Relugolix is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11637</drugbank-id>
    <name>Delamanid</name>
    <description>Leuprolide may increase the QTc-prolonging activities of Delamanid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00159</drugbank-id>
    <name>Icosapent</name>
    <description>Icosapent may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00229</drugbank-id>
    <name>Cefotiam</name>
    <description>Cefotiam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00244</drugbank-id>
    <name>Mesalazine</name>
    <description>Mesalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00267</drugbank-id>
    <name>Cefmenoxime</name>
    <description>Cefmenoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00274</drugbank-id>
    <name>Cefmetazole</name>
    <description>Cefmetazole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00282</drugbank-id>
    <name>Pamidronic acid</name>
    <description>Pamidronic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00300</drugbank-id>
    <name>Tenofovir disoproxil</name>
    <description>Tenofovir disoproxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00328</drugbank-id>
    <name>Indomethacin</name>
    <description>Indomethacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00369</drugbank-id>
    <name>Cidofovir</name>
    <description>Cidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00384</drugbank-id>
    <name>Triamterene</name>
    <description>Triamterene may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00430</drugbank-id>
    <name>Cefpiramide</name>
    <description>Cefpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00438</drugbank-id>
    <name>Ceftazidime</name>
    <description>Ceftazidime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00447</drugbank-id>
    <name>Loracarbef</name>
    <description>Loracarbef may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00456</drugbank-id>
    <name>Cefalotin</name>
    <description>Cefalotin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00461</drugbank-id>
    <name>Nabumetone</name>
    <description>Nabumetone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00465</drugbank-id>
    <name>Ketorolac</name>
    <description>Ketorolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00469</drugbank-id>
    <name>Tenoxicam</name>
    <description>Tenoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00482</drugbank-id>
    <name>Celecoxib</name>
    <description>Celecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00493</drugbank-id>
    <name>Cefotaxime</name>
    <description>Cefotaxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00500</drugbank-id>
    <name>Tolmetin</name>
    <description>Tolmetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00533</drugbank-id>
    <name>Rofecoxib</name>
    <description>Rofecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00554</drugbank-id>
    <name>Piroxicam</name>
    <description>Piroxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00563</drugbank-id>
    <name>Methotrexate</name>
    <description>Methotrexate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00567</drugbank-id>
    <name>Cephalexin</name>
    <description>Cephalexin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00573</drugbank-id>
    <name>Fenoprofen</name>
    <description>Fenoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00577</drugbank-id>
    <name>Valaciclovir</name>
    <description>Valaciclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00580</drugbank-id>
    <name>Valdecoxib</name>
    <description>Valdecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00586</drugbank-id>
    <name>Diclofenac</name>
    <description>Diclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00605</drugbank-id>
    <name>Sulindac</name>
    <description>Sulindac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00626</drugbank-id>
    <name>Bacitracin</name>
    <description>Bacitracin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00681</drugbank-id>
    <name>Amphotericin B</name>
    <description>Amphotericin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00689</drugbank-id>
    <name>Cephaloglycin</name>
    <description>Cephaloglycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00712</drugbank-id>
    <name>Flurbiprofen</name>
    <description>Flurbiprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00718</drugbank-id>
    <name>Adefovir dipivoxil</name>
    <description>Adefovir dipivoxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00742</drugbank-id>
    <name>Mannitol</name>
    <description>Mannitol may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00749</drugbank-id>
    <name>Etodolac</name>
    <description>Etodolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00784</drugbank-id>
    <name>Mefenamic acid</name>
    <description>Mefenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00787</drugbank-id>
    <name>Acyclovir</name>
    <description>Acyclovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00788</drugbank-id>
    <name>Naproxen</name>
    <description>Naproxen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00795</drugbank-id>
    <name>Sulfasalazine</name>
    <description>Sulfasalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00812</drugbank-id>
    <name>Phenylbutazone</name>
    <description>Phenylbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00814</drugbank-id>
    <name>Meloxicam</name>
    <description>Meloxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00821</drugbank-id>
    <name>Carprofen</name>
    <description>Carprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00833</drugbank-id>
    <name>Cefaclor</name>
    <description>Cefaclor may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00861</drugbank-id>
    <name>Diflunisal</name>
    <description>Diflunisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00903</drugbank-id>
    <name>Etacrynic acid</name>
    <description>Etacrynic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00923</drugbank-id>
    <name>Ceforanide</name>
    <description>Ceforanide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00936</drugbank-id>
    <name>Salicylic acid</name>
    <description>Salicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00939</drugbank-id>
    <name>Meclofenamic acid</name>
    <description>Meclofenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00945</drugbank-id>
    <name>Acetylsalicylic acid</name>
    <description>Acetylsalicylic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00958</drugbank-id>
    <name>Carboplatin</name>
    <description>Carboplatin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00991</drugbank-id>
    <name>Oxaprozin</name>
    <description>Oxaprozin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01009</drugbank-id>
    <name>Ketoprofen</name>
    <description>Ketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01014</drugbank-id>
    <name>Balsalazide</name>
    <description>Balsalazide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01050</drugbank-id>
    <name>Ibuprofen</name>
    <description>Ibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01066</drugbank-id>
    <name>Cefditoren</name>
    <description>Cefditoren may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01111</drugbank-id>
    <name>Colistimethate</name>
    <description>Colistimethate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01112</drugbank-id>
    <name>Cefuroxime</name>
    <description>Cefuroxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01139</drugbank-id>
    <name>Cefapirin</name>
    <description>Cefapirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01140</drugbank-id>
    <name>Cefadroxil</name>
    <description>Cefadroxil may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01150</drugbank-id>
    <name>Cefprozil</name>
    <description>Cefprozil may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01212</drugbank-id>
    <name>Ceftriaxone</name>
    <description>Ceftriaxone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01250</drugbank-id>
    <name>Olsalazine</name>
    <description>Olsalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01283</drugbank-id>
    <name>Lumiracoxib</name>
    <description>Lumiracoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01326</drugbank-id>
    <name>Cefamandole</name>
    <description>Cefamandole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01327</drugbank-id>
    <name>Cefazolin</name>
    <description>Cefazolin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01328</drugbank-id>
    <name>Cefonicid</name>
    <description>Cefonicid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01329</drugbank-id>
    <name>Cefoperazone</name>
    <description>Cefoperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01330</drugbank-id>
    <name>Cefotetan</name>
    <description>Cefotetan may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01331</drugbank-id>
    <name>Cefoxitin</name>
    <description>Cefoxitin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01332</drugbank-id>
    <name>Ceftizoxime</name>
    <description>Ceftizoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01333</drugbank-id>
    <name>Cefradine</name>
    <description>Cefradine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01397</drugbank-id>
    <name>Magnesium salicylate</name>
    <description>Magnesium salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01399</drugbank-id>
    <name>Salsalate</name>
    <description>Salsalate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01401</drugbank-id>
    <name>Choline magnesium trisalicylate</name>
    <description>Choline magnesium trisalicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01413</drugbank-id>
    <name>Cefepime</name>
    <description>Cefepime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01414</drugbank-id>
    <name>Cefacetrile</name>
    <description>Cefacetrile may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01415</drugbank-id>
    <name>Ceftibuten</name>
    <description>Ceftibuten may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01416</drugbank-id>
    <name>Cefpodoxime</name>
    <description>Cefpodoxime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01419</drugbank-id>
    <name>Antrafenine</name>
    <description>Antrafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01424</drugbank-id>
    <name>Aminophenazone</name>
    <description>Aminophenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01435</drugbank-id>
    <name>Antipyrine</name>
    <description>Antipyrine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01600</drugbank-id>
    <name>Tiaprofenic acid</name>
    <description>Tiaprofenic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01628</drugbank-id>
    <name>Etoricoxib</name>
    <description>Etoricoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02247</drugbank-id>
    <name>Hydrolyzed Cephalothin</name>
    <description>Hydrolyzed Cephalothin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03450</drugbank-id>
    <name>Cephalothin Group</name>
    <description>Cephalothin Group may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03585</drugbank-id>
    <name>Oxyphenbutazone</name>
    <description>Oxyphenbutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04570</drugbank-id>
    <name>Latamoxef</name>
    <description>Latamoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04743</drugbank-id>
    <name>Nimesulide</name>
    <description>Nimesulide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04812</drugbank-id>
    <name>Benoxaprofen</name>
    <description>Benoxaprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04817</drugbank-id>
    <name>Metamizole</name>
    <description>Metamizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04828</drugbank-id>
    <name>Zomepirac</name>
    <description>Zomepirac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04918</drugbank-id>
    <name>Ceftobiprole</name>
    <description>Ceftobiprole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05095</drugbank-id>
    <name>Cimicoxib</name>
    <description>Cimicoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06590</drugbank-id>
    <name>Ceftaroline fosamil</name>
    <description>Ceftaroline fosamil may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06725</drugbank-id>
    <name>Lornoxicam</name>
    <description>Lornoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06736</drugbank-id>
    <name>Aceclofenac</name>
    <description>Aceclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06737</drugbank-id>
    <name>Zaltoprofen</name>
    <description>Zaltoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07402</drugbank-id>
    <name>Azapropazone</name>
    <description>Azapropazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08439</drugbank-id>
    <name>Parecoxib</name>
    <description>Parecoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08797</drugbank-id>
    <name>Salicylamide</name>
    <description>Salicylamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08940</drugbank-id>
    <name>Kebuzone</name>
    <description>Kebuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08942</drugbank-id>
    <name>Isoxicam</name>
    <description>Isoxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08951</drugbank-id>
    <name>Indoprofen</name>
    <description>Indoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08955</drugbank-id>
    <name>Ibuproxam</name>
    <description>Ibuproxam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08976</drugbank-id>
    <name>Floctafenine</name>
    <description>Floctafenine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08981</drugbank-id>
    <name>Fenbufen</name>
    <description>Fenbufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08984</drugbank-id>
    <name>Etofenamate</name>
    <description>Etofenamate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08991</drugbank-id>
    <name>Epirizole</name>
    <description>Epirizole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09008</drugbank-id>
    <name>Cefaloridine</name>
    <description>Cefaloridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09062</drugbank-id>
    <name>Cefminox</name>
    <description>Cefminox may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09084</drugbank-id>
    <name>Benzydamine</name>
    <description>Benzydamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09213</drugbank-id>
    <name>Dexibuprofen</name>
    <description>Dexibuprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09214</drugbank-id>
    <name>Dexketoprofen</name>
    <description>Dexketoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09215</drugbank-id>
    <name>Droxicam</name>
    <description>Droxicam may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09216</drugbank-id>
    <name>Tolfenamic acid</name>
    <description>Tolfenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09217</drugbank-id>
    <name>Firocoxib</name>
    <description>Firocoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09218</drugbank-id>
    <name>Clonixin</name>
    <description>Clonixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09285</drugbank-id>
    <name>Morniflumate</name>
    <description>Morniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09288</drugbank-id>
    <name>Propacetamol</name>
    <description>Propacetamol may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09295</drugbank-id>
    <name>Talniflumate</name>
    <description>Talniflumate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09299</drugbank-id>
    <name>Tenofovir alafenamide</name>
    <description>Tenofovir alafenamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11367</drugbank-id>
    <name>Cefroxadine</name>
    <description>Cefroxadine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11455</drugbank-id>
    <name>Robenacoxib</name>
    <description>Robenacoxib may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11466</drugbank-id>
    <name>Tepoxalin</name>
    <description>Tepoxalin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11518</drugbank-id>
    <name>Flunixin</name>
    <description>Flunixin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11935</drugbank-id>
    <name>Flomoxef</name>
    <description>Flomoxef may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12151</drugbank-id>
    <name>Brincidofovir</name>
    <description>Brincidofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12445</drugbank-id>
    <name>Nitroaspirin</name>
    <description>Nitroaspirin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12545</drugbank-id>
    <name>Indobufen</name>
    <description>Indobufen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13001</drugbank-id>
    <name>Tinoridine</name>
    <description>Tinoridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13167</drugbank-id>
    <name>Alclofenac</name>
    <description>Alclofenac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13217</drugbank-id>
    <name>Fentiazac</name>
    <description>Fentiazac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13232</drugbank-id>
    <name>Suxibuzone</name>
    <description>Suxibuzone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13266</drugbank-id>
    <name>Cefatrizine</name>
    <description>Cefatrizine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13286</drugbank-id>
    <name>Bumadizone</name>
    <description>Bumadizone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13314</drugbank-id>
    <name>Alminoprofen</name>
    <description>Alminoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13371</drugbank-id>
    <name>Difenpiramide</name>
    <description>Difenpiramide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13407</drugbank-id>
    <name>Nifenazone</name>
    <description>Nifenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13432</drugbank-id>
    <name>Lonazolac</name>
    <description>Lonazolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13461</drugbank-id>
    <name>Cefcapene</name>
    <description>Cefcapene may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13470</drugbank-id>
    <name>Cefodizime</name>
    <description>Cefodizime may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13481</drugbank-id>
    <name>Tenidap</name>
    <description>Tenidap may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13499</drugbank-id>
    <name>Cefsulodin</name>
    <description>Cefsulodin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13504</drugbank-id>
    <name>Cefetamet</name>
    <description>Cefetamet may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13524</drugbank-id>
    <name>Propyphenazone</name>
    <description>Propyphenazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13527</drugbank-id>
    <name>Proglumetacin</name>
    <description>Proglumetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13538</drugbank-id>
    <name>Guacetisal</name>
    <description>Guacetisal may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13544</drugbank-id>
    <name>Ethenzamide</name>
    <description>Ethenzamide may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13612</drugbank-id>
    <name>Carbaspirin calcium</name>
    <description>Carbaspirin calcium may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13629</drugbank-id>
    <name>Mofebutazone</name>
    <description>Mofebutazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13638</drugbank-id>
    <name>Cefbuperazone</name>
    <description>Cefbuperazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13649</drugbank-id>
    <name>Proquazone</name>
    <description>Proquazone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13657</drugbank-id>
    <name>Benorilate</name>
    <description>Benorilate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13667</drugbank-id>
    <name>Cefozopran</name>
    <description>Cefozopran may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13682</drugbank-id>
    <name>Cefpirome</name>
    <description>Cefpirome may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13722</drugbank-id>
    <name>Pirprofen</name>
    <description>Pirprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13778</drugbank-id>
    <name>Cefazedone</name>
    <description>Cefazedone may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13783</drugbank-id>
    <name>Acemetacin</name>
    <description>Acemetacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13821</drugbank-id>
    <name>Ceftezole</name>
    <description>Ceftezole may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13860</drugbank-id>
    <name>Imidazole salicylate</name>
    <description>Imidazole salicylate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13868</drugbank-id>
    <name>Adefovir</name>
    <description>Adefovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14059</drugbank-id>
    <name>SC-236</name>
    <description>SC-236 may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14060</drugbank-id>
    <name>NS-398</name>
    <description>NS-398 may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14126</drugbank-id>
    <name>Tenofovir</name>
    <description>Tenofovir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01438</drugbank-id>
    <name>Phenazopyridine</name>
    <description>Phenazopyridine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00091</drugbank-id>
    <name>Cyclosporine</name>
    <description>Cyclosporine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB15066</drugbank-id>
    <name>Givosiran</name>
    <description>Givosiran may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01601</drugbank-id>
    <name>Lopinavir</name>
    <description>Lopinavir may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14507</drugbank-id>
    <name>Lithium citrate</name>
    <description>Lithium citrate may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09212</drugbank-id>
    <name>Loxoprofen</name>
    <description>Loxoprofen may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00452</drugbank-id>
    <name>Framycetin</name>
    <description>Framycetin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01421</drugbank-id>
    <name>Paromomycin</name>
    <description>Paromomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04263</drugbank-id>
    <name>Geneticin</name>
    <description>Geneticin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04626</drugbank-id>
    <name>Apramycin</name>
    <description>Apramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04808</drugbank-id>
    <name>Neamine</name>
    <description>Neamine may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08437</drugbank-id>
    <name>Puromycin</name>
    <description>Puromycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11512</drugbank-id>
    <name>Dihydrostreptomycin</name>
    <description>Dihydrostreptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11520</drugbank-id>
    <name>Hygromycin B</name>
    <description>Hygromycin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00017</drugbank-id>
    <name>Salmon calcitonin</name>
    <description>Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00035</drugbank-id>
    <name>Desmopressin</name>
    <description>Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00041</drugbank-id>
    <name>Aldesleukin</name>
    <description>Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00081</drugbank-id>
    <name>Tositumomab</name>
    <description>Leuprolide may decrease the excretion rate of Tositumomab which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00115</drugbank-id>
    <name>Cyanocobalamin</name>
    <description>Leuprolide may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00158</drugbank-id>
    <name>Folic acid</name>
    <description>Leuprolide may decrease the excretion rate of Folic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00165</drugbank-id>
    <name>Pyridoxine</name>
    <description>Leuprolide may decrease the excretion rate of Pyridoxine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00176</drugbank-id>
    <name>Fluvoxamine</name>
    <description>Leuprolide may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00182</drugbank-id>
    <name>Amphetamine</name>
    <description>Leuprolide may decrease the excretion rate of Amphetamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00185</drugbank-id>
    <name>Cevimeline</name>
    <description>Leuprolide may decrease the excretion rate of Cevimeline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00186</drugbank-id>
    <name>Lorazepam</name>
    <description>Leuprolide may decrease the excretion rate of Lorazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00190</drugbank-id>
    <name>Carbidopa</name>
    <description>Leuprolide may decrease the excretion rate of Carbidopa which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00193</drugbank-id>
    <name>Tramadol</name>
    <description>Leuprolide may decrease the excretion rate of Tramadol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00198</drugbank-id>
    <name>Oseltamivir</name>
    <description>Leuprolide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00200</drugbank-id>
    <name>Hydroxocobalamin</name>
    <description>Leuprolide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00206</drugbank-id>
    <name>Reserpine</name>
    <description>Leuprolide may decrease the excretion rate of Reserpine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00208</drugbank-id>
    <name>Ticlopidine</name>
    <description>Leuprolide may decrease the excretion rate of Ticlopidine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00213</drugbank-id>
    <name>Pantoprazole</name>
    <description>Leuprolide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00225</drugbank-id>
    <name>Gadodiamide</name>
    <description>Leuprolide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00231</drugbank-id>
    <name>Temazepam</name>
    <description>Leuprolide may decrease the excretion rate of Temazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00235</drugbank-id>
    <name>Milrinone</name>
    <description>Leuprolide may decrease the excretion rate of Milrinone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00237</drugbank-id>
    <name>Butabarbital</name>
    <description>Leuprolide may decrease the excretion rate of Butabarbital which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00254</drugbank-id>
    <name>Doxycycline</name>
    <description>Leuprolide may decrease the excretion rate of Doxycycline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00262</drugbank-id>
    <name>Carmustine</name>
    <description>Leuprolide may decrease the excretion rate of Carmustine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00264</drugbank-id>
    <name>Metoprolol</name>
    <description>Leuprolide may decrease the excretion rate of Metoprolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00271</drugbank-id>
    <name>Diatrizoate</name>
    <description>Leuprolide may decrease the excretion rate of Diatrizoate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00273</drugbank-id>
    <name>Topiramate</name>
    <description>Leuprolide may decrease the excretion rate of Topiramate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00279</drugbank-id>
    <name>Liothyronine</name>
    <description>Leuprolide may decrease the excretion rate of Liothyronine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00286</drugbank-id>
    <name>Conjugated estrogens</name>
    <description>Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00290</drugbank-id>
    <name>Bleomycin</name>
    <description>Leuprolide may decrease the excretion rate of Bleomycin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00292</drugbank-id>
    <name>Etomidate</name>
    <description>Leuprolide may decrease the excretion rate of Etomidate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00294</drugbank-id>
    <name>Etonogestrel</name>
    <description>Leuprolide may decrease the excretion rate of Etonogestrel which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00296</drugbank-id>
    <name>Ropivacaine</name>
    <description>Leuprolide may decrease the excretion rate of Ropivacaine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00303</drugbank-id>
    <name>Ertapenem</name>
    <description>Leuprolide may decrease the excretion rate of Ertapenem which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00316</drugbank-id>
    <name>Acetaminophen</name>
    <description>Leuprolide may decrease the excretion rate of Acetaminophen which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00319</drugbank-id>
    <name>Piperacillin</name>
    <description>Leuprolide may decrease the excretion rate of Piperacillin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00322</drugbank-id>
    <name>Floxuridine</name>
    <description>Leuprolide may decrease the excretion rate of Floxuridine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00323</drugbank-id>
    <name>Tolcapone</name>
    <description>Leuprolide may decrease the excretion rate of Tolcapone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00325</drugbank-id>
    <name>Nitroprusside</name>
    <description>Leuprolide may decrease the excretion rate of Nitroprusside which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00327</drugbank-id>
    <name>Hydromorphone</name>
    <description>Leuprolide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00330</drugbank-id>
    <name>Ethambutol</name>
    <description>Leuprolide may decrease the excretion rate of Ethambutol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00339</drugbank-id>
    <name>Pyrazinamide</name>
    <description>Leuprolide may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00349</drugbank-id>
    <name>Clobazam</name>
    <description>Leuprolide may decrease the excretion rate of Clobazam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00351</drugbank-id>
    <name>Megestrol acetate</name>
    <description>Leuprolide may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00355</drugbank-id>
    <name>Aztreonam</name>
    <description>Leuprolide may decrease the excretion rate of Aztreonam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00356</drugbank-id>
    <name>Chlorzoxazone</name>
    <description>Leuprolide may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00364</drugbank-id>
    <name>Sucralfate</name>
    <description>Leuprolide may decrease the excretion rate of Sucralfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00372</drugbank-id>
    <name>Thiethylperazine</name>
    <description>Leuprolide may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00377</drugbank-id>
    <name>Palonosetron</name>
    <description>Leuprolide may decrease the excretion rate of Palonosetron which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00380</drugbank-id>
    <name>Dexrazoxane</name>
    <description>Leuprolide may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00402</drugbank-id>
    <name>Eszopiclone</name>
    <description>Leuprolide may decrease the excretion rate of Eszopiclone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00413</drugbank-id>
    <name>Pramipexole</name>
    <description>Leuprolide may decrease the excretion rate of Pramipexole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00415</drugbank-id>
    <name>Ampicillin</name>
    <description>Leuprolide may decrease the excretion rate of Ampicillin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00418</drugbank-id>
    <name>Secobarbital</name>
    <description>Leuprolide may decrease the excretion rate of Secobarbital which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00422</drugbank-id>
    <name>Methylphenidate</name>
    <description>Leuprolide may decrease the excretion rate of Methylphenidate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00432</drugbank-id>
    <name>Trifluridine</name>
    <description>Leuprolide may decrease the excretion rate of Trifluridine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00435</drugbank-id>
    <name>Nitric Oxide</name>
    <description>Leuprolide may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00437</drugbank-id>
    <name>Allopurinol</name>
    <description>Leuprolide may decrease the excretion rate of Allopurinol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00441</drugbank-id>
    <name>Gemcitabine</name>
    <description>Leuprolide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00476</drugbank-id>
    <name>Duloxetine</name>
    <description>Leuprolide may decrease the excretion rate of Duloxetine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00480</drugbank-id>
    <name>Lenalidomide</name>
    <description>Leuprolide may decrease the excretion rate of Lenalidomide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00492</drugbank-id>
    <name>Fosinopril</name>
    <description>Leuprolide may decrease the excretion rate of Fosinopril which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00499</drugbank-id>
    <name>Flutamide</name>
    <description>Leuprolide may decrease the excretion rate of Flutamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00535</drugbank-id>
    <name>Cefdinir</name>
    <description>Leuprolide may decrease the excretion rate of Cefdinir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00548</drugbank-id>
    <name>Azelaic acid</name>
    <description>Leuprolide may decrease the excretion rate of Azelaic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00553</drugbank-id>
    <name>Methoxsalen</name>
    <description>Leuprolide may decrease the excretion rate of Methoxsalen which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00558</drugbank-id>
    <name>Zanamivir</name>
    <description>Leuprolide may decrease the excretion rate of Zanamivir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00569</drugbank-id>
    <name>Fondaparinux</name>
    <description>Leuprolide may decrease the excretion rate of Fondaparinux which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00583</drugbank-id>
    <name>Levocarnitine</name>
    <description>Leuprolide may decrease the excretion rate of Levocarnitine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00591</drugbank-id>
    <name>Fluocinolone acetonide</name>
    <description>Leuprolide may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00597</drugbank-id>
    <name>Gadoteridol</name>
    <description>Leuprolide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00598</drugbank-id>
    <name>Labetalol</name>
    <description>Leuprolide may decrease the excretion rate of Labetalol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00603</drugbank-id>
    <name>Medroxyprogesterone acetate</name>
    <description>Leuprolide may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00612</drugbank-id>
    <name>Bisoprolol</name>
    <description>Leuprolide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00624</drugbank-id>
    <name>Testosterone</name>
    <description>Leuprolide may decrease the excretion rate of Testosterone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00628</drugbank-id>
    <name>Clorazepic acid</name>
    <description>Leuprolide may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00631</drugbank-id>
    <name>Clofarabine</name>
    <description>Leuprolide may decrease the excretion rate of Clofarabine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00633</drugbank-id>
    <name>Dexmedetomidine</name>
    <description>Leuprolide may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00635</drugbank-id>
    <name>Prednisone</name>
    <description>Leuprolide may decrease the excretion rate of Prednisone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00651</drugbank-id>
    <name>Dyphylline</name>
    <description>Leuprolide may decrease the excretion rate of Dyphylline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00657</drugbank-id>
    <name>Mecamylamine</name>
    <description>Leuprolide may decrease the excretion rate of Mecamylamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00660</drugbank-id>
    <name>Metaxalone</name>
    <description>Leuprolide may decrease the excretion rate of Metaxalone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00665</drugbank-id>
    <name>Nilutamide</name>
    <description>Leuprolide may decrease the excretion rate of Nilutamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00669</drugbank-id>
    <name>Sumatriptan</name>
    <description>Leuprolide may decrease the excretion rate of Sumatriptan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00690</drugbank-id>
    <name>Flurazepam</name>
    <description>Leuprolide may decrease the excretion rate of Flurazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00692</drugbank-id>
    <name>Phentolamine</name>
    <description>Leuprolide may decrease the excretion rate of Phentolamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00698</drugbank-id>
    <name>Nitrofurantoin</name>
    <description>Leuprolide may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00706</drugbank-id>
    <name>Tamsulosin</name>
    <description>Leuprolide may decrease the excretion rate of Tamsulosin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00713</drugbank-id>
    <name>Oxacillin</name>
    <description>Leuprolide may decrease the excretion rate of Oxacillin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00716</drugbank-id>
    <name>Nedocromil</name>
    <description>Leuprolide may decrease the excretion rate of Nedocromil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00722</drugbank-id>
    <name>Lisinopril</name>
    <description>Leuprolide may decrease the excretion rate of Lisinopril which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00730</drugbank-id>
    <name>Thiabendazole</name>
    <description>Leuprolide may decrease the excretion rate of Thiabendazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00733</drugbank-id>
    <name>Pralidoxime</name>
    <description>Leuprolide may decrease the excretion rate of Pralidoxime which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00759</drugbank-id>
    <name>Tetracycline</name>
    <description>Leuprolide may decrease the excretion rate of Tetracycline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00760</drugbank-id>
    <name>Meropenem</name>
    <description>Leuprolide may decrease the excretion rate of Meropenem which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00761</drugbank-id>
    <name>Potassium chloride</name>
    <description>Leuprolide may decrease the excretion rate of Potassium chloride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00775</drugbank-id>
    <name>Tirofiban</name>
    <description>Leuprolide may decrease the excretion rate of Tirofiban which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00780</drugbank-id>
    <name>Phenelzine</name>
    <description>Leuprolide may decrease the excretion rate of Phenelzine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00782</drugbank-id>
    <name>Propantheline</name>
    <description>Leuprolide may decrease the excretion rate of Propantheline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00783</drugbank-id>
    <name>Estradiol</name>
    <description>Leuprolide may decrease the excretion rate of Estradiol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00789</drugbank-id>
    <name>Gadopentetic acid</name>
    <description>Leuprolide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00790</drugbank-id>
    <name>Perindopril</name>
    <description>Leuprolide may decrease the excretion rate of Perindopril which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00800</drugbank-id>
    <name>Fenoldopam</name>
    <description>Leuprolide may decrease the excretion rate of Fenoldopam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00804</drugbank-id>
    <name>Dicyclomine</name>
    <description>Leuprolide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00806</drugbank-id>
    <name>Pentoxifylline</name>
    <description>Leuprolide may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00811</drugbank-id>
    <name>Ribavirin</name>
    <description>Leuprolide may decrease the excretion rate of Ribavirin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00828</drugbank-id>
    <name>Fosfomycin</name>
    <description>Leuprolide may decrease the excretion rate of Fosfomycin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00829</drugbank-id>
    <name>Diazepam</name>
    <description>Leuprolide may decrease the excretion rate of Diazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00841</drugbank-id>
    <name>Dobutamine</name>
    <description>Leuprolide may decrease the excretion rate of Dobutamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00842</drugbank-id>
    <name>Oxazepam</name>
    <description>Leuprolide may decrease the excretion rate of Oxazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00851</drugbank-id>
    <name>Dacarbazine</name>
    <description>Leuprolide may decrease the excretion rate of Dacarbazine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00853</drugbank-id>
    <name>Temozolomide</name>
    <description>Leuprolide may decrease the excretion rate of Temozolomide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00894</drugbank-id>
    <name>Testolactone</name>
    <description>Leuprolide may decrease the excretion rate of Testolactone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00900</drugbank-id>
    <name>Didanosine</name>
    <description>Leuprolide may decrease the excretion rate of Didanosine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00911</drugbank-id>
    <name>Tinidazole</name>
    <description>Leuprolide may decrease the excretion rate of Tinidazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00918</drugbank-id>
    <name>Almotriptan</name>
    <description>Leuprolide may decrease the excretion rate of Almotriptan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00928</drugbank-id>
    <name>Azacitidine</name>
    <description>Leuprolide may decrease the excretion rate of Azacitidine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00953</drugbank-id>
    <name>Rizatriptan</name>
    <description>Leuprolide may decrease the excretion rate of Rizatriptan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00960</drugbank-id>
    <name>Pindolol</name>
    <description>Leuprolide may decrease the excretion rate of Pindolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00961</drugbank-id>
    <name>Mepivacaine</name>
    <description>Leuprolide may decrease the excretion rate of Mepivacaine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00962</drugbank-id>
    <name>Zaleplon</name>
    <description>Leuprolide may decrease the excretion rate of Zaleplon which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00980</drugbank-id>
    <name>Ramelteon</name>
    <description>Leuprolide may decrease the excretion rate of Ramelteon which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00988</drugbank-id>
    <name>Dopamine</name>
    <description>Leuprolide may decrease the excretion rate of Dopamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00993</drugbank-id>
    <name>Azathioprine</name>
    <description>Leuprolide may decrease the excretion rate of Azathioprine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00995</drugbank-id>
    <name>Auranofin</name>
    <description>Leuprolide may decrease the excretion rate of Auranofin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01002</drugbank-id>
    <name>Levobupivacaine</name>
    <description>Leuprolide may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01010</drugbank-id>
    <name>Edrophonium</name>
    <description>Leuprolide may decrease the excretion rate of Edrophonium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01011</drugbank-id>
    <name>Metyrapone</name>
    <description>Leuprolide may decrease the excretion rate of Metyrapone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01018</drugbank-id>
    <name>Guanfacine</name>
    <description>Leuprolide may decrease the excretion rate of Guanfacine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01020</drugbank-id>
    <name>Isosorbide mononitrate</name>
    <description>Leuprolide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01022</drugbank-id>
    <name>Phylloquinone</name>
    <description>Leuprolide may decrease the excretion rate of Phylloquinone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01024</drugbank-id>
    <name>Mycophenolic acid</name>
    <description>Leuprolide may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01030</drugbank-id>
    <name>Topotecan</name>
    <description>Leuprolide may decrease the excretion rate of Topotecan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01032</drugbank-id>
    <name>Probenecid</name>
    <description>Leuprolide may decrease the excretion rate of Probenecid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01043</drugbank-id>
    <name>Memantine</name>
    <description>Leuprolide may decrease the excretion rate of Memantine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01046</drugbank-id>
    <name>Lubiprostone</name>
    <description>Leuprolide may decrease the excretion rate of Lubiprostone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01048</drugbank-id>
    <name>Abacavir</name>
    <description>Leuprolide may decrease the excretion rate of Abacavir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01060</drugbank-id>
    <name>Amoxicillin</name>
    <description>Leuprolide may decrease the excretion rate of Amoxicillin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01068</drugbank-id>
    <name>Clonazepam</name>
    <description>Leuprolide may decrease the excretion rate of Clonazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01093</drugbank-id>
    <name>Dimethyl sulfoxide</name>
    <description>Leuprolide may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01099</drugbank-id>
    <name>Flucytosine</name>
    <description>Leuprolide may decrease the excretion rate of Flucytosine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01101</drugbank-id>
    <name>Capecitabine</name>
    <description>Leuprolide may decrease the excretion rate of Capecitabine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01105</drugbank-id>
    <name>Sibutramine</name>
    <description>Leuprolide may decrease the excretion rate of Sibutramine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01129</drugbank-id>
    <name>Rabeprazole</name>
    <description>Leuprolide may decrease the excretion rate of Rabeprazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01133</drugbank-id>
    <name>Tiludronic acid</name>
    <description>Leuprolide may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01135</drugbank-id>
    <name>Doxacurium</name>
    <description>Leuprolide may decrease the excretion rate of Doxacurium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01148</drugbank-id>
    <name>Flavoxate</name>
    <description>Leuprolide may decrease the excretion rate of Flavoxate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01156</drugbank-id>
    <name>Bupropion</name>
    <description>Leuprolide may decrease the excretion rate of Bupropion which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01157</drugbank-id>
    <name>Trimetrexate</name>
    <description>Leuprolide may decrease the excretion rate of Trimetrexate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01170</drugbank-id>
    <name>Guanethidine</name>
    <description>Leuprolide may decrease the excretion rate of Guanethidine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01181</drugbank-id>
    <name>Ifosfamide</name>
    <description>Leuprolide may decrease the excretion rate of Ifosfamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01203</drugbank-id>
    <name>Nadolol</name>
    <description>Leuprolide may decrease the excretion rate of Nadolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01205</drugbank-id>
    <name>Flumazenil</name>
    <description>Leuprolide may decrease the excretion rate of Flumazenil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01213</drugbank-id>
    <name>Fomepizole</name>
    <description>Leuprolide may decrease the excretion rate of Fomepizole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01215</drugbank-id>
    <name>Estazolam</name>
    <description>Leuprolide may decrease the excretion rate of Estazolam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01221</drugbank-id>
    <name>Ketamine</name>
    <description>Leuprolide may decrease the excretion rate of Ketamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01240</drugbank-id>
    <name>Epoprostenol</name>
    <description>Leuprolide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01249</drugbank-id>
    <name>Iodixanol</name>
    <description>Leuprolide may decrease the excretion rate of Iodixanol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01273</drugbank-id>
    <name>Varenicline</name>
    <description>Leuprolide may decrease the excretion rate of Varenicline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01275</drugbank-id>
    <name>Hydralazine</name>
    <description>Leuprolide may decrease the excretion rate of Hydralazine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01359</drugbank-id>
    <name>Penbutolol</name>
    <description>Leuprolide may decrease the excretion rate of Penbutolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01367</drugbank-id>
    <name>Rasagiline</name>
    <description>Leuprolide may decrease the excretion rate of Rasagiline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01409</drugbank-id>
    <name>Tiotropium</name>
    <description>Leuprolide may decrease the excretion rate of Tiotropium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01420</drugbank-id>
    <name>Testosterone propionate</name>
    <description>Leuprolide may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01427</drugbank-id>
    <name>Amrinone</name>
    <description>Leuprolide may decrease the excretion rate of Amrinone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01428</drugbank-id>
    <name>Oxybenzone</name>
    <description>Leuprolide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01431</drugbank-id>
    <name>Allylestrenol</name>
    <description>Leuprolide may decrease the excretion rate of Allylestrenol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01550</drugbank-id>
    <name>Fenproporex</name>
    <description>Leuprolide may decrease the excretion rate of Fenproporex which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01558</drugbank-id>
    <name>Bromazepam</name>
    <description>Leuprolide may decrease the excretion rate of Bromazepam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01563</drugbank-id>
    <name>Chloral hydrate</name>
    <description>Leuprolide may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01577</drugbank-id>
    <name>Metamfetamine</name>
    <description>Leuprolide may decrease the excretion rate of Metamfetamine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01587</drugbank-id>
    <name>Ketazolam</name>
    <description>Leuprolide may decrease the excretion rate of Ketazolam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01610</drugbank-id>
    <name>Valganciclovir</name>
    <description>Leuprolide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01638</drugbank-id>
    <name>Sorbitol</name>
    <description>Leuprolide may decrease the excretion rate of Sorbitol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01656</drugbank-id>
    <name>Roflumilast</name>
    <description>Leuprolide may decrease the excretion rate of Roflumilast which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01685</drugbank-id>
    <name>Topiroxostat</name>
    <description>Leuprolide may decrease the excretion rate of Topiroxostat which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04574</drugbank-id>
    <name>Estrone sulfate</name>
    <description>Leuprolide may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04871</drugbank-id>
    <name>Lorcaserin</name>
    <description>Leuprolide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04895</drugbank-id>
    <name>Pegaptanib</name>
    <description>Leuprolide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04896</drugbank-id>
    <name>Milnacipran</name>
    <description>Leuprolide may decrease the excretion rate of Milnacipran which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04920</drugbank-id>
    <name>Clevidipine</name>
    <description>Leuprolide may decrease the excretion rate of Clevidipine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05018</drugbank-id>
    <name>Migalastat</name>
    <description>Leuprolide may decrease the excretion rate of Migalastat which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05541</drugbank-id>
    <name>Brivaracetam</name>
    <description>Leuprolide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06154</drugbank-id>
    <name>Pentaerythritol tetranitrate</name>
    <description>Leuprolide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06186</drugbank-id>
    <name>Ipilimumab</name>
    <description>Leuprolide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06196</drugbank-id>
    <name>Icatibant</name>
    <description>Leuprolide may decrease the excretion rate of Icatibant which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06209</drugbank-id>
    <name>Prasugrel</name>
    <description>Leuprolide may decrease the excretion rate of Prasugrel which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06211</drugbank-id>
    <name>Doripenem</name>
    <description>Leuprolide may decrease the excretion rate of Doripenem which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06230</drugbank-id>
    <name>Nalmefene</name>
    <description>Leuprolide may decrease the excretion rate of Nalmefene which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06262</drugbank-id>
    <name>Droxidopa</name>
    <description>Leuprolide may decrease the excretion rate of Droxidopa which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06480</drugbank-id>
    <name>Prucalopride</name>
    <description>Leuprolide may decrease the excretion rate of Prucalopride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06623</drugbank-id>
    <name>Flupirtine</name>
    <description>Leuprolide may decrease the excretion rate of Flupirtine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06637</drugbank-id>
    <name>Dalfampridine</name>
    <description>Leuprolide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06695</drugbank-id>
    <name>Dabigatran etexilate</name>
    <description>Leuprolide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06700</drugbank-id>
    <name>Desvenlafaxine</name>
    <description>Leuprolide may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06702</drugbank-id>
    <name>Fesoterodine</name>
    <description>Leuprolide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06705</drugbank-id>
    <name>Gadofosveset trisodium</name>
    <description>Leuprolide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06710</drugbank-id>
    <name>Methyltestosterone</name>
    <description>Leuprolide may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06767</drugbank-id>
    <name>Ammonium chloride</name>
    <description>Leuprolide may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06782</drugbank-id>
    <name>Dimercaprol</name>
    <description>Leuprolide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06796</drugbank-id>
    <name>Mangafodipir</name>
    <description>Leuprolide may decrease the excretion rate of Mangafodipir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06800</drugbank-id>
    <name>Methylnaltrexone</name>
    <description>Leuprolide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06809</drugbank-id>
    <name>Plerixafor</name>
    <description>Leuprolide may decrease the excretion rate of Plerixafor which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06813</drugbank-id>
    <name>Pralatrexate</name>
    <description>Leuprolide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06823</drugbank-id>
    <name>Tiopronin</name>
    <description>Leuprolide may decrease the excretion rate of Tiopronin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06824</drugbank-id>
    <name>Triethylenetetramine</name>
    <description>Leuprolide may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08824</drugbank-id>
    <name>Ioflupane I-123</name>
    <description>Leuprolide may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08826</drugbank-id>
    <name>Deferiprone</name>
    <description>Leuprolide may decrease the excretion rate of Deferiprone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08840</drugbank-id>
    <name>N-methylnicotinamide</name>
    <description>Leuprolide may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08872</drugbank-id>
    <name>Gabapentin enacarbil</name>
    <description>Leuprolide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08877</drugbank-id>
    <name>Ruxolitinib</name>
    <description>Leuprolide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08897</drugbank-id>
    <name>Aclidinium</name>
    <description>Leuprolide may decrease the excretion rate of Aclidinium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08900</drugbank-id>
    <name>Teduglutide</name>
    <description>Leuprolide may decrease the excretion rate of Teduglutide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08905</drugbank-id>
    <name>Formestane</name>
    <description>Leuprolide may decrease the excretion rate of Formestane which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08909</drugbank-id>
    <name>Glycerol phenylbutyrate</name>
    <description>Leuprolide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08910</drugbank-id>
    <name>Pomalidomide</name>
    <description>Leuprolide may decrease the excretion rate of Pomalidomide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08911</drugbank-id>
    <name>Trametinib</name>
    <description>Leuprolide may decrease the excretion rate of Trametinib which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08918</drugbank-id>
    <name>Levomilnacipran</name>
    <description>Leuprolide may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08932</drugbank-id>
    <name>Macitentan</name>
    <description>Leuprolide may decrease the excretion rate of Macitentan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08934</drugbank-id>
    <name>Sofosbuvir</name>
    <description>Leuprolide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09027</drugbank-id>
    <name>Ledipasvir</name>
    <description>Leuprolide may decrease the excretion rate of Ledipasvir which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09050</drugbank-id>
    <name>Ceftolozane</name>
    <description>Leuprolide may decrease the excretion rate of Ceftolozane which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09068</drugbank-id>
    <name>Vortioxetine</name>
    <description>Leuprolide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09071</drugbank-id>
    <name>Tasimelteon</name>
    <description>Leuprolide may decrease the excretion rate of Tasimelteon which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09075</drugbank-id>
    <name>Edoxaban</name>
    <description>Leuprolide may decrease the excretion rate of Edoxaban which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09081</drugbank-id>
    <name>Idebenone</name>
    <description>Leuprolide may decrease the excretion rate of Idebenone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09091</drugbank-id>
    <name>Tixocortol</name>
    <description>Leuprolide may decrease the excretion rate of Tixocortol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09103</drugbank-id>
    <name>Ancestim</name>
    <description>Leuprolide may decrease the excretion rate of Ancestim which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09104</drugbank-id>
    <name>Magnesium hydroxide</name>
    <description>Leuprolide may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09106</drugbank-id>
    <name>Hydroxyethyl Starch</name>
    <description>Leuprolide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09111</drugbank-id>
    <name>Pentastarch</name>
    <description>Leuprolide may decrease the excretion rate of Pentastarch which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09121</drugbank-id>
    <name>Aurothioglucose</name>
    <description>Leuprolide may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09123</drugbank-id>
    <name>Dienogest</name>
    <description>Leuprolide may decrease the excretion rate of Dienogest which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09129</drugbank-id>
    <name>Chromic chloride</name>
    <description>Leuprolide may decrease the excretion rate of Chromic chloride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09132</drugbank-id>
    <name>Gadoteric acid</name>
    <description>Leuprolide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09133</drugbank-id>
    <name>Iothalamic acid</name>
    <description>Leuprolide may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09134</drugbank-id>
    <name>Ioversol</name>
    <description>Leuprolide may decrease the excretion rate of Ioversol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09135</drugbank-id>
    <name>Ioxilan</name>
    <description>Leuprolide may decrease the excretion rate of Ioxilan which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09136</drugbank-id>
    <name>Isosulfan blue</name>
    <description>Leuprolide may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09137</drugbank-id>
    <name>Technetium Tc-99m mebrofenin</name>
    <description>Leuprolide may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09139</drugbank-id>
    <name>Technetium Tc-99m oxidronate</name>
    <description>Leuprolide may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09148</drugbank-id>
    <name>Florbetaben (18F)</name>
    <description>Leuprolide may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09149</drugbank-id>
    <name>Florbetapir (18F)</name>
    <description>Leuprolide may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09156</drugbank-id>
    <name>Iopromide</name>
    <description>Leuprolide may decrease the excretion rate of Iopromide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09163</drugbank-id>
    <name>Technetium Tc-99m exametazime</name>
    <description>Leuprolide may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09165</drugbank-id>
    <name>Technetium Tc-99m pyrophosphate</name>
    <description>Leuprolide may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09185</drugbank-id>
    <name>Viloxazine</name>
    <description>Leuprolide may decrease the excretion rate of Viloxazine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09194</drugbank-id>
    <name>Etoperidone</name>
    <description>Leuprolide may decrease the excretion rate of Etoperidone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09195</drugbank-id>
    <name>Lorpiprazole</name>
    <description>Leuprolide may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09204</drugbank-id>
    <name>Arotinolol</name>
    <description>Leuprolide may decrease the excretion rate of Arotinolol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09205</drugbank-id>
    <name>Moxisylyte</name>
    <description>Leuprolide may decrease the excretion rate of Moxisylyte which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09209</drugbank-id>
    <name>Pholcodine</name>
    <description>Leuprolide may decrease the excretion rate of Pholcodine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09210</drugbank-id>
    <name>Piracetam</name>
    <description>Leuprolide may decrease the excretion rate of Piracetam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09219</drugbank-id>
    <name>Bisoxatin</name>
    <description>Leuprolide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09220</drugbank-id>
    <name>Nicorandil</name>
    <description>Leuprolide may decrease the excretion rate of Nicorandil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09223</drugbank-id>
    <name>Blonanserin</name>
    <description>Leuprolide may decrease the excretion rate of Blonanserin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09241</drugbank-id>
    <name>Methylene blue</name>
    <description>Leuprolide may decrease the excretion rate of Methylene blue which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09244</drugbank-id>
    <name>Pirlindole</name>
    <description>Leuprolide may decrease the excretion rate of Pirlindole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09245</drugbank-id>
    <name>Toloxatone</name>
    <description>Leuprolide may decrease the excretion rate of Toloxatone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09255</drugbank-id>
    <name>Dextran</name>
    <description>Leuprolide may decrease the excretion rate of Dextran which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09256</drugbank-id>
    <name>Tegafur</name>
    <description>Leuprolide may decrease the excretion rate of Tegafur which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09257</drugbank-id>
    <name>Gimeracil</name>
    <description>Leuprolide may decrease the excretion rate of Gimeracil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09262</drugbank-id>
    <name>Imidafenacin</name>
    <description>Leuprolide may decrease the excretion rate of Imidafenacin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09264</drugbank-id>
    <name>Idarucizumab</name>
    <description>Leuprolide may decrease the excretion rate of Idarucizumab which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09268</drugbank-id>
    <name>Picosulfuric acid</name>
    <description>Leuprolide may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09276</drugbank-id>
    <name>Sodium aurothiomalate</name>
    <description>Leuprolide may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09281</drugbank-id>
    <name>Magnesium trisilicate</name>
    <description>Leuprolide may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09292</drugbank-id>
    <name>Sacubitril</name>
    <description>Leuprolide may decrease the excretion rate of Sacubitril which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09301</drugbank-id>
    <name>Chondroitin sulfate</name>
    <description>Leuprolide may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09317</drugbank-id>
    <name>Synthetic Conjugated Estrogens, A</name>
    <description>Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09318</drugbank-id>
    <name>Synthetic Conjugated Estrogens, B</name>
    <description>Leuprolide may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09320</drugbank-id>
    <name>Procaine benzylpenicillin</name>
    <description>Leuprolide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09324</drugbank-id>
    <name>Sulbactam</name>
    <description>Leuprolide may decrease the excretion rate of Sulbactam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09325</drugbank-id>
    <name>Sodium fluoride</name>
    <description>Leuprolide may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09329</drugbank-id>
    <name>Antihemophilic Factor (Recombinant), PEGylated</name>
    <description>Leuprolide may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09344</drugbank-id>
    <name>Invert sugar</name>
    <description>Leuprolide may decrease the excretion rate of Invert sugar which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09357</drugbank-id>
    <name>Dexpanthenol</name>
    <description>Leuprolide may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09394</drugbank-id>
    <name>Phosphoric acid</name>
    <description>Leuprolide may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09395</drugbank-id>
    <name>Sodium acetate</name>
    <description>Leuprolide may decrease the excretion rate of Sodium acetate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09407</drugbank-id>
    <name>Magnesium chloride</name>
    <description>Leuprolide may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09418</drugbank-id>
    <name>Potassium perchlorate</name>
    <description>Leuprolide may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09472</drugbank-id>
    <name>Sodium sulfate</name>
    <description>Leuprolide may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09477</drugbank-id>
    <name>Enalaprilat</name>
    <description>Leuprolide may decrease the excretion rate of Enalaprilat which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09481</drugbank-id>
    <name>Magnesium carbonate</name>
    <description>Leuprolide may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09496</drugbank-id>
    <name>Octinoxate</name>
    <description>Leuprolide may decrease the excretion rate of Octinoxate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09502</drugbank-id>
    <name>Fludeoxyglucose (18F)</name>
    <description>Leuprolide may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09546</drugbank-id>
    <name>Iobenguane sulfate I-123</name>
    <description>Leuprolide may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09570</drugbank-id>
    <name>Ixazomib</name>
    <description>Leuprolide may decrease the excretion rate of Ixazomib which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11077</drugbank-id>
    <name>Polyethylene glycol 400</name>
    <description>Leuprolide may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11090</drugbank-id>
    <name>Potassium nitrate</name>
    <description>Leuprolide may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11098</drugbank-id>
    <name>Potassium bicarbonate</name>
    <description>Leuprolide may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11102</drugbank-id>
    <name>N-acetyltyrosine</name>
    <description>Leuprolide may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11114</drugbank-id>
    <name>Eucalyptus oil</name>
    <description>Leuprolide may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11127</drugbank-id>
    <name>Selenious acid</name>
    <description>Leuprolide may decrease the excretion rate of Selenious acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11130</drugbank-id>
    <name>Opium</name>
    <description>Leuprolide may decrease the excretion rate of Opium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11135</drugbank-id>
    <name>Selenium</name>
    <description>Leuprolide may decrease the excretion rate of Selenium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11136</drugbank-id>
    <name>Chromium</name>
    <description>Leuprolide may decrease the excretion rate of Chromium which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11145</drugbank-id>
    <name>Oxyquinoline</name>
    <description>Leuprolide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11156</drugbank-id>
    <name>Pyrantel</name>
    <description>Leuprolide may decrease the excretion rate of Pyrantel which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11164</drugbank-id>
    <name>Bicisate</name>
    <description>Leuprolide may decrease the excretion rate of Bicisate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11251</drugbank-id>
    <name>Tocopherol</name>
    <description>Leuprolide may decrease the excretion rate of Tocopherol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11278</drugbank-id>
    <name>DL-Methylephedrine</name>
    <description>Leuprolide may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11328</drugbank-id>
    <name>Tetradecyl hydrogen sulfate (ester)</name>
    <description>Leuprolide may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11338</drugbank-id>
    <name>Clove oil</name>
    <description>Leuprolide may decrease the excretion rate of Clove oil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11358</drugbank-id>
    <name>Evening primrose oil</name>
    <description>Leuprolide may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11364</drugbank-id>
    <name>Pidotimod</name>
    <description>Leuprolide may decrease the excretion rate of Pidotimod which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11560</drugbank-id>
    <name>Lesinurad</name>
    <description>Leuprolide may decrease the excretion rate of Lesinurad which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11577</drugbank-id>
    <name>Indigotindisulfonic acid</name>
    <description>Leuprolide may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11587</drugbank-id>
    <name>Etafedrine</name>
    <description>Leuprolide may decrease the excretion rate of Etafedrine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11598</drugbank-id>
    <name>Antithrombin III human</name>
    <description>Leuprolide may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11691</drugbank-id>
    <name>Naldemedine</name>
    <description>Leuprolide may decrease the excretion rate of Naldemedine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11699</drugbank-id>
    <name>Tropisetron</name>
    <description>Leuprolide may decrease the excretion rate of Tropisetron which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11817</drugbank-id>
    <name>Baricitinib</name>
    <description>Leuprolide may decrease the excretion rate of Baricitinib which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11915</drugbank-id>
    <name>Valbenazine</name>
    <description>Leuprolide may decrease the excretion rate of Valbenazine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11989</drugbank-id>
    <name>Benznidazole</name>
    <description>Leuprolide may decrease the excretion rate of Benznidazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12007</drugbank-id>
    <name>Isoflavone</name>
    <description>Leuprolide may decrease the excretion rate of Isoflavone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12107</drugbank-id>
    <name>Vaborbactam</name>
    <description>Leuprolide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12278</drugbank-id>
    <name>Propiverine</name>
    <description>Leuprolide may decrease the excretion rate of Propiverine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12783</drugbank-id>
    <name>Benserazide</name>
    <description>Leuprolide may decrease the excretion rate of Benserazide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13025</drugbank-id>
    <name>Tiapride</name>
    <description>Leuprolide may decrease the excretion rate of Tiapride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13139</drugbank-id>
    <name>Levosalbutamol</name>
    <description>Leuprolide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13156</drugbank-id>
    <name>Inosine pranobex</name>
    <description>Leuprolide may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13178</drugbank-id>
    <name>Inositol</name>
    <description>Leuprolide may decrease the excretion rate of Inositol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13185</drugbank-id>
    <name>Oxabolone cipionate</name>
    <description>Leuprolide may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13191</drugbank-id>
    <name>Phosphocreatine</name>
    <description>Leuprolide may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13269</drugbank-id>
    <name>Dichlorobenzyl alcohol</name>
    <description>Leuprolide may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13595</drugbank-id>
    <name>Almasilate</name>
    <description>Leuprolide may decrease the excretion rate of Almasilate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13884</drugbank-id>
    <name>Albutrepenonacog alfa</name>
    <description>Leuprolide may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13909</drugbank-id>
    <name>Bismuth subgallate</name>
    <description>Leuprolide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13943</drugbank-id>
    <name>Testosterone cypionate</name>
    <description>Leuprolide may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13944</drugbank-id>
    <name>Testosterone enanthate</name>
    <description>Leuprolide may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13946</drugbank-id>
    <name>Testosterone undecanoate</name>
    <description>Leuprolide may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13952</drugbank-id>
    <name>Estradiol acetate</name>
    <description>Leuprolide may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13954</drugbank-id>
    <name>Estradiol cypionate</name>
    <description>Leuprolide may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13955</drugbank-id>
    <name>Estradiol dienanthate</name>
    <description>Leuprolide may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13956</drugbank-id>
    <name>Estradiol valerate</name>
    <description>Leuprolide may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13967</drugbank-id>
    <name>Patent Blue</name>
    <description>Leuprolide may decrease the excretion rate of Patent Blue which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14006</drugbank-id>
    <name>Choline salicylate</name>
    <description>Leuprolide may decrease the excretion rate of Choline salicylate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14007</drugbank-id>
    <name>Pentetic acid</name>
    <description>Leuprolide may decrease the excretion rate of Pentetic acid which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14498</drugbank-id>
    <name>Potassium acetate</name>
    <description>Leuprolide may decrease the excretion rate of Potassium acetate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14499</drugbank-id>
    <name>Potassium sulfate</name>
    <description>Leuprolide may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14526</drugbank-id>
    <name>Chromic citrate</name>
    <description>Leuprolide may decrease the excretion rate of Chromic citrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14527</drugbank-id>
    <name>Chromic nitrate</name>
    <description>Leuprolide may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14528</drugbank-id>
    <name>Chromium gluconate</name>
    <description>Leuprolide may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14529</drugbank-id>
    <name>Chromium nicotinate</name>
    <description>Leuprolide may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14530</drugbank-id>
    <name>Chromous sulfate</name>
    <description>Leuprolide may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14754</drugbank-id>
    <name>Solriamfetol</name>
    <description>Leuprolide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06815</drugbank-id>
    <name>Pyrithione</name>
    <description>Leuprolide may decrease the excretion rate of Pyrithione which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11121</drugbank-id>
    <name>Chloroxylenol</name>
    <description>Leuprolide may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11085</drugbank-id>
    <name>Resorcinol</name>
    <description>Leuprolide may decrease the excretion rate of Resorcinol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00312</drugbank-id>
    <name>Pentobarbital</name>
    <description>Leuprolide may decrease the excretion rate of Pentobarbital which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00401</drugbank-id>
    <name>Nisoldipine</name>
    <description>Leuprolide may decrease the excretion rate of Nisoldipine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00404</drugbank-id>
    <name>Alprazolam</name>
    <description>Leuprolide may decrease the excretion rate of Alprazolam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00490</drugbank-id>
    <name>Buspirone</name>
    <description>Leuprolide may decrease the excretion rate of Buspirone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00661</drugbank-id>
    <name>Verapamil</name>
    <description>Leuprolide may decrease the excretion rate of Verapamil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00683</drugbank-id>
    <name>Midazolam</name>
    <description>Leuprolide may decrease the excretion rate of Midazolam which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00763</drugbank-id>
    <name>Methimazole</name>
    <description>Leuprolide may decrease the excretion rate of Methimazole which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00820</drugbank-id>
    <name>Tadalafil</name>
    <description>Leuprolide may decrease the excretion rate of Tadalafil which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01149</drugbank-id>
    <name>Nefazodone</name>
    <description>Leuprolide may decrease the excretion rate of Nefazodone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01183</drugbank-id>
    <name>Naloxone</name>
    <description>Leuprolide may decrease the excretion rate of Naloxone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01222</drugbank-id>
    <name>Budesonide</name>
    <description>Leuprolide may decrease the excretion rate of Budesonide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05676</drugbank-id>
    <name>Apremilast</name>
    <description>Leuprolide may decrease the excretion rate of Apremilast which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06228</drugbank-id>
    <name>Rivaroxaban</name>
    <description>Leuprolide may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08899</drugbank-id>
    <name>Enzalutamide</name>
    <description>Leuprolide may decrease the excretion rate of Enzalutamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08904</drugbank-id>
    <name>Certolizumab pegol</name>
    <description>Leuprolide may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09118</drugbank-id>
    <name>Stiripentol</name>
    <description>Leuprolide may decrease the excretion rate of Stiripentol which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11901</drugbank-id>
    <name>Apalutamide</name>
    <description>Leuprolide may decrease the excretion rate of Apalutamide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB15593</drugbank-id>
    <name>Golodirsen</name>
    <description>Leuprolide may decrease the excretion rate of Golodirsen which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00318</drugbank-id>
    <name>Codeine</name>
    <description>Leuprolide may decrease the excretion rate of Codeine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00454</drugbank-id>
    <name>Meperidine</name>
    <description>Leuprolide may decrease the excretion rate of Meperidine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00813</drugbank-id>
    <name>Fentanyl</name>
    <description>Leuprolide may decrease the excretion rate of Fentanyl which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00879</drugbank-id>
    <name>Emtricitabine</name>
    <description>Leuprolide may decrease the excretion rate of Emtricitabine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08996</drugbank-id>
    <name>Dimetacrine</name>
    <description>Leuprolide may decrease the excretion rate of Dimetacrine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14506</drugbank-id>
    <name>Lithium hydroxide</name>
    <description>Leuprolide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13987</drugbank-id>
    <name>Strontium chloride</name>
    <description>Leuprolide may decrease the excretion rate of Strontium chloride which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04890</drugbank-id>
    <name>Bepotastine</name>
    <description>Leuprolide may decrease the excretion rate of Bepotastine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04930</drugbank-id>
    <name>Permethrin</name>
    <description>Leuprolide may decrease the excretion rate of Permethrin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09095</drugbank-id>
    <name>Difluocortolone</name>
    <description>Leuprolide may decrease the excretion rate of Difluocortolone which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00479</drugbank-id>
    <name>Amikacin</name>
    <description>Amikacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00684</drugbank-id>
    <name>Tobramycin</name>
    <description>Tobramycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00798</drugbank-id>
    <name>Gentamicin</name>
    <description>Gentamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00955</drugbank-id>
    <name>Netilmicin</name>
    <description>Netilmicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00994</drugbank-id>
    <name>Neomycin</name>
    <description>Neomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01082</drugbank-id>
    <name>Streptomycin</name>
    <description>Streptomycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01172</drugbank-id>
    <name>Kanamycin</name>
    <description>Kanamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03615</drugbank-id>
    <name>Ribostamycin</name>
    <description>Ribostamycin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04729</drugbank-id>
    <name>Gentamicin C1a</name>
    <description>Gentamicin C1a may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06696</drugbank-id>
    <name>Arbekacin</name>
    <description>Arbekacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12604</drugbank-id>
    <name>Sisomicin</name>
    <description>Sisomicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13540</drugbank-id>
    <name>Isepamicin</name>
    <description>Isepamicin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00552</drugbank-id>
    <name>Pentostatin</name>
    <description>Leuprolide may decrease the excretion rate of Pentostatin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13145</drugbank-id>
    <name>Nedaplatin</name>
    <description>Leuprolide may decrease the excretion rate of Nedaplatin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00314</drugbank-id>
    <name>Capreomycin</name>
    <description>Leuprolide may decrease the excretion rate of Capreomycin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00390</drugbank-id>
    <name>Digoxin</name>
    <description>Leuprolide may decrease the excretion rate of Digoxin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00512</drugbank-id>
    <name>Vancomycin</name>
    <description>Leuprolide may decrease the excretion rate of Vancomycin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00515</drugbank-id>
    <name>Cisplatin</name>
    <description>Leuprolide may decrease the excretion rate of Cisplatin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00642</drugbank-id>
    <name>Pemetrexed</name>
    <description>Leuprolide may decrease the excretion rate of Pemetrexed which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12615</drugbank-id>
    <name>Plazomicin</name>
    <description>Leuprolide may decrease the excretion rate of Plazomicin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14509</drugbank-id>
    <name>Lithium carbonate</name>
    <description>Leuprolide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00564</drugbank-id>
    <name>Carbamazepine</name>
    <description>Leuprolide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00682</drugbank-id>
    <name>Warfarin</name>
    <description>Leuprolide may decrease the excretion rate of Warfarin which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00803</drugbank-id>
    <name>Colistin</name>
    <description>Colistin may decrease the excretion rate of Leuprolide which could result in a higher serum level.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00524</drugbank-id>
    <name>Metolazone</name>
    <description>Leuprolide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00695</drugbank-id>
    <name>Furosemide</name>
    <description>Leuprolide may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09338</drugbank-id>
    <name>Mersalyl</name>
    <description>Leuprolide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00214</drugbank-id>
    <name>Torasemide</name>
    <description>Torasemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00232</drugbank-id>
    <name>Methyclothiazide</name>
    <description>Methyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00310</drugbank-id>
    <name>Chlorthalidone</name>
    <description>Chlorthalidone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00311</drugbank-id>
    <name>Ethoxzolamide</name>
    <description>Ethoxzolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00421</drugbank-id>
    <name>Spironolactone</name>
    <description>Spironolactone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00436</drugbank-id>
    <name>Bendroflumethiazide</name>
    <description>Bendroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00562</drugbank-id>
    <name>Benzthiazide</name>
    <description>Benzthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00594</drugbank-id>
    <name>Amiloride</name>
    <description>Amiloride may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00606</drugbank-id>
    <name>Cyclothiazide</name>
    <description>Cyclothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00774</drugbank-id>
    <name>Hydroflumethiazide</name>
    <description>Hydroflumethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00880</drugbank-id>
    <name>Chlorothiazide</name>
    <description>Chlorothiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01021</drugbank-id>
    <name>Trichlormethiazide</name>
    <description>Trichlormethiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01119</drugbank-id>
    <name>Diazoxide</name>
    <description>Diazoxide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01144</drugbank-id>
    <name>Diclofenamide</name>
    <description>Diclofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01324</drugbank-id>
    <name>Polythiazide</name>
    <description>Polythiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01325</drugbank-id>
    <name>Quinethazone</name>
    <description>Quinethazone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01412</drugbank-id>
    <name>Theobromine</name>
    <description>Theobromine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02925</drugbank-id>
    <name>Piretanide</name>
    <description>Piretanide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04831</drugbank-id>
    <name>Tienilic acid</name>
    <description>Tienilic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05034</drugbank-id>
    <name>Ularitide</name>
    <description>Ularitide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08961</drugbank-id>
    <name>Azosemide</name>
    <description>Azosemide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09015</drugbank-id>
    <name>Canrenoic acid</name>
    <description>Canrenoic acid may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09125</drugbank-id>
    <name>Potassium citrate</name>
    <description>Potassium citrate may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09401</drugbank-id>
    <name>Isosorbide</name>
    <description>Isosorbide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12221</drugbank-id>
    <name>Canrenone</name>
    <description>Canrenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12670</drugbank-id>
    <name>Rolofylline</name>
    <description>Rolofylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12704</drugbank-id>
    <name>Spiradoline</name>
    <description>Spiradoline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13284</drugbank-id>
    <name>Meticrane</name>
    <description>Meticrane may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13405</drugbank-id>
    <name>Mefruside</name>
    <description>Mefruside may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13430</drugbank-id>
    <name>Mebutizide</name>
    <description>Mebutizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13532</drugbank-id>
    <name>Cyclopenthiazide</name>
    <description>Cyclopenthiazide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13617</drugbank-id>
    <name>Clorexolone</name>
    <description>Clorexolone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13663</drugbank-id>
    <name>Clofenamide</name>
    <description>Clofenamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13708</drugbank-id>
    <name>Fenquizone</name>
    <description>Fenquizone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13792</drugbank-id>
    <name>Clopamide</name>
    <description>Clopamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13801</drugbank-id>
    <name>Muzolimine</name>
    <description>Muzolimine may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13803</drugbank-id>
    <name>Xipamide</name>
    <description>Xipamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13989</drugbank-id>
    <name>Epitizide</name>
    <description>Epitizide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14018</drugbank-id>
    <name>Bromotheophylline</name>
    <description>Bromotheophylline may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14500</drugbank-id>
    <name>Potassium</name>
    <description>Potassium may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00703</drugbank-id>
    <name>Methazolamide</name>
    <description>Methazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00700</drugbank-id>
    <name>Eplerenone</name>
    <description>Eplerenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00819</drugbank-id>
    <name>Acetazolamide</name>
    <description>Acetazolamide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00872</drugbank-id>
    <name>Conivaptan</name>
    <description>Conivaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01395</drugbank-id>
    <name>Drospirenone</name>
    <description>Drospirenone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06212</drugbank-id>
    <name>Tolvaptan</name>
    <description>Tolvaptan may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06370</drugbank-id>
    <name>Indisulam</name>
    <description>Indisulam may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01345</drugbank-id>
    <name>Potassium cation</name>
    <description>Leuprolide may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00052</drugbank-id>
    <name>Somatotropin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00080</drugbank-id>
    <name>Daptomycin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Daptomycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00175</drugbank-id>
    <name>Pravastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pravastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00181</drugbank-id>
    <name>Baclofen</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Baclofen.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00242</drugbank-id>
    <name>Cladribine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cladribine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00382</drugbank-id>
    <name>Tacrine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tacrine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00389</drugbank-id>
    <name>Carbimazole</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Carbimazole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00439</drugbank-id>
    <name>Cerivastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cerivastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00443</drugbank-id>
    <name>Betamethasone</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Betamethasone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00471</drugbank-id>
    <name>Montelukast</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Montelukast.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00495</drugbank-id>
    <name>Zidovudine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Zidovudine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00501</drugbank-id>
    <name>Cimetidine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cimetidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00528</drugbank-id>
    <name>Lercanidipine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lercanidipine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00541</drugbank-id>
    <name>Vincristine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Vincristine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00550</drugbank-id>
    <name>Propylthiouracil</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Propylthiouracil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00584</drugbank-id>
    <name>Enalapril</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Enalapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00585</drugbank-id>
    <name>Nizatidine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nizatidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00602</drugbank-id>
    <name>Ivermectin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ivermectin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00620</drugbank-id>
    <name>Triamcinolone</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triamcinolone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00627</drugbank-id>
    <name>Niacin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Niacin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00630</drugbank-id>
    <name>Alendronic acid</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Alendronic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00636</drugbank-id>
    <name>Clofibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00649</drugbank-id>
    <name>Stavudine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Stavudine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00666</drugbank-id>
    <name>Nafarelin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Nafarelin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00688</drugbank-id>
    <name>Mycophenolate mofetil</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mycophenolate mofetil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00704</drugbank-id>
    <name>Naltrexone</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Naltrexone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00709</drugbank-id>
    <name>Lamivudine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lamivudine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00857</drugbank-id>
    <name>Terbinafine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Terbinafine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00859</drugbank-id>
    <name>Penicillamine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Penicillamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00863</drugbank-id>
    <name>Ranitidine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ranitidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00876</drugbank-id>
    <name>Eprosartan</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Eprosartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00884</drugbank-id>
    <name>Risedronic acid</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Risedronic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00887</drugbank-id>
    <name>Bumetanide</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bumetanide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00898</drugbank-id>
    <name>Ethanol</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ethanol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00968</drugbank-id>
    <name>Methyldopa</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Methyldopa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00987</drugbank-id>
    <name>Cytarabine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Cytarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01004</drugbank-id>
    <name>Ganciclovir</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ganciclovir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01006</drugbank-id>
    <name>Letrozole</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Letrozole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01017</drugbank-id>
    <name>Minocycline</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Minocycline.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01039</drugbank-id>
    <name>Fenofibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01076</drugbank-id>
    <name>Atorvastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Atorvastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01088</drugbank-id>
    <name>Iloprost</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Iloprost.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01095</drugbank-id>
    <name>Fluvastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fluvastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01097</drugbank-id>
    <name>Leflunomide</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Leflunomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01098</drugbank-id>
    <name>Rosuvastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Rosuvastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01168</drugbank-id>
    <name>Procarbazine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Procarbazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01197</drugbank-id>
    <name>Captopril</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Captopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01241</drugbank-id>
    <name>Gemfibrozil</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Gemfibrozil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01248</drugbank-id>
    <name>Docetaxel</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Docetaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01393</drugbank-id>
    <name>Bezafibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Bezafibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02703</drugbank-id>
    <name>Fusidic acid</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fusidic acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05109</drugbank-id>
    <name>Trabectedin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trabectedin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06693</drugbank-id>
    <name>Mevastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mevastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06817</drugbank-id>
    <name>Raltegravir</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Raltegravir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08860</drugbank-id>
    <name>Pitavastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Pitavastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08983</drugbank-id>
    <name>Etofibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Etofibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09055</drugbank-id>
    <name>Acipimox</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Acipimox.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09064</drugbank-id>
    <name>Ciprofibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ciprofibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09270</drugbank-id>
    <name>Ubidecarenone</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ubidecarenone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12554</drugbank-id>
    <name>Mebeverine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Mebeverine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13293</drugbank-id>
    <name>Ipecac</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ipecac.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13393</drugbank-id>
    <name>Emetine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Emetine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13433</drugbank-id>
    <name>Simfibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simfibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13460</drugbank-id>
    <name>Ronifibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ronifibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13780</drugbank-id>
    <name>Aluminium clofibrate</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Aluminium clofibrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13849</drugbank-id>
    <name>Clofibride</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibride.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13873</drugbank-id>
    <name>Fenofibric acid</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibric acid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00951</drugbank-id>
    <name>Isoniazid</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Isoniazid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00897</drugbank-id>
    <name>Triazolam</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01394</drugbank-id>
    <name>Colchicine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Colchicine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00065</drugbank-id>
    <name>Infliximab</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Infliximab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00203</drugbank-id>
    <name>Sildenafil</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Sildenafil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00224</drugbank-id>
    <name>Indinavir</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Indinavir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00227</drugbank-id>
    <name>Lovastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lovastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00252</drugbank-id>
    <name>Phenytoin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Phenytoin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00641</drugbank-id>
    <name>Simvastatin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Simvastatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01229</drugbank-id>
    <name>Paclitaxel</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Paclitaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01234</drugbank-id>
    <name>Dexamethasone</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Dexamethasone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09289</drugbank-id>
    <name>Tianeptine</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Tianeptine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00440</drugbank-id>
    <name>Trimethoprim</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Trimethoprim.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00982</drugbank-id>
    <name>Isotretinoin</name>
    <description>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Isotretinoin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00331</drugbank-id>
    <name>Metformin</name>
    <description>The therapeutic efficacy of Metformin can be decreased when used in combination with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00656</drugbank-id>
    <name>Trazodone</name>
    <description>The risk or severity of QTc prolongation can be increased when Trazodone is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11986</drugbank-id>
    <name>Entrectinib</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Entrectinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11642</drugbank-id>
    <name>Pitolisant</name>
    <description>Leuprolide may increase the QTc-prolonging activities of Pitolisant.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12825</drugbank-id>
    <name>Lefamulin</name>
    <description>Lefamulin may increase the QTc-prolonging activities of Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00557</drugbank-id>
    <name>Hydroxyzine</name>
    <description>The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Leuprolide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00246</drugbank-id>
    <name>Ziprasidone</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ziprasidone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00502</drugbank-id>
    <name>Haloperidol</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Haloperidol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00472</drugbank-id>
    <name>Fluoxetine</name>
    <description>The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Fluoxetine.</description>
  </drug-interaction>
  </drug-interactions>
<drug type="biotech" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00008</drugbank-id>
  <drugbank-id>BTD00043</drugbank-id>
  <drugbank-id>BIOD00043</drugbank-id>
  <name>Peginterferon alfa-2a</name>
  <description>Peginterferon alfa-2a is a form of recombinant interferon used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Treatment options for chronic Hepatitis C have advanced significantly since 2011, with the development of Direct Acting Antivirals (DAAs) resulting in less use of Peginterferon alfa-2a. Peginterferon alfa-2a is derived from the alfa-2a moeity of recombinant human interferon and acts by binding to human type 1 interferon receptors. Activation and dimerization of this receptor induces the body's innate antiviral response by activating the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway. Use of Peginterferon alfa-2a is associated with a wide range of severe adverse effects including the aggravation and development of endocrine and autoimmune disorders, retinopathies, cardiovascular and neuropsychiatric complications, and increased risk of hepatic decompensation in patients with cirrhosis. The use of Peginterferon alfa-2a has largely declined since newer interferon-free antiviral therapies have been developed.&#13;
    &#13;
    In a joint recommendation published in 2016, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) no longer recommend Peginterferon alfa-2a for the treatment of Hepatitis C [A19593]. Peginterferon alfa-2a was used alongside [DB00811] with the intent to cure, or achieve a sustained virologic response (SVR), after 48 weeks of therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626].&#13;
    &#13;
    Peginterferon alfa-2a is available as a fixed dose injector (tradename Pegasys) used for the treatment of chronic Hepatitis C. Approved in 2002 by the FDA, Pegasys is indicated for the treatment of HCV with [DB00811] or other antiviral drugs [FDA Label]. When combined together, Peginterferon alfa-2a and [DB00811] have been shown to achieve a SVR between 36% for genotype 1 and 59% for genotypes 2-6 after 48 weeks of treatment.</description>
  <indication>Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease [FDA Label]. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.&#13;
    &#13;
    Peginterferon alfa-2a is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation [FDA Label].</indication>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB06643</drugbank-id>
      <name>Denosumab</name>
      <description>The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00005</drugbank-id>
      <name>Etanercept</name>
      <description>The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00011</drugbank-id>
      <name>Interferon alfa-n1</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00018</drugbank-id>
      <name>Interferon alfa-n3</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00022</drugbank-id>
      <name>Peginterferon alfa-2b</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00026</drugbank-id>
      <name>Anakinra</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00033</drugbank-id>
      <name>Interferon gamma-1b</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00034</drugbank-id>
      <name>Interferon alfa-2a, Recombinant</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00051</drugbank-id>
      <name>Adalimumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00056</drugbank-id>
      <name>Gemtuzumab ozogamicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemtuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00059</drugbank-id>
      <name>Pegaspargase</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pegaspargase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00065</drugbank-id>
      <name>Infliximab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Infliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00068</drugbank-id>
      <name>Interferon beta-1b</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon beta-1b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00069</drugbank-id>
      <name>Interferon alfacon-1</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfacon-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00073</drugbank-id>
      <name>Rituximab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00074</drugbank-id>
      <name>Basiliximab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Basiliximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00075</drugbank-id>
      <name>Muromonab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Muromonab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00078</drugbank-id>
      <name>Ibritumomab tiuxetan</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibritumomab tiuxetan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00081</drugbank-id>
      <name>Tositumomab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tositumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00087</drugbank-id>
      <name>Alemtuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alemtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00092</drugbank-id>
      <name>Alefacept</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Alefacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00095</drugbank-id>
      <name>Efalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Efalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00098</drugbank-id>
      <name>Antithymocyte immunoglobulin (rabbit)</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antithymocyte immunoglobulin (rabbit).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00105</drugbank-id>
      <name>Interferon alfa-2b</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00111</drugbank-id>
      <name>Daclizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daclizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00112</drugbank-id>
      <name>Bevacizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bevacizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00120</drugbank-id>
      <name>Phenylalanine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Phenylalanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00180</drugbank-id>
      <name>Flunisolide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flunisolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00188</drugbank-id>
      <name>Bortezomib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bortezomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00242</drugbank-id>
      <name>Cladribine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cladribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00262</drugbank-id>
      <name>Carmustine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carmustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00276</drugbank-id>
      <name>Amsacrine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Amsacrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00290</drugbank-id>
      <name>Bleomycin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00291</drugbank-id>
      <name>Chlorambucil</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chlorambucil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00293</drugbank-id>
      <name>Raltitrexed</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Raltitrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00305</drugbank-id>
      <name>Mitomycin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00307</drugbank-id>
      <name>Bexarotene</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bexarotene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00309</drugbank-id>
      <name>Vindesine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vindesine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00322</drugbank-id>
      <name>Floxuridine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Floxuridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00328</drugbank-id>
      <name>Indomethacin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Indomethacin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00352</drugbank-id>
      <name>Tioguanine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tioguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinorelbine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00380</drugbank-id>
      <name>Dexrazoxane</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexrazoxane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00394</drugbank-id>
      <name>Beclomethasone dipropionate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Beclomethasone dipropionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00398</drugbank-id>
      <name>Sorafenib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sorafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00428</drugbank-id>
      <name>Streptozocin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Streptozocin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00432</drugbank-id>
      <name>Trifluridine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00441</drugbank-id>
      <name>Gemcitabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gemcitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00443</drugbank-id>
      <name>Betamethasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Betamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teniposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00445</drugbank-id>
      <name>Epirubicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Epirubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00446</drugbank-id>
      <name>Chloramphenicol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chloramphenicol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00480</drugbank-id>
      <name>Lenalidomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lenalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00488</drugbank-id>
      <name>Altretamine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Altretamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00515</drugbank-id>
      <name>Cisplatin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cisplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00526</drugbank-id>
      <name>Oxaliplatin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Oxaliplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00531</drugbank-id>
      <name>Cyclophosphamide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cyclophosphamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00541</drugbank-id>
      <name>Vincristine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vincristine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00544</drugbank-id>
      <name>Fluorouracil</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00550</drugbank-id>
      <name>Propylthiouracil</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Propylthiouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00552</drugbank-id>
      <name>Pentostatin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pentostatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methotrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carbamazepine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00570</drugbank-id>
      <name>Vinblastine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinblastine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00588</drugbank-id>
      <name>Fluticasone propionate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone propionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00591</drugbank-id>
      <name>Fluocinolone acetonide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocinolone acetonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00601</drugbank-id>
      <name>Linezolid</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Linezolid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Imatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00620</drugbank-id>
      <name>Triamcinolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triamcinolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00631</drugbank-id>
      <name>Clofarabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clofarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00642</drugbank-id>
      <name>Pemetrexed</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pemetrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00687</drugbank-id>
      <name>Fludrocortisone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludrocortisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00688</drugbank-id>
      <name>Mycophenolate mofetil</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolate mofetil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00694</drugbank-id>
      <name>Daunorubicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Daunorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00755</drugbank-id>
      <name>Tretinoin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tretinoin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00762</drugbank-id>
      <name>Irinotecan</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Irinotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00763</drugbank-id>
      <name>Methimazole</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methimazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00773</drugbank-id>
      <name>Etoposide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Etoposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00795</drugbank-id>
      <name>Sulfasalazine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sulfasalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00851</drugbank-id>
      <name>Dacarbazine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dacarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00853</drugbank-id>
      <name>Temozolomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temozolomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00859</drugbank-id>
      <name>Penicillamine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Penicillamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00877</drugbank-id>
      <name>Sirolimus</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00888</drugbank-id>
      <name>Mechlorethamine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mechlorethamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00928</drugbank-id>
      <name>Azacitidine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azacitidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00958</drugbank-id>
      <name>Carboplatin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carboplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Methylprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00970</drugbank-id>
      <name>Dactinomycin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dactinomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00987</drugbank-id>
      <name>Cytarabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cytarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00993</drugbank-id>
      <name>Azathioprine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azathioprine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00997</drugbank-id>
      <name>Doxorubicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01005</drugbank-id>
      <name>Hydroxyurea</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxyurea.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01008</drugbank-id>
      <name>Busulfan</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Busulfan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01024</drugbank-id>
      <name>Mycophenolic acid</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mycophenolic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01030</drugbank-id>
      <name>Topotecan</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Topotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01033</drugbank-id>
      <name>Mercaptopurine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mercaptopurine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01041</drugbank-id>
      <name>Thalidomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01042</drugbank-id>
      <name>Melphalan</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melphalan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01073</drugbank-id>
      <name>Fludarabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fludarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01099</drugbank-id>
      <name>Flucytosine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flucytosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01101</drugbank-id>
      <name>Capecitabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Capecitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01108</drugbank-id>
      <name>Trilostane</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trilostane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01168</drugbank-id>
      <name>Procarbazine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Procarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01169</drugbank-id>
      <name>Arsenic trioxide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Arsenic trioxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01177</drugbank-id>
      <name>Idarubicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01181</drugbank-id>
      <name>Ifosfamide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ifosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01196</drugbank-id>
      <name>Estramustine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Estramustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01204</drugbank-id>
      <name>Mitoxantrone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mitoxantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01206</drugbank-id>
      <name>Lomustine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Lomustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01222</drugbank-id>
      <name>Budesonide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Budesonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paclitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01248</drugbank-id>
      <name>Docetaxel</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Docetaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dasatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01257</drugbank-id>
      <name>Eculizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eculizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01262</drugbank-id>
      <name>Decitabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Decitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01268</drugbank-id>
      <name>Sunitinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sunitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01280</drugbank-id>
      <name>Nelarabine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nelarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01281</drugbank-id>
      <name>Abatacept</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abatacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01285</drugbank-id>
      <name>Corticotropin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Corticotropin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01380</drugbank-id>
      <name>Cortisone acetate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortisone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01384</drugbank-id>
      <name>Paramethasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Paramethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01394</drugbank-id>
      <name>Colchicine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Colchicine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01410</drugbank-id>
      <name>Ciclesonide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ciclesonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01423</drugbank-id>
      <name>Stepronin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Stepronin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01590</drugbank-id>
      <name>Everolimus</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Everolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01611</drugbank-id>
      <name>Hydroxychloroquine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydroxychloroquine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01816</drugbank-id>
      <name>Castanospermine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Castanospermine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02546</drugbank-id>
      <name>Vorinostat</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vorinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02806</drugbank-id>
      <name>2-Methoxyethanol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 2-Methoxyethanol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03523</drugbank-id>
      <name>Brequinar</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brequinar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04572</drugbank-id>
      <name>Thiotepa</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Thiotepa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04630</drugbank-id>
      <name>Aldosterone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldosterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04845</drugbank-id>
      <name>Ixabepilone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixabepilone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Nilotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04951</drugbank-id>
      <name>Pirfenidone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirfenidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04956</drugbank-id>
      <name>Afelimomab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Afelimomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05015</drugbank-id>
      <name>Belinostat</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05109</drugbank-id>
      <name>Trabectedin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trabectedin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05258</drugbank-id>
      <name>Interferon alfa</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05259</drugbank-id>
      <name>Glatiramer</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Glatiramer.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05260</drugbank-id>
      <name>Gallium nitrate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gallium nitrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05459</drugbank-id>
      <name>Briakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Briakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05472</drugbank-id>
      <name>Human interferon omega-1</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Human interferon omega-1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05676</drugbank-id>
      <name>Apremilast</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Apremilast.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trastuzumab emtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06168</drugbank-id>
      <name>Canakinumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Canakinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06273</drugbank-id>
      <name>Tocilizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tocilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06287</drugbank-id>
      <name>Temsirolimus</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Temsirolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06372</drugbank-id>
      <name>Rilonacept</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rilonacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06589</drugbank-id>
      <name>Pazopanib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pazopanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06603</drugbank-id>
      <name>Panobinostat</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Panobinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06612</drugbank-id>
      <name>Mepolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mepolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06616</drugbank-id>
      <name>Bosutinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bosutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06662</drugbank-id>
      <name>Abetimus</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Abetimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06674</drugbank-id>
      <name>Golimumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Golimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06681</drugbank-id>
      <name>Belatacept</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belatacept.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06769</drugbank-id>
      <name>Bendamustine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bendamustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06772</drugbank-id>
      <name>Cabazitaxel</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cabazitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pralatrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08059</drugbank-id>
      <name>Wortmannin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Wortmannin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08870</drugbank-id>
      <name>Brentuximab vedotin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brentuximab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08871</drugbank-id>
      <name>Eribulin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Eribulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08877</drugbank-id>
      <name>Ruxolitinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ruxolitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08879</drugbank-id>
      <name>Belimumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Belimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08880</drugbank-id>
      <name>Teriflunomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Teriflunomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08889</drugbank-id>
      <name>Carfilzomib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carfilzomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08901</drugbank-id>
      <name>Ponatinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ponatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08904</drugbank-id>
      <name>Certolizumab pegol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Certolizumab pegol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08906</drugbank-id>
      <name>Fluticasone furoate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone furoate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08908</drugbank-id>
      <name>Dimethyl fumarate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dimethyl fumarate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08910</drugbank-id>
      <name>Pomalidomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pomalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08935</drugbank-id>
      <name>Obinutuzumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Obinutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08970</drugbank-id>
      <name>Fluprednidene</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednidene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09029</drugbank-id>
      <name>Secukinumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Secukinumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09033</drugbank-id>
      <name>Vedolizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vedolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09036</drugbank-id>
      <name>Siltuximab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siltuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09052</drugbank-id>
      <name>Blinatumomab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Blinatumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09053</drugbank-id>
      <name>Ibrutinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ibrutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09054</drugbank-id>
      <name>Idelalisib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Idelalisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Palbociclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Olaparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09077</drugbank-id>
      <name>Dinutuximab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dinutuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09082</drugbank-id>
      <name>Vilanterol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vilanterol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09091</drugbank-id>
      <name>Tixocortol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tixocortol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09122</drugbank-id>
      <name>Peginterferon beta-1a</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon beta-1a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09312</drugbank-id>
      <name>Antilymphocyte immunoglobulin (horse)</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Antilymphocyte immunoglobulin (horse).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09378</drugbank-id>
      <name>Fluprednisolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09383</drugbank-id>
      <name>Meprednisone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Meprednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11466</drugbank-id>
      <name>Tepoxalin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tepoxalin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11487</drugbank-id>
      <name>Dexamethasone isonicotinate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Dexamethasone isonicotinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11529</drugbank-id>
      <name>Melengestrol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Melengestrol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11569</drugbank-id>
      <name>Ixekizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ixekizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11580</drugbank-id>
      <name>Ravulizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ravulizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11616</drugbank-id>
      <name>Pirarubicin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Pirarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11693</drugbank-id>
      <name>Voclosporin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Voclosporin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11708</drugbank-id>
      <name>Peficitinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peficitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11767</drugbank-id>
      <name>Sarilumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sarilumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11776</drugbank-id>
      <name>Brodalumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brodalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11803</drugbank-id>
      <name>Sirukumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sirukumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11817</drugbank-id>
      <name>Baricitinib</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Baricitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11834</drugbank-id>
      <name>Guselkumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Guselkumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11921</drugbank-id>
      <name>Deflazacort</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deflazacort.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11988</drugbank-id>
      <name>Ocrelizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ocrelizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12025</drugbank-id>
      <name>Triptolide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Triptolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12371</drugbank-id>
      <name>Siponimod</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Siponimod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12612</drugbank-id>
      <name>Ozanimod</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ozanimod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12617</drugbank-id>
      <name>Mizoribine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mizoribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12692</drugbank-id>
      <name>Gusperimus</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Gusperimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12814</drugbank-id>
      <name>Cepeginterferon alfa-2B</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cepeginterferon alfa-2B.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12902</drugbank-id>
      <name>Trofosfamide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Trofosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12947</drugbank-id>
      <name>Doxifluridine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Doxifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12991</drugbank-id>
      <name>Deoxyspergualin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Deoxyspergualin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12996</drugbank-id>
      <name>Acteoside</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Acteoside.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13003</drugbank-id>
      <name>Cortivazol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cortivazol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13014</drugbank-id>
      <name>Hypericin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hypericin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13068</drugbank-id>
      <name>9-(N-methyl-L-isoleucine)-cyclosporin A</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13208</drugbank-id>
      <name>Prednylidene</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Prednylidene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13223</drugbank-id>
      <name>Fluocortin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13241</drugbank-id>
      <name>Begelomab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Begelomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13491</drugbank-id>
      <name>Fluperolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluperolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13843</drugbank-id>
      <name>Cloprednol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Cloprednol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13856</drugbank-id>
      <name>Fluclorolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluclorolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13867</drugbank-id>
      <name>Fluticasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluticasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14066</drugbank-id>
      <name>Tetrandrine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Tetrandrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14219</drugbank-id>
      <name>Monomethyl fumarate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Monomethyl fumarate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14512</drugbank-id>
      <name>Mometasone furoate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone furoate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14539</drugbank-id>
      <name>Hydrocortisone acetate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14545</drugbank-id>
      <name>Hydrocortisone succinate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone succinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14724</drugbank-id>
      <name>Emapalumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Emapalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14762</drugbank-id>
      <name>Risankizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Risankizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14919</drugbank-id>
      <name>Rozanolixizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Rozanolixizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15253</drugbank-id>
      <name>Bleselumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Bleselumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01013</drugbank-id>
      <name>Clobetasol propionate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clobetasol propionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01047</drugbank-id>
      <name>Fluocinonide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocinonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14540</drugbank-id>
      <name>Hydrocortisone butyrate</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Hydrocortisone butyrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00547</drugbank-id>
      <name>Desoximetasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Desoximetasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00764</drugbank-id>
      <name>Mometasone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Mometasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08971</drugbank-id>
      <name>Fluocortolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11750</drugbank-id>
      <name>Clobetasol</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clobetasol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00324</drugbank-id>
      <name>Fluorometholone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorometholone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09095</drugbank-id>
      <name>Difluocortolone</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Difluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00108</drugbank-id>
      <name>Natalizumab</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Natalizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00337</drugbank-id>
      <name>Pimecrolimus</name>
      <description>The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01656</drugbank-id>
      <name>Roflumilast</name>
      <description>Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06688</drugbank-id>
      <name>Sipuleucel-T</name>
      <description>The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00041</drugbank-id>
      <name>Aldesleukin</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00363</drugbank-id>
      <name>Clozapine</name>
      <description>The risk or severity of neutropenia can be increased when Peginterferon alfa-2a is combined with Clozapine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00333</drugbank-id>
      <name>Methadone</name>
      <description>The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01265</drugbank-id>
      <name>Telbivudine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Telbivudine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00495</drugbank-id>
      <name>Zidovudine</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Zidovudine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08894</drugbank-id>
      <name>Peginesatide</name>
      <description>The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Peginesatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09107</drugbank-id>
      <name>Methoxy polyethylene glycol-epoetin beta</name>
      <description>The risk or severity of Thrombosis can be increased when Peginterferon alfa-2a is combined with Methoxy polyethylene glycol-epoetin beta.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00012</drugbank-id>
      <name>Darbepoetin alfa</name>
      <description>The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00016</drugbank-id>
      <name>Erythropoietin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00315</drugbank-id>
      <name>Zolmitriptan</name>
      <description>The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01015</drugbank-id>
      <name>Sulfamethoxazole</name>
      <description>The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04817</drugbank-id>
      <name>Metamizole</name>
      <description>The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01097</drugbank-id>
      <name>Leflunomide</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Leflunomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08895</drugbank-id>
      <name>Tofacitinib</name>
      <description>Peginterferon alfa-2a may increase the immunosuppressive activities of Tofacitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00072</drugbank-id>
      <name>Trastuzumab</name>
      <description>Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00019</drugbank-id>
      <name>Pegfilgrastim</name>
      <description>The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00061</drugbank-id>
      <name>Pegademase</name>
      <description>The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00082</drugbank-id>
      <name>Pegvisomant</name>
      <description>The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01839</drugbank-id>
      <name>Propylene glycol</name>
      <description>The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03394</drugbank-id>
      <name>Heptaethylene glycol</name>
      <description>The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04895</drugbank-id>
      <name>Pegaptanib</name>
      <description>The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05202</drugbank-id>
      <name>Egaptivon pegol</name>
      <description>The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05321</drugbank-id>
      <name>PEG-uricase</name>
      <description>The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05860</drugbank-id>
      <name>Peginterferon alfacon-1</name>
      <description>The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06022</drugbank-id>
      <name>GlycoPEG-GCSF</name>
      <description>The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06293</drugbank-id>
      <name>Pegnivacogin</name>
      <description>The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06325</drugbank-id>
      <name>Pegpleranib</name>
      <description>The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06611</drugbank-id>
      <name>Pegsunercept</name>
      <description>The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06811</drugbank-id>
      <name>Polidocanol</name>
      <description>The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09208</drugbank-id>
      <name>Pegloticase</name>
      <description>The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09287</drugbank-id>
      <name>Polyethylene glycol</name>
      <description>The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09329</drugbank-id>
      <name>Antihemophilic Factor (Recombinant), PEGylated</name>
      <description>The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11077</drugbank-id>
      <name>Polyethylene glycol 400</name>
      <description>The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11567</drugbank-id>
      <name>Insulin peglispro</name>
      <description>The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11661</drugbank-id>
      <name>Eptacog alfa pegol (activated)</name>
      <description>The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11707</drugbank-id>
      <name>Olaptesed Pegol</name>
      <description>The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12258</drugbank-id>
      <name>Abicipar Pegol</name>
      <description>The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12578</drugbank-id>
      <name>Lexaptepid Pegol</name>
      <description>The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12839</drugbank-id>
      <name>Pegvaliase</name>
      <description>The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12842</drugbank-id>
      <name>Pegamotecan</name>
      <description>The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13933</drugbank-id>
      <name>Nonacog beta pegol</name>
      <description>The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14700</drugbank-id>
      <name>Damoctocog alfa pegol</name>
      <description>The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14712</drugbank-id>
      <name>Elapegademase</name>
      <description>The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08868</drugbank-id>
      <name>Fingolimod</name>
      <description>Peginterferon alfa-2a may increase the immunosuppressive activities of Fingolimod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00864</drugbank-id>
      <name>Tacrolimus</name>
      <description>Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00201</drugbank-id>
      <name>Caffeine</name>
      <description>The metabolism of Caffeine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00651</drugbank-id>
      <name>Dyphylline</name>
      <description>The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00806</drugbank-id>
      <name>Pentoxifylline</name>
      <description>The metabolism of Pentoxifylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01303</drugbank-id>
      <name>Oxtriphylline</name>
      <description>The metabolism of Oxtriphylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01412</drugbank-id>
      <name>Theobromine</name>
      <description>The metabolism of Theobromine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01482</drugbank-id>
      <name>Fenethylline</name>
      <description>The metabolism of Fenethylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01667</drugbank-id>
      <name>8-azaguanine</name>
      <description>The metabolism of 8-azaguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01978</drugbank-id>
      <name>7,9-Dimethylguanine</name>
      <description>The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02134</drugbank-id>
      <name>Xanthine</name>
      <description>The metabolism of Xanthine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02245</drugbank-id>
      <name>7-Deazaguanine</name>
      <description>The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02377</drugbank-id>
      <name>Guanine</name>
      <description>The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02489</drugbank-id>
      <name>9-Methylguanine</name>
      <description>The metabolism of 9-Methylguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02568</drugbank-id>
      <name>Peldesine</name>
      <description>The metabolism of Peldesine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04076</drugbank-id>
      <name>Hypoxanthine</name>
      <description>The metabolism of Hypoxanthine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04356</drugbank-id>
      <name>9-Deazaguanine</name>
      <description>The metabolism of 9-Deazaguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06479</drugbank-id>
      <name>Propentofylline</name>
      <description>The metabolism of Propentofylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06575</drugbank-id>
      <name>Valomaciclovir</name>
      <description>The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07954</drugbank-id>
      <name>3-isobutyl-1-methyl-7H-xanthine</name>
      <description>The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08844</drugbank-id>
      <name>Uric acid</name>
      <description>The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09273</drugbank-id>
      <name>Doxofylline</name>
      <description>The metabolism of Doxofylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11919</drugbank-id>
      <name>6-O-benzylguanine</name>
      <description>The metabolism of 6-O-benzylguanine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12406</drugbank-id>
      <name>Lisofylline</name>
      <description>The metabolism of Lisofylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12531</drugbank-id>
      <name>Lobucavir</name>
      <description>The metabolism of Lobucavir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12926</drugbank-id>
      <name>Cafedrine</name>
      <description>The metabolism of Cafedrine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12927</drugbank-id>
      <name>Theodrenaline</name>
      <description>The metabolism of Theodrenaline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13203</drugbank-id>
      <name>Bamifylline</name>
      <description>The metabolism of Bamifylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13449</drugbank-id>
      <name>Proxyphylline</name>
      <description>The metabolism of Proxyphylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13573</drugbank-id>
      <name>Acefylline</name>
      <description>The metabolism of Acefylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13592</drugbank-id>
      <name>Etamiphylline</name>
      <description>The metabolism of Etamiphylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13634</drugbank-id>
      <name>Pentifylline</name>
      <description>The metabolism of Pentifylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13812</drugbank-id>
      <name>Bufylline</name>
      <description>The metabolism of Bufylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14018</drugbank-id>
      <name>Bromotheophylline</name>
      <description>The metabolism of Bromotheophylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14029</drugbank-id>
      <name>Furafylline</name>
      <description>The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14132</drugbank-id>
      <name>8-chlorotheophylline</name>
      <description>The metabolism of 8-chlorotheophylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15122</drugbank-id>
      <name>PCS-499</name>
      <description>The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00390</drugbank-id>
      <name>Digoxin</name>
      <description>Digoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00511</drugbank-id>
      <name>Acetyldigitoxin</name>
      <description>Acetyldigitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01078</drugbank-id>
      <name>Deslanoside</name>
      <description>Deslanoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01092</drugbank-id>
      <name>Ouabain</name>
      <description>Ouabain may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>Digitoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12843</drugbank-id>
      <name>Oleandrin</name>
      <description>Oleandrin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13240</drugbank-id>
      <name>Cymarin</name>
      <description>Cymarin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13307</drugbank-id>
      <name>Proscillaridin</name>
      <description>Proscillaridin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13401</drugbank-id>
      <name>Metildigoxin</name>
      <description>Metildigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13467</drugbank-id>
      <name>Lanatoside C</name>
      <description>Lanatoside C may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13537</drugbank-id>
      <name>Gitoformate</name>
      <description>Gitoformate may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13691</drugbank-id>
      <name>Acetyldigoxin</name>
      <description>Acetyldigoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13756</drugbank-id>
      <name>Peruvoside</name>
      <description>Peruvoside may decrease the cardiotoxic activities of Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01217</drugbank-id>
      <name>Anastrozole</name>
      <description>The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Anastrozole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06013</drugbank-id>
      <name>Aldoxorubicin</name>
      <description>The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Aldoxorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06171</drugbank-id>
      <name>Paclitaxel trevatide</name>
      <description>The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel trevatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13809</drugbank-id>
      <name>Paclitaxel poliglumex</name>
      <description>The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Paclitaxel poliglumex.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06366</drugbank-id>
      <name>Pertuzumab</name>
      <description>The risk or severity of cardiotoxicity can be increased when Peginterferon alfa-2a is combined with Pertuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04914</drugbank-id>
      <name>G17DT</name>
      <description>The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05144</drugbank-id>
      <name>PEV3A</name>
      <description>The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05325</drugbank-id>
      <name>INGN 225</name>
      <description>The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05374</drugbank-id>
      <name>Rindopepimut</name>
      <description>The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05440</drugbank-id>
      <name>SRP 299</name>
      <description>The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05942</drugbank-id>
      <name>GI-5005</name>
      <description>The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06400</drugbank-id>
      <name>Vitespen</name>
      <description>The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06584</drugbank-id>
      <name>TG4010</name>
      <description>The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09057</drugbank-id>
      <name>Anthrax immune globulin human</name>
      <description>The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10062</drugbank-id>
      <name>Rabies virus inactivated antigen, B</name>
      <description>The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10076</drugbank-id>
      <name>Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10276</drugbank-id>
      <name>Rotavirus vaccine</name>
      <description>The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10283</drugbank-id>
      <name>Rabies virus inactivated antigen, A</name>
      <description>The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10342</drugbank-id>
      <name>Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10583</drugbank-id>
      <name>Clostridium tetani toxoid antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10584</drugbank-id>
      <name>Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10600</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10769</drugbank-id>
      <name>Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10794</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10803</drugbank-id>
      <name>Typhoid Vi polysaccharide vaccine</name>
      <description>The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10989</drugbank-id>
      <name>Hepatitis A Vaccine</name>
      <description>The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10990</drugbank-id>
      <name>Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11038</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11040</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11041</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11044</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11603</drugbank-id>
      <name>Human rabies virus immune globulin</name>
      <description>The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11627</drugbank-id>
      <name>Hepatitis B Vaccine (Recombinant)</name>
      <description>The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12568</drugbank-id>
      <name>Tecemotide</name>
      <description>The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14022</drugbank-id>
      <name>Typhoid vaccine</name>
      <description>The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14384</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14385</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14394</drugbank-id>
      <name>Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen</name>
      <description>The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14445</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14449</drugbank-id>
      <name>Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen</name>
      <description>The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14619</drugbank-id>
      <name>Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14620</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)</name>
      <description>The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14711</drugbank-id>
      <name>Smallpox (Vaccinia) Vaccine, Live</name>
      <description>The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15274</drugbank-id>
      <name>Pertussis vaccine</name>
      <description>The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15461</drugbank-id>
      <name>Yersinia pestis 195/p antigen (formaldehyde inactivated)</name>
      <description>The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13924</drugbank-id>
      <name>Varicella Zoster Vaccine (Recombinant)</name>
      <description>The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15483</drugbank-id>
      <name>Modified vaccinia ankara</name>
      <description>The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15595</drugbank-id>
      <name>Ebola Zaire vaccine (live, attenuated)</name>
      <description>The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15654</drugbank-id>
      <name>Moderna COVID-19 Vaccine</name>
      <description>The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00054</drugbank-id>
      <name>Abciximab</name>
      <description>The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00063</drugbank-id>
      <name>Eptifibatide</name>
      <description>The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00208</drugbank-id>
      <name>Ticlopidine</name>
      <description>The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00775</drugbank-id>
      <name>Tirofiban</name>
      <description>The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00945</drugbank-id>
      <name>Acetylsalicylic acid</name>
      <description>The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00975</drugbank-id>
      <name>Dipyridamole</name>
      <description>The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01088</drugbank-id>
      <name>Iloprost</name>
      <description>The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01138</drugbank-id>
      <name>Sulfinpyrazone</name>
      <description>The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01207</drugbank-id>
      <name>Ridogrel</name>
      <description>The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01236</drugbank-id>
      <name>Sevoflurane</name>
      <description>The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01240</drugbank-id>
      <name>Epoprostenol</name>
      <description>The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04743</drugbank-id>
      <name>Nimesulide</name>
      <description>The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04905</drugbank-id>
      <name>Tesmilifene</name>
      <description>The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04932</drugbank-id>
      <name>Defibrotide</name>
      <description>The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05229</drugbank-id>
      <name>Beraprost</name>
      <description>The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05266</drugbank-id>
      <name>Ibudilast</name>
      <description>The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05767</drugbank-id>
      <name>Andrographolide</name>
      <description>The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06081</drugbank-id>
      <name>Caplacizumab</name>
      <description>The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06209</drugbank-id>
      <name>Prasugrel</name>
      <description>The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06441</drugbank-id>
      <name>Cangrelor</name>
      <description>The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07615</drugbank-id>
      <name>Tranilast</name>
      <description>The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08814</drugbank-id>
      <name>Triflusal</name>
      <description>The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08816</drugbank-id>
      <name>Ticagrelor</name>
      <description>The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08887</drugbank-id>
      <name>Icosapent ethyl</name>
      <description>The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09030</drugbank-id>
      <name>Vorapaxar</name>
      <description>The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09283</drugbank-id>
      <name>Trapidil</name>
      <description>The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12092</drugbank-id>
      <name>Naftopidil</name>
      <description>The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12163</drugbank-id>
      <name>Sarpogrelate</name>
      <description>The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12321</drugbank-id>
      <name>Ifetroban</name>
      <description>The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12445</drugbank-id>
      <name>Nitroaspirin</name>
      <description>The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12465</drugbank-id>
      <name>Ketanserin</name>
      <description>The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12545</drugbank-id>
      <name>Indobufen</name>
      <description>The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12749</drugbank-id>
      <name>Butylphthalide</name>
      <description>The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12771</drugbank-id>
      <name>Hydroxytyrosol</name>
      <description>The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13036</drugbank-id>
      <name>Ramatroban</name>
      <description>The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13327</drugbank-id>
      <name>Picotamide</name>
      <description>The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13367</drugbank-id>
      <name>Cloricromen</name>
      <description>The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13400</drugbank-id>
      <name>Linsidomine</name>
      <description>The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13510</drugbank-id>
      <name>Buflomedil</name>
      <description>The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13929</drugbank-id>
      <name>Relcovaptan</name>
      <description>The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13200</drugbank-id>
      <name>Lipegfilgrastim</name>
      <description>Peginterferon alfa-2a may increase the myelosuppressive activities of Lipegfilgrastim.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10318</drugbank-id>
      <name>Varicella Zoster Vaccine (Live/attenuated)</name>
      <description>The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Varicella Zoster Vaccine (Live/attenuated).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10317</drugbank-id>
      <name>Rubella virus vaccine</name>
      <description>The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10343</drugbank-id>
      <name>Bacillus calmette-guerin substrain tice live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10804</drugbank-id>
      <name>Bacillus calmette-guerin substrain connaught live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10805</drugbank-id>
      <name>Yellow Fever Vaccine</name>
      <description>The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11003</drugbank-id>
      <name>Anthrax vaccine</name>
      <description>The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11050</drugbank-id>
      <name>Typhoid Vaccine Live</name>
      <description>The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12386</drugbank-id>
      <name>Bacillus calmette-guerin substrain danish 1331 live antigen</name>
      <description>The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12768</drugbank-id>
      <name>BCG vaccine</name>
      <description>The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14409</drugbank-id>
      <name>Human adenovirus e serotype 4 strain cl-68578 antigen</name>
      <description>The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14443</drugbank-id>
      <name>Vibrio cholerae CVD 103-HgR strain live antigen</name>
      <description>The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14685</drugbank-id>
      <name>Adenovirus type 7 vaccine live</name>
      <description>The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00039</drugbank-id>
      <name>Palifermin</name>
      <description>The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00176</drugbank-id>
      <name>Fluvoxamine</name>
      <description>The metabolism of Fluvoxamine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00184</drugbank-id>
      <name>Nicotine</name>
      <description>The metabolism of Nicotine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00195</drugbank-id>
      <name>Betaxolol</name>
      <description>The metabolism of Betaxolol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00280</drugbank-id>
      <name>Disopyramide</name>
      <description>The metabolism of Disopyramide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00281</drugbank-id>
      <name>Lidocaine</name>
      <description>The metabolism of Lidocaine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00286</drugbank-id>
      <name>Conjugated estrogens</name>
      <description>The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00296</drugbank-id>
      <name>Ropivacaine</name>
      <description>The metabolism of Ropivacaine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00316</drugbank-id>
      <name>Acetaminophen</name>
      <description>The metabolism of Acetaminophen can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00334</drugbank-id>
      <name>Olanzapine</name>
      <description>The metabolism of Olanzapine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00356</drugbank-id>
      <name>Chlorzoxazone</name>
      <description>The metabolism of Chlorzoxazone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00365</drugbank-id>
      <name>Grepafloxacin</name>
      <description>The metabolism of Grepafloxacin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00370</drugbank-id>
      <name>Mirtazapine</name>
      <description>The metabolism of Mirtazapine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00379</drugbank-id>
      <name>Mexiletine</name>
      <description>The metabolism of Mexiletine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00382</drugbank-id>
      <name>Tacrine</name>
      <description>The metabolism of Tacrine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00384</drugbank-id>
      <name>Triamterene</name>
      <description>The metabolism of Triamterene can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00420</drugbank-id>
      <name>Promazine</name>
      <description>The metabolism of Promazine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00425</drugbank-id>
      <name>Zolpidem</name>
      <description>The metabolism of Zolpidem can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00442</drugbank-id>
      <name>Entecavir</name>
      <description>The metabolism of Entecavir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00461</drugbank-id>
      <name>Nabumetone</name>
      <description>The metabolism of Nabumetone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00468</drugbank-id>
      <name>Quinine</name>
      <description>The metabolism of Quinine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00472</drugbank-id>
      <name>Fluoxetine</name>
      <description>The metabolism of Fluoxetine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00476</drugbank-id>
      <name>Duloxetine</name>
      <description>The metabolism of Duloxetine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00477</drugbank-id>
      <name>Chlorpromazine</name>
      <description>The metabolism of Chlorpromazine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00499</drugbank-id>
      <name>Flutamide</name>
      <description>The metabolism of Flutamide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00502</drugbank-id>
      <name>Haloperidol</name>
      <description>The metabolism of Haloperidol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00518</drugbank-id>
      <name>Albendazole</name>
      <description>The metabolism of Albendazole can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00533</drugbank-id>
      <name>Rofecoxib</name>
      <description>The metabolism of Rofecoxib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00568</drugbank-id>
      <name>Cinnarizine</name>
      <description>The metabolism of Cinnarizine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00571</drugbank-id>
      <name>Propranolol</name>
      <description>The metabolism of Propranolol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00586</drugbank-id>
      <name>Diclofenac</name>
      <description>The metabolism of Diclofenac can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00629</drugbank-id>
      <name>Guanabenz</name>
      <description>The metabolism of Guanabenz can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00661</drugbank-id>
      <name>Verapamil</name>
      <description>The metabolism of Verapamil can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00715</drugbank-id>
      <name>Paroxetine</name>
      <description>The metabolism of Paroxetine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00730</drugbank-id>
      <name>Thiabendazole</name>
      <description>The metabolism of Thiabendazole can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00740</drugbank-id>
      <name>Riluzole</name>
      <description>The metabolism of Riluzole can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00744</drugbank-id>
      <name>Zileuton</name>
      <description>The metabolism of Zileuton can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00758</drugbank-id>
      <name>Clopidogrel</name>
      <description>The metabolism of Clopidogrel can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00783</drugbank-id>
      <name>Estradiol</name>
      <description>The metabolism of Estradiol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00787</drugbank-id>
      <name>Acyclovir</name>
      <description>The metabolism of Acyclovir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00788</drugbank-id>
      <name>Naproxen</name>
      <description>The metabolism of Naproxen can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00831</drugbank-id>
      <name>Trifluoperazine</name>
      <description>The metabolism of Trifluoperazine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00850</drugbank-id>
      <name>Perphenazine</name>
      <description>The metabolism of Perphenazine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00857</drugbank-id>
      <name>Terbinafine</name>
      <description>The metabolism of Terbinafine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00863</drugbank-id>
      <name>Ranitidine</name>
      <description>The metabolism of Ranitidine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00898</drugbank-id>
      <name>Ethanol</name>
      <description>The metabolism of Ethanol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00934</drugbank-id>
      <name>Maprotiline</name>
      <description>The metabolism of Maprotiline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00969</drugbank-id>
      <name>Alosetron</name>
      <description>The metabolism of Alosetron can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00978</drugbank-id>
      <name>Lomefloxacin</name>
      <description>The metabolism of Lomefloxacin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00980</drugbank-id>
      <name>Ramelteon</name>
      <description>The metabolism of Ramelteon can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00998</drugbank-id>
      <name>Frovatriptan</name>
      <description>The metabolism of Frovatriptan can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01002</drugbank-id>
      <name>Levobupivacaine</name>
      <description>The metabolism of Levobupivacaine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01012</drugbank-id>
      <name>Cinacalcet</name>
      <description>The metabolism of Cinacalcet can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01037</drugbank-id>
      <name>Selegiline</name>
      <description>The metabolism of Selegiline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01056</drugbank-id>
      <name>Tocainide</name>
      <description>The metabolism of Tocainide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01058</drugbank-id>
      <name>Praziquantel</name>
      <description>The metabolism of Praziquantel can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01065</drugbank-id>
      <name>Melatonin</name>
      <description>The metabolism of Melatonin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01087</drugbank-id>
      <name>Primaquine</name>
      <description>The metabolism of Primaquine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01094</drugbank-id>
      <name>Hesperetin</name>
      <description>The metabolism of Hesperetin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01115</drugbank-id>
      <name>Nifedipine</name>
      <description>The metabolism of Nifedipine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01136</drugbank-id>
      <name>Carvedilol</name>
      <description>The metabolism of Carvedilol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01166</drugbank-id>
      <name>Cilostazol</name>
      <description>The metabolism of Cilostazol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01182</drugbank-id>
      <name>Propafenone</name>
      <description>The metabolism of Propafenone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01184</drugbank-id>
      <name>Domperidone</name>
      <description>The metabolism of Domperidone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01191</drugbank-id>
      <name>Dexfenfluramine</name>
      <description>The metabolism of Dexfenfluramine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01367</drugbank-id>
      <name>Rasagiline</name>
      <description>The metabolism of Rasagiline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01405</drugbank-id>
      <name>Temafloxacin</name>
      <description>The metabolism of Temafloxacin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01424</drugbank-id>
      <name>Aminophenazone</name>
      <description>The metabolism of Aminophenazone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01435</drugbank-id>
      <name>Antipyrine</name>
      <description>The metabolism of Antipyrine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01558</drugbank-id>
      <name>Bromazepam</name>
      <description>The metabolism of Bromazepam can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01623</drugbank-id>
      <name>Thiothixene</name>
      <description>The metabolism of Thiothixene can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01628</drugbank-id>
      <name>Etoricoxib</name>
      <description>The metabolism of Etoricoxib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01645</drugbank-id>
      <name>Genistein</name>
      <description>The metabolism of Genistein can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02709</drugbank-id>
      <name>Resveratrol</name>
      <description>The metabolism of Resveratrol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03783</drugbank-id>
      <name>Phenacetin</name>
      <description>The metabolism of Phenacetin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04574</drugbank-id>
      <name>Estrone sulfate</name>
      <description>The metabolism of Estrone sulfate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04841</drugbank-id>
      <name>Flunarizine</name>
      <description>The metabolism of Flunarizine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04871</drugbank-id>
      <name>Lorcaserin</name>
      <description>The metabolism of Lorcaserin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04948</drugbank-id>
      <name>Lofexidine</name>
      <description>The metabolism of Lofexidine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06148</drugbank-id>
      <name>Mianserin</name>
      <description>The metabolism of Mianserin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06210</drugbank-id>
      <name>Eltrombopag</name>
      <description>The metabolism of Eltrombopag can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06216</drugbank-id>
      <name>Asenapine</name>
      <description>The metabolism of Asenapine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06235</drugbank-id>
      <name>Vadimezan</name>
      <description>The metabolism of Vadimezan can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06292</drugbank-id>
      <name>Dapagliflozin</name>
      <description>The metabolism of Dapagliflozin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06594</drugbank-id>
      <name>Agomelatine</name>
      <description>The metabolism of Agomelatine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06770</drugbank-id>
      <name>Benzyl alcohol</name>
      <description>The metabolism of Benzyl alcohol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06774</drugbank-id>
      <name>Capsaicin</name>
      <description>The metabolism of Capsaicin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08496</drugbank-id>
      <name>(R)-warfarin</name>
      <description>The metabolism of (R)-warfarin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08883</drugbank-id>
      <name>Perampanel</name>
      <description>The metabolism of Perampanel can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09071</drugbank-id>
      <name>Tasimelteon</name>
      <description>The metabolism of Tasimelteon can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09118</drugbank-id>
      <name>Stiripentol</name>
      <description>The metabolism of Stiripentol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09225</drugbank-id>
      <name>Zotepine</name>
      <description>The metabolism of Zotepine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09288</drugbank-id>
      <name>Propacetamol</name>
      <description>The metabolism of Propacetamol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09290</drugbank-id>
      <name>Ramosetron</name>
      <description>The metabolism of Ramosetron can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11967</drugbank-id>
      <name>Binimetinib</name>
      <description>The metabolism of Binimetinib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12026</drugbank-id>
      <name>Voxilaprevir</name>
      <description>The metabolism of Voxilaprevir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12245</drugbank-id>
      <name>Triclabendazole</name>
      <description>The metabolism of Triclabendazole can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12332</drugbank-id>
      <name>Rucaparib</name>
      <description>The metabolism of Rucaparib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12945</drugbank-id>
      <name>Dihydralazine</name>
      <description>The metabolism of Dihydralazine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13952</drugbank-id>
      <name>Estradiol acetate</name>
      <description>The metabolism of Estradiol acetate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13953</drugbank-id>
      <name>Estradiol benzoate</name>
      <description>The metabolism of Estradiol benzoate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13954</drugbank-id>
      <name>Estradiol cypionate</name>
      <description>The metabolism of Estradiol cypionate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13955</drugbank-id>
      <name>Estradiol dienanthate</name>
      <description>The metabolism of Estradiol dienanthate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13956</drugbank-id>
      <name>Estradiol valerate</name>
      <description>The metabolism of Estradiol valerate can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11757</drugbank-id>
      <name>Istradefylline</name>
      <description>The metabolism of Istradefylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00972</drugbank-id>
      <name>Azelastine</name>
      <description>The metabolism of Azelastine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00625</drugbank-id>
      <name>Efavirenz</name>
      <description>The metabolism of Efavirenz can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01233</drugbank-id>
      <name>Metoclopramide</name>
      <description>The metabolism of Metoclopramide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04889</drugbank-id>
      <name>Bicifadine</name>
      <description>The metabolism of Bicifadine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05708</drugbank-id>
      <name>GTS-21</name>
      <description>The metabolism of GTS-21 can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01195</drugbank-id>
      <name>Flecainide</name>
      <description>The metabolism of Flecainide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00977</drugbank-id>
      <name>Ethinylestradiol</name>
      <description>The metabolism of Ethinylestradiol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00321</drugbank-id>
      <name>Amitriptyline</name>
      <description>The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01142</drugbank-id>
      <name>Doxepin</name>
      <description>The metabolism of Doxepin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00532</drugbank-id>
      <name>Mephenytoin</name>
      <description>The metabolism of Mephenytoin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00924</drugbank-id>
      <name>Cyclobenzaprine</name>
      <description>The metabolism of Cyclobenzaprine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11689</drugbank-id>
      <name>Selumetinib</name>
      <description>The metabolism of Selumetinib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00655</drugbank-id>
      <name>Estrone</name>
      <description>The metabolism of Estrone can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00299</drugbank-id>
      <name>Penciclovir</name>
      <description>The metabolism of Penciclovir can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00675</drugbank-id>
      <name>Tamoxifen</name>
      <description>The metabolism of Tamoxifen can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00277</drugbank-id>
      <name>Theophylline</name>
      <description>The metabolism of Theophylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00682</drugbank-id>
      <name>Warfarin</name>
      <description>The metabolism of Warfarin can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00697</drugbank-id>
      <name>Tizanidine</name>
      <description>The metabolism of Tizanidine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01100</drugbank-id>
      <name>Pimozide</name>
      <description>The metabolism of Pimozide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01223</drugbank-id>
      <name>Aminophylline</name>
      <description>The metabolism of Aminophylline can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01418</drugbank-id>
      <name>Acenocoumarol</name>
      <description>The metabolism of Acenocoumarol can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>The metabolism of Anagrelide can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00530</drugbank-id>
      <name>Erlotinib</name>
      <description>The metabolism of Erlotinib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06626</drugbank-id>
      <name>Axitinib</name>
      <description>The metabolism of Axitinib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09256</drugbank-id>
      <name>Tegafur</name>
      <description>The metabolism of Tegafur can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13874</drugbank-id>
      <name>Enasidenib</name>
      <description>The metabolism of Enasidenib can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00458</drugbank-id>
      <name>Imipramine</name>
      <description>The metabolism of Imipramine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00575</drugbank-id>
      <name>Clonidine</name>
      <description>The metabolism of Clonidine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01242</drugbank-id>
      <name>Clomipramine</name>
      <description>The metabolism of Clomipramine can be decreased when combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00001</drugbank-id>
      <name>Lepirudin</name>
      <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00006</drugbank-id>
      <name>Bivalirudin</name>
      <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00009</drugbank-id>
      <name>Alteplase</name>
      <description>The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00013</drugbank-id>
      <name>Urokinase</name>
      <description>The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00015</drugbank-id>
      <name>Reteplase</name>
      <description>The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00029</drugbank-id>
      <name>Anistreplase</name>
      <description>The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00031</drugbank-id>
      <name>Tenecteplase</name>
      <description>The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00055</drugbank-id>
      <name>Drotrecogin alfa</name>
      <description>The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00086</drugbank-id>
      <name>Streptokinase</name>
      <description>The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00266</drugbank-id>
      <name>Dicoumarol</name>
      <description>The risk or severity of bleeding can be increased when Dicoumarol is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00278</drugbank-id>
      <name>Argatroban</name>
      <description>The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00407</drugbank-id>
      <name>Ardeparin</name>
      <description>The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00498</drugbank-id>
      <name>Phenindione</name>
      <description>The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00569</drugbank-id>
      <name>Fondaparinux</name>
      <description>The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00686</drugbank-id>
      <name>Pentosan polysulfate</name>
      <description>The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00946</drugbank-id>
      <name>Phenprocoumon</name>
      <description>The risk or severity of bleeding can be increased when Phenprocoumon is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01109</drugbank-id>
      <name>Heparin</name>
      <description>The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01225</drugbank-id>
      <name>Enoxaparin</name>
      <description>The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03410</drugbank-id>
      <name>4-hydroxycoumarin</name>
      <description>The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04665</drugbank-id>
      <name>Coumarin</name>
      <description>The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04898</drugbank-id>
      <name>Ximelagatran</name>
      <description>The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04925</drugbank-id>
      <name>Desmoteplase</name>
      <description>The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05099</drugbank-id>
      <name>Ancrod</name>
      <description>The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05254</drugbank-id>
      <name>Fibrinolysin</name>
      <description>The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06228</drugbank-id>
      <name>Rivaroxaban</name>
      <description>The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06271</drugbank-id>
      <name>Sulodexide</name>
      <description>The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06294</drugbank-id>
      <name>Semuloparin</name>
      <description>The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06406</drugbank-id>
      <name>Idraparinux</name>
      <description>The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06543</drugbank-id>
      <name>Astaxanthin</name>
      <description>The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06605</drugbank-id>
      <name>Apixaban</name>
      <description>The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06635</drugbank-id>
      <name>Otamixaban</name>
      <description>The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06679</drugbank-id>
      <name>Amediplase</name>
      <description>The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06695</drugbank-id>
      <name>Dabigatran etexilate</name>
      <description>The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06754</drugbank-id>
      <name>Danaparoid</name>
      <description>The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06779</drugbank-id>
      <name>Dalteparin</name>
      <description>The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06822</drugbank-id>
      <name>Tinzaparin</name>
      <description>The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07767</drugbank-id>
      <name>Ferulic acid</name>
      <description>The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08794</drugbank-id>
      <name>Ethyl biscoumacetate</name>
      <description>The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08813</drugbank-id>
      <name>Nadroparin</name>
      <description>The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08994</drugbank-id>
      <name>Ditazole</name>
      <description>The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09075</drugbank-id>
      <name>Edoxaban</name>
      <description>The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09125</drugbank-id>
      <name>Potassium citrate</name>
      <description>The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09154</drugbank-id>
      <name>Sodium citrate</name>
      <description>The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09255</drugbank-id>
      <name>Dextran</name>
      <description>The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09258</drugbank-id>
      <name>Bemiparin</name>
      <description>The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09260</drugbank-id>
      <name>Parnaparin</name>
      <description>The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11095</drugbank-id>
      <name>Desirudin</name>
      <description>The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11154</drugbank-id>
      <name>Zinc citrate</name>
      <description>The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11166</drugbank-id>
      <name>Antithrombin Alfa</name>
      <description>The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11312</drugbank-id>
      <name>Protein C</name>
      <description>The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11598</drugbank-id>
      <name>Antithrombin III human</name>
      <description>The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11984</drugbank-id>
      <name>Letaxaban</name>
      <description>The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12289</drugbank-id>
      <name>Darexaban</name>
      <description>The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12364</drugbank-id>
      <name>Betrixaban</name>
      <description>The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12598</drugbank-id>
      <name>Nafamostat</name>
      <description>The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12726</drugbank-id>
      <name>Monteplase</name>
      <description>The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12831</drugbank-id>
      <name>Gabexate</name>
      <description>The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13136</drugbank-id>
      <name>Fluindione</name>
      <description>The risk or severity of bleeding can be increased when Fluindione is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13149</drugbank-id>
      <name>Protein S human</name>
      <description>The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13199</drugbank-id>
      <name>Brinase</name>
      <description>The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13275</drugbank-id>
      <name>Clorindione</name>
      <description>The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13347</drugbank-id>
      <name>Diphenadione</name>
      <description>The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13451</drugbank-id>
      <name>Tioclomarol</name>
      <description>The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13616</drugbank-id>
      <name>Melagatran</name>
      <description>The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13646</drugbank-id>
      <name>Saruplase</name>
      <description>The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14055</drugbank-id>
      <name>(S)-Warfarin</name>
      <description>The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14094</drugbank-id>
      <name>Tocopherylquinone</name>
      <description>The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14598</drugbank-id>
      <name>Edetate calcium disodium anhydrous</name>
      <description>The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14726</drugbank-id>
      <name>Dabigatran</name>
      <description>The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13124</drugbank-id>
      <name>Troxerutin</name>
      <description>The risk or severity of bleeding can be increased when Troxerutin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00974</drugbank-id>
      <name>Edetic acid</name>
      <description>The risk or severity of bleeding can be increased when Edetic acid is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09259</drugbank-id>
      <name>Reviparin</name>
      <description>The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00232</drugbank-id>
      <name>Methyclothiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00436</drugbank-id>
      <name>Bendroflumethiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00562</drugbank-id>
      <name>Benzthiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00606</drugbank-id>
      <name>Cyclothiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00774</drugbank-id>
      <name>Hydroflumethiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00880</drugbank-id>
      <name>Chlorothiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00999</drugbank-id>
      <name>Hydrochlorothiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01021</drugbank-id>
      <name>Trichlormethiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01324</drugbank-id>
      <name>Polythiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13430</drugbank-id>
      <name>Mebutizide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13532</drugbank-id>
      <name>Cyclopenthiazide</name>
      <description>The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09042</drugbank-id>
      <name>Tedizolid phosphate</name>
      <description>The risk or severity of myelosuppression can be increased when Peginterferon alfa-2a is combined with Tedizolid phosphate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00091</drugbank-id>
      <name>Cyclosporine</name>
      <description>Peginterferon alfa-2a may increase the immunosuppressive activities of Cyclosporine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00268</drugbank-id>
      <name>Ropinirole</name>
      <description>The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ropinirole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00115</drugbank-id>
      <name>Cyanocobalamin</name>
      <description>The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00437</drugbank-id>
      <name>Allopurinol</name>
      <description>The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12978</drugbank-id>
      <name>Pexidartinib</name>
      <description>Peginterferon alfa-2a may increase the hepatotoxic activities of Pexidartinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14513</drugbank-id>
      <name>Magnesium</name>
      <description>The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01601</drugbank-id>
      <name>Lopinavir</name>
      <description>The serum concentration of Peginterferon alfa-2a can be increased when it is combined with Lopinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12530</drugbank-id>
      <name>Inebilizumab</name>
      <description>The risk or severity of infection can be increased when Peginterferon alfa-2a is combined with Inebilizumab.</description>
    </drug-interaction>
  </drug-interactions>
</drug>
<drug type="biotech" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00009</drugbank-id>
  <drugbank-id>BTD00050</drugbank-id>
  <drugbank-id>BIOD00050</drugbank-id>
  <name>Alteplase</name>
  <description>Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells</description>
  <cas-number>105857-23-6</cas-number>
  <unii>1RXS4UE564</unii>
  <state>liquid</state>
  <indication>For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli</indication>
<drug-interactions>
  <drug-interaction>
    <drugbank-id>DB13602</drugbank-id>
    <name>Promegestone</name>
    <description>Promegestone may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13685</drugbank-id>
    <name>Quingestanol</name>
    <description>Quingestanol may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13857</drugbank-id>
    <name>Demegestone</name>
    <description>Demegestone may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13866</drugbank-id>
    <name>Etynodiol</name>
    <description>Etynodiol may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13981</drugbank-id>
    <name>Nomegestrol acetate</name>
    <description>Nomegestrol acetate may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14570</drugbank-id>
    <name>Hydroxyprogesterone</name>
    <description>Hydroxyprogesterone may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14678</drugbank-id>
    <name>Norethindrone enanthate</name>
    <description>Norethindrone enanthate may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14679</drugbank-id>
    <name>Quingestanol acetate</name>
    <description>Quingestanol acetate may decrease the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00233</drugbank-id>
    <name>Aminosalicylic acid</name>
    <description>The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01294</drugbank-id>
    <name>Bismuth subsalicylate</name>
    <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06251</drugbank-id>
    <name>Dersalazine</name>
    <description>The risk or severity of bleeding can be increased when Dersalazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06807</drugbank-id>
    <name>Phenyl aminosalicylate</name>
    <description>The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09543</drugbank-id>
    <name>Methyl salicylate</name>
    <description>The risk or severity of bleeding can be increased when Methyl salicylate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11079</drugbank-id>
    <name>Trolamine salicylate</name>
    <description>The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13509</drugbank-id>
    <name>Aloxiprin</name>
    <description>The risk or severity of bleeding can be increased when Aloxiprin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14006</drugbank-id>
    <name>Choline salicylate</name>
    <description>The risk or severity of bleeding can be increased when Choline salicylate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14026</drugbank-id>
    <name>Thiosalicylic acid</name>
    <description>The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00054</drugbank-id>
    <name>Abciximab</name>
    <description>The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00063</drugbank-id>
    <name>Eptifibatide</name>
    <description>The risk or severity of bleeding can be increased when Eptifibatide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00208</drugbank-id>
    <name>Ticlopidine</name>
    <description>The risk or severity of bleeding can be increased when Ticlopidine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00261</drugbank-id>
    <name>Anagrelide</name>
    <description>The risk or severity of bleeding can be increased when Anagrelide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00758</drugbank-id>
    <name>Clopidogrel</name>
    <description>The risk or severity of bleeding can be increased when Clopidogrel is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00775</drugbank-id>
    <name>Tirofiban</name>
    <description>The risk or severity of bleeding can be increased when Tirofiban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00975</drugbank-id>
    <name>Dipyridamole</name>
    <description>The risk or severity of bleeding can be increased when Dipyridamole is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01088</drugbank-id>
    <name>Iloprost</name>
    <description>The risk or severity of bleeding can be increased when Iloprost is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01138</drugbank-id>
    <name>Sulfinpyrazone</name>
    <description>The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01166</drugbank-id>
    <name>Cilostazol</name>
    <description>The risk or severity of bleeding can be increased when Cilostazol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01207</drugbank-id>
    <name>Ridogrel</name>
    <description>The risk or severity of bleeding can be increased when Ridogrel is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01236</drugbank-id>
    <name>Sevoflurane</name>
    <description>The risk or severity of bleeding can be increased when Sevoflurane is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01240</drugbank-id>
    <name>Epoprostenol</name>
    <description>The risk or severity of bleeding can be increased when Epoprostenol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02709</drugbank-id>
    <name>Resveratrol</name>
    <description>The risk or severity of bleeding can be increased when Resveratrol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04743</drugbank-id>
    <name>Nimesulide</name>
    <description>The risk or severity of bleeding can be increased when Nimesulide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04905</drugbank-id>
    <name>Tesmilifene</name>
    <description>The risk or severity of bleeding can be increased when Tesmilifene is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04932</drugbank-id>
    <name>Defibrotide</name>
    <description>The risk or severity of bleeding can be increased when Defibrotide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05229</drugbank-id>
    <name>Beraprost</name>
    <description>The risk or severity of bleeding can be increased when Beraprost is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05266</drugbank-id>
    <name>Ibudilast</name>
    <description>The risk or severity of bleeding can be increased when Ibudilast is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05767</drugbank-id>
    <name>Andrographolide</name>
    <description>The risk or severity of bleeding can be increased when Andrographolide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06081</drugbank-id>
    <name>Caplacizumab</name>
    <description>The risk or severity of bleeding can be increased when Caplacizumab is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06209</drugbank-id>
    <name>Prasugrel</name>
    <description>The risk or severity of bleeding can be increased when Prasugrel is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06441</drugbank-id>
    <name>Cangrelor</name>
    <description>The risk or severity of bleeding can be increased when Cangrelor is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07615</drugbank-id>
    <name>Tranilast</name>
    <description>The risk or severity of bleeding can be increased when Tranilast is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08814</drugbank-id>
    <name>Triflusal</name>
    <description>The risk or severity of bleeding can be increased when Triflusal is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08816</drugbank-id>
    <name>Ticagrelor</name>
    <description>The risk or severity of bleeding can be increased when Ticagrelor is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08887</drugbank-id>
    <name>Icosapent ethyl</name>
    <description>The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09283</drugbank-id>
    <name>Trapidil</name>
    <description>The risk or severity of bleeding can be increased when Trapidil is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12092</drugbank-id>
    <name>Naftopidil</name>
    <description>The risk or severity of bleeding can be increased when Naftopidil is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12163</drugbank-id>
    <name>Sarpogrelate</name>
    <description>The risk or severity of bleeding can be increased when Sarpogrelate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12321</drugbank-id>
    <name>Ifetroban</name>
    <description>The risk or severity of bleeding can be increased when Ifetroban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12445</drugbank-id>
    <name>Nitroaspirin</name>
    <description>The risk or severity of bleeding can be increased when Nitroaspirin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12465</drugbank-id>
    <name>Ketanserin</name>
    <description>The risk or severity of bleeding can be increased when Ketanserin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12545</drugbank-id>
    <name>Indobufen</name>
    <description>The risk or severity of bleeding can be increased when Indobufen is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12749</drugbank-id>
    <name>Butylphthalide</name>
    <description>The risk or severity of bleeding can be increased when Butylphthalide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12771</drugbank-id>
    <name>Hydroxytyrosol</name>
    <description>The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13036</drugbank-id>
    <name>Ramatroban</name>
    <description>The risk or severity of bleeding can be increased when Ramatroban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13327</drugbank-id>
    <name>Picotamide</name>
    <description>The risk or severity of bleeding can be increased when Picotamide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13367</drugbank-id>
    <name>Cloricromen</name>
    <description>The risk or severity of bleeding can be increased when Cloricromen is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13400</drugbank-id>
    <name>Linsidomine</name>
    <description>The risk or severity of bleeding can be increased when Linsidomine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13510</drugbank-id>
    <name>Buflomedil</name>
    <description>The risk or severity of bleeding can be increased when Buflomedil is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13929</drugbank-id>
    <name>Relcovaptan</name>
    <description>The risk or severity of bleeding can be increased when Relcovaptan is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00374</drugbank-id>
    <name>Treprostinil</name>
    <description>The risk or severity of adverse effects can be increased when Alteplase is combined with Treprostinil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03404</drugbank-id>
    <name>Hemin</name>
    <description>Hemin may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13783</drugbank-id>
    <name>Acemetacin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00624</drugbank-id>
    <name>Testosterone</name>
    <description>Testosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01420</drugbank-id>
    <name>Testosterone propionate</name>
    <description>Testosterone propionate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01481</drugbank-id>
    <name>1-Testosterone</name>
    <description>1-Testosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01485</drugbank-id>
    <name>4-Hydroxytestosterone</name>
    <description>4-Hydroxytestosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01510</drugbank-id>
    <name>Dehydrochloromethyltestosterone</name>
    <description>Dehydrochloromethyltestosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01541</drugbank-id>
    <name>Boldenone</name>
    <description>Boldenone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01543</drugbank-id>
    <name>18-methyl-19-nortestosterone</name>
    <description>18-methyl-19-nortestosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01564</drugbank-id>
    <name>Calusterone</name>
    <description>Calusterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01569</drugbank-id>
    <name>Formebolone</name>
    <description>Formebolone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01572</drugbank-id>
    <name>Methyl-1-testosterone</name>
    <description>Methyl-1-testosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07447</drugbank-id>
    <name>5beta-dihydrotestosterone</name>
    <description>5beta-dihydrotestosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08619</drugbank-id>
    <name>Testosterone succinate</name>
    <description>Testosterone succinate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11429</drugbank-id>
    <name>Mibolerone</name>
    <description>Mibolerone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13943</drugbank-id>
    <name>Testosterone cypionate</name>
    <description>Testosterone cypionate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13944</drugbank-id>
    <name>Testosterone enanthate</name>
    <description>Testosterone enanthate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13946</drugbank-id>
    <name>Testosterone undecanoate</name>
    <description>Testosterone undecanoate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13947</drugbank-id>
    <name>Testosterone enantate benzilic acid hydrazone</name>
    <description>Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13951</drugbank-id>
    <name>Stanolone acetate</name>
    <description>Stanolone acetate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13958</drugbank-id>
    <name>Trestolone acetate</name>
    <description>Trestolone acetate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14093</drugbank-id>
    <name>(1,2,6,7-3H)Testosterone</name>
    <description>(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14655</drugbank-id>
    <name>Drostanolone propionate</name>
    <description>Drostanolone propionate may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11051</drugbank-id>
    <name>Azficel-T</name>
    <description>The risk or severity of adverse effects can be increased when Alteplase is combined with Azficel-T.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09568</drugbank-id>
    <name>Omega-3-carboxylic acids</name>
    <description>The therapeutic efficacy of Alteplase can be increased when used in combination with Omega-3-carboxylic acids.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00258</drugbank-id>
    <name>Calcium acetate</name>
    <description>The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01164</drugbank-id>
    <name>Calcium chloride</name>
    <description>The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01373</drugbank-id>
    <name>Calcium</name>
    <description>The therapeutic efficacy of Calcium can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11126</drugbank-id>
    <name>Calcium gluconate</name>
    <description>The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11608</drugbank-id>
    <name>Eftrenonacog alfa</name>
    <description>The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13884</drugbank-id>
    <name>Albutrepenonacog alfa</name>
    <description>The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13923</drugbank-id>
    <name>Emicizumab</name>
    <description>The therapeutic efficacy of Emicizumab can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14738</drugbank-id>
    <name>Turoctocog alfa pegol</name>
    <description>The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00025</drugbank-id>
    <name>Antihemophilic factor, human recombinant</name>
    <description>The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00036</drugbank-id>
    <name>Coagulation factor VIIa Recombinant Human</name>
    <description>The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00100</drugbank-id>
    <name>Coagulation Factor IX (Recombinant)</name>
    <description>The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01783</drugbank-id>
    <name>Pantothenic acid</name>
    <description>The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01942</drugbank-id>
    <name>Formic acid</name>
    <description>The therapeutic efficacy of Formic acid can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02261</drugbank-id>
    <name>Platelet Activating Factor</name>
    <description>The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06724</drugbank-id>
    <name>Calcium carbonate</name>
    <description>The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09109</drugbank-id>
    <name>Turoctocog alfa</name>
    <description>The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09222</drugbank-id>
    <name>Fibrinogen human</name>
    <description>The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09310</drugbank-id>
    <name>Catridecacog</name>
    <description>The therapeutic efficacy of Catridecacog can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09329</drugbank-id>
    <name>Antihemophilic Factor (Recombinant), PEGylated</name>
    <description>The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11093</drugbank-id>
    <name>Calcium citrate</name>
    <description>The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11168</drugbank-id>
    <name>Calcium threonate</name>
    <description>The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11311</drugbank-id>
    <name>Prothrombin</name>
    <description>The therapeutic efficacy of Prothrombin can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11330</drugbank-id>
    <name>Factor IX Complex (Human)</name>
    <description>The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11348</drugbank-id>
    <name>Calcium Phosphate</name>
    <description>The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11606</drugbank-id>
    <name>Susoctocog alfa</name>
    <description>The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11668</drugbank-id>
    <name>Rusalatide acetate</name>
    <description>The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12409</drugbank-id>
    <name>Vatreptacog alfa</name>
    <description>The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12909</drugbank-id>
    <name>Factor XIII (human)</name>
    <description>The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13133</drugbank-id>
    <name>Von Willebrand Factor Human</name>
    <description>The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13148</drugbank-id>
    <name>Coagulation factor X human</name>
    <description>The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13150</drugbank-id>
    <name>Coagulation factor VII human</name>
    <description>The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13151</drugbank-id>
    <name>Anti-inhibitor coagulant complex</name>
    <description>The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13152</drugbank-id>
    <name>Coagulation Factor IX Human</name>
    <description>The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13192</drugbank-id>
    <name>Antihemophilic factor human</name>
    <description>The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13197</drugbank-id>
    <name>Kallidinogenase</name>
    <description>The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13201</drugbank-id>
    <name>Trenonacog alfa</name>
    <description>The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13933</drugbank-id>
    <name>Nonacog beta pegol</name>
    <description>The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13999</drugbank-id>
    <name>Moroctocog alfa</name>
    <description>The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14473</drugbank-id>
    <name>Beroctocog alfa</name>
    <description>The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14562</drugbank-id>
    <name>Andexanet alfa</name>
    <description>The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14577</drugbank-id>
    <name>Calcium cation</name>
    <description>The therapeutic efficacy of Calcium cation can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14700</drugbank-id>
    <name>Damoctocog alfa pegol</name>
    <description>The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00176</drugbank-id>
    <name>Fluvoxamine</name>
    <description>The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00215</drugbank-id>
    <name>Citalopram</name>
    <description>The risk or severity of hemorrhage can be increased when Citalopram is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00472</drugbank-id>
    <name>Fluoxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00715</drugbank-id>
    <name>Paroxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Paroxetine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01149</drugbank-id>
    <name>Nefazodone</name>
    <description>The risk or severity of hemorrhage can be increased when Nefazodone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04832</drugbank-id>
    <name>Zimelidine</name>
    <description>The risk or severity of hemorrhage can be increased when Zimelidine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04884</drugbank-id>
    <name>Dapoxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06731</drugbank-id>
    <name>Seproxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Seproxetine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08953</drugbank-id>
    <name>Indalpine</name>
    <description>The risk or severity of hemorrhage can be increased when Indalpine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12693</drugbank-id>
    <name>Ritanserin</name>
    <description>The risk or severity of hemorrhage can be increased when Ritanserin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13233</drugbank-id>
    <name>Alaproclate</name>
    <description>The risk or severity of hemorrhage can be increased when Alaproclate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00476</drugbank-id>
    <name>Duloxetine</name>
    <description>The risk or severity of hemorrhage can be increased when Duloxetine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01105</drugbank-id>
    <name>Sibutramine</name>
    <description>The risk or severity of hemorrhage can be increased when Sibutramine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04896</drugbank-id>
    <name>Milnacipran</name>
    <description>The risk or severity of hemorrhage can be increased when Milnacipran is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06700</drugbank-id>
    <name>Desvenlafaxine</name>
    <description>The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08918</drugbank-id>
    <name>Levomilnacipran</name>
    <description>The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00285</drugbank-id>
    <name>Venlafaxine</name>
    <description>Venlafaxine may increase the antiplatelet activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00182</drugbank-id>
    <name>Amphetamine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00601</drugbank-id>
    <name>Linezolid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00614</drugbank-id>
    <name>Furazolidone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00721</drugbank-id>
    <name>Procaine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00752</drugbank-id>
    <name>Tranylcypromine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00780</drugbank-id>
    <name>Phenelzine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00805</drugbank-id>
    <name>Minaprine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01037</drugbank-id>
    <name>Selegiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01168</drugbank-id>
    <name>Procarbazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01171</drugbank-id>
    <name>Moclobemide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01247</drugbank-id>
    <name>Isocarboxazid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01367</drugbank-id>
    <name>Rasagiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01626</drugbank-id>
    <name>Pargyline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04017</drugbank-id>
    <name>Clorgiline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04818</drugbank-id>
    <name>Iproniazid</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04820</drugbank-id>
    <name>Nialamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06654</drugbank-id>
    <name>Safinamide</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08550</drugbank-id>
    <name>7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09241</drugbank-id>
    <name>Methylene blue</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09243</drugbank-id>
    <name>Hydracarbazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09244</drugbank-id>
    <name>Pirlindole</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09245</drugbank-id>
    <name>Toloxatone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09246</drugbank-id>
    <name>Benmoxin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09248</drugbank-id>
    <name>Mebanazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09249</drugbank-id>
    <name>Octamoxin</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09250</drugbank-id>
    <name>Pheniprazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09251</drugbank-id>
    <name>Phenoxypropazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09252</drugbank-id>
    <name>Pivhydrazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09253</drugbank-id>
    <name>Safrazine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09254</drugbank-id>
    <name>Caroxazone</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13875</drugbank-id>
    <name>Harmaline</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13876</drugbank-id>
    <name>Brofaromine</name>
    <description>The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00006</drugbank-id>
    <name>Bivalirudin</name>
    <description>The risk or severity of bleeding can be increased when Bivalirudin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00266</drugbank-id>
    <name>Dicoumarol</name>
    <description>The risk or severity of bleeding can be increased when Dicoumarol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00278</drugbank-id>
    <name>Argatroban</name>
    <description>The risk or severity of bleeding can be increased when Argatroban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00407</drugbank-id>
    <name>Ardeparin</name>
    <description>The risk or severity of bleeding can be increased when Ardeparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00498</drugbank-id>
    <name>Phenindione</name>
    <description>The risk or severity of bleeding can be increased when Phenindione is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00569</drugbank-id>
    <name>Fondaparinux</name>
    <description>The risk or severity of bleeding can be increased when Fondaparinux is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00682</drugbank-id>
    <name>Warfarin</name>
    <description>The risk or severity of bleeding can be increased when Warfarin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00946</drugbank-id>
    <name>Phenprocoumon</name>
    <description>The risk or severity of bleeding can be increased when Phenprocoumon is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00974</drugbank-id>
    <name>Edetic acid</name>
    <description>The risk or severity of bleeding can be increased when Edetic acid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01109</drugbank-id>
    <name>Heparin</name>
    <description>The risk or severity of bleeding can be increased when Heparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01225</drugbank-id>
    <name>Enoxaparin</name>
    <description>The risk or severity of bleeding can be increased when Enoxaparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01418</drugbank-id>
    <name>Acenocoumarol</name>
    <description>The risk or severity of bleeding can be increased when Acenocoumarol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04898</drugbank-id>
    <name>Ximelagatran</name>
    <description>The risk or severity of bleeding can be increased when Ximelagatran is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05099</drugbank-id>
    <name>Ancrod</name>
    <description>The risk or severity of bleeding can be increased when Ancrod is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06271</drugbank-id>
    <name>Sulodexide</name>
    <description>The risk or severity of bleeding can be increased when Sulodexide is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06406</drugbank-id>
    <name>Idraparinux</name>
    <description>The risk or severity of bleeding can be increased when Idraparinux is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06635</drugbank-id>
    <name>Otamixaban</name>
    <description>The risk or severity of bleeding can be increased when Otamixaban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06754</drugbank-id>
    <name>Danaparoid</name>
    <description>The risk or severity of bleeding can be increased when Danaparoid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06779</drugbank-id>
    <name>Dalteparin</name>
    <description>The risk or severity of bleeding can be increased when Dalteparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB07767</drugbank-id>
    <name>Ferulic acid</name>
    <description>The risk or severity of bleeding can be increased when Ferulic acid is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08794</drugbank-id>
    <name>Ethyl biscoumacetate</name>
    <description>The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08813</drugbank-id>
    <name>Nadroparin</name>
    <description>The risk or severity of bleeding can be increased when Nadroparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09255</drugbank-id>
    <name>Dextran</name>
    <description>The risk or severity of bleeding can be increased when Dextran is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11095</drugbank-id>
    <name>Desirudin</name>
    <description>The risk or severity of bleeding can be increased when Desirudin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11268</drugbank-id>
    <name>Protocatechualdehyde</name>
    <description>The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11312</drugbank-id>
    <name>Protein C</name>
    <description>The risk or severity of bleeding can be increased when Protein C is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11598</drugbank-id>
    <name>Antithrombin III human</name>
    <description>The risk or severity of bleeding can be increased when Antithrombin III human is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11984</drugbank-id>
    <name>Letaxaban</name>
    <description>The risk or severity of bleeding can be increased when Letaxaban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12289</drugbank-id>
    <name>Darexaban</name>
    <description>The risk or severity of bleeding can be increased when Darexaban is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12598</drugbank-id>
    <name>Nafamostat</name>
    <description>The risk or severity of bleeding can be increased when Nafamostat is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12831</drugbank-id>
    <name>Gabexate</name>
    <description>The risk or severity of bleeding can be increased when Gabexate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13124</drugbank-id>
    <name>Troxerutin</name>
    <description>The risk or severity of bleeding can be increased when Troxerutin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13136</drugbank-id>
    <name>Fluindione</name>
    <description>The risk or severity of bleeding can be increased when Fluindione is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13149</drugbank-id>
    <name>Protein S human</name>
    <description>The risk or severity of bleeding can be increased when Protein S human is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13616</drugbank-id>
    <name>Melagatran</name>
    <description>The risk or severity of bleeding can be increased when Melagatran is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09125</drugbank-id>
    <name>Potassium citrate</name>
    <description>The risk or severity of bleeding can be increased when Potassium citrate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09154</drugbank-id>
    <name>Sodium citrate</name>
    <description>The risk or severity of bleeding can be increased when Sodium citrate is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00031</drugbank-id>
    <name>Tenecteplase</name>
    <description>The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00055</drugbank-id>
    <name>Drotrecogin alfa</name>
    <description>The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06822</drugbank-id>
    <name>Tinzaparin</name>
    <description>The risk or severity of bleeding can be increased when Tinzaparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13199</drugbank-id>
    <name>Brinase</name>
    <description>The risk or severity of bleeding can be increased when Brinase is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13646</drugbank-id>
    <name>Saruplase</name>
    <description>The risk or severity of bleeding can be increased when Saruplase is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00086</drugbank-id>
    <name>Streptokinase</name>
    <description>The risk or severity of bleeding can be increased when Streptokinase is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04925</drugbank-id>
    <name>Desmoteplase</name>
    <description>The risk or severity of bleeding can be increased when Desmoteplase is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05254</drugbank-id>
    <name>Fibrinolysin</name>
    <description>The risk or severity of bleeding can be increased when Fibrinolysin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06543</drugbank-id>
    <name>Astaxanthin</name>
    <description>The risk or severity of bleeding can be increased when Astaxanthin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08994</drugbank-id>
    <name>Ditazole</name>
    <description>The risk or severity of bleeding can be increased when Ditazole is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09258</drugbank-id>
    <name>Bemiparin</name>
    <description>The risk or severity of bleeding can be increased when Bemiparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09260</drugbank-id>
    <name>Parnaparin</name>
    <description>The risk or severity of bleeding can be increased when Parnaparin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13275</drugbank-id>
    <name>Clorindione</name>
    <description>The risk or severity of bleeding can be increased when Clorindione is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13347</drugbank-id>
    <name>Diphenadione</name>
    <description>The risk or severity of bleeding can be increased when Diphenadione is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13451</drugbank-id>
    <name>Tioclomarol</name>
    <description>The risk or severity of bleeding can be increased when Tioclomarol is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00001</drugbank-id>
    <name>Lepirudin</name>
    <description>The risk or severity of bleeding can be increased when Lepirudin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00015</drugbank-id>
    <name>Reteplase</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00029</drugbank-id>
    <name>Anistreplase</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14094</drugbank-id>
    <name>Tocopherylquinone</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Tocopherylquinone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06679</drugbank-id>
    <name>Amediplase</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Amediplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB03410</drugbank-id>
    <name>4-hydroxycoumarin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with 4-hydroxycoumarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08496</drugbank-id>
    <name>(R)-warfarin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with (R)-warfarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14055</drugbank-id>
    <name>(S)-Warfarin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with (S)-Warfarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12364</drugbank-id>
    <name>Betrixaban</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Betrixaban.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14598</drugbank-id>
    <name>Edetate calcium disodium anhydrous</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Edetate calcium disodium anhydrous.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11154</drugbank-id>
    <name>Zinc citrate</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Zinc citrate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11166</drugbank-id>
    <name>Antithrombin Alfa</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Antithrombin Alfa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04665</drugbank-id>
    <name>Coumarin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Coumarin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14726</drugbank-id>
    <name>Dabigatran</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Dabigatran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06294</drugbank-id>
    <name>Semuloparin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Semuloparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12726</drugbank-id>
    <name>Monteplase</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Monteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09259</drugbank-id>
    <name>Reviparin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Reviparin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00177</drugbank-id>
    <name>Valsartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Valsartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00178</drugbank-id>
    <name>Ramipril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Ramipril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00230</drugbank-id>
    <name>Pregabalin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Pregabalin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00492</drugbank-id>
    <name>Fosinopril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Fosinopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00519</drugbank-id>
    <name>Trandolapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Trandolapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00542</drugbank-id>
    <name>Benazepril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Benazepril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00584</drugbank-id>
    <name>Enalapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Enalapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00678</drugbank-id>
    <name>Losartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Losartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00691</drugbank-id>
    <name>Moexipril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Moexipril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00722</drugbank-id>
    <name>Lisinopril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Lisinopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00790</drugbank-id>
    <name>Perindopril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Perindopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00876</drugbank-id>
    <name>Eprosartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Eprosartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00877</drugbank-id>
    <name>Sirolimus</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Sirolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00881</drugbank-id>
    <name>Quinapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Quinapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00886</drugbank-id>
    <name>Omapatrilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Omapatrilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00966</drugbank-id>
    <name>Telmisartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Telmisartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01050</drugbank-id>
    <name>Ibuprofen</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Ibuprofen.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01180</drugbank-id>
    <name>Rescinnamine</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Rescinnamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01197</drugbank-id>
    <name>Captopril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Captopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01261</drugbank-id>
    <name>Sitagliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Sitagliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01340</drugbank-id>
    <name>Cilazapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Cilazapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01342</drugbank-id>
    <name>Forasartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Forasartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01347</drugbank-id>
    <name>Saprisartan</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Saprisartan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01348</drugbank-id>
    <name>Spirapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Spirapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04876</drugbank-id>
    <name>Vildagliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Vildagliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06011</drugbank-id>
    <name>AMG-222</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with AMG-222.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06127</drugbank-id>
    <name>Bisegliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Bisegliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06196</drugbank-id>
    <name>Icatibant</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Icatibant.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06203</drugbank-id>
    <name>Alogliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Alogliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06245</drugbank-id>
    <name>Lanoteplase</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Lanoteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06287</drugbank-id>
    <name>Temsirolimus</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Temsirolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06335</drugbank-id>
    <name>Saxagliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Saxagliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08382</drugbank-id>
    <name>Gosogliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Gosogliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08822</drugbank-id>
    <name>Azilsartan medoxomil</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Azilsartan medoxomil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08836</drugbank-id>
    <name>Temocapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Temocapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08882</drugbank-id>
    <name>Linagliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Linagliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09292</drugbank-id>
    <name>Sacubitril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Sacubitril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09477</drugbank-id>
    <name>Enalaprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Enalaprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11723</drugbank-id>
    <name>Dutogliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Dutogliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11783</drugbank-id>
    <name>Imidapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Imidapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11950</drugbank-id>
    <name>Teneligliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Teneligliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11992</drugbank-id>
    <name>Omarigliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Omarigliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12268</drugbank-id>
    <name>Carmegliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Carmegliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12412</drugbank-id>
    <name>Gemigliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Gemigliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12417</drugbank-id>
    <name>Anagliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Anagliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12625</drugbank-id>
    <name>Evogliptin</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Evogliptin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13166</drugbank-id>
    <name>Zofenopril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Zofenopril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13312</drugbank-id>
    <name>Delapril</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Delapril.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14125</drugbank-id>
    <name>Benazeprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Benazeprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14207</drugbank-id>
    <name>Fosinoprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Fosinoprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14208</drugbank-id>
    <name>Ramiprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Ramiprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14209</drugbank-id>
    <name>Trandolaprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Trandolaprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14210</drugbank-id>
    <name>Moexiprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Moexiprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14213</drugbank-id>
    <name>Perindoprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Perindoprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14217</drugbank-id>
    <name>Quinaprilat</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Quinaprilat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14231</drugbank-id>
    <name>Quinoline Yellow WS</name>
    <description>The risk or severity of angioedema can be increased when Alteplase is combined with Quinoline Yellow WS.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00203</drugbank-id>
    <name>Sildenafil</name>
    <description>The risk or severity of hemorrhage can be increased when Alteplase is combined with Sildenafil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00008</drugbank-id>
    <name>Peginterferon alfa-2a</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2a.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00011</drugbank-id>
    <name>Interferon alfa-n1</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00018</drugbank-id>
    <name>Interferon alfa-n3</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00022</drugbank-id>
    <name>Peginterferon alfa-2b</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00033</drugbank-id>
    <name>Interferon gamma-1b</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00034</drugbank-id>
    <name>Interferon alfa-2a, Recombinant</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00041</drugbank-id>
    <name>Aldesleukin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00056</drugbank-id>
    <name>Gemtuzumab ozogamicin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Gemtuzumab ozogamicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00068</drugbank-id>
    <name>Interferon beta-1b</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon beta-1b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00069</drugbank-id>
    <name>Interferon alfacon-1</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfacon-1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00073</drugbank-id>
    <name>Rituximab</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Rituximab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00078</drugbank-id>
    <name>Ibritumomab tiuxetan</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Ibritumomab tiuxetan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00087</drugbank-id>
    <name>Alemtuzumab</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Alemtuzumab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00105</drugbank-id>
    <name>Interferon alfa-2b</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2b.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00120</drugbank-id>
    <name>Phenylalanine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Phenylalanine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00188</drugbank-id>
    <name>Bortezomib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Bortezomib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00242</drugbank-id>
    <name>Cladribine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cladribine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00262</drugbank-id>
    <name>Carmustine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Carmustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00276</drugbank-id>
    <name>Amsacrine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Amsacrine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00291</drugbank-id>
    <name>Chlorambucil</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Chlorambucil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00293</drugbank-id>
    <name>Raltitrexed</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Raltitrexed.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00305</drugbank-id>
    <name>Mitomycin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Mitomycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00307</drugbank-id>
    <name>Bexarotene</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Bexarotene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00309</drugbank-id>
    <name>Vindesine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Vindesine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00322</drugbank-id>
    <name>Floxuridine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Floxuridine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00352</drugbank-id>
    <name>Tioguanine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Tioguanine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00361</drugbank-id>
    <name>Vinorelbine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Vinorelbine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00380</drugbank-id>
    <name>Dexrazoxane</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Dexrazoxane.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00398</drugbank-id>
    <name>Sorafenib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Sorafenib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00428</drugbank-id>
    <name>Streptozocin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Streptozocin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00441</drugbank-id>
    <name>Gemcitabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Gemcitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00444</drugbank-id>
    <name>Teniposide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Teniposide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00445</drugbank-id>
    <name>Epirubicin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Epirubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00446</drugbank-id>
    <name>Chloramphenicol</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Chloramphenicol.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00480</drugbank-id>
    <name>Lenalidomide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Lenalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00488</drugbank-id>
    <name>Altretamine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Altretamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00495</drugbank-id>
    <name>Zidovudine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Zidovudine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00515</drugbank-id>
    <name>Cisplatin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cisplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00526</drugbank-id>
    <name>Oxaliplatin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Oxaliplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00531</drugbank-id>
    <name>Cyclophosphamide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cyclophosphamide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00544</drugbank-id>
    <name>Fluorouracil</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Fluorouracil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00552</drugbank-id>
    <name>Pentostatin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Pentostatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00563</drugbank-id>
    <name>Methotrexate</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Methotrexate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00564</drugbank-id>
    <name>Carbamazepine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Carbamazepine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00570</drugbank-id>
    <name>Vinblastine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Vinblastine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00619</drugbank-id>
    <name>Imatinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Imatinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00631</drugbank-id>
    <name>Clofarabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Clofarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00642</drugbank-id>
    <name>Pemetrexed</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Pemetrexed.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00694</drugbank-id>
    <name>Daunorubicin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Daunorubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00762</drugbank-id>
    <name>Irinotecan</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Irinotecan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00773</drugbank-id>
    <name>Etoposide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Etoposide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00851</drugbank-id>
    <name>Dacarbazine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Dacarbazine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00853</drugbank-id>
    <name>Temozolomide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Temozolomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00859</drugbank-id>
    <name>Penicillamine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Penicillamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00864</drugbank-id>
    <name>Tacrolimus</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Tacrolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00888</drugbank-id>
    <name>Mechlorethamine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Mechlorethamine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00928</drugbank-id>
    <name>Azacitidine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Azacitidine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00958</drugbank-id>
    <name>Carboplatin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Carboplatin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00970</drugbank-id>
    <name>Dactinomycin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Dactinomycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00987</drugbank-id>
    <name>Cytarabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cytarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00997</drugbank-id>
    <name>Doxorubicin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Doxorubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01005</drugbank-id>
    <name>Hydroxyurea</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Hydroxyurea.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01008</drugbank-id>
    <name>Busulfan</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Busulfan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01030</drugbank-id>
    <name>Topotecan</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Topotecan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01033</drugbank-id>
    <name>Mercaptopurine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Mercaptopurine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01041</drugbank-id>
    <name>Thalidomide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Thalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01042</drugbank-id>
    <name>Melphalan</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Melphalan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01073</drugbank-id>
    <name>Fludarabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Fludarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01099</drugbank-id>
    <name>Flucytosine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Flucytosine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01101</drugbank-id>
    <name>Capecitabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Capecitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01169</drugbank-id>
    <name>Arsenic trioxide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Arsenic trioxide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01177</drugbank-id>
    <name>Idarubicin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Idarubicin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01204</drugbank-id>
    <name>Mitoxantrone</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Mitoxantrone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01206</drugbank-id>
    <name>Lomustine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Lomustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01229</drugbank-id>
    <name>Paclitaxel</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Paclitaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01248</drugbank-id>
    <name>Docetaxel</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Docetaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01262</drugbank-id>
    <name>Decitabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Decitabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01280</drugbank-id>
    <name>Nelarabine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Nelarabine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01590</drugbank-id>
    <name>Everolimus</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Everolimus.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB02546</drugbank-id>
    <name>Vorinostat</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Vorinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04572</drugbank-id>
    <name>Thiotepa</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Thiotepa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04845</drugbank-id>
    <name>Ixabepilone</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Ixabepilone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04868</drugbank-id>
    <name>Nilotinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Nilotinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05015</drugbank-id>
    <name>Belinostat</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Belinostat.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05109</drugbank-id>
    <name>Trabectedin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Trabectedin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05258</drugbank-id>
    <name>Interferon alfa</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05472</drugbank-id>
    <name>Human interferon omega-1</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Human interferon omega-1.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB05773</drugbank-id>
    <name>Trastuzumab emtansine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Trastuzumab emtansine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06616</drugbank-id>
    <name>Bosutinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Bosutinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06769</drugbank-id>
    <name>Bendamustine</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Bendamustine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06772</drugbank-id>
    <name>Cabazitaxel</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cabazitaxel.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08871</drugbank-id>
    <name>Eribulin</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Eribulin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08877</drugbank-id>
    <name>Ruxolitinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Ruxolitinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08889</drugbank-id>
    <name>Carfilzomib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Carfilzomib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08895</drugbank-id>
    <name>Tofacitinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Tofacitinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08901</drugbank-id>
    <name>Ponatinib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Ponatinib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB08910</drugbank-id>
    <name>Pomalidomide</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Pomalidomide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09042</drugbank-id>
    <name>Tedizolid phosphate</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Tedizolid phosphate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09052</drugbank-id>
    <name>Blinatumomab</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Blinatumomab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09073</drugbank-id>
    <name>Palbociclib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Palbociclib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09074</drugbank-id>
    <name>Olaparib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Olaparib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09077</drugbank-id>
    <name>Dinutuximab</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Dinutuximab.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09122</drugbank-id>
    <name>Peginterferon beta-1a</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon beta-1a.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB12814</drugbank-id>
    <name>Cepeginterferon alfa-2B</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Cepeginterferon alfa-2B.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00229</drugbank-id>
    <name>Cefotiam</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotiam.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00267</drugbank-id>
    <name>Cefmenoxime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmenoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00274</drugbank-id>
    <name>Cefmetazole</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefmetazole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00430</drugbank-id>
    <name>Cefpiramide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpiramide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00438</drugbank-id>
    <name>Ceftazidime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftazidime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00447</drugbank-id>
    <name>Loracarbef</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Loracarbef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00456</drugbank-id>
    <name>Cefalotin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefalotin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00493</drugbank-id>
    <name>Cefotaxime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotaxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00535</drugbank-id>
    <name>Cefdinir</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefdinir.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00567</drugbank-id>
    <name>Cephalexin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephalexin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00671</drugbank-id>
    <name>Cefixime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefixime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00689</drugbank-id>
    <name>Cephaloglycin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephaloglycin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00833</drugbank-id>
    <name>Cefaclor</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaclor.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00923</drugbank-id>
    <name>Ceforanide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceforanide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01066</drugbank-id>
    <name>Cefditoren</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefditoren.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01112</drugbank-id>
    <name>Cefuroxime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefuroxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01139</drugbank-id>
    <name>Cefapirin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefapirin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01140</drugbank-id>
    <name>Cefadroxil</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefadroxil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01150</drugbank-id>
    <name>Cefprozil</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefprozil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01212</drugbank-id>
    <name>Ceftriaxone</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftriaxone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01326</drugbank-id>
    <name>Cefamandole</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01327</drugbank-id>
    <name>Cefazolin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazolin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01328</drugbank-id>
    <name>Cefonicid</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefonicid.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01329</drugbank-id>
    <name>Cefoperazone</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoperazone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01330</drugbank-id>
    <name>Cefotetan</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotetan.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01331</drugbank-id>
    <name>Cefoxitin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefoxitin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01332</drugbank-id>
    <name>Ceftizoxime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftizoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01333</drugbank-id>
    <name>Cefradine</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefradine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01413</drugbank-id>
    <name>Cefepime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefepime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01414</drugbank-id>
    <name>Cefacetrile</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefacetrile.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01415</drugbank-id>
    <name>Ceftibuten</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftibuten.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01416</drugbank-id>
    <name>Cefpodoxime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpodoxime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04570</drugbank-id>
    <name>Latamoxef</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Latamoxef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB04918</drugbank-id>
    <name>Ceftobiprole</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftobiprole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB06590</drugbank-id>
    <name>Ceftaroline fosamil</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftaroline fosamil.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09008</drugbank-id>
    <name>Cefaloridine</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefaloridine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09050</drugbank-id>
    <name>Ceftolozane</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftolozane.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09062</drugbank-id>
    <name>Cefminox</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefminox.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11367</drugbank-id>
    <name>Cefroxadine</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefroxadine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB11935</drugbank-id>
    <name>Flomoxef</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Flomoxef.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13266</drugbank-id>
    <name>Cefatrizine</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefatrizine.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13461</drugbank-id>
    <name>Cefcapene</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefcapene.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13470</drugbank-id>
    <name>Cefodizime</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefodizime.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13499</drugbank-id>
    <name>Cefsulodin</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefsulodin.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13504</drugbank-id>
    <name>Cefetamet</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefetamet.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13638</drugbank-id>
    <name>Cefbuperazone</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefbuperazone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13667</drugbank-id>
    <name>Cefozopran</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefozopran.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13682</drugbank-id>
    <name>Cefpirome</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefpirome.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13778</drugbank-id>
    <name>Cefazedone</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefazedone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13821</drugbank-id>
    <name>Ceftezole</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Ceftezole.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB14725</drugbank-id>
    <name>Cefamandole nafate</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefamandole nafate.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00254</drugbank-id>
    <name>Doxycycline</name>
    <description>The risk or severity of bleeding can be increased when Doxycycline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00207</drugbank-id>
    <name>Azithromycin</name>
    <description>The risk or severity of adverse effects can be increased when Azithromycin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09539</drugbank-id>
    <name>Omega-3-acid ethyl esters</name>
    <description>The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00945</drugbank-id>
    <name>Acetylsalicylic acid</name>
    <description>Acetylsalicylic acid may increase the anticoagulant activities of Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01606</drugbank-id>
    <name>Tazobactam</name>
    <description>The risk or severity of bleeding can be increased when Tazobactam is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00199</drugbank-id>
    <name>Erythromycin</name>
    <description>The risk or severity of bleeding can be increased when Erythromycin is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00656</drugbank-id>
    <name>Trazodone</name>
    <description>The risk or severity of bleeding can be increased when Trazodone is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00620</drugbank-id>
    <name>Triamcinolone</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Triamcinolone.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB09079</drugbank-id>
    <name>Nintedanib</name>
    <description>The risk or severity of bleeding can be increased when Alteplase is combined with Nintedanib.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01175</drugbank-id>
    <name>Escitalopram</name>
    <description>The risk or severity of bleeding can be increased when Escitalopram is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01104</drugbank-id>
    <name>Sertraline</name>
    <description>The risk or severity of bleeding can be increased when Sertraline is combined with Alteplase.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00232</drugbank-id>
    <name>Methyclothiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Methyclothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00436</drugbank-id>
    <name>Bendroflumethiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Bendroflumethiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00562</drugbank-id>
    <name>Benzthiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Benzthiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00606</drugbank-id>
    <name>Cyclothiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00774</drugbank-id>
    <name>Hydroflumethiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydroflumethiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00880</drugbank-id>
    <name>Chlorothiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Chlorothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB00999</drugbank-id>
    <name>Hydrochlorothiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Hydrochlorothiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB01021</drugbank-id>
    <name>Trichlormethiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Trichlormethiazide.</description>
  </drug-interaction>
  <drug-interaction>
     <drugbank-id>DB01324</drugbank-id>
    <name>Polythiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Polythiazide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13430</drugbank-id>
    <name>Mebutizide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Mebutizide.</description>
  </drug-interaction>
  <drug-interaction>
    <drugbank-id>DB13532</drugbank-id>
    <name>Cyclopenthiazide</name>
    <description>The therapeutic efficacy of Alteplase can be decreased when used in combination with Cyclopenthiazide.</description>
  </drug-interaction>
</drug-interactions>
</drug>
</drugbank>